CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 1,8-naphthyridine derivative
Accession: CHEBI:73537
browse the term
Definition: Any naphthyridine derivative that is a derivative of 1,8-naphthyridine.
Synonyms: related_synonym: 1,8-naphthyridine derivatives
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions affects binding decreases activity
ISO EXP
Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine]; Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]; NADP promotes the reaction [Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]] Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] Enoxacin binds to CYP1A2 protein Enoxacin results in decreased activity of CYP1A2 protein
CTD
PMID:7946932 PMID:8905919 PMID:15905806
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Enoxacin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
affects binding
ISO
Enoxacin binds to KCNH2 protein
CTD
PMID:34058295
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
G
Nos1
nitric oxide synthase 1
multiple interactions
ISO
7-nitroindazole inhibits the reaction [[Enoxacin co-treated with fenbufen] results in increased activity of NOS1 protein]; [Enoxacin co-treated with fenbufen] results in increased activity of NOS1 protein
CTD
PMID:9623721
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Nalidixic Acid inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]
CTD
PMID:16148020
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Mmp13
matrix metallopeptidase 13
multiple interactions decreases expression
ISO
Nalidixic Acid inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA] Nalidixic Acid results in decreased expression of MMP13 mRNA
CTD
PMID:16148020
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
G
Aars1
alanyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of AARS1 mRNA
CTD
PMID:35537566
NCBI chr19:55,906,694...55,930,499
Ensembl chr19:38,999,163...39,021,147
G
Aarsd1
alanyl-tRNA synthetase domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of AARSD1 mRNA
CTD
PMID:35537566
NCBI chr10:86,340,625...86,353,732
Ensembl chr10:86,340,626...86,353,729
G
Aatk
apoptosis-associated tyrosine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of AATK mRNA
CTD
PMID:35537566
NCBI chr10:105,290,752...105,327,219
Ensembl chr10:105,291,585...105,327,112
G
Abca2
ATP binding cassette subfamily A member 2
decreases expression
ISO
trovafloxacin results in decreased expression of ABCA2 mRNA
CTD
PMID:35537566
NCBI chr 3:8,244,515...8,264,545
Ensembl chr 3:8,244,639...8,264,537
G
Abca5
ATP binding cassette subfamily A member 5
decreases expression
ISO
trovafloxacin results in decreased expression of ABCA5 mRNA
CTD
PMID:35537566
NCBI chr10:95,240,159...95,309,195
Ensembl chr10:95,240,154...95,308,976
G
Abca7
ATP binding cassette subfamily A member 7
decreases expression
ISO
trovafloxacin results in decreased expression of ABCA7 mRNA
CTD
PMID:35537566
NCBI chr 7:9,691,452...9,711,466
Ensembl chr 7:9,691,449...9,711,425
G
Abca8
ATP binding cassette subfamily A member 8
decreases expression
ISO
trovafloxacin results in decreased expression of ABCA8B mRNA
CTD
PMID:35537566
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
G
Abcb7
ATP binding cassette subfamily B member 7
decreases expression
ISO
trovafloxacin results in decreased expression of ABCB7 mRNA
CTD
PMID:35537566
NCBI chr X:69,295,598...69,436,775
Ensembl chr X:69,295,552...69,436,858
G
Abcd2
ATP binding cassette subfamily D member 2
decreases expression
ISO
trovafloxacin results in decreased expression of ABCD2 mRNA
CTD
PMID:35537566
NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:122,263,032...122,311,642
G
Abhd15
abhydrolase domain containing 15
decreases expression
ISO
trovafloxacin results in decreased expression of ABHD15 mRNA
CTD
PMID:35537566
NCBI chr10:62,363,209...62,368,600
Ensembl chr10:62,363,209...62,368,600
G
Acaca
acetyl-CoA carboxylase alpha
decreases expression
EXP
trovafloxacin results in decreased expression of ACACA mRNA
CTD
PMID:24136188
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Acap1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
decreases expression
ISO
trovafloxacin results in decreased expression of ACAP1 mRNA
CTD
PMID:35537566
NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472
G
Ackr4
atypical chemokine receptor 4
increases expression
ISO
trovafloxacin results in increased expression of ACKR4 mRNA
CTD
PMID:35537566
NCBI chr 8:104,716,537...104,720,972
Ensembl chr 8:104,716,067...104,723,617
G
Acot3
acyl-CoA thioesterase 3
decreases expression
ISO
trovafloxacin results in decreased expression of ACOT3 mRNA
CTD
PMID:35537566
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
G
Acot4
acyl-CoA thioesterase 4
decreases expression
ISO
trovafloxacin results in decreased expression of ACOT4 mRNA
CTD
PMID:35537566
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
G
Acrbp
acrosin binding protein
increases expression
ISO
trovafloxacin results in increased expression of ACRBP mRNA
CTD
PMID:35537566
NCBI chr 4:159,537,395...159,550,454
Ensembl chr 4:157,841,841...157,864,213
G
Acsf2
acyl-CoA synthetase family member 2
decreases expression
EXP
trovafloxacin results in decreased expression of ACSF2 mRNA
CTD
PMID:24136188
NCBI chr10:80,001,389...80,043,796
Ensembl chr10:79,504,511...79,546,673
G
Acsf3
acyl-CoA synthetase family member 3
decreases expression
ISO
trovafloxacin results in decreased expression of ACSF3 mRNA
CTD
PMID:35537566
NCBI chr19:50,835,116...50,875,557
Ensembl chr19:50,835,221...50,875,553
G
Acss1
acyl-CoA synthetase short-chain family member 1
decreases expression
ISO
trovafloxacin results in decreased expression of ACSS1 mRNA
CTD
PMID:35537566
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:139,450,383...139,500,325
G
Acss2
acyl-CoA synthetase short-chain family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of ACSS2 mRNA
CTD
PMID:35537566
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:144,004,336...144,059,675
G
Actb
actin, beta
decreases expression
EXP
trovafloxacin results in decreased expression of ACTB mRNA
CTD
PMID:24136188
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
G
Actg1
actin, gamma 1
decreases expression
EXP
trovafloxacin results in decreased expression of ACTG1 mRNA
CTD
PMID:24136188
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Actr3b
actin related protein 3B
decreases expression
ISO
trovafloxacin results in decreased expression of ACTR3B mRNA
CTD
PMID:35537566
NCBI chr 4:9,261,631...9,355,496
Ensembl chr 4:9,262,233...9,355,441
G
Acvrl1
activin A receptor like type 1
increases expression
ISO
trovafloxacin results in increased expression of ACVRL1 mRNA
CTD
PMID:35537566
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
G
Acy1
aminoacylase 1
decreases expression
EXP
trovafloxacin results in decreased expression of ACY1 mRNA
CTD
PMID:24136188
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
G
Adam1a
ADAM metallopeptidase domain 1a
increases expression
ISO
trovafloxacin results in increased expression of ADAM1A mRNA
CTD
PMID:35537566
NCBI chr12:35,017,433...35,020,300
Ensembl chr12:35,017,315...35,020,311
G
Adam22
ADAM metallopeptidase domain 22
increases expression
ISO
trovafloxacin results in increased expression of ADAM22 mRNA
CTD
PMID:35537566
NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962
G
Adam33
ADAM metallopeptidase domain 33
increases expression
ISO
trovafloxacin results in increased expression of ADAM33 mRNA
CTD
PMID:35537566
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
G
Adam3a
ADAM metallopeptidase domain 3A
decreases expression
ISO
trovafloxacin results in decreased expression of ADAM3 mRNA
CTD
PMID:35537566
NCBI chr16:67,299,949...67,349,970
Ensembl chr16:67,299,949...67,349,968
G
Adam8
ADAM metallopeptidase domain 8
increases expression
ISO
trovafloxacin results in increased expression of ADAM8 mRNA
CTD
PMID:35537566
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
decreases expression
ISO
trovafloxacin results in decreased expression of ADAMTS4 mRNA
CTD
PMID:35537566
NCBI chr13:86,203,011...86,212,500
Ensembl chr13:83,670,183...83,680,065
G
Adap2
ArfGAP with dual PH domains 2
increases expression decreases expression
EXP ISO
trovafloxacin results in increased expression of ADAP2 mRNA trovafloxacin results in decreased expression of ADAP2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
G
Add3
adducin 3
decreases expression
ISO
trovafloxacin results in decreased expression of ADD3 mRNA
CTD
PMID:35537566
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adgre4
adhesion G protein-coupled receptor E4
increases expression
ISO
trovafloxacin results in increased expression of ADGRE4 mRNA
CTD
PMID:35537566
NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760
G
Adgrl1
adhesion G protein-coupled receptor L1
decreases expression
ISO
trovafloxacin results in decreased expression of ADGRL1 mRNA
CTD
PMID:35537566
NCBI chr19:24,202,405...24,244,137
Ensembl chr19:24,204,360...24,244,139
G
Adgrv1
adhesion G protein-coupled receptor V1
decreases expression
ISO
trovafloxacin results in decreased expression of ADGRV1 mRNA
CTD
PMID:35537566
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
decreases expression
ISO
trovafloxacin results in decreased expression of ADH7 mRNA
CTD
PMID:35537566
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
G
Adipor2
adiponectin receptor 2
decreases expression
EXP
trovafloxacin results in decreased expression of ADIPOR2 mRNA
CTD
PMID:24136188
NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:152,524,623...152,559,355
G
Adm
adrenomedullin
decreases expression
ISO
trovafloxacin results in decreased expression of ADM mRNA
CTD
PMID:35537566
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Adra1a
adrenoceptor alpha 1A
increases expression
ISO
trovafloxacin results in increased expression of ADRA1A mRNA
CTD
PMID:35537566
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:40,832,534...40,927,500
G
Adrb2
adrenoceptor beta 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ADRB2 mRNA
CTD
PMID:18930950
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Aen
apoptosis enhancing nuclease
increases expression
ISO
trovafloxacin results in increased expression of AEN mRNA
CTD
PMID:35537566
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
G
Afap1l1
actin filament associated protein 1-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of AFAP1L1 mRNA
CTD
PMID:35537566
NCBI chr18:55,183,786...55,244,174
Ensembl chr18:55,183,786...55,244,146
G
Agbl3
AGBL carboxypeptidase 3
decreases expression
ISO
trovafloxacin results in decreased expression of AGBL3 mRNA
CTD
PMID:35537566
NCBI chr 4:63,448,789...63,535,538
Ensembl chr 4:63,453,940...63,531,188
G
Agbl5
AGBL carboxypeptidase 5
decreases expression
ISO
trovafloxacin results in decreased expression of AGBL5 mRNA
CTD
PMID:35537566
NCBI chr 6:25,472,333...25,492,173
Ensembl chr 6:25,472,333...25,490,738
G
Agl
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
decreases expression
ISO
trovafloxacin results in decreased expression of AGL mRNA
CTD
PMID:35537566
NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:204,705,053...204,760,828
G
Agmo
alkylglycerol monooxygenase
decreases expression
ISO
trovafloxacin results in decreased expression of AGMO mRNA
CTD
PMID:35537566
NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623
G
Agtpbp1
ATP/GTP binding carboxypeptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of AGTPBP1 mRNA
CTD
PMID:35537566
NCBI chr17:5,092,108...5,244,414
Ensembl chr17:5,120,609...5,238,869
G
Ahcyl1
adenosylhomocysteinase-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of AHCYL1 mRNA
CTD
PMID:35537566
NCBI chr 2:195,294,149...195,328,586
Ensembl chr 2:195,294,153...195,345,815
G
Ahi1
Abelson helper integration site 1
decreases expression
ISO
trovafloxacin results in decreased expression of AHI1 mRNA
CTD
PMID:35537566
NCBI chr 1:17,580,859...17,711,775
Ensembl chr 1:15,762,462...15,891,041
G
Ak1
adenylate kinase 1
increases expression
ISO
trovafloxacin results in increased expression of AK1 mRNA
CTD
PMID:35537566
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:15,912,485...15,923,041
G
Ak6
adenylate kinase 6
increases expression
ISO
trovafloxacin results in increased expression of AK6 mRNA
CTD
PMID:35537566
NCBI chr 2:31,794,316...31,806,375
Ensembl chr 2:31,794,519...31,806,371 Ensembl chr20:31,794,519...31,806,371
G
Akap7
A-kinase anchoring protein 7
decreases expression
ISO
trovafloxacin results in decreased expression of AKAP7 mRNA
CTD
PMID:35537566
NCBI chr 1:20,087,190...20,217,799
Ensembl chr 1:20,087,373...20,217,797
G
Akna
AT-hook transcription factor
decreases expression
ISO
trovafloxacin results in decreased expression of AKNA mRNA
CTD
PMID:35537566
NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017
G
Akr1b7
aldo-keto reductase family 1, member B7
decreases expression
ISO
trovafloxacin results in decreased expression of AKR1B7 mRNA
CTD
PMID:35537566
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
G
Akr7a3
aldo-keto reductase family 7 member A3
decreases expression
EXP
trovafloxacin results in decreased expression of AKR7A3 mRNA
CTD
PMID:24136188
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation multiple interactions
ISO
trovafloxacin results in increased phosphorylation of AKT1 protein TNF protein promotes the reaction [trovafloxacin results in increased phosphorylation of AKT1 protein]
CTD
PMID:33609687
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Aldh16a1
aldehyde dehydrogenase 16 family, member A1
decreases expression
ISO
trovafloxacin results in decreased expression of ALDH16A1 mRNA
CTD
PMID:35537566
NCBI chr 1:95,626,727...95,639,808
Ensembl chr 1:95,613,558...95,640,131
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
decreases expression
ISO
trovafloxacin results in decreased expression of ALDH18A1 mRNA
CTD
PMID:35537566
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression
EXP
trovafloxacin results in decreased expression of ALDH1A1 mRNA
CTD
PMID:24136188
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
decreases expression
EXP
trovafloxacin results in decreased expression of ALDH1B1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
decreases expression
ISO
trovafloxacin results in decreased expression of ALDH1L2 mRNA
CTD
PMID:35537566
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
G
Alkbh4
alkB homolog 4, lysine demethylase
increases expression
ISO
trovafloxacin results in increased expression of ALKBH4 mRNA
CTD
PMID:35537566
NCBI chr12:20,524,030...20,529,947
Ensembl chr12:20,524,030...20,529,947
G
Alms1
ALMS1, centrosome and basal body associated protein
decreases expression
ISO
trovafloxacin results in decreased expression of ALMS1 mRNA
CTD
PMID:35537566
NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:118,125,607...118,226,005
G
Amacr
alpha-methylacyl-CoA racemase
decreases expression
ISO
trovafloxacin results in decreased expression of AMACR mRNA
CTD
PMID:35537566
NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:59,946,153...59,958,255
G
Amd1
adenosylmethionine decarboxylase 1
decreases expression
EXP
trovafloxacin results in decreased expression of AMD1 mRNA
CTD
PMID:24136188
NCBI chr20:45,250,289...45,324,939
Ensembl chr20:43,697,237...43,711,476
G
Amdhd2
amidohydrolase domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of AMDHD2 mRNA
CTD
PMID:35537566
NCBI chr10:13,692,136...13,700,632
Ensembl chr10:13,187,578...13,196,095
G
Amh
anti-Mullerian hormone
increases expression
ISO
trovafloxacin results in increased expression of AMH mRNA
CTD
PMID:35537566
NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:8,906,836...8,909,282
G
Amigo3
adhesion molecule with Ig like domain 3
increases expression
ISO
trovafloxacin results in increased expression of AMIGO3 mRNA
CTD
PMID:35537566
NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:108,693,060...108,744,555
G
Ammecr1l
AMMECR1 like
increases expression
EXP
trovafloxacin results in increased expression of AMMECR1L mRNA
CTD
PMID:24136188
NCBI chr18:23,386,114...23,411,177
Ensembl chr18:23,386,903...23,410,920
G
Amotl1
angiomotin-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of AMOTL1 mRNA
CTD
PMID:35537566
NCBI chr 8:11,348,651...11,467,564
Ensembl chr 8:11,353,674...11,467,573
G
Amotl2
angiomotin like 2
decreases expression
ISO
trovafloxacin results in decreased expression of AMOTL2 mRNA
CTD
PMID:35537566
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
G
Amz1
archaelysin family metallopeptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of AMZ1 mRNA
CTD
PMID:35537566
NCBI chr12:13,886,518...13,924,275
Ensembl chr12:13,891,123...13,909,783
G
Anapc1
anaphase promoting complex subunit 1
decreases expression
ISO
trovafloxacin results in decreased expression of ANAPC1 mRNA
CTD
PMID:35537566
NCBI chr 3:115,850,117...115,930,259
Ensembl chr 3:115,850,185...115,930,273
G
Anapc5
anaphase-promoting complex subunit 5
decreases expression
ISO
trovafloxacin results in decreased expression of ANAPC5 mRNA
CTD
PMID:35537566
NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781
G
Ang
angiogenin
decreases expression
ISO
trovafloxacin results in decreased expression of ANG mRNA
CTD
PMID:35537566
NCBI chr15:26,786,233...26,796,883
G
Angel1
angel homolog 1
decreases expression
ISO
trovafloxacin results in decreased expression of ANGEL1 mRNA
CTD
PMID:35537566
NCBI chr 6:106,349,125...106,386,202
Ensembl chr 6:106,349,126...106,386,209
G
Angel2
angel homolog 2
decreases expression
ISO
trovafloxacin results in decreased expression of ANGEL2 mRNA
CTD
PMID:35537566
NCBI chr13:102,509,111...102,529,501
Ensembl chr13:102,510,589...102,529,493
G
Angptl3
angiopoietin-like 3
increases expression
ISO
trovafloxacin results in increased expression of ANGPTL3 mRNA
CTD
PMID:35537566
NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:113,703,012...113,709,957
G
Angptl4
angiopoietin-like 4
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ANGPTL4 mRNA
CTD
PMID:18930950
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Angptl6
angiopoietin-like 6
decreases expression
ISO
trovafloxacin results in decreased expression of ANGPTL6 mRNA
CTD
PMID:35537566
NCBI chr 8:27,689,804...27,696,172
Ensembl chr 8:19,413,619...19,419,925
G
Ankle1
ankyrin repeat and LEM domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of ANKLE1 mRNA
CTD
PMID:35537566
NCBI chr16:18,076,413...18,082,356
Ensembl chr16:18,076,492...18,083,729
G
Ankrd23
ankyrin repeat domain 23
increases expression
ISO
trovafloxacin results in increased expression of ANKRD23 mRNA
CTD
PMID:35537566
NCBI chr 9:46,269,107...46,274,578
Ensembl chr 9:38,773,240...38,779,839
G
Ankrd55
ankyrin repeat domain 55
decreases expression
ISO
trovafloxacin results in decreased expression of ANKRD55 mRNA
CTD
PMID:35537566
NCBI chr 2:45,617,011...45,717,086
Ensembl chr 2:43,883,857...43,983,680
G
Ankzf1
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ANKZF1 mRNA
CTD
PMID:35537566
NCBI chr 9:76,688,194...76,695,162
Ensembl chr 9:76,688,194...76,696,469
G
Anln
anillin, actin binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of ANLN mRNA
CTD
PMID:35537566
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
G
Ano7
anoctamin 7
increases expression
ISO
trovafloxacin results in increased expression of ANO7 mRNA
CTD
PMID:35537566
NCBI chr 9:93,917,524...93,945,323
Ensembl chr 9:93,917,524...93,945,323
G
Antkmt
adenine nucleotide translocase lysine methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of FAM173A mRNA
CTD
PMID:35537566
NCBI chr10:14,812,274...14,814,798
Ensembl chr10:14,812,269...14,814,193
G
Antxr2
ANTXR cell adhesion molecule 2
increases expression
ISO
trovafloxacin results in increased expression of ANTXR2 mRNA
CTD
PMID:35537566
NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094
G
Anxa9
annexin A9
decreases expression
ISO
trovafloxacin results in decreased expression of ANXA9 mRNA
CTD
PMID:35537566
NCBI chr 2:182,873,185...182,884,501
Ensembl chr 2:182,872,929...182,883,374
G
Ap1g2
adaptor related protein complex 1 subunit gamma 2
decreases expression
ISO
trovafloxacin results in decreased expression of AP1G2 mRNA
CTD
PMID:35537566
NCBI chr15:28,571,571...28,579,421
Ensembl chr15:28,571,568...28,589,004
G
Ap1s1
adaptor related protein complex 1 subunit sigma 1
decreases expression
EXP
trovafloxacin results in decreased expression of AP1S1 mRNA
CTD
PMID:24136188
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
G
Ap5z1
adaptor related protein complex 5 subunit zeta 1
decreases expression
ISO
trovafloxacin results in decreased expression of AP5Z1 mRNA
CTD
PMID:35537566
NCBI chr12:17,207,315...17,222,975
Ensembl chr12:12,093,834...12,108,511
G
Apbb3
amyloid beta precursor protein binding family B member 3
increases expression
ISO
trovafloxacin results in increased expression of APBB3 mRNA
CTD
PMID:35537566
NCBI chr18:28,273,168...28,280,347
Ensembl chr18:28,270,545...28,280,094
G
Apc2
APC regulator of WNT signaling pathway 2
increases expression
ISO
trovafloxacin results in increased expression of APC2 mRNA
CTD
PMID:35537566
NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:9,392,336...9,414,310
G
Apeh
acylaminoacyl-peptide hydrolase
decreases expression
ISO
trovafloxacin results in decreased expression of APEH mRNA
CTD
PMID:35537566
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of APEX1 mRNA
CTD
PMID:18930950
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
G
Apex2
apurinic/apyrimidinic endodeoxyribonuclease 2
increases expression
ISO
trovafloxacin results in increased expression of APEX2 mRNA
CTD
PMID:35537566
NCBI chr X:19,425,684...19,508,459
Ensembl chr X:19,487,419...19,508,439
G
Apoa5
apolipoprotein A5
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of APOA5 mRNA
CTD
PMID:18930950
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:46,561,229...46,563,816
G
Apoe
apolipoprotein E
increases expression
ISO
trovafloxacin results in increased expression of APOE mRNA
CTD
PMID:35537566
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Aqp9
aquaporin 9
decreases expression
ISO
trovafloxacin results in decreased expression of AQP9 mRNA
CTD
PMID:35537566
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:71,797,234...71,837,395
G
Arf2
ADP-ribosylation factor 2
increases expression
ISO
trovafloxacin results in increased expression of ARF2 mRNA
CTD
PMID:35537566
NCBI chr10:89,367,843...89,389,644
Ensembl chr10:88,867,836...88,889,659
G
Arhgap19
Rho GTPase activating protein 19
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGAP19 mRNA
CTD
PMID:35537566
NCBI chr 1:240,571,554...240,617,361
Ensembl chr 1:240,580,871...240,617,287
G
Arhgap24
Rho GTPase activating protein 24
decreases expression
EXP
trovafloxacin results in decreased expression of ARHGAP24 mRNA
CTD
PMID:24136188
NCBI chr14:6,800,624...7,183,877
Ensembl chr14:6,800,631...7,183,823
G
Arhgap26
Rho GTPase activating protein 26
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGAP26 mRNA
CTD
PMID:35537566
NCBI chr18:30,702,602...31,489,047
Ensembl chr18:30,838,671...31,235,194
G
Arhgap33
Rho GTPase activating protein 33
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGAP33 mRNA
CTD
PMID:35537566
NCBI chr 1:85,776,112...85,789,767
Ensembl chr 1:85,776,108...85,789,678
G
Arhgap6
Rho GTPase activating protein 6
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGAP6 mRNA
CTD
PMID:35537566
NCBI chr X:24,953,464...25,490,003
Ensembl chr X:24,953,464...25,488,663
G
Arhgef17
Rho guanine nucleotide exchange factor 17
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGEF17 mRNA
CTD
PMID:35537566
NCBI chr 1:155,230,607...155,290,163
Ensembl chr 1:155,233,168...155,290,498
G
Arhgef3
Rho guanine nucleotide exchange factor 3
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGEF3 mRNA
CTD
PMID:35537566
NCBI chr16:2,301,573...2,581,951
Ensembl chr16:2,300,138...2,581,945
G
Arhgef39
Rho guanine nucleotide exchange factor 39
decreases expression
ISO
trovafloxacin results in decreased expression of ARHGEF39 mRNA
CTD
PMID:35537566
NCBI chr 5:57,752,509...57,756,079
Ensembl chr 5:57,752,509...57,756,109
G
Arid5a
AT-rich interaction domain 5A
decreases expression
ISO
trovafloxacin results in decreased expression of ARID5A mRNA
CTD
PMID:35537566
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
G
Arid5b
AT-rich interaction domain 5B
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ARID5B mRNA
CTD
PMID:18930950
NCBI chr20:20,305,693...20,489,689
Ensembl chr20:20,307,731...20,487,433
G
Arl10
ARF like GTPase 10
increases expression
ISO
trovafloxacin results in increased expression of ARL10 mRNA
CTD
PMID:35537566
NCBI chr17:10,030,213...10,038,625
Ensembl chr17:10,030,213...10,038,703
G
Arl11
ARF like GTPase 11
decreases expression
ISO
trovafloxacin results in decreased expression of ARL11 mRNA
CTD
PMID:35537566
NCBI chr15:39,659,404...39,661,651
Ensembl chr15:35,480,018...35,496,596
G
Arl4c
ARF like GTPase 4C
decreases expression
ISO
trovafloxacin results in decreased expression of ARL4C mRNA
CTD
PMID:35537566
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
G
Arl4d
ARF like GTPase 4D
increases expression
ISO
trovafloxacin results in increased expression of ARL4D mRNA
CTD
PMID:35537566
NCBI chr10:87,092,276...87,103,079
Ensembl chr10:86,595,661...86,602,836
G
Arl6ip5
ARF like GTPase 6 interacting protein 5
increases expression
ISO
trovafloxacin results in increased expression of ARL6IP5 mRNA
CTD
PMID:35537566
NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:129,810,645...129,838,608
G
Armc2
armadillo repeat containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of ARMC2 mRNA
CTD
PMID:35537566
NCBI chr20:45,395,859...45,501,808
Ensembl chr20:45,394,127...45,504,819
G
Armc7
armadillo repeat containing 7
increases expression
ISO
trovafloxacin results in increased expression of ARMC7 mRNA
CTD
PMID:35537566
NCBI chr10:100,723,080...100,739,636
Ensembl chr10:100,723,105...100,739,636
G
Armt1
acidic residue methyltransferase 1
decreases expression
EXP
trovafloxacin results in decreased expression of ARMT1 mRNA
CTD
PMID:24136188
NCBI chr 1:40,894,558...40,918,302
Ensembl chr 1:40,894,550...40,918,302
G
Arrb1
arrestin, beta 1
decreases expression
ISO
trovafloxacin results in decreased expression of ARRB1 mRNA
CTD
PMID:35537566
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
G
Arsa
arylsulfatase A
decreases expression
ISO
trovafloxacin results in decreased expression of ARSA mRNA
CTD
PMID:35537566
NCBI chr 7:122,422,971...122,426,971
Ensembl chr 7:120,543,362...120,548,783
G
Arv1
ARV1 homolog, fatty acid homeostasis modulator
increases expression
ISO
trovafloxacin results in increased expression of ARV1 mRNA
CTD
PMID:35537566
NCBI chr19:52,692,337...52,704,156
Ensembl chr19:52,692,337...52,704,156
G
Asb10
ankyrin repeat and SOCS box-containing 10
decreases expression
ISO
trovafloxacin results in decreased expression of ASB10 mRNA
CTD
PMID:35537566
NCBI chr 4:10,630,318...10,644,270
Ensembl chr 4:10,630,448...10,639,060
G
Asb6
ankyrin repeat and SOCS box-containing 6
increases expression
ISO
trovafloxacin results in increased expression of ASB6 mRNA
CTD
PMID:35537566
NCBI chr 3:14,110,628...14,115,274
Ensembl chr 3:14,110,628...14,115,242
G
Asf1b
anti-silencing function 1B histone chaperone
decreases expression
ISO
trovafloxacin results in decreased expression of ASF1B mRNA
CTD
PMID:35537566
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
ISO
trovafloxacin results in decreased expression of ASNS mRNA
CTD
PMID:35537566
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:35,785,237...35,803,423
G
Aspm
assembly factor for spindle microtubules
decreases expression
ISO
trovafloxacin results in decreased expression of ASPM mRNA
CTD
PMID:35537566
NCBI chr13:53,625,584...53,674,489
Ensembl chr13:51,074,849...51,123,755
G
Aspscr1
ASPSCR1 tether for SLC2A4, UBX domain containing
decreases expression
ISO
trovafloxacin results in decreased expression of ASPSCR1 mRNA
CTD
PMID:35537566
NCBI chr10:105,952,215...105,990,059
Ensembl chr10:105,952,227...105,989,904
G
Asrgl1
asparaginase and isoaspartyl peptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ASRGL1 mRNA
CTD
PMID:35537566
NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:206,006,109...206,027,108
G
Atf2
activating transcription factor 2
multiple interactions increases phosphorylation
ISO
pyrazolanthrone inhibits the reaction [trovafloxacin results in increased phosphorylation of ATF2 protein]
CTD
PMID:24525298
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:58,718,332...58,795,236
G
Atf4
activating transcription factor 4
decreases expression
ISO
trovafloxacin results in decreased expression of ATF4 mRNA
CTD
PMID:35537566
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Atf5
activating transcription factor 5
decreases expression
ISO
trovafloxacin results in decreased expression of ATF5 mRNA
CTD
PMID:35537566
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atg10
autophagy related 10
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased expression of ATG10 mRNA
CTD
PMID:33609687
NCBI chr 2:23,843,695...24,133,459
Ensembl chr 2:22,108,426...22,398,233
G
Atg101
autophagy related 101
increases expression
ISO
trovafloxacin results in increased expression of ATG101 mRNA
CTD
PMID:33609687
NCBI chr 7:134,277,223...134,286,387
Ensembl chr 7:132,398,483...132,407,633
G
Atg12
autophagy related 12
increases expression
ISO
trovafloxacin results in increased expression of ATG12 mRNA
CTD
PMID:33609687 PMID:35537566
NCBI chr18:41,638,841...41,649,311
Ensembl chr18:39,452,191...39,462,418
G
Atg14
autophagy related 14
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG14 mRNA TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG14 mRNA]
CTD
PMID:33609687
NCBI chr15:23,275,457...23,306,817
Ensembl chr15:20,795,750...20,827,113
G
Atg16l1
autophagy related 16-like 1
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG16L1 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ATG16L1 mRNA
CTD
PMID:33609687
NCBI chr 9:95,869,839...95,905,354
Ensembl chr 9:88,422,038...88,457,529
G
Atg16l2
autophagy related 16-like 2
decreases expression
ISO
trovafloxacin results in decreased expression of ATG16L2 mRNA
CTD
PMID:33609687
NCBI chr 1:165,100,946...165,123,307
Ensembl chr 1:155,684,564...155,703,420
G
Atg2a
autophagy related 2A
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased expression of ATG2A mRNA
CTD
PMID:33609687
NCBI chr 1:212,971,822...212,991,505
Ensembl chr 1:203,542,559...203,562,242
G
Atg2b
autophagy related 2B
increases expression
ISO
trovafloxacin results in increased expression of ATG2B mRNA
CTD
PMID:33609687
NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:124,525,523...124,592,015
G
Atg3
autophagy related 3
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG3 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ATG3 mRNA
CTD
PMID:33609687
NCBI chr11:69,130,948...69,159,280
Ensembl chr11:55,624,917...55,653,224
G
Atg4a
autophagy related 4A, cysteine peptidase
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG4A mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ATG4A mRNA
CTD
PMID:33609687
NCBI chr X:109,453,712...109,553,758
Ensembl chr X:104,665,345...104,765,268
G
Atg4c
autophagy related 4C, cysteine peptidase
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in decreased expression of ATG4C mRNA
CTD
PMID:33609687
NCBI chr 5:118,977,594...119,050,894
Ensembl chr 5:113,867,092...113,934,830
G
Atg5
autophagy related 5
affects response to substance multiple interactions increases expression
ISO
ATG5 protein affects the susceptibility to trovafloxacin ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of CASP3 protein]; ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of PARP1 protein]; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK1 protein]; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK3 protein]; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK8 protein]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG5 mRNA]
CTD
PMID:33609687
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:47,798,290...47,889,209
G
Atg9b
autophagy related 9B
increases expression multiple interactions
ISO
trovafloxacin results in increased expression of ATG9B mRNA TNF protein promotes the reaction [trovafloxacin results in increased expression of ATG9B mRNA]; trovafloxacin promotes the reaction [TNF protein results in increased expression of ATG9B mRNA]
CTD
PMID:33609687
NCBI chr 4:11,678,548...11,686,097
Ensembl chr 4:10,786,114...10,793,651
G
Atm
ATM serine/threonine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of ATM mRNA
CTD
PMID:35537566
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Atosb
atos homolog B
increases expression
ISO
trovafloxacin results in increased expression of ATOSB mRNA
CTD
PMID:35537566
NCBI chr 5:57,260,839...57,274,524
Ensembl chr 5:57,260,841...57,268,892
G
Atp11c
ATPase phospholipid transporting 11C
decreases expression
ISO
trovafloxacin results in decreased expression of ATP11C mRNA
CTD
PMID:35537566
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
decreases expression
ISO
trovafloxacin results in decreased expression of ATP1A3 mRNA
CTD
PMID:35537566
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:80,572,796...80,601,918
G
Atp5mc3
ATP synthase membrane subunit c locus 3
increases expression
ISO
trovafloxacin results in increased expression of ATP5MC3 mRNA
CTD
PMID:35537566
NCBI chr 3:79,218,014...79,220,664
Ensembl chr 3:58,810,535...58,814,279
G
Atp5me
ATP synthase membrane subunit e
increases expression
ISO
trovafloxacin results in increased expression of ATP5ME mRNA
CTD
PMID:35537566
NCBI chr14:1,319,868...1,320,996
Ensembl chr14:1,319,868...1,321,013
G
Atp5mk
ATP synthase membrane subunit K
increases expression
ISO
trovafloxacin results in increased expression of ATP5MK mRNA
CTD
PMID:35537566
NCBI chr 1:245,973,910...245,980,702
Ensembl chr 1:245,973,914...245,980,761 Ensembl chr10:245,973,914...245,980,761
G
Atp6v0e2
ATPase, H+ transporting V0 subunit e2
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of ATP6V0E2 mRNA trovafloxacin results in increased expression of ATP6V0E2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:77,482,226...77,488,777
G
Atp8a1
ATPase phospholipid transporting 8A1
decreases expression
ISO
trovafloxacin results in decreased expression of ATP8A1 mRNA
CTD
PMID:35537566
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
G
Atr
ATR serine/threonine kinase
multiple interactions decreases expression
ISO
4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased phosphorylation of ATR protein]; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of and results in increased activity of ATR protein; trovafloxacin results in increased phosphorylation of and results in increased activity of ATR protein; U 0126 inhibits the reaction [trovafloxacin results in increased activity of ATR protein] trovafloxacin results in decreased expression of ATR mRNA
CTD
PMID:25748550 PMID:35537566
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
Atrn
attractin
increases expression
EXP
trovafloxacin results in increased expression of ATRN mRNA
CTD
PMID:24136188
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
G
Atxn7l3b
ataxin 7-like 3B
increases expression
ISO
trovafloxacin results in increased expression of ATXN7L3B mRNA
CTD
PMID:35537566
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
G
Aunip
aurora kinase A and ninein interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of AUNIP mRNA
CTD
PMID:35537566
NCBI chr 5:146,722,329...146,734,924
Ensembl chr 5:146,722,337...146,736,501
G
Aurka
aurora kinase A
decreases expression
ISO
trovafloxacin results in decreased expression of AURKA mRNA
CTD
PMID:35537566
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
decreases expression
ISO
trovafloxacin results in decreased expression of AURKB mRNA
CTD
PMID:35537566
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:53,745,142...53,750,837
G
B2m
beta-2 microglobulin
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of B2M mRNA
CTD
PMID:18930950
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:109,095,729...109,101,766
G
B4galnt2
beta-1,4-N-acetyl-galactosaminyl transferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of B4GALNT2 mRNA
CTD
PMID:35537566
NCBI chr10:81,298,338...81,324,738
Ensembl chr10:80,802,941...80,857,700
G
Baiap2l1
BAR/IMD domain containing adaptor protein 2 like 1
decreases expression
ISO
trovafloxacin results in decreased expression of BAIAP2L1 mRNA
CTD
PMID:35537566
NCBI chr12:15,364,090...15,453,602
Ensembl chr12:10,250,473...10,339,928
G
Bard1
BRCA1 associated RING domain 1
decreases expression
ISO
trovafloxacin results in decreased expression of BARD1 mRNA
CTD
PMID:35537566
NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:72,623,155...72,694,265
G
Batf2
basic leucine zipper ATF-like transcription factor 2
increases expression
ISO
trovafloxacin results in increased expression of BATF2 mRNA
CTD
PMID:35537566
NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889
G
Bbs9
Bardet-Biedl syndrome 9
increases expression
ISO
trovafloxacin results in increased expression of BBS9 mRNA
CTD
PMID:35537566
NCBI chr 8:21,013,865...21,437,934
Ensembl chr 8:21,013,944...21,437,930
G
Bcar3
BCAR3 adaptor protein, NSP family member
increases expression
ISO
trovafloxacin results in increased expression of BCAR3 mRNA
CTD
PMID:35537566
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
G
Bcat1
branched chain amino acid transaminase 1
decreases expression
ISO
trovafloxacin results in decreased expression of BCAT1 mRNA
CTD
PMID:35537566
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:177,964,834...178,046,597
G
Bcdin3d
BCDIN3 domain containing RNA methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of BCDIN3D mRNA
CTD
PMID:35537566
NCBI chr 7:130,605,540...130,610,134
Ensembl chr 7:130,605,541...130,610,115
G
Bco2
beta-carotene oxygenase 2
decreases expression
ISO
trovafloxacin results in decreased expression of BCO2 mRNA
CTD
PMID:35537566
NCBI chr 8:50,882,174...50,907,676
Ensembl chr 8:50,882,181...50,915,467
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
increases expression
ISO
trovafloxacin results in increased expression of BDH1 mRNA
CTD
PMID:35537566
NCBI chr11:82,806,125...82,848,133
Ensembl chr11:69,302,534...69,337,671
G
Bdh2
3-hydroxybutyrate dehydrogenase 2
increases expression
ISO
trovafloxacin results in increased expression of BDH2 mRNA
CTD
PMID:35537566
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
G
Bend6
BEN domain containing 6
decreases expression
ISO
trovafloxacin results in decreased expression of BEND6 mRNA
CTD
PMID:35537566
NCBI chr 9:36,081,033...36,135,309
Ensembl chr 9:36,081,484...36,135,228
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
increases expression
ISO
trovafloxacin results in increased expression of BET1L mRNA
CTD
PMID:35537566
NCBI chr 1:205,361,041...205,365,036
Ensembl chr 1:195,931,411...195,935,040
G
Bhlhe40
basic helix-loop-helix family, member e40
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BHLHE40 mRNA
CTD
PMID:18930950
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions decreases expression
ISO
trovafloxacin inhibits the reaction [TNF protein results in increased expression of BIRC2 mRNA] trovafloxacin results in decreased expression of BIRC2 mRNA [trovafloxacin co-treated with TNF protein] results in decreased expression of BIRC2 mRNA trovafloxacin results in decreased expression of BIRC2 protein
CTD
PMID:32035082
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of BIRC3 mRNA trovafloxacin results in decreased expression of BIRC3 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of BIRC3 mRNA
CTD
PMID:18930950 PMID:32035082
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
trovafloxacin results in decreased expression of BIRC5 mRNA
CTD
PMID:35537566
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Blm
BLM RecQ like helicase
decreases expression
ISO
trovafloxacin results in decreased expression of BLM mRNA
CTD
PMID:35537566
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:134,409,857...134,484,312
G
Bloc1s2
biogenesis of lysosomal organelles complex-1, subunit 2
increases expression
ISO
trovafloxacin results in increased expression of BLOC1S2 mRNA
CTD
PMID:35537566
NCBI chr 1:252,973,818...252,980,873
Ensembl chr 1:243,024,614...243,031,653
G
Blzf1
basic leucine zipper nuclear factor 1
increases expression
ISO
trovafloxacin results in increased expression of BLZF1 mRNA
CTD
PMID:35537566
NCBI chr13:76,641,757...76,656,977
Ensembl chr13:76,641,515...76,656,999
G
Bmf
Bcl2 modifying factor
decreases expression
ISO
trovafloxacin results in decreased expression of BMF mRNA
CTD
PMID:35537566
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
G
Bok
BCL2 family apoptosis regulator BOK
decreases expression
ISO
trovafloxacin results in decreased expression of BOK mRNA
CTD
PMID:35537566
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
G
Bora
bora, aurora kinase A activator
decreases expression
ISO
trovafloxacin results in decreased expression of BORA mRNA
CTD
PMID:35537566
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
G
Borcs5
BLOC-1 related complex subunit 5
decreases expression
ISO
trovafloxacin results in decreased expression of BORCS5 mRNA
CTD
PMID:35537566
NCBI chr 4:167,458,640...167,543,556
Ensembl chr 4:167,473,177...167,540,993
G
Bphl
biphenyl hydrolase like
decreases expression
ISO
trovafloxacin results in decreased expression of BPHL mRNA
CTD
PMID:35537566
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
G
Bpnt1
3'(2'), 5'-bisphosphate nucleotidase 1
decreases expression
EXP
trovafloxacin results in decreased expression of BPNT1 mRNA
CTD
PMID:24136188
NCBI chr13:99,397,127...99,425,056
Ensembl chr13:96,868,580...96,893,503
G
Brca1
BRCA1, DNA repair associated
decreases expression
ISO
trovafloxacin results in decreased expression of BRCA1 mRNA
CTD
PMID:35537566
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,418,000...86,477,304
G
Brca2
BRCA2, DNA repair associated
decreases expression
ISO
trovafloxacin results in decreased expression of BRCA2 mRNA
CTD
PMID:35537566
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:59,819...100,567
G
Brd2
bromodomain containing 2
increases expression
ISO
trovafloxacin results in increased expression of BRD2 mRNA
CTD
PMID:35537566
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
G
Brdt
bromodomain testis associated
decreases expression
ISO
trovafloxacin results in decreased expression of BRDT mRNA
CTD
PMID:35537566
NCBI chr14:2,387,372...2,445,857
Ensembl chr14:2,387,796...2,445,842
G
Brip1
BRCA1 interacting DNA helicase 1
decreases expression
ISO
trovafloxacin results in decreased expression of BRIP1 mRNA
CTD
PMID:35537566
NCBI chr10:71,402,035...71,528,083
Ensembl chr10:70,907,371...71,030,324
G
Bsdc1
BSD domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of BSDC1 mRNA
CTD
PMID:35537566
NCBI chr 5:141,798,918...141,827,091
Ensembl chr 5:141,798,981...141,827,092
G
Bst2
bone marrow stromal cell antigen 2
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of BST2 mRNA trovafloxacin results in increased expression of BST2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,217,407...18,220,979
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of BUB1 mRNA
CTD
PMID:35537566
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
ISO
trovafloxacin results in decreased expression of BUB1B mRNA
CTD
PMID:35537566
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:105,563,138...105,615,547
G
C11h21orf91
similar to human chromosome 21 open reading frame 91
decreases expression
ISO
trovafloxacin results in decreased expression of D16ERTD472E mRNA
CTD
PMID:35537566
NCBI chr11:17,229,129...17,262,307
Ensembl chr11:17,229,138...17,262,483
G
C1d
C1D nuclear receptor corepressor
increases expression
ISO
trovafloxacin results in increased expression of C1D mRNA
CTD
PMID:35537566
NCBI chr14:91,660,951...91,673,177
Ensembl chr14:91,660,989...91,672,852
G
C1qtnf12
C1q and TNF related 12
increases expression
ISO
trovafloxacin results in increased expression of FAM132A mRNA
CTD
PMID:35537566
NCBI chr 5:166,551,628...166,556,003
Ensembl chr 5:166,551,628...166,556,003
G
C1qtnf6
C1q and TNF related 6
decreases expression
ISO
trovafloxacin results in decreased expression of C1QTNF6 mRNA
CTD
PMID:35537566
NCBI chr 7:111,958,348...111,964,948
Ensembl chr 7:110,077,878...110,084,412
G
C1rl
complement C1r subcomponent like
decreases expression
ISO
trovafloxacin results in decreased expression of C1RL mRNA
CTD
PMID:35537566
NCBI chr 4:157,394,183...157,410,771
Ensembl chr 4:157,394,200...157,410,134
G
C2cd5
C2 calcium-dependent domain containing 5
decreases expression
ISO
trovafloxacin results in decreased expression of C2CD5 mRNA
CTD
PMID:35537566
NCBI chr 4:175,969,544...176,055,597
Ensembl chr 4:175,969,545...176,055,558
G
C2h4orf33
similar to human chromosome 4 open reading frame 33
decreases expression
ISO
trovafloxacin results in decreased expression of D3ERTD751E mRNA
CTD
PMID:35537566
NCBI chr 2:124,764,263...124,830,001
Ensembl chr 2:124,769,940...124,832,449
G
C5h1orf50
similar to human chromosome 1 open reading frame 50
increases expression
EXP
trovafloxacin results in increased expression of C5H1ORF50 mRNA
CTD
PMID:24136188
NCBI chr 5:132,837,135...132,841,744
Ensembl chr 5:132,836,506...132,841,762
G
C5l1
complement C5 like 1
increases expression
EXP
trovafloxacin results in increased expression of C5L1 mRNA
CTD
PMID:24136188
NCBI chr 3:18,401,716...18,420,064
Ensembl chr 3:18,404,899...18,420,054
G
C8h11orf54
similar to human chromosome 11 open reading frame 54
decreases expression
EXP
trovafloxacin results in decreased expression of C8H11ORF54 mRNA
CTD
PMID:24136188
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
decreases expression
ISO
trovafloxacin results in decreased expression of CACNA1D mRNA
CTD
PMID:35537566
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,228,306...5,668,215
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
decreases expression
ISO
trovafloxacin results in decreased expression of CAD mRNA
CTD
PMID:35537566
NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:25,292,133...25,319,861
G
Calhm2
calcium homeostasis modulator family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of CALHM2 mRNA
CTD
PMID:35537566
NCBI chr 1:246,022,324...246,028,050
Ensembl chr 1:246,022,324...246,028,218
G
Calhm6
calcium homeostasis modulator family member 6
decreases expression
ISO
trovafloxacin results in decreased expression of FAM26F mRNA
CTD
PMID:35537566
NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278
G
Camkk2
calcium/calmodulin-dependent protein kinase kinase 2
decreases expression
ISO
trovafloxacin results in decreased expression of CAMKK2 mRNA
CTD
PMID:35537566
NCBI chr12:39,451,828...39,505,719
Ensembl chr12:33,791,052...33,843,279
G
Camsap3
calmodulin regulated spectrin-associated protein family, member 3
increases expression
ISO
trovafloxacin results in increased expression of CAMSAP3 mRNA
CTD
PMID:35537566
NCBI chr12:6,440,959...6,464,582
Ensembl chr12:1,643,251...1,666,685
G
Caprin1
cell cycle associated protein 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CAPRIN1 mRNA
CTD
PMID:18930950
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
G
Car12
carbonic anhydrase 12
decreases expression
ISO
trovafloxacin results in decreased expression of CAR12 mRNA
CTD
PMID:35537566
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Car7
carbonic anhydrase 7
decreases expression
ISO
trovafloxacin results in decreased expression of CAR7 mRNA
CTD
PMID:35537566
NCBI chr19:429,063...438,478
Ensembl chr19:429,075...438,467
G
Card11
caspase recruitment domain family, member 11
decreases expression
ISO
trovafloxacin results in decreased expression of CARD11 mRNA
CTD
PMID:35537566
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
G
Carmil2
capping protein regulator and myosin 1 linker 2
increases expression
ISO
trovafloxacin results in increased expression of RLTPR mRNA
CTD
PMID:35537566
NCBI chr19:33,571,255...33,586,783
Ensembl chr19:33,574,257...33,586,965
G
Cars1
cysteinyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of CARS1 mRNA
CTD
PMID:35537566
NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:198,753,691...198,795,941
G
Casd1
CAS1 domain containing 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CASD1 mRNA
CTD
PMID:18930950
NCBI chr 4:32,659,196...32,739,228
Ensembl chr 4:32,658,748...32,739,202
G
Casp3
caspase 3
multiple interactions increases activity increases cleavage
ISO
[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [trovafloxacin results in increased activity of CASP3 protein]; [TNF protein co-treated with trovafloxacin] results in increased activity of CASP3 protein; [trovafloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL1B protein] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL6 protein] results in increased activity of CASP3 protein; [trovafloxacin co-treated with TNF protein] results in increased activity of CASP3 protein; ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased activity of CASP3 protein] [TNF protein co-treated with trovafloxacin] results in increased cleavage of CASP3 protein
CTD
PMID:19638433 PMID:24097668 PMID:25748550 PMID:30876886 PMID:33609687
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression
EXP
trovafloxacin results in increased expression of CASP6 mRNA
CTD
PMID:24136188
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
decreases expression
EXP
trovafloxacin results in decreased expression of CASP7 mRNA
CTD
PMID:24136188
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased activity of CASP8 protein
CTD
PMID:24097668
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased activity of CASP9 protein
CTD
PMID:24097668
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
increases expression
ISO
trovafloxacin results in increased expression of CAV1 mRNA
CTD
PMID:35537566
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
G
Cbfa2t3
CBFA2/RUNX1 partner transcriptional co-repressor 3
decreases expression
ISO
trovafloxacin results in decreased expression of CBFA2T3 mRNA
CTD
PMID:35537566
NCBI chr19:50,679,897...50,750,028
Ensembl chr19:50,680,729...50,749,610
G
Cbs
cystathionine beta synthase
decreases expression
ISO
trovafloxacin results in decreased expression of CBS mRNA
CTD
PMID:35537566
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,708,090...9,732,764
G
Cc2d1b
coiled-coil and C2 domain containing 1B
decreases expression
ISO
trovafloxacin results in decreased expression of CC2D1B mRNA
CTD
PMID:35537566
NCBI chr 5:123,353,289...123,367,343
Ensembl chr 5:123,353,292...123,367,318
G
Cc2d2a
coiled-coil and C2 domain containing 2A
decreases expression
ISO
trovafloxacin results in decreased expression of CC2D2A mRNA
CTD
PMID:35537566
NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949
G
Ccdc137
coiled-coil domain containing 137
increases expression
ISO
trovafloxacin results in increased expression of CCDC137 mRNA
CTD
PMID:35537566
NCBI chr10:105,730,776...105,737,158
Ensembl chr10:105,730,739...105,737,158
G
Ccdc15
coiled-coil domain containing 15
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC15 mRNA
CTD
PMID:35537566
NCBI chr 8:36,991,147...37,068,849
Ensembl chr 8:36,998,867...37,068,919
G
Ccdc163
coiled-coil domain containing 163
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC163 mRNA
CTD
PMID:35537566
NCBI chr 5:130,172,014...130,178,934
Ensembl chr 5:130,172,774...130,178,929
G
Ccdc18
coiled-coil domain containing 18
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC18 mRNA
CTD
PMID:35537566
NCBI chr14:1,501,749...1,607,672
Ensembl chr14:1,501,784...1,607,711
G
Ccdc181
coiled-coil domain containing 181
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC181 mRNA
CTD
PMID:35537566
NCBI chr13:76,624,567...76,638,224
Ensembl chr13:76,624,567...76,638,224
G
Ccdc34
coiled-coil domain containing 34
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC34 mRNA
CTD
PMID:35537566
NCBI chr 3:96,553,074...96,588,310
Ensembl chr 3:96,552,992...96,588,146
G
Ccdc6
coiled-coil domain containing 6
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CCDC6 mRNA
CTD
PMID:18930950
NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,433,695...18,528,658
G
Ccdc62
coiled-coil domain containing 62
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC62 mRNA
CTD
PMID:35537566
NCBI chr12:32,623,170...32,659,912
Ensembl chr12:32,623,170...32,660,017
G
Ccdc74a
coiled-coil domain containing 74A
increases expression
ISO
trovafloxacin results in increased expression of CCDC74A mRNA
CTD
PMID:35537566
NCBI chr11:83,355,888...83,360,269
Ensembl chr11:83,355,874...83,360,378
G
Ccdc86
coiled-coil domain containing 86
increases expression
ISO
trovafloxacin results in increased expression of CCDC86 mRNA
CTD
PMID:35537566
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
G
Ccdc91
coiled-coil domain containing 91
decreases expression
ISO
trovafloxacin results in decreased expression of CCDC91 mRNA
CTD
PMID:35537566
NCBI chr 4:180,402,327...180,574,364
Ensembl chr 4:180,402,376...180,574,364
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
trovafloxacin promotes the reaction [TNF protein results in increased expression of CCL2 protein]
CTD
PMID:19638433
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl22
C-C motif chemokine ligand 22
increases expression
ISO
trovafloxacin results in increased expression of CCL22 mRNA
CTD
PMID:35537566
NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,257,601...10,264,400
G
Ccl3
C-C motif chemokine ligand 3
increases expression
ISO
trovafloxacin results in increased expression of CCL3 mRNA
CTD
PMID:35537566
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO
trovafloxacin results in increased expression of CCL4 mRNA
CTD
PMID:35537566
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231
G
Ccna2
cyclin A2
decreases expression
ISO
trovafloxacin results in decreased expression of CCNA2 mRNA
CTD
PMID:35537566
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
trovafloxacin results in decreased expression of CCNB1 mRNA
CTD
PMID:35537566
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
decreases expression
EXP ISO
trovafloxacin results in decreased expression of CCNB2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of CCND1 mRNA trovafloxacin results in increased expression of CCND1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccng2
cyclin G2
decreases expression
ISO
trovafloxacin results in decreased expression of CCNG2 mRNA
CTD
PMID:35537566
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Ccnj
cyclin J
increases expression
ISO
trovafloxacin results in increased expression of CCNJ mRNA
CTD
PMID:35537566
NCBI chr 1:239,659,588...239,677,367
G
Ccnl1
cyclin L1
increases expression
ISO
trovafloxacin results in increased expression of CCNL1 mRNA
CTD
PMID:35537566
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
G
Ccr10
C-C motif chemokine receptor 10
increases expression
ISO
trovafloxacin results in increased expression of CCR10 mRNA
CTD
PMID:35537566
NCBI chr10:86,108,551...86,110,988
Ensembl chr10:86,108,551...86,110,988
G
Ccsap
centriole, cilia and spindle-associated protein
decreases expression
ISO
trovafloxacin results in decreased expression of CCSAP mRNA
CTD
PMID:35537566
NCBI chr19:68,722,417...68,740,908
Ensembl chr19:51,826,994...51,842,753
G
Cd101
CD101 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD101 mRNA
CTD
PMID:35537566
NCBI chr 2:188,422,989...188,459,536
Ensembl chr 2:188,422,351...188,459,502
G
Cd109
CD109 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD109 mRNA
CTD
PMID:35537566
NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
G
Cd200r1l
CD200 receptor 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of CD200R4 mRNA
CTD
PMID:35537566
NCBI chr11:55,842,632...55,860,914
Ensembl chr11:55,842,634...55,885,680
G
Cd207
CD207 molecule
increases expression
ISO
trovafloxacin results in increased expression of CD207 mRNA
CTD
PMID:35537566
NCBI chr 4:116,155,229...116,161,587
Ensembl chr 4:116,155,212...116,161,518
G
Cd24
CD24 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD24A mRNA
CTD
PMID:35537566
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd244
CD244 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD244 mRNA
CTD
PMID:35537566
NCBI chr13:86,583,727...86,606,902
Ensembl chr13:84,052,493...84,074,492
G
Cd27
CD27 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD27 mRNA
CTD
PMID:35537566
NCBI chr 4:158,030,700...158,035,862
Ensembl chr 4:158,030,703...158,035,592
G
Cd300lb
CD300 molecule-like family member b
increases expression
ISO
trovafloxacin results in increased expression of CD300LB mRNA
CTD
PMID:35537566
NCBI chr10:99,964,801...99,974,790
Ensembl chr10:99,964,801...99,974,790
G
Cd33
CD33 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD33 mRNA
CTD
PMID:35537566
NCBI chr 1:93,935,418...93,940,452
Ensembl chr 1:93,930,971...93,950,149
G
Cd36
CD36 molecule
decreases expression
EXP
trovafloxacin results in decreased expression of CD36 mRNA
CTD
PMID:24136188
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd5
Cd5 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD5 mRNA
CTD
PMID:35537566
NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:207,365,337...207,386,313
G
Cd80
Cd80 molecule
increases expression
ISO
trovafloxacin results in increased expression of CD80 mRNA
CTD
PMID:35537566
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:62,254,624...62,292,030
G
Cd86
CD86 molecule
decreases expression
ISO
trovafloxacin results in decreased expression of CD86 mRNA
CTD
PMID:35537566
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818
G
Cd8b
CD8 subunit beta
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CD8B mRNA
CTD
PMID:18930950
NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:103,312,578...103,328,553
G
Cdc20
cell division cycle 20
decreases expression
EXP ISO
trovafloxacin results in decreased expression of CDC20 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
G
Cdc25b
cell division cycle 25B
decreases expression
ISO
trovafloxacin results in decreased expression of CDC25B mRNA
CTD
PMID:35537566
NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:118,407,128...118,417,272
G
Cdc25c
cell division cycle 25C
decreases expression
ISO
trovafloxacin results in decreased expression of CDC25C mRNA
CTD
PMID:35537566
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,335,834...26,356,185
G
Cdc26
cell division cycle 26
increases expression
ISO
trovafloxacin results in increased expression of CDC26 mRNA
CTD
PMID:35537566
NCBI chr 5:75,844,852...75,859,830
G
Cdc34
cell division cycle 34, ubiquitin conjugating enzyme
increases expression
ISO
trovafloxacin results in increased expression of CDC34 mRNA
CTD
PMID:35537566
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
G
Cdc42ep4
CDC42 effector protein 4
increases expression
EXP
trovafloxacin results in increased expression of CDC42EP4 mRNA
CTD
PMID:24136188
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
G
Cdca2
cell division cycle associated 2
decreases expression
ISO
trovafloxacin results in decreased expression of CDCA2 mRNA
CTD
PMID:35537566
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
trovafloxacin results in decreased expression of CDCA3 mRNA
CTD
PMID:35537566
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdca5
cell division cycle associated 5
decreases expression
ISO
trovafloxacin results in decreased expression of CDCA5 mRNA
CTD
PMID:35537566
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
G
Cdca8
cell division cycle associated 8
decreases expression
ISO
trovafloxacin results in decreased expression of CDCA8 mRNA
CTD
PMID:35537566
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
G
Cdin1
CDAN1 interacting nuclease 1
decreases expression
ISO
trovafloxacin results in decreased expression of CDIN1 mRNA
CTD
PMID:35537566
NCBI chr 3:102,441,553...102,646,935
Ensembl chr 3:102,441,704...102,646,682
G
Cdk1
cyclin-dependent kinase 1
decreases expression
EXP ISO
trovafloxacin results in decreased expression of CDK1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cdk10
cyclin-dependent kinase 10
decreases expression
ISO
trovafloxacin results in decreased expression of CDK10 mRNA
CTD
PMID:35537566
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
G
Cdk16
cyclin-dependent kinase 16
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CDK16 mRNA
CTD
PMID:18930950
NCBI chr X:4,046,330...4,057,825
Ensembl chr X:1,492,814...1,504,148
G
Cdk2ap2
cyclin-dependent kinase 2 associated protein 2
increases expression
ISO
trovafloxacin results in increased expression of CDK2AP2 mRNA
CTD
PMID:35537566
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
G
Cdk5rap2
CDK5 regulatory subunit associated protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of CDK5RAP2 mRNA
CTD
PMID:35537566
NCBI chr 5:83,792,282...83,961,129
Ensembl chr 5:83,792,284...83,960,782
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CDKN1A mRNA trovafloxacin results in increased expression of CDKN1A mRNA
CTD
PMID:18930950 PMID:25748550 PMID:35537566
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
trovafloxacin results in decreased expression of CDKN2C mRNA
CTD
PMID:35537566
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Cdkn2d
cyclin dependent kinase inhibitor 2D
decreases expression
ISO
trovafloxacin results in decreased expression of CDKN2D mRNA
CTD
PMID:35537566
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP ISO
trovafloxacin results in decreased expression of CDKN3 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cdo1
cysteine dioxygenase type 1
increases expression
ISO
trovafloxacin results in increased expression of CDO1 mRNA
CTD
PMID:35537566
NCBI chr18:41,619,076...41,633,719
Ensembl chr18:39,432,474...39,447,296
G
Cdon
cell adhesion associated, oncogene regulated
decreases expression
ISO
trovafloxacin results in decreased expression of CDON mRNA
CTD
PMID:35537566
NCBI chr 8:33,775,123...33,861,635
Ensembl chr 8:33,806,183...33,859,033
G
Cdsn
corneodesmosin
decreases expression
ISO
trovafloxacin results in decreased expression of CDSN mRNA
CTD
PMID:35537566
NCBI chr20:3,179,432...3,184,252
Ensembl chr20:3,179,438...3,184,250
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CEBPA mRNA
CTD
PMID:18930950
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
G
Cebpg
CCAAT/enhancer binding protein gamma
decreases expression
ISO
trovafloxacin results in decreased expression of CEBPG mRNA
CTD
PMID:35537566
NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:87,684,019...87,694,569
G
Celf6
CUGBP, Elav-like family member 6
decreases expression
ISO
trovafloxacin results in decreased expression of CELF6 mRNA
CTD
PMID:35537566
NCBI chr 8:59,975,095...60,006,060
Ensembl chr 8:59,975,088...60,005,041
G
Cenatac
centrosomal AT-AC splicing factor
increases expression
ISO
trovafloxacin results in increased expression of CENATAC mRNA
CTD
PMID:35537566
NCBI chr 8:44,735,968...44,742,859
Ensembl chr 8:44,735,972...44,742,837
G
Cenpa
centromere protein A
decreases expression
ISO
trovafloxacin results in decreased expression of CENPA mRNA
CTD
PMID:35537566
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cenpe
centromere protein E
decreases expression
ISO
trovafloxacin results in decreased expression of CENPE mRNA
CTD
PMID:35537566
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
G
Cenpf
centromere protein F
decreases expression
ISO
trovafloxacin results in decreased expression of CENPF mRNA
CTD
PMID:35537566
NCBI chr13:103,715,344...103,760,931
Ensembl chr13:101,184,127...101,229,669
G
Cenpi
centromere protein I
decreases expression
ISO
trovafloxacin results in decreased expression of CENPI mRNA
CTD
PMID:35537566
NCBI chr X:97,515,919...97,567,671
Ensembl chr X:97,515,972...97,567,657
G
Cenpk
centromere protein K
decreases expression
ISO
trovafloxacin results in decreased expression of CENPK mRNA
CTD
PMID:35537566
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
G
Cenpl
centromere protein L
decreases expression
ISO
trovafloxacin results in decreased expression of CENPL mRNA
CTD
PMID:35537566
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
G
Cenpm
centromere protein M
decreases expression
ISO
trovafloxacin results in decreased expression of CENPM mRNA
CTD
PMID:35537566
NCBI chr 7:113,748,026...113,759,296
Ensembl chr 7:113,747,516...113,764,258
G
Cenpn
centromere protein N
decreases expression
ISO
trovafloxacin results in decreased expression of CENPN mRNA
CTD
PMID:35537566
NCBI chr19:44,971,265...44,994,019
Ensembl chr19:44,968,308...44,994,012
G
Cenpp
centromere protein P
decreases expression
ISO
trovafloxacin results in decreased expression of CENPP mRNA
CTD
PMID:35537566
NCBI chr17:15,014,087...15,189,312
Ensembl chr17:15,014,058...15,189,304
G
Cenpq
centromere protein Q
decreases expression
ISO
trovafloxacin results in decreased expression of CENPQ mRNA
CTD
PMID:35537566
NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789
G
Cenpu
centromere protein U
decreases expression
ISO
trovafloxacin results in decreased expression of CENPU mRNA
CTD
PMID:35537566
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
G
Cep128
centrosomal protein 128
decreases expression
ISO
trovafloxacin results in decreased expression of CEP128 mRNA
CTD
PMID:35537566
NCBI chr 6:109,951,009...110,328,686
Ensembl chr 6:109,951,061...110,328,713
G
Cep131
centrosomal protein 131
decreases expression
ISO
trovafloxacin results in decreased expression of CEP131 mRNA
CTD
PMID:35537566
NCBI chr10:105,346,015...105,370,380
Ensembl chr10:105,346,015...105,370,380
G
Cep162
centrosomal protein 162
decreases expression
ISO
trovafloxacin results in decreased expression of CEP162 mRNA
CTD
PMID:35537566
NCBI chr 8:97,029,677...97,088,243
Ensembl chr 8:88,149,726...88,206,830
G
Cep192
centrosomal protein 192
decreases expression
ISO
trovafloxacin results in decreased expression of CEP192 mRNA
CTD
PMID:35537566
NCBI chr18:61,373,937...61,458,405
Ensembl chr18:61,332,158...61,458,379
G
Cep290
centrosomal protein 290
decreases expression
ISO
trovafloxacin results in decreased expression of CEP290 mRNA
CTD
PMID:35537566
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
G
Cep55
centrosomal protein 55
decreases expression
ISO
trovafloxacin results in decreased expression of CEP55 mRNA
CTD
PMID:35537566
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
G
Cep57l1
centrosomal protein 57-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of CEP57L1 mRNA
CTD
PMID:35537566
NCBI chr20:45,238,039...45,294,575
Ensembl chr20:45,238,044...45,294,540
G
Cep72
centrosomal protein 72
decreases expression
ISO
trovafloxacin results in decreased expression of CEP72 mRNA
CTD
PMID:35537566
NCBI chr 1:29,225,312...29,255,294
Ensembl chr 1:29,225,361...29,255,271
G
Cep78
centrosomal protein 78
decreases expression
ISO
trovafloxacin results in decreased expression of CEP78 mRNA
CTD
PMID:35537566
NCBI chr 1:213,246,183...213,275,275
Ensembl chr 1:213,246,187...213,275,181
G
Cep83
centrosomal protein 83
decreases expression
ISO
trovafloxacin results in decreased expression of CEP83 mRNA
CTD
PMID:35537566
NCBI chr 7:29,280,358...29,389,574
Ensembl chr 7:29,280,419...29,389,574
G
Cerkl
CERK like autophagy regulator
decreases expression
ISO
trovafloxacin results in decreased expression of CERKL mRNA
CTD
PMID:35537566
NCBI chr 3:64,238,714...64,344,695
Ensembl chr 3:64,237,522...64,340,675
G
Cfap184
cilia and flagella associated protein 184
increases expression
ISO
trovafloxacin results in increased expression of CCDC96 mRNA
CTD
PMID:35537566
NCBI chr14:78,501,256...78,503,715
Ensembl chr14:74,276,960...74,278,888
G
Cfl2
cofilin 2
increases expression
ISO
trovafloxacin results in increased expression of CFL2 mRNA
CTD
PMID:35537566
NCBI chr 6:72,355,664...72,359,709
Ensembl chr 6:72,355,664...72,359,674
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of CHAC1 mRNA
CTD
PMID:35537566
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Chadl
chondroadherin-like
increases expression
ISO
trovafloxacin results in increased expression of CHADL mRNA
CTD
PMID:35537566
NCBI chr 7:115,085,447...115,097,565
Ensembl chr 7:113,210,748...113,217,272
G
Chd5
chromodomain helicase DNA binding protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of CHD5 mRNA
CTD
PMID:35537566
NCBI chr 5:162,848,273...162,898,997
Ensembl chr 5:162,848,394...162,896,291
G
Chfr
checkpoint with forkhead and ring finger domains
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CHFR mRNA
CTD
PMID:18930950
NCBI chr12:52,164,214...52,197,860
Ensembl chr12:46,504,497...46,538,014
G
Chka
choline kinase alpha
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CHKA mRNA
CTD
PMID:18930950
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Chpf
chondroitin polymerizing factor
increases expression
ISO
trovafloxacin results in increased expression of CHPF mRNA
CTD
PMID:35537566
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
G
Chst1
carbohydrate sulfotransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of CHST1 mRNA
CTD
PMID:35537566
NCBI chr 3:78,552,059...78,574,740
Ensembl chr 3:78,548,525...78,574,883
G
Chst7
carbohydrate sulfotransferase 7
decreases expression
ISO
trovafloxacin results in decreased expression of CHST7 mRNA
CTD
PMID:35537566
NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840
G
Chtf18
chromosome transmission fidelity factor 18
decreases expression
ISO
trovafloxacin results in decreased expression of CHTF18 mRNA
CTD
PMID:35537566
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
G
Cib2
calcium and integrin binding family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of CIB2 mRNA
CTD
PMID:35537566
NCBI chr 8:54,930,265...54,947,157
G
Cip2a
cellular inhibitor of PP2A
decreases expression
ISO
trovafloxacin results in decreased expression of CIP2A mRNA
CTD
PMID:35537566
NCBI chr11:51,792,143...51,823,016
Ensembl chr11:51,795,024...51,822,938
G
Cit
citron rho-interacting serine/threonine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of CIT mRNA
CTD
PMID:35537566
NCBI chr12:40,603,073...40,764,846
Ensembl chr12:40,605,563...40,763,860
G
Ckap2
cytoskeleton associated protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of CKAP2 mRNA
CTD
PMID:35537566
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
G
Ckap2l
cytoskeleton associated protein 2-like
decreases expression
ISO
trovafloxacin results in decreased expression of CKAP2L mRNA
CTD
PMID:35537566
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
G
Ckap5
cytoskeleton associated protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of CKAP5 mRNA
CTD
PMID:35537566
NCBI chr 3:97,946,966...98,049,050
Ensembl chr 3:77,491,276...77,593,264
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
EXP
trovafloxacin results in decreased expression of CKS2 mRNA
CTD
PMID:24136188
NCBI chr17:13,722,360...13,727,519
G
Clcn5
chloride voltage-gated channel 5
decreases expression
ISO
trovafloxacin results in decreased expression of CLCN5 mRNA
CTD
PMID:35537566
NCBI chr X:17,857,260...18,011,844
Ensembl chr X:15,185,451...15,334,264
G
Cldn11
claudin 11
decreases expression
ISO
trovafloxacin results in decreased expression of CLDN11 mRNA
CTD
PMID:35537566
NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:112,207,745...112,221,050
G
Cldn14
claudin 14
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CLDN14 mRNA
CTD
PMID:18930950
NCBI chr11:46,701,940...46,799,049
Ensembl chr11:33,232,220...33,329,171
G
Clec2l
C-type lectin domain family 2, member L
decreases expression
ISO
trovafloxacin results in decreased expression of CLEC2L mRNA
CTD
PMID:35537566
NCBI chr 4:67,392,118...67,414,539
Ensembl chr 4:67,397,873...67,414,537
G
Clec4a1
C-type lectin domain family 4, member A1
decreases expression
ISO
trovafloxacin results in decreased expression of CLEC4A1 mRNA
CTD
PMID:35537566
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
G
Clec7a
C-type lectin domain containing 7A
decreases expression
ISO
trovafloxacin results in decreased expression of CLEC7A mRNA
CTD
PMID:35537566
NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:162,902,732...162,913,897
G
Clint1
clathrin interactor 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CLINT1 mRNA
CTD
PMID:18930950
NCBI chr10:30,298,618...30,353,185
Ensembl chr10:30,298,704...30,353,063
G
Clip2
CAP-GLY domain containing linker protein 2
increases expression
ISO
trovafloxacin results in increased expression of CLIP2 mRNA
CTD
PMID:35537566
NCBI chr12:22,163,044...22,227,023
Ensembl chr12:22,163,218...22,227,023
G
Clk1
CDC-like kinase 1
increases expression
ISO
trovafloxacin results in increased expression of CLK1 mRNA
CTD
PMID:35537566
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
G
Cln6
CLN6, transmembrane ER protein
decreases expression
ISO
trovafloxacin results in decreased expression of CLN6 mRNA
CTD
PMID:35537566
NCBI chr 8:63,303,356...63,318,360
Ensembl chr 8:63,303,029...63,318,360
G
Clspn
claspin
decreases expression
ISO
trovafloxacin results in decreased expression of CLSPN mRNA
CTD
PMID:35537566
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
G
Cmah
cytidine monophospho-N-acetylneuraminic acid hydroxylase
decreases expression
ISO
trovafloxacin results in decreased expression of CMAH mRNA
CTD
PMID:35537566
NCBI chr17:40,557,161...40,642,350
Ensembl chr17:40,583,667...40,642,275
G
Cmbl
carboxymethylenebutenolidase homolog
decreases expression
ISO
trovafloxacin results in decreased expression of CMBL mRNA
CTD
PMID:35537566
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cmpk2
cytidine/uridine monophosphate kinase 2
increases expression
ISO
trovafloxacin results in increased expression of CMPK2 mRNA
CTD
PMID:35537566
NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:43,073,796...43,085,183
G
Cntln
centlein
decreases expression
ISO
trovafloxacin results in decreased expression of CNTLN mRNA
CTD
PMID:35537566
NCBI chr 5:99,295,865...99,576,402
Ensembl chr 5:99,296,000...99,576,396
G
Cntrl
centriolin
decreases expression
ISO
trovafloxacin results in decreased expression of CNTRL mRNA
CTD
PMID:35537566
NCBI chr 3:18,428,147...18,500,362
Ensembl chr 3:18,428,103...18,500,380
G
Cntrob
centrobin, centriole duplication and spindle assembly protein
decreases expression
ISO
trovafloxacin results in decreased expression of CNTROB mRNA
CTD
PMID:35537566
NCBI chr10:54,022,523...54,047,793
Ensembl chr10:54,022,852...54,044,849
G
Coasy
Coenzyme A synthase
decreases expression
ISO
trovafloxacin results in decreased expression of COASY mRNA
CTD
PMID:35537566
NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841
G
Col14a1
collagen type XIV alpha 1 chain
decreases expression
ISO
trovafloxacin results in decreased expression of COL14A1 mRNA
CTD
PMID:35537566
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
G
Col15a1
collagen type XV alpha 1 chain
decreases expression
ISO
trovafloxacin results in decreased expression of COL15A1 mRNA
CTD
PMID:35537566
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
G
Comt
catechol-O-methyltransferase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of COMT mRNA
CTD
PMID:18930950
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Copg1
COPI coat complex subunit gamma 1
decreases expression
EXP
trovafloxacin results in decreased expression of COPG1 mRNA
CTD
PMID:24136188
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
G
Cops9
COP9 signalosome subunit 9
increases expression
ISO
trovafloxacin results in increased expression of MYEOV2 mRNA
CTD
PMID:35537566
NCBI chr 9:93,209,843...93,214,774
Ensembl chr 9:93,209,843...93,213,317
G
Coq10a
coenzyme Q10A
decreases expression
ISO
trovafloxacin results in decreased expression of COQ10A mRNA
CTD
PMID:35537566
NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161
G
Coq2
coenzyme Q2, polyprenyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of COQ2 mRNA
CTD
PMID:35537566
NCBI chr14:8,941,429...8,961,418
Ensembl chr14:8,941,461...8,960,891
G
Coro1b
coronin 1B
decreases expression
ISO
trovafloxacin results in decreased expression of CORO1B mRNA
CTD
PMID:35537566
NCBI chr 1:201,442,977...201,448,416
Ensembl chr 1:201,443,014...201,448,416
G
Coro6
coronin 6
decreases expression
ISO
trovafloxacin results in decreased expression of CORO6 mRNA
CTD
PMID:35537566
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
G
Coro7
coronin 7
decreases expression
ISO
trovafloxacin results in decreased expression of CORO7 mRNA
CTD
PMID:35537566
NCBI chr10:10,880,299...10,941,001
Ensembl chr10:10,885,196...10,941,001
G
Cox4i2
cytochrome c oxidase subunit 4i2
increases expression
ISO
trovafloxacin results in increased expression of COX4I2 mRNA
CTD
PMID:35537566
NCBI chr 3:161,686,193...161,699,605
Ensembl chr 3:141,228,443...141,239,331
G
Cox6a2
cytochrome c oxidase subunit 6A2
decreases expression
ISO
trovafloxacin results in decreased expression of COX6A2 mRNA
CTD
PMID:35537566
NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:182,788,528...182,789,274
G
Cpe
carboxypeptidase E
increases expression
ISO
trovafloxacin results in increased expression of CPE mRNA
CTD
PMID:35537566
NCBI chr16:29,796,707...29,908,647
Ensembl chr16:25,030,276...25,142,233
G
Cpeb4
cytoplasmic polyadenylation element binding protein 4
increases expression
ISO
trovafloxacin results in increased expression of CPEB4 mRNA
CTD
PMID:35537566
NCBI chr10:15,717,794...15,780,482
Ensembl chr10:15,717,794...15,780,603
G
Cped1
cadherin-like and PC-esterase domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of CPED1 mRNA
CTD
PMID:35537566
NCBI chr 4:50,516,712...50,789,651
Ensembl chr 4:50,516,819...50,788,674
G
Cpox
coproporphyrinogen oxidase
decreases expression
EXP
trovafloxacin results in decreased expression of CPOX mRNA
CTD
PMID:24136188
NCBI chr11:55,405,778...55,415,761
Ensembl chr11:41,936,591...41,946,746
G
Cpsf1
cleavage and polyadenylation specific factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of CPSF1 mRNA
CTD
PMID:35537566
NCBI chr 7:108,319,429...108,330,018
Ensembl chr 7:108,319,434...108,329,934
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
EXP
trovafloxacin results in increased expression of CPT1A mRNA
CTD
PMID:24136188
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Cradd
CASP2 and RIPK1 domain containing adaptor with death domain
decreases expression
ISO
trovafloxacin results in decreased expression of CRADD mRNA
CTD
PMID:35537566
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
G
Crebzf
CREB/ATF bZIP transcription factor
increases expression
ISO
trovafloxacin results in increased expression of CREBZF mRNA
CTD
PMID:35537566
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
G
Crk
CRK proto-oncogene, adaptor protein
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CRK mRNA
CTD
PMID:18930950
NCBI chr10:61,028,736...61,054,971
Ensembl chr10:60,530,464...60,553,406
G
Cryzl1
crystallin zeta like 1
decreases expression
ISO
trovafloxacin results in decreased expression of CRYZL1 mRNA
CTD
PMID:35537566
NCBI chr11:30,933,140...30,977,936
Ensembl chr11:30,933,144...30,977,867
G
Cs
citrate synthase
decreases expression
EXP
trovafloxacin results in decreased expression of CS mRNA
CTD
PMID:24136188
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:758,345...791,421
G
Csad
cysteine sulfinic acid decarboxylase
decreases expression
ISO
trovafloxacin results in decreased expression of CSAD mRNA
CTD
PMID:35537566
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
G
Csrnp1
cysteine and serine rich nuclear protein 1
increases expression
ISO
trovafloxacin results in increased expression of CSRNP1 mRNA
CTD
PMID:35537566
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
G
Cst7
cystatin F
decreases expression
ISO
trovafloxacin results in decreased expression of CST7 mRNA
CTD
PMID:35537566
NCBI chr 3:139,396,830...139,405,557
Ensembl chr 3:139,396,850...139,405,557
G
Cstf2t
cleavage stimulation factor subunit 2, tau variant
increases expression
ISO
trovafloxacin results in increased expression of CSTF2T mRNA
CTD
PMID:35537566
NCBI chr 1:228,952,617...228,956,183
Ensembl chr 1:228,952,504...228,955,873
G
Ctdsp1
CTD small phosphatase 1
decreases expression
ISO
trovafloxacin results in decreased expression of CTDSP1 mRNA
CTD
PMID:35537566
NCBI chr 9:75,973,694...75,979,298
Ensembl chr 9:75,973,962...75,979,297
G
Cth
cystathionine gamma-lyase
decreases expression
ISO
trovafloxacin results in decreased expression of CTH mRNA
CTD
PMID:35537566
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:246,975,894...247,002,234
G
Ctsc
cathepsin C
decreases expression
ISO
trovafloxacin results in decreased expression of CTSC mRNA
CTD
PMID:35537566
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:142,028,392...142,060,387
G
Ctse
cathepsin E
decreases expression
ISO
trovafloxacin results in decreased expression of CTSE mRNA
CTD
PMID:35537566
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
G
Ctsf
cathepsin F
decreases expression
ISO
trovafloxacin results in decreased expression of CTSF mRNA
CTD
PMID:35537566
NCBI chr 1:202,152,777...202,158,525
Ensembl chr 1:202,152,728...202,158,525
G
Cttnbp2nl
CTTNBP2 N-terminal like
increases expression
ISO
trovafloxacin results in increased expression of CTTNBP2NL mRNA
CTD
PMID:35537566
NCBI chr 2:192,507,963...192,554,548
Ensembl chr 2:192,507,963...192,541,101
G
Cutc
cutC copper transporter
decreases expression
ISO
trovafloxacin results in decreased expression of CUTC mRNA
CTD
PMID:35537566
NCBI chr 1:242,622,281...242,637,048
Ensembl chr 1:242,622,276...242,637,047
G
Cux2
cut-like homeobox 2
increases expression
ISO
trovafloxacin results in increased expression of CUX2 mRNA
CTD
PMID:35537566
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CXCL2 mRNA; trovafloxacin promotes the reaction [TNF protein results in increased expression of CXCL2 protein] trovafloxacin results in increased expression of CXCL2 mRNA
CTD
PMID:18930950 PMID:19638433 PMID:35537566
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CXCL3 mRNA; trovafloxacin promotes the reaction [TNF protein results in increased expression of CXCL1 protein]
CTD
PMID:18930950 PMID:19638433
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cyb5a
cytochrome b5 type A
increases expression
ISO
trovafloxacin results in increased expression of CYB5A mRNA
CTD
PMID:35537566
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyb5d1
cytochrome b5 domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of CYB5D1 mRNA
CTD
PMID:35537566
NCBI chr10:54,113,428...54,117,744
Ensembl chr10:54,113,438...54,117,911
G
Cyb5rl
cytochrome b5 reductase-like
decreases expression
ISO
trovafloxacin results in decreased expression of CYB5RL mRNA
CTD
PMID:35537566
NCBI chr 5:121,846,223...121,868,287
Ensembl chr 5:121,847,952...121,868,745
G
Cyfip2
cytoplasmic FMR1 interacting protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of CYFIP2 mRNA
CTD
PMID:35537566
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases activity
ISO
trovafloxacin results in decreased activity of CYP19A1 protein
CTD
PMID:26141389
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
trovafloxacin results in decreased expression of CYP27A1 mRNA
CTD
PMID:35537566
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2b12
cytochrome P450, family 2, subfamily b, polypeptide 12
decreases expression
EXP
trovafloxacin results in decreased expression of CYP2B12 mRNA
CTD
PMID:24136188
NCBI chr 1:82,007,609...82,019,409
Ensembl chr 1:82,007,609...82,080,480
G
Cyp2u1
cytochrome P450, family 2, subfamily u, polypeptide 1
decreases expression
ISO
trovafloxacin results in decreased expression of CYP2U1 mRNA
CTD
PMID:35537566
NCBI chr 2:222,523,516...222,541,055
Ensembl chr 2:219,849,407...219,866,882
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
decreases expression
ISO
trovafloxacin results in decreased expression of CYP4F39 mRNA
CTD
PMID:35537566
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CYP7A1 mRNA
CTD
PMID:18930950
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:19,376,974...19,386,688
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
increases expression
EXP
trovafloxacin results in increased expression of CYP8B1 mRNA
CTD
PMID:24136188
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166
G
Cyren
cell cycle regulator of NHEJ
decreases expression
ISO
trovafloxacin results in decreased expression of CYREN mRNA
CTD
PMID:35537566
NCBI chr 4:63,547,311...63,553,394
Ensembl chr 4:63,547,335...63,551,602
G
Cyth4
cytohesin 4
increases expression
ISO
trovafloxacin results in increased expression of CYTH4 mRNA
CTD
PMID:35537566
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
G
Dancr
differentiation antagonizing non-protein coding RNA
increases expression
ISO
trovafloxacin results in increased expression of DANCR mRNA
CTD
PMID:35537566
NCBI chr14:34,126,956...34,127,936
G
Dapk1
death associated protein kinase 1
decreases expression
EXP
trovafloxacin results in decreased expression of DAPK1 mRNA
CTD
PMID:24136188
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,930,213...4,090,991
G
Dars2
aspartyl-tRNA synthetase 2 (mitochondrial)
decreases expression
ISO
trovafloxacin results in decreased expression of DARS2 mRNA
CTD
PMID:35537566
NCBI chr13:73,308,726...73,336,558
Ensembl chr13:73,308,726...73,336,934
G
Daxx
death-domain associated protein
increases expression
ISO
trovafloxacin results in increased expression of DAXX mRNA
CTD
PMID:35537566
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,970,092...4,975,843
G
Dbf4
DBF4-CDC7 kinase regulatory subunit
decreases expression
ISO
trovafloxacin results in decreased expression of DBF4 mRNA
CTD
PMID:35537566
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
G
Dcp1b
decapping mRNA 1B
decreases expression
ISO
trovafloxacin results in decreased expression of DCP1B mRNA
CTD
PMID:35537566
NCBI chr 4:152,358,267...152,395,747
Ensembl chr 4:152,358,241...152,397,145
G
Ddit3
DNA-damage inducible transcript 3
decreases expression
ISO
trovafloxacin results in decreased expression of DDIT3 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Ddx1
DEAD-box helicase 1
decreases expression
EXP
trovafloxacin results in decreased expression of DDX1 mRNA
CTD
PMID:24136188
NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:35,996,469...36,027,365
G
Ddx17
DEAD-box helicase 17
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of DDX17 mRNA
CTD
PMID:18930950
NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:111,089,445...111,109,193
G
Ddx23
DEAD-box helicase 23
increases expression
ISO
trovafloxacin results in increased expression of DDX23 mRNA
CTD
PMID:35537566
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
G
Ddx59
DEAD-box helicase 59
decreases expression
ISO
trovafloxacin results in decreased expression of DDX59 mRNA
CTD
PMID:35537566
NCBI chr13:47,876,258...47,901,214
Ensembl chr13:47,876,261...47,901,214
G
Ddx6
DEAD-box helicase 6
increases expression
ISO
trovafloxacin results in increased expression of DDX6 mRNA
CTD
PMID:35537566
NCBI chr 8:53,827,661...53,864,538
Ensembl chr 8:44,931,974...44,964,405 Ensembl chr 8:44,931,974...44,964,405
G
Ddx60
DEXD/H-box helicase 60
increases expression
ISO
trovafloxacin results in increased expression of DDX60 mRNA
CTD
PMID:35537566
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Dek
DEK proto-oncogene
decreases expression
ISO
trovafloxacin results in decreased expression of DEK mRNA
CTD
PMID:35537566
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
G
Dennd2d
DENN domain containing 2D
decreases expression
ISO
trovafloxacin results in decreased expression of DENND2D mRNA
CTD
PMID:35537566
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
G
Dennd4a
DENN domain containing 4A
decreases expression
ISO
trovafloxacin results in decreased expression of DENND4A mRNA
CTD
PMID:35537566
NCBI chr 8:65,322,920...65,436,331
Ensembl chr 8:65,322,941...65,436,330
G
Dennd5b
DENN domain containing 5B
increases expression
ISO
trovafloxacin results in increased expression of DENND5B mRNA
CTD
PMID:35537566
NCBI chr 4:181,959,597...182,089,661
Ensembl chr 4:181,961,386...182,089,362
G
Depdc1
DEP domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of DEPDC1A mRNA
CTD
PMID:35537566
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
G
Depdc1b
DEP domain containing 1B
decreases expression
ISO
trovafloxacin results in decreased expression of DEPDC1B mRNA
CTD
PMID:35537566
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
G
Depdc7
DEP domain containing 7
decreases expression
ISO
trovafloxacin results in decreased expression of DEPDC7 mRNA
CTD
PMID:35537566
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
G
Deptor
DEP domain containing MTOR-interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of DEPTOR mRNA
CTD
PMID:35537566
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
G
Derl2
derlin 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of DERL2 mRNA
CTD
PMID:18930950
NCBI chr10:55,727,764...55,739,442
Ensembl chr10:55,727,643...55,739,518
G
Det1
DET1 partner of COP1 E3 ubiquitin ligase
decreases expression
ISO
trovafloxacin results in decreased expression of DET1 mRNA
CTD
PMID:35537566
NCBI chr 1:132,749,736...132,765,963
Ensembl chr 1:132,749,756...132,765,923
G
Dffb
DNA fragmentation factor subunit beta
increases expression
ISO
trovafloxacin results in increased expression of DFFB mRNA
CTD
PMID:35537566
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
EXP ISO
trovafloxacin results in decreased expression of DGAT2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428
G
Dgke
diacylglycerol kinase epsilon
increases expression
ISO
trovafloxacin results in increased expression of DGKE mRNA
CTD
PMID:35537566
NCBI chr10:74,348,931...74,374,509
Ensembl chr10:73,855,583...73,877,100
G
Dgkg
diacylglycerol kinase, gamma
decreases expression
ISO
trovafloxacin results in decreased expression of DGKG mRNA
CTD
PMID:35537566
NCBI chr11:78,384,212...78,579,158
Ensembl chr11:78,384,458...78,577,212
G
Dguok
deoxyguanosine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of DGUOK mRNA
CTD
PMID:35537566
NCBI chr 4:117,544,784...117,572,414
Ensembl chr 4:115,979,094...116,014,733
G
Dhrs3
dehydrogenase/reductase 3
decreases expression
ISO
trovafloxacin results in decreased expression of DHRS3 mRNA
CTD
PMID:35537566
NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:156,747,962...156,782,417
G
Dhrs4
dehydrogenase/reductase 4
decreases expression
ISO
trovafloxacin results in decreased expression of DHRS4 mRNA
CTD
PMID:35537566
NCBI chr15:32,924,482...32,948,103
Ensembl chr15:28,966,553...28,978,127
G
Dhx58
DEXH-box helicase 58
increases expression
ISO
trovafloxacin results in increased expression of DHX58 mRNA
CTD
PMID:35537566
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
G
Diaph3
diaphanous-related formin 3
decreases expression
ISO
trovafloxacin results in decreased expression of DIAPH3 mRNA
CTD
PMID:35537566
NCBI chr15:68,951,992...69,421,623
Ensembl chr15:62,543,375...63,012,975
G
Disp3
dispatched RND transporter family member 3
decreases expression
ISO
trovafloxacin results in decreased expression of DISP3 mRNA
CTD
PMID:35537566
NCBI chr 5:158,672,015...158,720,806
Ensembl chr 5:158,672,015...158,720,806
G
Dixdc1
DIX domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of DIXDC1 mRNA
CTD
PMID:35537566
NCBI chr 8:51,007,835...51,081,191
Ensembl chr 8:51,007,838...51,081,090
G
Dlgap5
DLG associated protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of DLGAP5 mRNA
CTD
PMID:35537566
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dlst
dihydrolipoamide S-succinyltransferase
decreases expression
EXP
trovafloxacin results in decreased expression of DLST mRNA
CTD
PMID:24136188
NCBI chr 6:110,489,576...110,512,841
Ensembl chr 6:104,758,631...104,783,296
G
Dmac1
distal membrane arm assembly component 1
increases expression
ISO
trovafloxacin results in increased expression of DMAC1 mRNA
CTD
PMID:35537566
NCBI chr 5:89,241,173...89,243,793
Ensembl chr 5:89,242,661...89,243,757
G
Dmpk
DM1 protein kinase
increases expression
ISO
trovafloxacin results in increased expression of DMPK mRNA
CTD
PMID:35537566
NCBI chr 1:78,730,255...78,740,585
Ensembl chr 1:78,730,275...78,740,593
G
Dnah17
dynein, axonemal, heavy chain 17
increases expression
ISO
trovafloxacin results in increased expression of DNAH17 mRNA
CTD
PMID:35537566
NCBI chr10:103,748,033...103,862,009
Ensembl chr10:103,249,363...103,364,901
G
Dnajb2
DnaJ heat shock protein family (Hsp40) member B2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of DNAJB2 mRNA
CTD
PMID:18930950
NCBI chr 9:76,731,060...76,739,278
Ensembl chr 9:76,731,065...76,739,277
G
Dnase2
deoxyribonuclease 2, lysosomal
decreases expression
ISO
trovafloxacin results in decreased expression of DNASE2A mRNA
CTD
PMID:35537566
NCBI chr19:40,149,505...40,152,225
Ensembl chr19:23,244,664...23,247,376
G
Dnd1
DND microRNA-mediated repression inhibitor 1
increases expression
ISO
trovafloxacin results in increased expression of DND1 mRNA
CTD
PMID:35537566
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of DNMT1 mRNA
CTD
PMID:35537566
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3l
DNA methyltransferase 3 like
decreases expression
ISO
trovafloxacin results in decreased expression of DNMT3L mRNA
CTD
PMID:35537566
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
EXP
trovafloxacin results in decreased expression of DNPH1 mRNA
CTD
PMID:24136188
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
G
Dock11
dedicator of cytokinesis 11
decreases expression
ISO
trovafloxacin results in decreased expression of DOCK11 mRNA
CTD
PMID:35537566
NCBI chr X:115,131,720...115,314,854
Ensembl chr X:115,131,909...115,314,854
G
Dock2
dedicator of cytokinesis 2
decreases expression
ISO
trovafloxacin results in decreased expression of DOCK2 mRNA
CTD
PMID:35537566
NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808
G
Dock9
dedicator of cytokinesis 9
decreases expression
ISO
trovafloxacin results in decreased expression of DOCK9 mRNA
CTD
PMID:35537566
NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153
G
Donson
DNA replication fork stabilization factor DONSON
decreases expression
ISO
trovafloxacin results in decreased expression of DONSON mRNA
CTD
PMID:35537566
NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889
G
Dpf1
double PHD fingers 1
increases expression
ISO
trovafloxacin results in increased expression of DPF1 mRNA
CTD
PMID:35537566
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
G
Drc3
dynein regulatory complex subunit 3
decreases expression
ISO
trovafloxacin results in decreased expression of DRC3 mRNA
CTD
PMID:35537566
NCBI chr10:45,620,045...45,698,902
Ensembl chr10:45,157,354...45,199,369
G
Dscc1
DNA replication and sister chromatid cohesion 1
decreases expression
ISO
trovafloxacin results in decreased expression of DSCC1 mRNA
CTD
PMID:35537566
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
G
Dsn1
DSN1 component of MIS12 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of DSN1 mRNA
CTD
PMID:35537566
NCBI chr 3:145,652,741...145,668,025
Ensembl chr 3:145,652,737...145,665,856
G
Dtnb
dystrobrevin, beta
decreases expression
ISO
trovafloxacin results in decreased expression of DTNB mRNA
CTD
PMID:35537566
NCBI chr 6:26,566,418...26,763,467
Ensembl chr 6:26,566,925...26,766,335
G
Dtnbp1
dystrobrevin binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of DTNBP1 mRNA
CTD
PMID:35537566
NCBI chr17:19,891,313...19,982,770
Ensembl chr17:19,685,215...19,776,661
G
Dtx1
deltex E3 ubiquitin ligase 1
decreases expression
ISO
trovafloxacin results in decreased expression of DTX1 mRNA
CTD
PMID:35537566
NCBI chr12:35,849,647...35,880,835
Ensembl chr12:35,849,617...35,880,838
G
Dtymk
deoxythymidylate kinase
decreases expression
EXP
trovafloxacin results in decreased expression of DTYMK mRNA
CTD
PMID:24136188
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:94,315,552...94,324,870
G
Dus1l
dihydrouridine synthase 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of DUS1L mRNA
CTD
PMID:35537566
NCBI chr10:106,055,519...106,062,656
Ensembl chr10:106,055,519...106,062,781
G
Dus4l
dihydrouridine synthase 4-like
decreases expression
ISO
trovafloxacin results in decreased expression of DUS4L mRNA
CTD
PMID:35537566
NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
trovafloxacin results in increased expression of DUSP1 mRNA
CTD
PMID:35537566
NCBI chr10:17,184,853...17,187,646
G
Dusp16
dual specificity phosphatase 16
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of DUSP16 mRNA
CTD
PMID:18930950
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp2
dual specificity phosphatase 2
increases expression
ISO
trovafloxacin results in increased expression of DUSP2 mRNA
CTD
PMID:35537566
NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:114,556,325...114,558,499
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
trovafloxacin results in increased expression of DUSP5 mRNA
CTD
PMID:35537566
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Dusp8
dual specificity phosphatase 8
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of DUSP8 mRNA
CTD
PMID:18930950
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
G
Dut
deoxyuridine triphosphatase
decreases expression
EXP ISO
trovafloxacin results in decreased expression of DUT mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:112,498,982...112,510,771
G
Dym
dymeclin
decreases expression
ISO
trovafloxacin results in decreased expression of DYM mRNA
CTD
PMID:35537566
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
G
Dync2i2
dynein 2 intermediate chain 2
decreases expression
ISO
trovafloxacin results in decreased expression of DYNC2I2 mRNA
CTD
PMID:35537566
NCBI chr 3:33,703,882...33,719,960
Ensembl chr 3:13,306,039...13,322,121
G
Dyrk1b
dual specificity tyrosine phosphorylation regulated kinase 1B
increases expression
ISO
trovafloxacin results in increased expression of DYRK1B mRNA
CTD
PMID:35537566
NCBI chr 1:92,606,743...92,624,089
Ensembl chr 1:83,479,147...83,487,169
G
Dyrk3
dual specificity tyrosine phosphorylation regulated kinase 3
increases expression
ISO
trovafloxacin results in increased expression of DYRK3 mRNA
CTD
PMID:35537566
NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778
G
Dzip3
DAZ interacting zinc finger protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of DZIP3 mRNA
CTD
PMID:35537566
NCBI chr11:51,823,235...51,893,353
Ensembl chr11:51,823,231...51,893,353
G
E2f1
E2F transcription factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of E2F1 mRNA
CTD
PMID:35537566
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
E2f7
E2F transcription factor 7
decreases expression
ISO
trovafloxacin results in decreased expression of E2F7 mRNA
CTD
PMID:35537566
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
G
E2f8
E2F transcription factor 8
decreases expression
ISO
trovafloxacin results in decreased expression of E2F8 mRNA
CTD
PMID:35537566
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Eaf1
ELL associated factor 1
increases expression
ISO
trovafloxacin results in increased expression of EAF1 mRNA
CTD
PMID:35537566
NCBI chr16:6,698,322...6,713,071
Ensembl chr16:6,698,322...6,713,071
G
Ears2
glutamyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
trovafloxacin results in decreased expression of EARS2 mRNA
CTD
PMID:35537566
NCBI chr 1:186,025,740...186,057,165
Ensembl chr 1:176,597,986...176,625,836
G
Echdc2
enoyl CoA hydratase domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of ECHDC2 mRNA
CTD
PMID:35537566
NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859
G
Echdc3
enoyl CoA hydratase domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of ECHDC3 mRNA
CTD
PMID:35537566
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
G
Eci1
enoyl-CoA delta isomerase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ECI1 mRNA
CTD
PMID:35537566
NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,456,563...13,470,061
G
Ect2
epithelial cell transforming 2
decreases expression
ISO
trovafloxacin results in decreased expression of ECT2 mRNA
CTD
PMID:35537566
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
G
Eda2r
ectodysplasin A2 receptor
increases expression
ISO
trovafloxacin results in increased expression of EDA2R mRNA
CTD
PMID:35537566
NCBI chr X:62,224,763...62,269,333
Ensembl chr X:62,228,229...62,269,268
G
Eef2k
eukaryotic elongation factor-2 kinase
decreases expression
ISO
trovafloxacin results in decreased expression of EEF2K mRNA
CTD
PMID:35537566
NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
G
Eef2kmt
eukaryotic elongation factor 2 lysine methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of EEF2KMT mRNA
CTD
PMID:35537566
NCBI chr10:10,336,933...10,349,463
Ensembl chr10:10,336,974...10,347,039
G
Efcab11
EF-hand calcium binding domain 11
decreases expression
ISO
trovafloxacin results in decreased expression of EFCAB11 mRNA
CTD
PMID:35537566
NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046
G
Efcab2
EF-hand calcium binding domain 2
decreases expression
ISO
trovafloxacin results in decreased expression of EFCAB2 mRNA
CTD
PMID:35537566
NCBI chr13:90,152,002...90,237,918
Ensembl chr13:90,152,185...90,238,218
G
Efcab5
EF-hand calcium binding domain 5
decreases expression
ISO
trovafloxacin results in decreased expression of EFCAB5 mRNA
CTD
PMID:35537566
NCBI chr10:61,926,419...62,042,745
Ensembl chr10:61,926,953...62,042,749
G
Efnb3
ephrin B3
increases expression
ISO
trovafloxacin results in increased expression of EFNB3 mRNA
CTD
PMID:35537566
NCBI chr10:54,274,506...54,281,951
Ensembl chr10:54,274,506...54,280,471
G
Egfl7
EGF-like-domain, multiple 7
decreases expression
ISO
trovafloxacin results in decreased expression of EGFL7 mRNA
CTD
PMID:35537566
NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of EGFR mRNA
CTD
PMID:18930950
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egr3
early growth response 3
decreases expression
ISO
trovafloxacin results in decreased expression of EGR3 mRNA
CTD
PMID:35537566
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ei24
EI24, autophagy associated transmembrane protein
increases expression
ISO
trovafloxacin results in increased expression of EI24 mRNA
CTD
PMID:35537566
NCBI chr 8:44,683,138...44,699,502
Ensembl chr 8:36,494,289...36,510,571
G
Eid1
EP300 interacting inhibitor of differentiation 1
increases expression
ISO
trovafloxacin results in increased expression of EID1 mRNA
CTD
PMID:35537566
NCBI chr 3:112,922,961...112,924,680
Ensembl chr 3:112,922,668...112,924,752
G
Eid2b
EP300 interacting inhibitor of differentiation 2B
increases expression
ISO
trovafloxacin results in increased expression of EID2B mRNA
CTD
PMID:35537566
NCBI chr 1:92,673,119...92,674,899
Ensembl chr 1:83,545,563...83,546,734
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
increases expression
ISO
trovafloxacin results in increased expression of EIF2AK2 mRNA
CTD
PMID:35537566
NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:16,188,979...16,224,971
G
Eif2b2
eukaryotic translation initiation factor 2B subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of EIF2B2 mRNA
CTD
PMID:35537566
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
decreases expression
EXP
trovafloxacin results in decreased expression of EIF2S1 mRNA
CTD
PMID:24136188
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
G
Eif2s2
eukaryotic translation initiation factor 2 subunit beta
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of EIF2S2 mRNA
CTD
PMID:18930950
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
G
Eif3a
eukaryotic translation initiation factor 3, subunit A
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of EIF3A mRNA
CTD
PMID:18930950
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
G
Eif3c
eukaryotic translation initiation factor 3, subunit C
decreases expression
EXP
trovafloxacin results in decreased expression of EIF3C mRNA
CTD
PMID:24136188
NCBI chr 1:181,134,604...181,152,489
Ensembl chr 1:181,134,604...181,152,493
G
Eif3l
eukaryotic translation initiation factor 3, subunit L
decreases expression
EXP
trovafloxacin results in decreased expression of EIF3L mRNA
CTD
PMID:24136188
NCBI chr 7:110,652,565...110,663,614
Ensembl chr 7:110,627,107...110,663,614
G
Eif4a2
eukaryotic translation initiation factor 4A2
increases expression
EXP ISO
trovafloxacin results in increased expression of EIF4A2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein; Sirolimus inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein] trovafloxacin results in decreased expression of EIF4EBP1 mRNA
CTD
PMID:33609687 PMID:35537566
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:64,790,226...64,805,984
G
Eif6
eukaryotic translation initiation factor 6
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of EIF6 mRNA
CTD
PMID:18930950
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Ell2
elongation factor for RNA polymerase II 2
increases expression
ISO
trovafloxacin results in increased expression of ELL2 mRNA
CTD
PMID:35537566
NCBI chr 2:5,189,375...5,258,781
Ensembl chr 2:5,189,971...5,258,781
G
Elmo3
engulfment and cell motility 3
increases expression
ISO
trovafloxacin results in increased expression of ELMO3 mRNA
CTD
PMID:35537566
NCBI chr19:33,181,952...33,186,399
Ensembl chr19:33,182,036...33,186,410
G
Elovl6
ELOVL fatty acid elongase 6
decreases expression
EXP
trovafloxacin results in decreased expression of ELOVL6 mRNA
CTD
PMID:24136188
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Emc1
ER membrane protein complex subunit 1
decreases expression
EXP
trovafloxacin results in decreased expression of EMC1 mRNA
CTD
PMID:24136188
NCBI chr 5:151,608,557...151,633,888
Ensembl chr 5:151,608,568...151,633,888
G
Eme1
essential meiotic structure-specific endonuclease 1
decreases expression
ISO
trovafloxacin results in decreased expression of EME1 mRNA
CTD
PMID:35537566
NCBI chr10:80,083,585...80,092,450
Ensembl chr10:79,586,729...79,595,435
G
Eml6
EMAP like 6
decreases expression
ISO
trovafloxacin results in decreased expression of EML6 mRNA
CTD
PMID:35537566
NCBI chr14:103,471,537...103,806,120
Ensembl chr14:103,476,372...103,805,849
G
Endog
endonuclease G
decreases expression
ISO
trovafloxacin results in decreased expression of ENDOG mRNA
CTD
PMID:35537566
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
G
Eno3
enolase 3
decreases expression
ISO
trovafloxacin results in decreased expression of ENO3 mRNA
CTD
PMID:35537566
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ENPP1 mRNA
CTD
PMID:35537566
NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:20,698,764...20,763,715
G
Enpp6
ectonucleotide pyrophosphatase/phosphodiesterase 6
decreases expression
ISO
trovafloxacin results in decreased expression of ENPP6 mRNA
CTD
PMID:35537566
NCBI chr16:45,165,883...45,294,126
Ensembl chr16:45,169,178...45,294,077
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ENTPD1 mRNA
CTD
PMID:35537566
NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:239,425,430...239,552,317
G
Epha2
Eph receptor A2
increases expression
ISO
trovafloxacin results in increased expression of EPHA2 mRNA
CTD
PMID:35537566
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Ephx1
epoxide hydrolase 1
decreases expression
EXP
trovafloxacin results in decreased expression of EPHX1 mRNA
CTD
PMID:24136188
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Epm2a
EPM2A glucan phosphatase, laforin
decreases expression
ISO
trovafloxacin results in decreased expression of EPM2A mRNA
CTD
PMID:35537566
NCBI chr 1:7,547,369...7,673,449
Ensembl chr 1:5,727,066...5,920,555
G
Epm2aip1
EPM2A interacting protein 1
increases expression
ISO
trovafloxacin results in increased expression of EPM2AIP1 mRNA
CTD
PMID:35537566
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of EPRS1 mRNA
CTD
PMID:35537566
NCBI chr13:99,431,955...99,503,510
Ensembl chr13:96,901,575...96,971,966
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of ERCC1 mRNA
CTD
PMID:35537566
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:78,996,390...79,007,963
G
Ercc6l
ERCC excision repair 6 like, spindle assembly checkpoint helicase
decreases expression
ISO
trovafloxacin results in decreased expression of ERCC6L mRNA
CTD
PMID:35537566
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
G
Ergic1
endoplasmic reticulum-golgi intermediate compartment 1
decreases expression
EXP
trovafloxacin results in decreased expression of ERGIC1 mRNA
CTD
PMID:24136188
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
G
Ermp1
endoplasmic reticulum metallopeptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ERMP1 mRNA
CTD
PMID:35537566
NCBI chr 1:227,383,992...227,422,120
Ensembl chr 1:227,387,920...227,436,909
G
Erp29
endoplasmic reticulum protein 29
decreases expression
EXP
trovafloxacin results in decreased expression of ERP29 mRNA
CTD
PMID:24136188
NCBI chr12:40,750,177...40,756,607
Ensembl chr12:35,089,707...35,096,376
G
Errfi1
ERBB receptor feedback inhibitor 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ERRFI1 mRNA
CTD
PMID:18930950
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:161,323,998...161,337,282
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of ESCO2 mRNA
CTD
PMID:35537566
NCBI chr15:44,210,124...44,230,785
Ensembl chr15:40,034,568...40,055,306 Ensembl chr15:40,034,568...40,055,306
G
Esd
esterase D
increases expression
ISO
trovafloxacin results in increased expression of ESD mRNA
CTD
PMID:35537566
NCBI chr15:56,453,082...56,472,582
Ensembl chr15:50,043,632...50,063,144
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
ISO
trovafloxacin results in decreased expression of ESPL1 mRNA
CTD
PMID:35537566
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
G
Esr1
estrogen receptor 1
decreases expression
ISO
trovafloxacin results in decreased expression of ESR1 mRNA
CTD
PMID:35537566
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esyt1
extended synaptotagmin 1
decreases expression
ISO
trovafloxacin results in decreased expression of ESYT1 mRNA
CTD
PMID:35537566
NCBI chr 7:928,848...946,199
Ensembl chr 7:928,848...946,199
G
Esyt2
extended synaptotagmin 2
decreases expression
ISO
trovafloxacin results in decreased expression of ESYT2 mRNA
CTD
PMID:35537566
NCBI chr 6:137,219,653...137,312,590
Ensembl chr 6:137,219,707...137,312,590
G
Ets2
ETS proto-oncogene 2, transcription factor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ETS2 mRNA
CTD
PMID:18930950
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Etv3
ETS variant transcription factor 3
increases expression
ISO
trovafloxacin results in increased expression of ETV3 mRNA
CTD
PMID:35537566
NCBI chr 2:172,965,461...172,980,320
Ensembl chr 2:172,965,588...172,980,314
G
Evi2a
ecotropic viral integration site 2A
increases expression
ISO
trovafloxacin results in increased expression of EVI2A mRNA
CTD
PMID:35537566
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
G
Evi5
ecotropic viral integration site 5
decreases expression
ISO
trovafloxacin results in decreased expression of EVI5 mRNA
CTD
PMID:35537566
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
G
Exd2
exonuclease 3'-5' domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of EXD2 mRNA
CTD
PMID:35537566
NCBI chr 6:100,116,867...100,150,452
Ensembl chr 6:100,116,867...100,150,442
G
Extl1
exostosin-like glycosyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of EXTL1 mRNA
CTD
PMID:35537566
NCBI chr 5:146,573,911...146,589,115
Ensembl chr 5:146,573,912...146,589,115
G
Eya4
EYA transcriptional coactivator and phosphatase 4
decreases expression
ISO
trovafloxacin results in decreased expression of EYA4 mRNA
CTD
PMID:35537566
NCBI chr 1:22,172,275...22,415,978
Ensembl chr 1:22,172,275...22,415,976
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
ISO
trovafloxacin results in decreased expression of EZH2 mRNA
CTD
PMID:35537566
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:76,624,399...76,687,362
G
F10
coagulation factor X
decreases expression
ISO
trovafloxacin results in decreased expression of F10 mRNA
CTD
PMID:35537566
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
F12
coagulation factor XII
increases expression
ISO
trovafloxacin results in increased expression of F12 mRNA
CTD
PMID:35537566
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530
G
F2
coagulation factor II, thrombin
multiple interactions
ISO
[Lipopolysaccharides co-treated with trovafloxacin] results in increased activity of F2 protein
CTD
PMID:19367693
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
F7
coagulation factor VII
decreases expression
ISO
trovafloxacin results in decreased expression of F7 mRNA
CTD
PMID:35537566
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
Faah
fatty acid amide hydrolase
decreases expression
ISO
trovafloxacin results in decreased expression of FAAH mRNA
CTD
PMID:35537566
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
G
Faap100
FA core complex associated protein 100
decreases expression
ISO
trovafloxacin results in decreased expression of FAAP100 mRNA
CTD
PMID:35537566
NCBI chr10:105,641,677...105,653,809
Ensembl chr10:105,639,414...105,653,494
G
Faf1
Fas associated factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of FAF1 mRNA
CTD
PMID:35537566
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
G
Fahd2a
fumarylacetoacetate hydrolase domain containing 2A
decreases expression
ISO
trovafloxacin results in decreased expression of FAHD2A mRNA
CTD
PMID:35537566
NCBI chr 3:114,657,176...114,665,349
Ensembl chr 3:114,655,865...114,665,356
G
Fam120c
family with sequence similarity 120 member C
decreases expression
ISO
trovafloxacin results in decreased expression of FAM120C mRNA
CTD
PMID:35537566
NCBI chr X:20,324,046...20,477,831
Ensembl chr X:20,323,381...20,477,275
G
Fam131a
family with sequence similarity 131, member A
decreases expression
ISO
trovafloxacin results in decreased expression of FAM131A mRNA
CTD
PMID:35537566
NCBI chr11:80,211,577...80,221,527
Ensembl chr11:80,211,745...80,221,511
G
Fam13c
family with sequence similarity 13, member C
decreases expression
ISO
trovafloxacin results in decreased expression of FAM13C mRNA
CTD
PMID:35537566
NCBI chr20:18,065,625...18,187,792
Ensembl chr20:18,065,628...18,187,592
G
Fam171a2
family with sequence similarity 171, member A2
decreases expression
ISO
trovafloxacin results in decreased expression of FAM171A2 mRNA
CTD
PMID:35537566
NCBI chr10:87,894,049...87,904,213
Ensembl chr10:87,394,007...87,404,053
G
Fam171b
family with sequence similarity 171, member B
decreases expression
ISO
trovafloxacin results in decreased expression of FAM171B mRNA
CTD
PMID:35537566
NCBI chr 3:68,930,755...68,986,113
Ensembl chr 3:68,930,822...68,986,127
G
Fam222b
family with sequence similarity 222, member B
increases expression
ISO
trovafloxacin results in increased expression of FAM222B mRNA
CTD
PMID:35537566
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
G
Fam83d
family with sequence similarity 83, member D
decreases expression
ISO
trovafloxacin results in decreased expression of FAM83D mRNA
CTD
PMID:35537566
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
G
Fam83h
family with sequence similarity 83, member H
increases expression
ISO
trovafloxacin results in increased expression of FAM83H mRNA
CTD
PMID:35537566
NCBI chr 7:107,716,431...107,724,619
Ensembl chr 7:107,716,431...107,728,672
G
Fam98a
family with sequence similarity 98, member A
decreases expression
EXP
trovafloxacin results in decreased expression of FAM98A mRNA
CTD
PMID:24136188
NCBI chr 6:19,874,082...19,888,744
Ensembl chr 6:19,874,071...19,888,742
G
Fanca
FA complementation group A
decreases expression
ISO
trovafloxacin results in decreased expression of FANCA mRNA
CTD
PMID:35537566
NCBI chr19:68,210,562...68,271,080
Ensembl chr19:51,304,021...51,362,527
G
Fancb
FA complementation group B
decreases expression
ISO
trovafloxacin results in decreased expression of FANCB mRNA
CTD
PMID:35537566
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
G
Fancc
FA complementation group C
decreases expression
ISO
trovafloxacin results in decreased expression of FANCC mRNA
CTD
PMID:35537566
NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,681,324...1,829,376
G
Fancd2
FA complementation group D2
decreases expression
ISO
trovafloxacin results in decreased expression of FANCD2 mRNA
CTD
PMID:35537566
NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:146,679,179...146,743,412
G
Fanci
FA complementation group I
decreases expression
ISO
trovafloxacin results in decreased expression of FANCI mRNA
CTD
PMID:35537566
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
G
Fasn
fatty acid synthase
multiple interactions decreases expression
ISO EXP
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of FASN mRNA trovafloxacin results in decreased expression of FASN mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fbxl12
F-box and leucine-rich repeat protein 12
increases expression
ISO
trovafloxacin results in increased expression of FBXL12 mRNA
CTD
PMID:35537566
NCBI chr 8:19,175,864...19,183,373
Ensembl chr 8:19,160,352...19,183,607
G
Fbxo15
F-box protein 15
decreases expression
ISO
trovafloxacin results in decreased expression of FBXO15 mRNA
CTD
PMID:35537566
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
G
Fbxo33
F-box protein 33
increases expression
ISO
trovafloxacin results in increased expression of FBXO33 mRNA
CTD
PMID:35537566
NCBI chr 6:76,900,619...76,934,232
Ensembl chr 6:76,900,631...76,932,669
G
Fbxo36
F-box protein 36
increases expression
ISO
trovafloxacin results in increased expression of FBXO36 mRNA
CTD
PMID:35537566
NCBI chr 9:86,042,522...86,107,220
Ensembl chr 9:86,040,862...86,107,229
G
Fbxo48
F-box protein 48
decreases expression
ISO
trovafloxacin results in decreased expression of FBXO48 mRNA
CTD
PMID:35537566
NCBI chr14:91,380,857...91,382,314
Ensembl chr14:91,380,857...91,382,314
G
Fbxo5
F-box protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of FBXO5 mRNA
CTD
PMID:35537566
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fbxo9
f-box protein 9
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of FBXO9 mRNA
CTD
PMID:18930950
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
G
Fbxw10
F-box and WD repeat domain containing 10
decreases expression
ISO
trovafloxacin results in decreased expression of FBXW10 mRNA
CTD
PMID:35537566
NCBI chr10:47,513,313...47,551,909
Ensembl chr10:47,486,297...47,551,907
G
Fcf1
Fcf1 rRNA-processing protein
increases expression
ISO
trovafloxacin results in increased expression of FCF1 mRNA
CTD
PMID:35537566
NCBI chr 6:104,617,780...104,629,643
Ensembl chr 6:104,617,770...104,629,643
G
Fcgr2b
Fc gamma receptor 2B
decreases expression
ISO
trovafloxacin results in decreased expression of FCGR2B mRNA
CTD
PMID:35537566
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:83,193,163...83,207,778
G
Fchsd1
FCH and double SH3 domains 1
increases expression
ISO
trovafloxacin results in increased expression of FCHSD1 mRNA
CTD
PMID:35537566
NCBI chr18:29,793,899...29,804,533
Ensembl chr18:29,793,899...29,804,466
G
Fdxr
ferredoxin reductase
decreases expression
ISO
trovafloxacin results in decreased expression of FDXR mRNA
CTD
PMID:35537566
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Ffar4
free fatty acid receptor 4
decreases expression
ISO
trovafloxacin results in decreased expression of FFAR4 mRNA
CTD
PMID:35537566
NCBI chr 1:235,873,576...235,891,597
Ensembl chr 1:235,873,576...235,891,597
G
Fga
fibrinogen alpha chain
multiple interactions
ISO
[Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of FGA protein
CTD
PMID:19367693
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:168,374,120...168,381,528
G
Fgd4
FYVE, RhoGEF and PH domain containing 4
decreases expression
ISO
trovafloxacin results in decreased expression of FGD4 mRNA
CTD
PMID:35537566
NCBI chr11:84,399,989...84,551,013
Ensembl chr11:84,399,816...84,546,972
G
Fgf22
fibroblast growth factor 22
increases expression
ISO
trovafloxacin results in increased expression of FGF22 mRNA
CTD
PMID:35537566
NCBI chr 7:10,598,254...10,600,945
Ensembl chr 7:9,948,071...9,950,486
G
Fignl2
fidgetin-like 2
increases expression
ISO
trovafloxacin results in increased expression of FIGNL2 mRNA
CTD
PMID:35537566
NCBI chr 7:132,160,006...132,187,896
Ensembl chr 7:132,162,390...132,164,336
G
Filip1l
filamin A interacting protein 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of FILIP1L mRNA
CTD
PMID:35537566
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
G
Fjx1
four-jointed box kinase 1
increases expression
EXP
trovafloxacin results in increased expression of ANKHD1-EIF4EBP3 mRNA
CTD
PMID:24136188
NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:88,774,220...88,776,321
G
Fkbp11
FKBP prolyl isomerase 11
decreases expression
ISO
trovafloxacin results in decreased expression of FKBP11 mRNA
CTD
PMID:35537566
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
G
Fkbp15
FKBP prolyl isomerase family member 15
decreases expression
ISO
trovafloxacin results in decreased expression of FKBP15 mRNA
CTD
PMID:35537566
NCBI chr 5:75,750,786...75,815,038
Ensembl chr 5:75,750,787...75,814,990
G
Fkbp4
FKBP prolyl isomerase 4
decreases expression
EXP
trovafloxacin results in decreased expression of FKBP4 mRNA
CTD
PMID:24136188
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
G
Fkbp8
FKBP prolyl isomerase 8
decreases expression
ISO
trovafloxacin results in decreased expression of FKBP8 mRNA
CTD
PMID:35537566
NCBI chr16:18,929,581...18,936,621
Ensembl chr16:18,893,576...18,902,612
G
Fkbpl
FKBP prolyl isomerase like
decreases expression
ISO
trovafloxacin results in decreased expression of FKBPL mRNA
CTD
PMID:35537566
NCBI chr20:4,099,845...4,101,315
Ensembl chr20:4,099,806...4,101,368
G
Flrt2
fibronectin leucine rich transmembrane protein 2
increases expression
ISO
trovafloxacin results in increased expression of FLRT2 mRNA
CTD
PMID:35537566
NCBI chr 6:114,777,547...114,872,688
Ensembl chr 6:114,777,599...114,872,785
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
increases expression
EXP
trovafloxacin results in increased expression of FMO3 mRNA
CTD
PMID:24136188
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Fmo5
flavin containing dimethylaniline monoxygenase 5
decreases expression
ISO
trovafloxacin results in decreased expression of FMO5 mRNA
CTD
PMID:35537566
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
G
Fnbp1l
formin binding protein 1-like
increases expression
ISO
trovafloxacin results in increased expression of FNBP1L mRNA
CTD
PMID:35537566
NCBI chr 2:210,647,241...210,748,203
Ensembl chr 2:210,647,246...210,738,455
G
Fnbp4
formin binding protein 4
increases expression
ISO
trovafloxacin results in increased expression of FNBP4 mRNA
CTD
PMID:35537566
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
G
Fndc8
fibronectin type III domain containing 8
increases expression
ISO
trovafloxacin results in increased expression of FNDC8 mRNA
CTD
PMID:35537566
NCBI chr10:68,323,500...68,331,638
Ensembl chr10:67,825,952...67,834,090
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of FOS mRNA trovafloxacin results in increased expression of FOS mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
trovafloxacin results in increased expression of FOSL1 mRNA
CTD
PMID:35537566
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
increases expression
ISO
trovafloxacin results in increased expression of FOSL2 mRNA
CTD
PMID:35537566
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:24,300,956...24,320,034
G
Foxm1
forkhead box M1
decreases expression
ISO
trovafloxacin results in decreased expression of FOXM1 mRNA
CTD
PMID:35537566
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
G
Frat2
FRAT regulator of WNT signaling pathway 2
decreases expression
ISO
trovafloxacin results in decreased expression of FRAT2 mRNA
CTD
PMID:35537566
NCBI chr 1:240,654,120...240,656,449
Ensembl chr 1:240,654,137...240,656,517
G
Frs3
fibroblast growth factor receptor substrate 3
increases expression
ISO
trovafloxacin results in increased expression of FRS3 mRNA
CTD
PMID:35537566
NCBI chr 9:13,288,559...13,297,285
Ensembl chr 9:13,288,667...13,295,382
G
Fry
FRY microtubule binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of FRY mRNA
CTD
PMID:35537566
NCBI chr12:9,530,360...9,773,391
Ensembl chr12:4,493,891...4,799,116
G
Fubp1
far upstream element binding protein 1
increases expression
ISO
trovafloxacin results in increased expression of FUBP1 mRNA
CTD
PMID:35537566
NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:241,159,512...241,186,602
G
Fut10
fucosyltransferase 10
decreases expression
ISO
trovafloxacin results in decreased expression of FUT10 mRNA
CTD
PMID:35537566
NCBI chr16:60,868,761...60,958,762
Ensembl chr16:60,877,952...60,958,683
G
Fut4
fucosyltransferase 4
increases expression
ISO
trovafloxacin results in increased expression of FUT4 mRNA
CTD
PMID:35537566
NCBI chr 8:11,586,721...11,590,682
Ensembl chr 8:11,586,721...11,590,682
G
Fut8
fucosyltransferase 8
decreases expression
ISO
trovafloxacin results in decreased expression of FUT8 mRNA
CTD
PMID:35537566
NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677
G
Fuz
fuzzy planar cell polarity protein
decreases expression
ISO
trovafloxacin results in decreased expression of FUZ mRNA
CTD
PMID:35537566
NCBI chr 1:95,379,542...95,384,532
Ensembl chr 1:95,379,587...95,384,530
G
Fzd7
frizzled class receptor 7
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of FZD7 mRNA
CTD
PMID:18930950
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
Fzd8
frizzled class receptor 8
increases expression
ISO
trovafloxacin results in increased expression of FZD8 mRNA
CTD
PMID:35537566
NCBI chr17:62,007,849...62,015,485
Ensembl chr17:57,314,450...57,320,650
G
G2e3
G2/M-phase specific E3 ubiquitin protein ligase
decreases expression
ISO
trovafloxacin results in decreased expression of G2E3 mRNA
CTD
PMID:35537566
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of G6PC1 mRNA
CTD
PMID:18930950
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
decreases expression
EXP
trovafloxacin results in decreased expression of G6PD mRNA
CTD
PMID:24136188
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gaa
alpha glucosidase
decreases expression
ISO
trovafloxacin results in decreased expression of GAA mRNA
CTD
PMID:35537566
NCBI chr10:105,028,106...105,045,365
Ensembl chr10:104,529,747...104,546,836
G
Gabarapl1
GABA type A receptor associated protein like 1
multiple interactions increases expression
ISO
[trovafloxacin co-treated with TNF protein] results in increased expression of GABARAPL1 mRNA trovafloxacin results in increased expression of GABARAPL1 mRNA
CTD
PMID:33609687
NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:162,980,249...162,989,450
G
Gabarapl2
GABA type A receptor associated protein like 2
multiple interactions increases expression
ISO
TNF protein inhibits the reaction [trovafloxacin results in increased expression of GABARAPL2 mRNA]
CTD
PMID:33609687
NCBI chr19:56,819,826...56,830,662
Ensembl chr19:39,910,534...39,924,628
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases expression
ISO
trovafloxacin results in decreased expression of GADD45A mRNA
CTD
PMID:35537566
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
trovafloxacin results in increased expression of GADD45B mRNA
CTD
PMID:35537566
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of GADD45G mRNA trovafloxacin results in increased expression of GADD45G mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Gal3st4
galactose-3-O-sulfotransferase 4
increases expression
ISO
trovafloxacin results in increased expression of GAL3ST4 mRNA
CTD
PMID:35537566
NCBI chr12:17,267,963...17,276,951
Ensembl chr12:17,267,963...17,276,833
G
Galc
galactosylceramidase
decreases expression
ISO
trovafloxacin results in decreased expression of GALC mRNA
CTD
PMID:35537566
NCBI chr 6:123,182,636...123,252,024
Ensembl chr 6:117,452,895...117,515,830
G
Gan
gigaxonin
increases expression
ISO
trovafloxacin results in increased expression of GAN mRNA
CTD
PMID:35537566
NCBI chr19:45,207,783...45,265,066
Ensembl chr19:45,207,184...45,254,107
G
Ganc
glucosidase, alpha; neutral C
decreases expression
ISO
trovafloxacin results in decreased expression of GANC mRNA
CTD
PMID:35537566
NCBI chr 3:107,353,369...107,406,104
Ensembl chr 3:107,353,369...107,405,241
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
decreases expression
EXP
trovafloxacin results in decreased expression of GAPDH mRNA
CTD
PMID:24136188
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gapdhs
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
increases expression
ISO
trovafloxacin results in increased expression of GAPDHS mRNA
CTD
PMID:35537566
NCBI chr 1:85,979,096...85,994,153
Ensembl chr 1:85,979,098...85,993,640
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of GARS1 mRNA
CTD
PMID:35537566
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
decreases expression
ISO
trovafloxacin results in decreased expression of GAS2 mRNA
CTD
PMID:35537566
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gas5
growth arrest specific 5
increases expression
ISO
trovafloxacin results in increased expression of GAS5 mRNA
CTD
PMID:35537566
NCBI chr13:73,303,611...73,306,932
G
Gas8
growth arrest specific 8
increases expression
ISO
trovafloxacin results in increased expression of GAS8 mRNA
CTD
PMID:35537566
NCBI chr19:68,461,280...68,480,810
Ensembl chr19:51,552,816...51,572,305
G
Gbp1
guanylate binding protein 1
increases expression
ISO
trovafloxacin results in increased expression of GBP2B mRNA
CTD
PMID:35537566
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gbp2
guanylate binding protein 2
increases expression
ISO
trovafloxacin results in increased expression of GBP2 mRNA
CTD
PMID:35537566
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gbp6
guanylate binding protein family member 6
increases expression
ISO
trovafloxacin results in increased expression of GBP6 mRNA
CTD
PMID:35537566
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gbp7
guanylate binding protein 7
increases expression
ISO
trovafloxacin results in increased expression of GBP7 mRNA
CTD
PMID:35537566
NCBI chr 2:231,275,521...231,297,289
Ensembl chr 2:231,275,640...231,297,278
G
Gcat
glycine C-acetyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of GCAT mRNA
CTD
PMID:35537566
NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:110,595,091...110,601,473
G
Gcgr
glucagon receptor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GCGR mRNA
CTD
PMID:18930950
NCBI chr10:106,306,803...106,314,970
Ensembl chr10:105,808,473...105,816,640
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression multiple interactions
EXP ISO
trovafloxacin results in decreased expression of GCLC mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GCLC mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gen1
GEN1 Holliday junction 5' flap endonuclease
decreases expression
ISO
trovafloxacin results in decreased expression of GEN1 mRNA
CTD
PMID:35537566
NCBI chr 6:33,947,599...33,978,461
Ensembl chr 6:33,948,206...33,978,401
G
Get1
guided entry of tail-anchored proteins factor 1
increases expression
ISO
trovafloxacin results in increased expression of WRB mRNA
CTD
PMID:35537566
NCBI chr11:35,438,555...35,460,156
Ensembl chr11:35,445,815...35,459,973
G
Gfm1
G elongation factor, mitochondrial 1
decreases expression
EXP
trovafloxacin results in decreased expression of GFM1 mRNA
CTD
PMID:24136188
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
G
Gfod2
Gfo/Idh/MocA-like oxidoreductase domain containing 2
increases expression
ISO
trovafloxacin results in increased expression of GFOD2 mRNA
CTD
PMID:35537566
NCBI chr19:33,599,689...33,647,060
Ensembl chr19:33,604,187...33,647,004
G
Ggcx
gamma-glutamyl carboxylase
decreases expression
EXP
trovafloxacin results in decreased expression of GGCX mRNA
CTD
PMID:24136188
NCBI chr 4:104,469,737...104,485,631
Ensembl chr 4:104,469,765...104,487,063
G
Gins2
GINS complex subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of GINS2 mRNA
CTD
PMID:35537566
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
G
Gipc1
GIPC PDZ domain containing family, member 1
decreases expression
ISO
trovafloxacin results in decreased expression of GIPC1 mRNA
CTD
PMID:35537566
NCBI chr19:24,474,291...24,487,083
Ensembl chr19:24,453,123...24,486,997
G
Gja1
gap junction protein, alpha 1
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of GJA1 mRNA trovafloxacin results in increased expression of GJA1 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Glis2
GLIS family zinc finger 2
increases expression
ISO
trovafloxacin results in increased expression of GLIS2 mRNA
CTD
PMID:35537566
NCBI chr10:10,951,157...10,978,524
Ensembl chr10:10,951,371...10,971,578
G
Glmp
glycosylated lysosomal membrane protein
decreases expression
ISO
trovafloxacin results in decreased expression of GLMP mRNA
CTD
PMID:35537566
NCBI chr 2:173,794,273...173,797,863
Ensembl chr 2:173,794,255...173,799,960
G
Glp2r
glucagon-like peptide 2 receptor
increases expression
ISO
trovafloxacin results in increased expression of GLP2R mRNA
CTD
PMID:35537566
NCBI chr10:52,402,748...52,466,012
Ensembl chr10:52,402,748...52,466,012
G
Glrx3
glutaredoxin 3
decreases expression
EXP
trovafloxacin results in decreased expression of GLRX3 mRNA
CTD
PMID:24136188
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
G
Gls2
glutaminase 2
decreases expression
ISO
trovafloxacin results in decreased expression of GLS2 mRNA
CTD
PMID:35537566
NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:617,288...633,426
G
Glyat
glycine-N-acyltransferase
increases expression
EXP
trovafloxacin results in increased expression of GLYAT mRNA
CTD
PMID:24136188
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
G
Gmfb
glia maturation factor, beta
increases expression
ISO
trovafloxacin results in increased expression of GMFB mRNA
CTD
PMID:35537566
NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331
G
Gnat2
G protein subunit alpha transducin 2
decreases expression
ISO
trovafloxacin results in decreased expression of GNAT2 mRNA
CTD
PMID:35537566
NCBI chr 2:195,726,371...195,735,866
Ensembl chr 2:195,726,762...195,735,866
G
Gnl3
G protein nucleolar 3
increases expression
EXP
trovafloxacin results in increased expression of GNL3 mRNA
CTD
PMID:24136188
NCBI chr16:6,207,402...6,213,491
Ensembl chr16:6,207,402...6,213,392
G
Gnpat
glyceronephosphate O-acyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of GNPAT mRNA
CTD
PMID:35537566
NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361
G
Gnpnat1
glucosamine-phosphate N-acetyltransferase 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GNPNAT1 mRNA
CTD
PMID:18930950
NCBI chr15:21,076,129...21,088,526
Ensembl chr15:18,596,442...18,608,739
G
Gnptg
N-acetylglucosamine-1-phosphate transferase subunit gamma
decreases expression
ISO
trovafloxacin results in decreased expression of GNPTG mRNA
CTD
PMID:35537566
NCBI chr10:14,252,186...14,257,128
Ensembl chr10:14,251,136...14,257,096
G
Golga2
golgin A2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GOLGA2 mRNA
CTD
PMID:18930950
NCBI chr 3:15,583,862...15,604,279
Ensembl chr 3:15,584,039...15,604,279
G
Golga4
golgin A4
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GOLGA4 mRNA
CTD
PMID:18930950
NCBI chr 8:118,208,200...118,285,003
G
Gpaa1
glycosylphosphatidylinositol anchor attachment 1
decreases expression
ISO
trovafloxacin results in decreased expression of GPAA1 mRNA
CTD
PMID:35537566
NCBI chr 7:108,051,896...108,055,479
Ensembl chr 7:108,051,861...108,055,484
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
EXP
trovafloxacin results in decreased expression of GPAM mRNA
CTD
PMID:24136188
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:254,106,331...254,142,639
G
Gpat3
glycerol-3-phosphate acyltransferase 3
decreases expression
ISO
trovafloxacin results in decreased expression of AGPAT9 mRNA
CTD
PMID:35537566
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpatch3
G patch domain containing 3
increases expression
ISO
trovafloxacin results in increased expression of GPATCH3 mRNA
CTD
PMID:35537566
NCBI chr 5:145,800,107...145,809,519
Ensembl chr 5:145,800,111...145,809,250
G
Gpc1
glypican 1
increases expression
ISO
trovafloxacin results in increased expression of GPC1 mRNA
CTD
PMID:35537566
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
G
Gphn
gephyrin
decreases expression
ISO
trovafloxacin results in decreased expression of GPHN mRNA
CTD
PMID:35537566
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:96,892,148...97,483,612
G
Gpld1
glycosylphosphatidylinositol specific phospholipase D1
increases expression
EXP
trovafloxacin results in increased expression of GPLD1 mRNA
CTD
PMID:24136188
NCBI chr17:40,084,427...40,132,035
Ensembl chr17:40,084,617...40,126,939
G
Gpr155
G protein-coupled receptor 155
decreases expression
ISO
trovafloxacin results in decreased expression of GPR155 mRNA
CTD
PMID:35537566
NCBI chr 3:58,216,422...58,270,350
Ensembl chr 3:58,216,423...58,270,275
G
Gpr160
G protein-coupled receptor 160
decreases expression
ISO
trovafloxacin results in decreased expression of GPR160 mRNA
CTD
PMID:35537566
NCBI chr 2:112,483,364...112,563,072
Ensembl chr 2:112,484,935...112,563,148
G
Gpr17
G protein-coupled receptor 17
increases expression
ISO
trovafloxacin results in increased expression of GPR17 mRNA
CTD
PMID:35537566
NCBI chr18:23,576,232...23,583,153
Ensembl chr18:23,577,242...23,582,966
G
Gpr176
G protein-coupled receptor 176
decreases expression
ISO
trovafloxacin results in decreased expression of GPR176 mRNA
CTD
PMID:35537566
NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226
G
Gpr19
G protein-coupled receptor 19
decreases expression
ISO
trovafloxacin results in decreased expression of GPR19 mRNA
CTD
PMID:35537566
NCBI chr 4:167,710,944...167,739,232
Ensembl chr 4:167,710,666...167,741,036
G
Gpr34
G protein-coupled receptor 34
decreases expression
ISO
trovafloxacin results in decreased expression of GPR34 mRNA
CTD
PMID:35537566
NCBI chr X:9,104,829...9,113,796
Ensembl chr X:9,104,565...9,148,601
G
Gpr35
G protein-coupled receptor 35
decreases expression
ISO
trovafloxacin results in decreased expression of GPR35 mRNA
CTD
PMID:35537566
NCBI chr 9:93,527,165...93,539,573
Ensembl chr 9:93,527,127...93,539,299
G
Gpr65
G-protein coupled receptor 65
decreases expression
ISO
trovafloxacin results in decreased expression of GPR65 mRNA
CTD
PMID:35537566
NCBI chr 6:117,515,786...117,536,514
Ensembl chr 6:117,515,648...117,536,512
G
Gpsm2
G-protein signaling modulator 2
decreases expression
ISO
trovafloxacin results in decreased expression of GPSM2 mRNA
CTD
PMID:35537566
NCBI chr 2:199,015,250...199,063,788
Ensembl chr 2:196,327,149...196,375,154
G
Gpt2
glutamic--pyruvic transaminase 2
decreases expression
ISO
trovafloxacin results in decreased expression of GPT2 mRNA
CTD
PMID:35537566
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:21,517,621...21,560,610
G
Grhl1
grainyhead-like transcription factor 1
increases expression
ISO
trovafloxacin results in increased expression of GRHL1 mRNA
CTD
PMID:35537566
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
G
Grin3b
glutamate ionotropic receptor NMDA type subunit 3B
increases expression
ISO
trovafloxacin results in increased expression of GRIN3B mRNA
CTD
PMID:35537566
NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183
G
Grwd1
glutamate-rich WD repeat containing 1
increases expression
ISO
trovafloxacin results in increased expression of GRWD1 mRNA
CTD
PMID:35537566
NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:96,301,261...96,307,201
G
Gsr
glutathione-disulfide reductase
decreases expression
EXP
trovafloxacin results in decreased expression of GSR mRNA
CTD
PMID:24136188
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gss
glutathione synthetase
decreases expression
EXP
trovafloxacin results in decreased expression of GSS mRNA
CTD
PMID:24136188
NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:144,047,850...144,078,198
G
Gsta3
glutathione S-transferase alpha 3
decreases expression
EXP
trovafloxacin results in decreased expression of GSTA3 mRNA
CTD
PMID:24136188
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gtf3a
general transcription factor III A
decreases expression
ISO
trovafloxacin results in decreased expression of GTF3A mRNA
CTD
PMID:35537566
NCBI chr12:8,136,746...8,144,690
Ensembl chr12:8,136,747...8,144,690
G
Gtpbp2
GTP binding protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of GTPBP2 mRNA
CTD
PMID:35537566
NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241
G
Gtpbp6
GTP binding protein 6 (putative)
increases expression
ISO
trovafloxacin results in increased expression of GTPBP6 mRNA
CTD
PMID:35537566
NCBI chr12:46,574,913...46,578,873
Ensembl chr12:46,574,435...46,578,873
G
Gtse1
G-2 and S-phase expressed 1
increases expression
ISO
trovafloxacin results in increased expression of GTSE1 mRNA
CTD
PMID:35537566
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
G
Gvin1
GTPase, very large interferon inducible 1
increases expression
ISO
trovafloxacin results in increased expression of GVIN2 mRNA
CTD
PMID:35537566
NCBI chr 1:160,279,767...160,306,701
Ensembl chr 1:160,277,126...160,306,331
G
H1f0
H1.0 linker histone
decreases expression
ISO
trovafloxacin results in decreased expression of H1F0 mRNA
CTD
PMID:35537566
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
G
H1f10
H1.10 linker histone
decreases expression
ISO
trovafloxacin results in decreased expression of H1F10 mRNA
CTD
PMID:35537566
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
G
H1f2
H1.2 linker histone, cluster member
decreases expression
ISO
trovafloxacin results in decreased expression of H1F2 mRNA
CTD
PMID:35537566
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
H1f4
H1.4 linker histone, cluster member
decreases expression
ISO
trovafloxacin results in decreased expression of H1F4 mRNA
CTD
PMID:35537566
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
G
H1f5
H1.5 linker histone, cluster member
decreases expression
ISO
trovafloxacin results in decreased expression of H1F5 mRNA
CTD
PMID:35537566
NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160
G
H2ac10
H2A clustered histone 10
decreases expression
ISO
trovafloxacin results in decreased expression of H2AC10 mRNA
CTD
PMID:35537566
NCBI chr17:41,570,532...41,571,020
Ensembl chr17:41,570,273...41,571,049
G
H2ac4
H2A clustered histone 4
decreases expression
ISO
trovafloxacin results in decreased expression of H2AC4 mRNA
CTD
PMID:35537566
NCBI chr17:47,495,624...47,496,127
Ensembl chr17:42,799,652...42,800,381
G
H2ax
H2A.X variant histone
multiple interactions increases expression increases phosphorylation decreases expression
ISO
[TNF protein co-treated with trovafloxacin] results in increased expression of H2AX protein modified form; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased expression of H2AX protein modified form]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [trovafloxacin results in increased expression of H2AX protein modified form]; TNF protein promotes the reaction [trovafloxacin results in increased expression of H2AX protein modified form] trovafloxacin results in increased phosphorylation of H2AX protein trovafloxacin results in decreased expression of H2AX mRNA
CTD
PMID:24817034 PMID:25748550 PMID:35537566
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
H2bc18
H2B clustered histone 18
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC18 mRNA
CTD
PMID:35537566
NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529
G
H2bc3
H2B clustered histone 3
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC3 mRNA
CTD
PMID:35537566
NCBI chr17:41,380,056...41,380,686
G
H2bc6
H2B clustered histone 6
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC6 mRNA
CTD
PMID:35537566
NCBI chr17:41,520,775...41,521,238
G
H2bc8
H2B clustered histone 8
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC8 mRNA
CTD
PMID:35537566
NCBI chr17:47,404,405...47,405,155
G
H2bc9
H2B clustered histone 9
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC9 mRNA
CTD
PMID:35537566
NCBI chr17:47,166,372...47,174,369
G
H4cl1
histone H4C like 1
decreases expression
ISO
trovafloxacin results in decreased expression of H4C6 mRNA
CTD
PMID:35537566
NCBI chr17:41,368,743...41,426,735
G
H4f3
H1.3 linker histone, cluster member
decreases expression
ISO
trovafloxacin results in decreased expression of H1F3 mRNA
CTD
PMID:35537566
NCBI chr17:41,551,524...41,552,303
Ensembl chr17:41,529,667...41,552,334
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
decreases expression
EXP
trovafloxacin results in decreased expression of HACD3 mRNA
CTD
PMID:24136188
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
G
Hacd4
3-hydroxyacyl-CoA dehydratase 4
decreases expression
ISO
trovafloxacin results in decreased expression of HACD4 mRNA
CTD
PMID:35537566
NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:102,887,588...102,915,338
G
Hacl1
2-hydroxyacyl-CoA lyase 1
increases expression decreases expression
EXP ISO
trovafloxacin results in increased expression of HACL1 mRNA trovafloxacin results in decreased expression of HACL1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,824,906...6,863,027
G
Hao2
hydroxyacid oxidase 2
increases expression
EXP
trovafloxacin results in increased expression of HAO2 mRNA
CTD
PMID:24136188
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Haspin
histone H3 associated protein kinase
decreases expression
ISO
trovafloxacin results in decreased expression of GSG2 mRNA
CTD
PMID:35537566
NCBI chr10:57,747,731...57,750,518
Ensembl chr10:57,747,573...57,750,512
G
Haus4
HAUS augmin-like complex, subunit 4
decreases expression
ISO
trovafloxacin results in decreased expression of HAUS4 mRNA
CTD
PMID:35537566
NCBI chr15:27,994,530...28,006,147
Ensembl chr15:27,994,532...28,005,938
G
Haus5
HAUS augmin-like complex, subunit 5
decreases expression
ISO
trovafloxacin results in decreased expression of HAUS5 mRNA
CTD
PMID:35537566
NCBI chr 1:85,912,371...85,924,327
Ensembl chr 1:85,912,374...85,923,337
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
trovafloxacin results in increased expression of HBEGF mRNA
CTD
PMID:35537566
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,105,760...28,116,441
G
Hcn2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
decreases expression
ISO
trovafloxacin results in decreased expression of HCN2 mRNA
CTD
PMID:35537566
NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:9,970,368...9,988,841
G
Hdhd3
haloacid dehalogenase-like hydrolase domain containing 3
increases expression
ISO
trovafloxacin results in increased expression of HDHD3 mRNA
CTD
PMID:35537566
NCBI chr 5:75,951,308...75,954,775
Ensembl chr 5:75,946,013...75,955,266
G
Hdlbp
high density lipoprotein binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of HDLBP mRNA
CTD
PMID:35537566
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
G
Hemk1
HemK methyltransferase family member 1
decreases expression
ISO
trovafloxacin results in decreased expression of HEMK1 mRNA
CTD
PMID:35537566
NCBI chr 8:107,999,658...108,010,732
Ensembl chr 8:107,999,644...108,010,256
G
Herc1
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1
decreases expression
ISO
trovafloxacin results in decreased expression of HERC1 mRNA
CTD
PMID:35537566
NCBI chr 8:66,857,169...67,070,318
Ensembl chr 8:66,856,935...67,070,312
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
decreases expression
ISO
trovafloxacin results in decreased expression of HERPUD1 mRNA
CTD
PMID:35537566
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,598,417...10,618,424
G
Hilpda
hypoxia inducible lipid droplet-associated
increases expression
ISO
trovafloxacin results in increased expression of HILPDA mRNA
CTD
PMID:35537566
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hip1r
huntingtin interacting protein 1 related
decreases expression
ISO
trovafloxacin results in decreased expression of HIP1R mRNA
CTD
PMID:35537566
NCBI chr12:32,590,164...32,618,841
Ensembl chr12:32,590,165...32,618,734
G
Hirip3
HIRA interacting protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of HIRIP3 mRNA
CTD
PMID:35537566
NCBI chr 1:181,472,537...181,475,082
Ensembl chr 1:181,472,056...181,475,079
G
Hist1h2af
histone cluster 1 H2A family member F
decreases expression
ISO
trovafloxacin results in decreased expression of H2AC8 mRNA
CTD
PMID:35537566
NCBI chr17:41,807,261...41,807,653
Ensembl chr17:41,379,404...41,379,796
G
Hist1h2ail1
histone cluster 1 H2a family member I like 1
decreases expression
ISO
trovafloxacin results in decreased expression of H3C10 mRNA; trovafloxacin results in decreased expression of H3C11 mRNA; trovafloxacin results in decreased expression of H3C6 mRNA
CTD
PMID:35537566
NCBI chr17:41,568,181...41,569,093
Ensembl chr17:41,568,471...41,569,109
G
Hist1h2bc
histone cluster 1, H2bc
decreases expression
ISO
trovafloxacin results in decreased expression of H2BC4 mRNA
CTD
PMID:35537566
NCBI chr17:47,388,085...47,392,349
Ensembl chr17:42,694,723...42,696,642
G
Hist1h4b
histone cluster 1 H4 family member B
decreases expression
ISO
trovafloxacin results in decreased expression of H4C9 mRNA
CTD
PMID:35537566
NCBI chr17:47,176,246...47,180,690
Ensembl chr17:42,480,313...42,485,370
G
Hist1h4m
histone cluster 1, H4m
decreases expression
ISO
trovafloxacin results in decreased expression of H4C1 mRNA
CTD
PMID:35537566
NCBI chr17:47,393,764...47,394,168
Ensembl chr17:42,698,025...42,698,958
G
Hltf
helicase-like transcription factor
decreases expression
ISO
trovafloxacin results in decreased expression of HLTF mRNA
CTD
PMID:35537566
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
G
Hmga2
high mobility group AT-hook 2
increases expression
ISO
trovafloxacin results in increased expression of HMGA2 mRNA
CTD
PMID:35537566
NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb2
high mobility group box 2
decreases expression
ISO
trovafloxacin results in decreased expression of HMGB2 mRNA
CTD
PMID:35537566
NCBI chr16:37,721,374...37,723,950
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
G
Hmgb3
high mobility group box 3
decreases expression
ISO
trovafloxacin results in decreased expression of HMGB3 mRNA
CTD
PMID:35537566
NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292
G
Hmgn3
high mobility group nucleosomal binding domain 3
decreases expression
EXP
trovafloxacin results in decreased expression of HMGN3 mRNA
CTD
PMID:24136188
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
G
Hmgn5
high mobility group nucleosome binding domain 5
decreases expression
ISO
trovafloxacin results in decreased expression of HMGN5 mRNA
CTD
PMID:35537566
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441 Ensembl chr 1:74,085,875...74,094,441
G
Hmmr
hyaluronan-mediated motility receptor
decreases expression
ISO
trovafloxacin results in decreased expression of HMMR mRNA
CTD
PMID:35537566
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,132,977...25,163,060
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of HMOX1 mRNA
CTD
PMID:18930950
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
ISO
trovafloxacin results in increased expression of HNRNPA1 mRNA
CTD
PMID:35537566
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
increases expression
ISO
trovafloxacin results in increased expression of HNRNPDL mRNA
CTD
PMID:35537566
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hnrnpf
heterogeneous nuclear ribonucleoprotein F
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of HNRNPF mRNA
CTD
PMID:18930950
NCBI chr 4:151,083,262...151,104,464
Ensembl chr 4:151,083,062...151,109,038
G
Hnrnpl
heterogeneous nuclear ribonucleoprotein L
increases expression
ISO
trovafloxacin results in increased expression of HNRNPL mRNA
CTD
PMID:35537566
NCBI chr 1:93,226,373...93,239,084
Ensembl chr 1:84,100,879...84,111,553
G
Hoxb5
homeo box B5
decreases expression
ISO
trovafloxacin results in decreased expression of HOXB5 mRNA
CTD
PMID:35537566
NCBI chr10:81,765,911...81,768,119
Ensembl chr10:81,269,372...81,271,580
G
Hoxb8
homeo box B8
increases expression
ISO
trovafloxacin results in increased expression of HOXB8 mRNA
CTD
PMID:35537566
NCBI chr10:81,745,430...81,747,181
Ensembl chr10:81,248,887...81,250,638
G
Hp
haptoglobin
decreases expression
ISO
trovafloxacin results in decreased expression of HP mRNA
CTD
PMID:35537566
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hs3st3b1
heparan sulfate-glucosamine 3-sulfotransferase 3B1
decreases expression
ISO
trovafloxacin results in decreased expression of HS3ST3B1 mRNA
CTD
PMID:35537566
NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970
G
Hspb6
heat shock protein family B (small) member 6
decreases expression
ISO
trovafloxacin results in decreased expression of HSPB6 mRNA
CTD
PMID:35537566
NCBI chr 1:85,806,898...85,809,072
Ensembl chr 1:85,806,146...85,809,071
G
Hspb7
heat shock protein family B (small) member 7
decreases expression
ISO
trovafloxacin results in decreased expression of HSPB7 mRNA
CTD
PMID:35537566
NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266
G
Hsph1
heat shock protein family H (Hsp110) member 1
decreases expression
EXP
trovafloxacin results in decreased expression of HSPH1 mRNA
CTD
PMID:24136188
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
decreases expression
EXP
trovafloxacin results in decreased expression of HTATIP2 mRNA
CTD
PMID:24136188
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Htra2
HtrA serine peptidase 2
decreases expression
ISO
trovafloxacin results in decreased expression of HTRA2 mRNA
CTD
PMID:35537566
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:115,556,916...115,560,095
G
Huwe1
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1
decreases expression
ISO
trovafloxacin results in decreased expression of HUWE1 mRNA
CTD
PMID:35537566
NCBI chr X:24,350,708...24,480,798
Ensembl chr X:20,873,795...21,001,262
G
Hyi
hydroxypyruvate isomerase
decreases expression
ISO
trovafloxacin results in decreased expression of HYI mRNA
CTD
PMID:35537566
NCBI chr 5:131,894,575...131,897,709
Ensembl chr 5:131,894,598...131,897,251
G
Hyls1
HYLS1, centriolar and ciliogenesis associated
decreases expression
ISO
trovafloxacin results in decreased expression of HYLS1 mRNA
CTD
PMID:35537566
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
G
Iars1
isoleucyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of IARS1 mRNA
CTD
PMID:35537566
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
G
Iars2
isoleucyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
trovafloxacin results in decreased expression of IARS2 mRNA
CTD
PMID:35537566
NCBI chr13:96,831,484...96,865,518
Ensembl chr13:96,831,484...96,865,501
G
Icam1
intercellular adhesion molecule 1
multiple interactions decreases expression increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ICAM1 mRNA; trovafloxacin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] trovafloxacin results in decreased expression of ICAM1 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ICAM1 mRNA trovafloxacin results in increased expression of ICAM1 mRNA
CTD
PMID:18930950 PMID:32035082 PMID:35537566
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Icam2
intercellular adhesion molecule 2
decreases expression
ISO
trovafloxacin results in decreased expression of ICAM2 mRNA
CTD
PMID:35537566
NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293
G
Icam4
intercellular adhesion molecule 4, Landsteiner-Wiener blood group
decreases expression
ISO
trovafloxacin results in decreased expression of ICAM4 mRNA
CTD
PMID:35537566
NCBI chr 8:19,566,075...19,567,171
Ensembl chr 8:19,566,075...19,567,171
G
Id1
inhibitor of DNA binding 1
increases expression
ISO
trovafloxacin results in increased expression of ID1 mRNA
CTD
PMID:35537566
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:141,211,267...141,212,419
G
Id2
inhibitor of DNA binding 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of ID2 mRNA
CTD
PMID:18930950
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Ide
insulin degrading enzyme
decreases expression
EXP
trovafloxacin results in decreased expression of IDE mRNA
CTD
PMID:24136188
NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:234,995,351...235,102,440
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
decreases expression
EXP ISO
trovafloxacin results in decreased expression of IDH2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Ier3
immediate early response 3
increases expression
ISO
trovafloxacin results in increased expression of IER3 mRNA
CTD
PMID:35537566
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ier5l
immediate early response 5-like
decreases expression
ISO
trovafloxacin results in decreased expression of IER5L mRNA
CTD
PMID:35537566
NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647
G
Ifi35
interferon-induced protein 35
increases expression
ISO
trovafloxacin results in increased expression of IFI35 mRNA
CTD
PMID:35537566
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifi44
interferon-induced protein 44
increases expression
ISO
trovafloxacin results in increased expression of IFI44 mRNA
CTD
PMID:35537566
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
increases expression
ISO
trovafloxacin results in increased expression of IFI44L mRNA
CTD
PMID:35537566
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
increases expression
ISO
trovafloxacin results in increased expression of IFIT2 mRNA
CTD
PMID:35537566
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
trovafloxacin results in increased expression of IFIT3 mRNA
CTD
PMID:35537566
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
ISO
trovafloxacin results in increased expression of IFITM3 mRNA
CTD
PMID:35537566
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifng
interferon gamma
multiple interactions
ISO EXP
IFNG protein promotes the reaction [[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TNF protein]; IFNG protein results in increased susceptibility to [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5]; trovafloxacin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IFNG protein] [IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin
CTD
PMID:18930950 PMID:19362101 PMID:19638433
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ifrd1
interferon-related developmental regulator 1
increases expression multiple interactions decreases expression
EXP ISO
trovafloxacin results in increased expression of IFRD1 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IFRD1 mRNA trovafloxacin results in decreased expression of IFRD1 mRNA
CTD
PMID:18930950 PMID:24136188 PMID:35537566
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ifrd2
interferon-related developmental regulator 2
decreases expression
ISO
trovafloxacin results in decreased expression of IFRD2 mRNA
CTD
PMID:35537566
NCBI chr 8:108,260,969...108,266,191
Ensembl chr 8:108,260,969...108,266,194
G
Ift140
intraflagellar transport 140
decreases expression
ISO
trovafloxacin results in decreased expression of IFT140 mRNA
CTD
PMID:35537566
NCBI chr10:14,537,134...14,624,926
Ensembl chr10:14,032,648...14,120,433
G
Ift172
intraflagellar transport 172
decreases expression
ISO
trovafloxacin results in decreased expression of IFT172 mRNA
CTD
PMID:35537566
NCBI chr 6:30,801,841...30,841,239
Ensembl chr 6:25,081,980...25,120,860
G
Igf1
insulin-like growth factor 1
increases expression
ISO
trovafloxacin results in increased expression of IGF1 mRNA
CTD
PMID:35537566
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
increases expression
ISO
trovafloxacin results in increased expression of IGF2BP1 mRNA
CTD
PMID:35537566
NCBI chr10:81,405,021...81,447,814
Ensembl chr10:80,908,076...80,951,129
G
Igfbp1
insulin-like growth factor binding protein 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IGFBP1 mRNA
CTD
PMID:18930950
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:82,047,415...82,052,482
G
Ighmbp2
immunoglobulin mu DNA binding protein 2
increases expression
ISO
trovafloxacin results in increased expression of IGHMBP2 mRNA
CTD
PMID:35537566
NCBI chr 1:200,506,641...200,529,293
Ensembl chr 1:200,506,338...200,529,514
G
Igsf3
immunoglobulin superfamily, member 3
increases expression
ISO
trovafloxacin results in increased expression of IGSF3 mRNA
CTD
PMID:35537566
NCBI chr 2:188,811,394...188,899,645
Ensembl chr 2:188,811,380...188,899,645
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of IKBKB mRNA
CTD
PMID:35537566
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il12rb2
interleukin 12 receptor subunit beta 2
decreases expression
ISO
trovafloxacin results in decreased expression of IL12RB2 mRNA
CTD
PMID:35537566
NCBI chr 4:96,426,396...96,515,251
Ensembl chr 4:96,426,842...96,515,289
G
Il15
interleukin 15
increases expression
ISO
trovafloxacin results in increased expression of IL15 mRNA
CTD
PMID:35537566
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:25,640,251...25,706,820
G
Il16
interleukin 16
decreases expression
ISO
trovafloxacin results in decreased expression of IL16 mRNA
CTD
PMID:35537566
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
G
Il17ra
interleukin 17 receptor A
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IL17RA mRNA
CTD
PMID:18930950
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
G
Il18
interleukin 18
multiple interactions
ISO
IL18 protein results in increased susceptibility to [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5]; trovafloxacin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL18 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IL18 protein]
CTD
PMID:18930950 PMID:19638433
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
increases expression
ISO
trovafloxacin results in increased expression of IL18BP mRNA
CTD
PMID:35537566
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il18rap
interleukin 18 receptor accessory protein
decreases expression
ISO
trovafloxacin results in decreased expression of IL18RAP mRNA
CTD
PMID:35537566
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
G
Il1a
interleukin 1 alpha
multiple interactions increases expression
ISO EXP
[IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin; [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin trovafloxacin results in increased expression of IL1A mRNA
CTD
PMID:19362101 PMID:35537566
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [trovafloxacin results in increased activity of CASP3 protein]; [trovafloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL1B protein] affects the localization of SELE protein; [trovafloxacin co-treated with IL1B protein] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL1B protein] results in increased expression of SELE mRNA; trovafloxacin promotes the reaction [IL1B protein results in increased secretion of SELE protein] trovafloxacin promotes the reaction [TNF protein results in increased expression of IL1B protein]
CTD
PMID:10822086 PMID:19638433 PMID:30876886
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il21r
interleukin 21 receptor
decreases expression
ISO
trovafloxacin results in decreased expression of IL21R mRNA
CTD
PMID:35537566
NCBI chr 1:189,598,682...189,626,340
Ensembl chr 1:180,168,097...180,195,522
G
Il27
interleukin 27
increases expression
ISO
trovafloxacin results in increased expression of IL27 mRNA
CTD
PMID:35537566
NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:181,173,372...181,178,582
G
Il6
interleukin 6
multiple interactions
ISO
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [trovafloxacin results in increased activity of CASP3 protein]; [trovafloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [trovafloxacin co-treated with IL6 protein] results in increased activity of CASP3 protein trovafloxacin promotes the reaction [TNF protein results in increased expression of IL6 protein]
CTD
PMID:19362101 PMID:19638433 PMID:30876886
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Immp2l
inner mitochondrial membrane peptidase subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of IMMP2L mRNA
CTD
PMID:35537566
NCBI chr 6:58,070,035...58,970,165
Ensembl chr 6:58,070,283...58,969,840
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
trovafloxacin results in decreased expression of IMPA2 mRNA
CTD
PMID:35537566
NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641
G
Ina
internexin neuronal intermediate filament protein, alpha
increases expression
ISO
trovafloxacin results in increased expression of INA mRNA
CTD
PMID:35537566
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Incenp
inner centromere protein
decreases expression
ISO
trovafloxacin results in decreased expression of INCENP mRNA
CTD
PMID:35537566
NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265
G
Inka2
inka box actin regulator 2
increases expression
ISO
trovafloxacin results in increased expression of INKA2 mRNA
CTD
PMID:35537566
NCBI chr 2:193,185,275...193,200,643
Ensembl chr 2:193,185,275...193,200,642
G
Ints6l
integrator complex subunit 6 like
decreases expression
ISO
trovafloxacin results in decreased expression of DDX26B mRNA
CTD
PMID:35537566
NCBI chr X:134,258,117...134,325,706
Ensembl chr X:134,258,125...134,309,617
G
Invs
inversin
decreases expression
ISO
trovafloxacin results in decreased expression of INVS mRNA
CTD
PMID:35537566
NCBI chr 5:62,610,916...62,763,813
Ensembl chr 5:62,610,968...62,763,350
G
Ip6k2
inositol hexakisphosphate kinase 2
increases expression
EXP
trovafloxacin results in increased expression of IP6K2 mRNA
CTD
PMID:24136188
NCBI chr 8:109,483,843...109,510,172
Ensembl chr 8:109,484,310...109,510,166
G
Iqcd
IQ motif containing D
increases expression
ISO
trovafloxacin results in increased expression of IQCD mRNA
CTD
PMID:35537566
NCBI chr12:35,955,522...35,972,420
Ensembl chr12:35,934,716...35,972,523
G
Iqgap3
IQ motif containing GTPase activating protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of IQGAP3 mRNA
CTD
PMID:35537566
NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956
G
Irf1
interferon regulatory factor 1
multiple interactions decreases expression
ISO EXP
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IRF1 mRNA trovafloxacin results in decreased expression of IRF1 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:37,916,670...37,924,166
G
Irf4
interferon regulatory factor 4
decreases expression
ISO
trovafloxacin results in decreased expression of IRF4 mRNA
CTD
PMID:35537566
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Irf7
interferon regulatory factor 7
increases expression
ISO
trovafloxacin results in increased expression of IRF7 mRNA
CTD
PMID:35537566
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832
G
Irgm
immunity-related GTPase M
increases expression
ISO
trovafloxacin results in increased expression of IRGM1 mRNA
CTD
PMID:35537566
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,233,455...33,241,578
G
Isg20
interferon stimulated exonuclease gene 20
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ISG20 mRNA
CTD
PMID:18930950
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Ist1
IST1 factor associated with ESCRT-III
increases expression
EXP
trovafloxacin results in increased expression of IST1 mRNA
CTD
PMID:24136188
NCBI chr19:37,648,840...37,671,019
Ensembl chr19:37,648,095...37,670,956
G
Isyna1
inositol-3-phosphate synthase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ISYNA1 mRNA
CTD
PMID:35537566
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
G
Itgax
integrin subunit alpha X
decreases expression
ISO
trovafloxacin results in decreased expression of ITGAX mRNA
CTD
PMID:35537566
NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:182,719,609...182,740,698
G
Itgb5
integrin subunit beta 5
decreases expression
ISO
trovafloxacin results in decreased expression of ITGB5 mRNA
CTD
PMID:35537566
NCBI chr11:80,333,588...80,449,373
Ensembl chr11:66,829,285...66,944,472
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
decreases expression
ISO
trovafloxacin results in decreased expression of ITPR1 mRNA
CTD
PMID:35537566
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:141,187,418...141,510,491
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
decreases expression
ISO
trovafloxacin results in decreased expression of ITPR2 mRNA
CTD
PMID:35537566
NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:179,027,281...179,404,164
G
Ivns1abp
influenza virus NS1A binding protein
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IVNS1ABP mRNA
CTD
PMID:18930950
NCBI chr13:65,977,069...65,996,685
Ensembl chr13:63,427,041...63,446,701
G
Izumo4
IZUMO family member 4
decreases expression
ISO
trovafloxacin results in decreased expression of IZUMO4 mRNA
CTD
PMID:35537566
NCBI chr 7:9,007,276...9,010,428
Ensembl chr 7:9,007,280...9,010,032
G
Jade1
jade family PHD finger 1
decreases expression
ISO
trovafloxacin results in decreased expression of JADE1 mRNA
CTD
PMID:35537566
NCBI chr 2:124,543,233...124,596,361
Ensembl chr 2:124,543,286...124,596,354
G
Jag1
jagged canonical Notch ligand 1
increases expression
ISO
trovafloxacin results in increased expression of JAG1 mRNA
CTD
PMID:35537566
NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:124,406,794...124,442,209
G
Jak3
Janus kinase 3
decreases expression
ISO
trovafloxacin results in decreased expression of JAK3 mRNA
CTD
PMID:35537566
NCBI chr16:18,418,807...18,432,515
Ensembl chr16:18,386,405...18,398,536
G
Jaml
junction adhesion molecule like
decreases expression
ISO
trovafloxacin results in decreased expression of JAML mRNA
CTD
PMID:35537566
NCBI chr 8:45,384,836...45,415,459
Ensembl chr 8:45,383,495...45,416,565
G
Jdp2
Jun dimerization protein 2
increases expression
ISO
trovafloxacin results in increased expression of JDP2 mRNA
CTD
PMID:35537566
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Jpx
JPX transcript, XIST activator
decreases expression
ISO
trovafloxacin results in decreased expression of JPX mRNA
CTD
PMID:35537566
NCBI chr X:68,511,491...68,665,132
G
Jsrp1
junctional sarcoplasmic reticulum protein 1
increases expression
ISO
trovafloxacin results in increased expression of JSRP1 mRNA
CTD
PMID:35537566
NCBI chr 7:8,889,486...8,906,055
Ensembl chr 7:8,901,609...8,906,055
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of JUNB mRNA
CTD
PMID:18930950
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kansl1l
KAT8 regulatory NSL complex subunit 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of KANSL1L mRNA
CTD
PMID:35537566
NCBI chr 9:68,211,151...68,316,992
Ensembl chr 9:68,211,189...68,300,222
G
Kbtbd11
kelch repeat and BTB domain containing 11
increases expression
ISO
trovafloxacin results in increased expression of KBTBD11 mRNA
CTD
PMID:35537566
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
G
Kbtbd6
kelch repeat and BTB domain containing 6
decreases expression
ISO
trovafloxacin results in decreased expression of KBTBD6 mRNA
CTD
PMID:35537566
NCBI chr15:54,848,285...54,850,042
Ensembl chr15:54,848,446...54,850,453
G
Kbtbd8
kelch repeat and BTB domain containing 8
increases expression
ISO
trovafloxacin results in increased expression of KBTBD8 mRNA
CTD
PMID:35537566
NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697
G
Kcna3
potassium voltage-gated channel subfamily A member 3
decreases expression
ISO
trovafloxacin results in decreased expression of KCNA3 mRNA
CTD
PMID:35537566
NCBI chr 2:194,632,106...194,634,059
Ensembl chr 2:194,632,196...194,650,138
G
Kcnab2
potassium voltage-gated channel subfamily A regulatory beta subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of KCNAB2 mRNA
CTD
PMID:35537566
NCBI chr 5:168,182,228...168,270,760
Ensembl chr 5:162,901,896...162,988,243
G
Kcne3
potassium voltage-gated channel subfamily E regulatory subunit 3
decreases expression
ISO
trovafloxacin results in decreased expression of KCNE3 mRNA
CTD
PMID:35537566
NCBI chr 1:154,523,903...154,530,865
Ensembl chr 1:154,523,830...154,532,020
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
increases expression
ISO
trovafloxacin results in increased expression of KCNN4 mRNA
CTD
PMID:35537566
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:79,959,322...79,974,340
G
Kctd12b
potassium channel tetramerization domain containing 12b
decreases expression
ISO
trovafloxacin results in decreased expression of KCTD12B mRNA
CTD
PMID:35537566
NCBI chr X:17,643,707...17,654,820
Ensembl chr X:17,643,615...17,654,820
G
Kdr
kinase insert domain receptor
decreases expression
ISO
trovafloxacin results in decreased expression of KDR mRNA
CTD
PMID:35537566
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Khdc4
KH domain containing 4, pre-mRNA splicing factor
increases expression
ISO
trovafloxacin results in increased expression of KHDC4 mRNA
CTD
PMID:35537566
NCBI chr 2:174,149,059...174,177,816
Ensembl chr 2:174,149,141...174,177,504
G
Khk
ketohexokinase
decreases expression
ISO
trovafloxacin results in decreased expression of KHK mRNA
CTD
PMID:35537566
NCBI chr 6:31,165,246...31,175,779
Ensembl chr 6:25,445,300...25,455,717
G
Kiaa0232
KIAA0232 homolog
increases expression
ISO
trovafloxacin results in increased expression of D5ERTD579E mRNA
CTD
PMID:35537566
NCBI chr14:74,094,421...74,159,316
Ensembl chr14:74,094,488...74,159,326
G
Kif13a
kinesin family member 13A
decreases expression
ISO
trovafloxacin results in decreased expression of KIF13A mRNA
CTD
PMID:35537566
NCBI chr17:17,766,597...17,948,517
Ensembl chr17:17,766,597...17,943,615
G
Kif14
kinesin family member 14
decreases expression
ISO
trovafloxacin results in decreased expression of KIF14 mRNA
CTD
PMID:35537566
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
G
Kif15
kinesin family member 15
decreases expression
ISO
trovafloxacin results in decreased expression of KIF15 mRNA
CTD
PMID:35537566
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Kif18a
kinesin family member 18A
decreases expression
ISO
trovafloxacin results in decreased expression of KIF18A mRNA
CTD
PMID:35537566
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
G
Kif18b
kinesin family member 18B
decreases expression
ISO
trovafloxacin results in decreased expression of KIF18B mRNA
CTD
PMID:35537566
NCBI chr10:88,370,520...88,392,388
Ensembl chr10:87,870,428...87,889,850
G
Kif20a
kinesin family member 20A
decreases expression
ISO
trovafloxacin results in decreased expression of KIF20A mRNA
CTD
PMID:35537566
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif20b
kinesin family member 20B
decreases expression
ISO
trovafloxacin results in decreased expression of KIF20B mRNA
CTD
PMID:35537566
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
G
Kif21b
kinesin family member 21B
decreases expression
ISO
trovafloxacin results in decreased expression of KIF21B mRNA
CTD
PMID:35537566
NCBI chr13:50,127,842...50,177,822
Ensembl chr13:47,576,160...47,626,127
G
Kif22
kinesin family member 22
decreases expression
ISO
trovafloxacin results in decreased expression of KIF22 mRNA
CTD
PMID:35537566
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
G
Kif23
kinesin family member 23
decreases expression
ISO
trovafloxacin results in decreased expression of KIF23 mRNA
CTD
PMID:35537566
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif24
kinesin family member 24
decreases expression
ISO
trovafloxacin results in decreased expression of KIF24 mRNA
CTD
PMID:35537566
NCBI chr 5:56,561,019...56,628,040
Ensembl chr 5:56,561,154...56,628,025
G
Kif2c
kinesin family member 2C
decreases expression
ISO
trovafloxacin results in decreased expression of KIF2C mRNA
CTD
PMID:35537566
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Kif4a
kinesin family member 4A
decreases expression
ISO
trovafloxacin results in decreased expression of KIF4 mRNA
CTD
PMID:35537566
NCBI chr X:65,721,746...65,824,277
Ensembl chr X:65,721,779...65,824,139
G
Kitlg
KIT ligand
increases expression
ISO
trovafloxacin results in increased expression of KITL mRNA
CTD
PMID:35537566
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Klf11
KLF transcription factor 11
decreases expression
ISO
trovafloxacin results in decreased expression of KLF11 mRNA
CTD
PMID:35537566
NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:41,285,842...41,297,550
G
Klf4
KLF transcription factor 4
decreases expression
ISO
trovafloxacin results in decreased expression of KLF4 mRNA
CTD
PMID:35537566
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:70,278,972...70,283,602
G
Klf9
KLF transcription factor 9
increases expression
EXP
trovafloxacin results in increased expression of KLF9 mRNA
CTD
PMID:24136188
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
G
Klhdc8b
kelch domain containing 8B
increases expression
ISO
trovafloxacin results in increased expression of KLHDC8B mRNA
CTD
PMID:35537566
NCBI chr 8:109,141,594...109,146,584
Ensembl chr 8:109,141,594...109,146,918
G
Klhl12
kelch-like family member 12
increases expression
ISO
trovafloxacin results in increased expression of KLHL12 mRNA
CTD
PMID:35537566
NCBI chr13:45,899,913...45,933,648
Ensembl chr13:45,899,928...45,933,643
G
Klhl24
kelch-like family member 24
increases expression decreases expression
EXP ISO
trovafloxacin results in increased expression of KLHL24 mRNA trovafloxacin results in decreased expression of KLHL24 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
G
Klhl33
kelch-like family member 33
decreases expression
ISO
trovafloxacin results in decreased expression of KLHL33 mRNA
CTD
PMID:35537566
NCBI chr15:24,105,923...24,114,445
Ensembl chr15:24,105,930...24,114,438
G
Klhl42
kelch-like family, member 42
increases expression
ISO
trovafloxacin results in increased expression of KLHL42 mRNA
CTD
PMID:35537566
NCBI chr 4:179,999,655...180,027,283
Ensembl chr 4:180,004,580...180,027,283
G
Knl1
kinetochore scaffold 1
decreases expression
ISO
trovafloxacin results in decreased expression of KNL1 mRNA
CTD
PMID:35537566
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of KNSTRN mRNA
CTD
PMID:35537566
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
G
Kntc1
kinetochore associated 1
decreases expression
ISO
trovafloxacin results in decreased expression of KNTC1 mRNA
CTD
PMID:35537566
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
G
Kpna2
karyopherin subunit alpha 2
decreases expression
EXP
trovafloxacin results in decreased expression of KPNA2 mRNA
CTD
PMID:24136188
NCBI chr10:92,433,678...92,445,841
Ensembl chr10:91,933,951...91,946,150
G
Kpnb1
karyopherin subunit beta 1
decreases expression
EXP
trovafloxacin results in decreased expression of KPNB1 mRNA
CTD
PMID:24136188
NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,145,420...82,174,605
G
Kptn
kaptin (actin binding protein)
decreases expression
ISO
trovafloxacin results in decreased expression of KPTN mRNA
CTD
PMID:35537566
NCBI chr 1:76,808,737...76,809,531
G
Krt18
keratin 18
decreases expression
EXP
trovafloxacin results in decreased expression of KRT18 mRNA
CTD
PMID:24136188
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
G
Ksr1
kinase suppressor of ras 1
decreases expression
ISO
trovafloxacin results in decreased expression of KSR1 mRNA
CTD
PMID:35537566
NCBI chr10:63,961,771...64,098,076
Ensembl chr10:63,961,759...64,098,076
G
L1cam
L1 cell adhesion molecule
decreases expression
ISO
trovafloxacin results in decreased expression of L1CAM mRNA
CTD
PMID:35537566
NCBI chr X:156,748,597...156,775,116
Ensembl chr X:151,597,277...151,623,857
G
L3hypdh
trans-L-3-hydroxyproline dehydratase
decreases expression
ISO
trovafloxacin results in decreased expression of L3HYPDH mRNA
CTD
PMID:35537566
NCBI chr 6:90,636,310...90,647,106
Ensembl chr 6:90,636,310...90,647,106
G
Lactb2
lactamase, beta 2
decreases expression
ISO
trovafloxacin results in decreased expression of LACTB2 mRNA
CTD
PMID:35537566
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
G
Laptm4b
lysosomal protein transmembrane 4 beta
decreases expression
EXP
trovafloxacin results in decreased expression of LAPTM4B mRNA
CTD
PMID:24136188
NCBI chr 7:65,434,525...65,477,386
Ensembl chr 7:65,434,394...65,477,383
G
Lars1
leucyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of LARS1 mRNA
CTD
PMID:35537566
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
G
Lasp1
LIM and SH3 protein 1
increases expression
ISO
trovafloxacin results in increased expression of LASP1 mRNA
CTD
PMID:35537566
NCBI chr10:83,290,820...83,331,989
Ensembl chr10:82,795,137...82,943,292
G
Lbr
lamin B receptor
decreases expression
ISO
trovafloxacin results in decreased expression of LBR mRNA
CTD
PMID:35537566
NCBI chr13:96,071,058...96,095,709
Ensembl chr13:93,538,920...93,564,017
G
Lcat
lecithin cholesterol acyltransferase
increases expression
ISO
trovafloxacin results in increased expression of LCAT mRNA
CTD
PMID:35537566
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Ldhal6b
lactate dehydrogenase A-like 6B
increases expression
ISO
trovafloxacin results in increased expression of LDHAL6B mRNA
CTD
PMID:35537566
NCBI chr 1:48,402,997...48,404,420
Ensembl chr 1:45,991,991...45,999,272
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of LDLR mRNA
CTD
PMID:18930950
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Ldlrad3
low density lipoprotein receptor class A domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of LDLRAD3 mRNA
CTD
PMID:35537566
NCBI chr 3:88,239,529...88,481,340
Ensembl chr 3:88,239,622...88,481,267
G
Ldlrap1
low density lipoprotein receptor adaptor protein 1
increases expression
ISO
trovafloxacin results in increased expression of LDLRAP1 mRNA
CTD
PMID:35537566
NCBI chr 5:146,955,607...146,978,601
Ensembl chr 5:146,955,607...146,978,601
G
Lekr1
leucine, glutamate and lysine rich 1
increases expression
ISO
trovafloxacin results in increased expression of LEKR1 mRNA
CTD
PMID:35537566
NCBI chr 2:149,889,615...150,061,167
Ensembl chr 2:149,891,106...150,060,469
G
Lenep
lens epithelial protein
increases expression
ISO
trovafloxacin results in increased expression of LENEP mRNA
CTD
PMID:35537566
NCBI chr 2:174,819,439...174,820,127
Ensembl chr 2:174,819,459...174,820,127
G
Letm1
leucine zipper and EF-hand containing transmembrane protein 1
decreases expression
EXP
trovafloxacin results in decreased expression of LETM1 mRNA
CTD
PMID:24136188
NCBI chr14:76,942,647...76,982,220
Ensembl chr14:76,942,729...76,984,904
G
Lgals9
galectin 9
increases expression
ISO
trovafloxacin results in increased expression of LGALS9 mRNA
CTD
PMID:35537566
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
G
Lgalsl
galectin-like
decreases expression
EXP
trovafloxacin results in decreased expression of LGALSL mRNA
CTD
PMID:24136188
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
G
Lgr4
leucine-rich repeat-containing G protein-coupled receptor 4
increases expression
ISO
trovafloxacin results in increased expression of LGR4 mRNA
CTD
PMID:35537566
NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:96,447,858...96,548,899
G
Lhx2
LIM homeobox 2
decreases expression
ISO
trovafloxacin results in decreased expression of LHX2 mRNA
CTD
PMID:35537566
NCBI chr 3:42,523,345...42,553,646
Ensembl chr 3:22,126,007...22,143,908
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
trovafloxacin results in increased expression of LIF mRNA
CTD
PMID:35537566
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:79,134,574...79,140,482
G
Lig1
DNA ligase 1
decreases expression
ISO
trovafloxacin results in decreased expression of LIG1 mRNA
CTD
PMID:35537566
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lilrb4
leukocyte immunoglobulin like receptor B4
increases expression
ISO
trovafloxacin results in increased expression of LILRB4B mRNA
CTD
PMID:35537566
NCBI chr 1:78,847,685...78,853,294
Ensembl chr 1:69,805,250...69,810,660
G
Lin54
lin-54 DREAM MuvB core complex component
decreases expression
ISO
trovafloxacin results in decreased expression of LIN54 mRNA
CTD
PMID:35537566
NCBI chr14:9,129,775...9,188,244
Ensembl chr14:9,130,336...9,187,790
G
Lipn
lipase, family member N
decreases expression
ISO
trovafloxacin results in decreased expression of LIPN mRNA
CTD
PMID:35537566
NCBI chr 1:231,584,950...231,603,456
Ensembl chr 1:231,584,956...231,603,468
G
Litaf
lipopolysaccharide-induced TNF factor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of LITAF mRNA
CTD
PMID:18930950
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:4,625,552...4,692,763
G
Lix1
limb and CNS expressed 1
decreases expression
ISO
trovafloxacin results in decreased expression of LIX1 mRNA
CTD
PMID:35537566
NCBI chr 1:66,802,044...66,859,040
Ensembl chr 1:58,128,961...58,185,964
G
Llgl2
LLGL scribble cell polarity complex component 2
increases expression
ISO
trovafloxacin results in increased expression of LLGL2 mRNA
CTD
PMID:35537566
NCBI chr10:101,050,978...101,086,527
Ensembl chr10:101,051,408...101,086,525
G
Lmna
lamin A/C
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of LMNA mRNA trovafloxacin results in increased expression of LMNA mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:173,939,751...173,960,423
G
Lmnb1
lamin B1
decreases expression
ISO
trovafloxacin results in decreased expression of LMNB1 mRNA
CTD
PMID:35537566
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lmo4
LIM domain only 4
decreases expression
ISO
trovafloxacin results in decreased expression of LMO4 mRNA
CTD
PMID:35537566
NCBI chr 2:233,264,180...233,280,881
Ensembl chr 2:233,264,182...233,280,880
G
LOC120094467
small nucleolar RNA SNORA43
increases expression
ISO
trovafloxacin results in increased expression of SNORA43 mRNA
CTD
PMID:35537566
NCBI chr 8:110,101,179...110,101,316
Ensembl chr 8:110,101,179...110,101,316
G
Lonp1
lon peptidase 1, mitochondrial
decreases expression
ISO
trovafloxacin results in decreased expression of LONP1 mRNA
CTD
PMID:35537566
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Lpin1
lipin 1
increases expression
EXP
trovafloxacin results in increased expression of LPIN1 mRNA
CTD
PMID:24136188
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:39,312,748...39,417,097
G
Lpin3
lipin 3
increases expression
ISO
trovafloxacin results in increased expression of LPIN3 mRNA
CTD
PMID:35537566
NCBI chr 3:149,533,719...149,558,494
Ensembl chr 3:149,534,051...149,558,327
G
Lrp6
LDL receptor related protein 6
increases expression
EXP
trovafloxacin results in increased expression of LRP6 mRNA
CTD
PMID:24136188
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
G
Lrp8
LDL receptor related protein 8
decreases expression
ISO
trovafloxacin results in decreased expression of LRP8 mRNA
CTD
PMID:35537566
NCBI chr 5:122,563,468...122,635,434
Ensembl chr 5:122,563,453...122,631,352
G
Lrrc41
leucine rich repeat containing 41
increases expression
ISO
trovafloxacin results in increased expression of LRRC41 mRNA
CTD
PMID:35537566
NCBI chr 5:134,791,256...134,812,177
Ensembl chr 5:129,554,547...129,575,449
G
Lrrc63
leucine rich repeat containing 63
decreases expression
ISO
trovafloxacin results in decreased expression of LRRC63 mRNA
CTD
PMID:35537566
NCBI chr15:50,400,199...50,437,321
Ensembl chr15:50,400,200...50,437,321
G
Lrrc75a
leucine rich repeat containing 75A
decreases expression
ISO
trovafloxacin results in decreased expression of LRRC75A mRNA
CTD
PMID:35537566
NCBI chr10:47,298,222...47,343,301
Ensembl chr10:47,297,288...47,343,664
G
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
decreases expression
ISO
trovafloxacin results in decreased expression of LRRC8C mRNA
CTD
PMID:35537566
NCBI chr14:4,528,721...4,621,259
Ensembl chr14:4,227,832...4,315,249
G
Lrrcc1
leucine rich repeat and coiled-coil centrosomal protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of LRRCC1 mRNA
CTD
PMID:35537566
NCBI chr 2:87,025,671...87,060,313
Ensembl chr 2:87,025,598...87,060,294
G
Lrrk2
leucine-rich repeat kinase 2
decreases expression
ISO
trovafloxacin results in decreased expression of LRRK2 mRNA
CTD
PMID:35537566
NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:122,826,696...122,987,703
G
Lrrn4cl
LRRN4 C-terminal like
decreases expression
ISO
trovafloxacin results in decreased expression of LRRN4CL mRNA
CTD
PMID:35537566
NCBI chr 1:205,743,580...205,759,879
G
Lrwd1
leucine-rich repeats and WD repeat domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of LRWD1 mRNA
CTD
PMID:35537566
NCBI chr12:20,530,035...20,543,078
Ensembl chr12:20,530,012...20,549,536
G
Lsm4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
EXP
trovafloxacin results in decreased expression of LSM4 mRNA
CTD
PMID:24136188
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
G
Lsm6
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated
increases expression
ISO
trovafloxacin results in increased expression of LSM6 mRNA
CTD
PMID:35537566
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
G
Lta4h
leukotriene A4 hydrolase
decreases expression
EXP
trovafloxacin results in decreased expression of LTA4H mRNA
CTD
PMID:24136188
NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:27,969,789...28,001,600
G
Ltbp2
latent transforming growth factor beta binding protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of LTBP2 mRNA
CTD
PMID:35537566
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
G
Ltbp4
latent transforming growth factor beta binding protein 4
decreases expression
ISO
trovafloxacin results in decreased expression of LTBP4 mRNA
CTD
PMID:35537566
NCBI chr 1:82,600,136...82,634,346
Ensembl chr 1:82,600,136...82,632,178
G
Luc7l
LUC7-like
increases expression
ISO
trovafloxacin results in increased expression of LUC7L mRNA
CTD
PMID:35537566
NCBI chr10:15,273,340...15,307,131
Ensembl chr10:15,273,348...15,303,112
G
Lyl1
LYL1, basic helix-loop-helix family member
decreases expression
ISO
trovafloxacin results in decreased expression of LYL1 mRNA
CTD
PMID:35537566
NCBI chr19:23,452,140...23,455,007
Ensembl chr19:23,452,140...23,455,007
G
Lyz2
lysozyme 2
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of LYZ2 mRNA trovafloxacin results in increased expression of LYZ2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:52,906,811...52,912,106
G
Macf1
microtubule-actin crosslinking factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of MACF1 mRNA
CTD
PMID:35537566
NCBI chr 5:135,623,734...135,949,097
Ensembl chr 5:135,623,742...135,945,905
G
Mad2l1
mitotic arrest deficient 2 like 1
decreases expression
ISO
trovafloxacin results in decreased expression of MAD2L1 mRNA
CTD
PMID:35537566
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
G
Maf
MAF bZIP transcription factor
decreases expression
ISO
trovafloxacin results in decreased expression of MAF mRNA
CTD
PMID:35537566
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
G
Mal2
mal, T-cell differentiation protein 2
decreases expression
EXP
trovafloxacin results in decreased expression of MAL2 mRNA
CTD
PMID:24136188
NCBI chr 7:85,900,453...85,933,433
Ensembl chr 7:85,900,453...85,933,429
G
Man2a1
mannosidase, alpha, class 2A, member 1
decreases expression
ISO
trovafloxacin results in decreased expression of MAN2A1 mRNA
CTD
PMID:35537566
NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349
G
Man2a2
mannosidase, alpha, class 2A, member 2
decreases expression
ISO
trovafloxacin results in decreased expression of MAN2A2 mRNA
CTD
PMID:35537566
NCBI chr 1:134,304,714...134,327,611
Ensembl chr 1:134,306,236...134,327,315
G
Manbal
mannosidase beta like
increases expression
ISO
trovafloxacin results in increased expression of MANBAL mRNA
CTD
PMID:35537566
NCBI chr 3:146,035,082...146,064,676
Ensembl chr 3:146,035,066...146,064,676
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MANF mRNA
CTD
PMID:18930950
NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:107,548,352...107,551,438
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
multiple interactions increases expression
ISO
TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3A mRNA]
CTD
PMID:33609687
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions increases expression
ISO
[trovafloxacin co-treated with TNF protein] results in increased expression of MAP1LC3B mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein trovafloxacin results in increased expression of MAP1LC3B mRNA
CTD
PMID:33609687
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map2k6
mitogen-activated protein kinase kinase 6
decreases expression
ISO
trovafloxacin results in decreased expression of MAP2K6 mRNA
CTD
PMID:35537566
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,373,204...95,488,293
G
Map2k7
mitogen activated protein kinase kinase 7
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MAP2K7 mRNA
CTD
PMID:18930950
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:2,591,219...2,604,222
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MAP3K8 mRNA
CTD
PMID:18930950
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:53,383,131...53,403,216
G
Mapk1
mitogen activated protein kinase 1
increases activity multiple interactions increases phosphorylation
ISO
trovafloxacin results in increased activity of MAPK1 protein U 0126 inhibits the reaction [trovafloxacin results in increased activity of MAPK1 protein] [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of MAPK1 protein; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK1 protein]
CTD
PMID:24525298 PMID:32035082 PMID:33609687
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases activity multiple interactions increases phosphorylation
ISO
trovafloxacin results in increased activity of MAPK3 protein U 0126 inhibits the reaction [trovafloxacin results in increased activity of MAPK3 protein] [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of MAPK3 protein; ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK3 protein]
CTD
PMID:24525298 PMID:32035082 PMID:33609687
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
ISO
trovafloxacin results in increased phosphorylation of MAPK8 protein ATG5 protein affects the reaction [trovafloxacin results in increased phosphorylation of MAPK8 protein]
CTD
PMID:33609687
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
increases expression
ISO
trovafloxacin results in increased expression of MAPK8IP3 mRNA
CTD
PMID:35537566
NCBI chr10:14,422,936...14,463,387
Ensembl chr10:13,918,400...13,958,273
G
Mapkapk2
MAPK activated protein kinase 2
multiple interactions increases phosphorylation
ISO
SB 203580 inhibits the reaction [trovafloxacin results in increased phosphorylation of MAPKAPK2 protein]
CTD
PMID:24525298
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
G
Marcksl1
MARCKS-like 1
increases expression
ISO
trovafloxacin results in increased expression of MARCKSL1 mRNA
CTD
PMID:35537566
NCBI chr 5:147,135,827...147,138,150
Ensembl chr 5:141,850,110...141,853,817
G
Mastl
microtubule associated serine/threonine kinase-like
decreases expression
ISO
trovafloxacin results in decreased expression of MASTL mRNA
CTD
PMID:35537566
NCBI chr17:85,250,512...85,287,479
Ensembl chr17:85,251,997...85,287,353
G
Mavs
mitochondrial antiviral signaling protein
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MAVS mRNA
CTD
PMID:18930950
NCBI chr 3:138,904,673...138,919,129
Ensembl chr 3:118,451,743...118,466,094
G
Maz
MYC associated zinc finger protein
decreases expression
ISO
trovafloxacin results in decreased expression of MAZ mRNA
CTD
PMID:35537566
NCBI chr 1:181,629,742...181,635,193
Ensembl chr 1:181,629,729...181,650,408
G
Mblac1
metallo-beta-lactamase domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of MBLAC1 mRNA
CTD
PMID:35537566
NCBI chr12:17,071,465...17,072,736
Ensembl chr12:17,071,465...17,072,735
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
trovafloxacin results in decreased expression of MCAM mRNA
CTD
PMID:35537566
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mcf2l
MCF.2 cell line derived transforming sequence-like
decreases expression
ISO
trovafloxacin results in decreased expression of MCF2L mRNA
CTD
PMID:35537566
NCBI chr16:76,507,133...76,652,893
Ensembl chr16:76,507,133...76,652,733
G
Mcm5
minichromosome maintenance complex component 5
decreases expression
ISO
trovafloxacin results in decreased expression of MCM5 mRNA
CTD
PMID:35537566
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
trovafloxacin results in decreased expression of MCM7 mRNA
CTD
PMID:35537566
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mcm8
minichromosome maintenance 8 homologous recombination repair factor
decreases expression
ISO
trovafloxacin results in decreased expression of MCM8 mRNA
CTD
PMID:35537566
NCBI chr 3:120,086,741...120,117,008
Ensembl chr 3:120,086,763...120,117,008
G
Mcm9
minichromosome maintenance 9 homologous recombination repair factor
decreases expression
ISO
trovafloxacin results in decreased expression of MCM9 mRNA
CTD
PMID:35537566
NCBI chr20:32,818,219...32,929,577
Ensembl chr20:32,844,951...32,929,600
G
Mdc1
mediator of DNA damage checkpoint 1
decreases expression
ISO
trovafloxacin results in decreased expression of MDC1 mRNA
CTD
PMID:35537566
NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,895,505...2,910,240
G
Mdh2
malate dehydrogenase 2
decreases expression
EXP
trovafloxacin results in decreased expression of MDH2 mRNA
CTD
PMID:24136188
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:20,894,262...20,907,271
G
Mdm1
Mdm1 nuclear protein
decreases expression
ISO
trovafloxacin results in decreased expression of MDM1 mRNA
CTD
PMID:35537566
NCBI chr 7:53,729,603...53,766,034
Ensembl chr 7:53,729,610...53,766,034
G
Mdm2
MDM2 proto-oncogene
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MDM2 mRNA trovafloxacin results in increased expression of MDM2 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Me1
malic enzyme 1
decreases expression
EXP
trovafloxacin results in decreased expression of ME1 mRNA
CTD
PMID:24136188
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
G
Med10
mediator complex subunit 10
increases expression
ISO
trovafloxacin results in increased expression of MED10 mRNA
CTD
PMID:35537566
NCBI chr 1:33,470,064...33,481,698
Ensembl chr 1:33,470,066...33,475,767
G
Med14
mediator complex subunit 14
decreases expression
ISO
trovafloxacin results in decreased expression of MED14 mRNA
CTD
PMID:35537566
NCBI chr X:10,036,749...10,127,910
Ensembl chr X:10,036,805...10,126,240
G
Med20
mediator complex subunit 20
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MED20 mRNA trovafloxacin results in increased expression of MED20 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 9:13,370,146...13,382,756
Ensembl chr 9:13,370,146...13,382,476
G
Med22
mediator complex subunit 22
increases expression
ISO
trovafloxacin results in increased expression of MED22 mRNA
CTD
PMID:35537566
NCBI chr 3:10,233,754...10,238,836
Ensembl chr 3:10,233,754...10,238,836
G
Med29
mediator complex subunit 29
increases expression
ISO
trovafloxacin results in increased expression of MED29 mRNA
CTD
PMID:35537566
NCBI chr 1:92,805,505...92,810,908
Ensembl chr 1:83,677,961...83,683,365
G
Megf9
multiple EGF-like-domains 9
decreases expression
ISO
trovafloxacin results in decreased expression of MEGF9 mRNA
CTD
PMID:35537566
NCBI chr 5:83,993,565...84,105,622
Ensembl chr 5:83,993,565...84,105,622
G
Melk
maternal embryonic leucine zipper kinase
decreases expression
ISO
trovafloxacin results in decreased expression of MELK mRNA
CTD
PMID:35537566
NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:58,540,449...58,600,937
G
Mfsd1
major facilitator superfamily domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of MFSD1 mRNA
CTD
PMID:35537566
NCBI chr 2:151,846,130...151,866,168
Ensembl chr 2:151,846,146...151,867,045
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
ISO
trovafloxacin results in increased expression of MFSD2A mRNA
CTD
PMID:35537566
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
G
Mfsd3
major facilitator superfamily domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of MFSD3 mRNA
CTD
PMID:35537566
NCBI chr 7:108,419,644...108,423,469
Ensembl chr 7:108,421,350...108,423,461
G
Mfsd4b3
major facilitator superfamily domain containing 4B3
decreases expression
ISO
trovafloxacin results in decreased expression of MFSD4B3-PS mRNA
CTD
PMID:35537566
NCBI chr20:43,369,151...43,394,397
Ensembl chr20:43,371,903...43,394,510
G
Mgarp
mitochondria-localized glutamic acid-rich protein
decreases expression
ISO
trovafloxacin results in decreased expression of MGARP mRNA
CTD
PMID:35537566
NCBI chr 2:137,582,152...137,590,294
Ensembl chr 2:135,431,283...135,439,612
G
Mgll
monoglyceride lipase
decreases expression
EXP
trovafloxacin results in decreased expression of MGLL mRNA
CTD
PMID:24136188
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mgmt
O-6-methylguanine-DNA methyltransferase
increases expression
ISO
trovafloxacin results in increased expression of MGMT mRNA
CTD
PMID:35537566
NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:191,710,930...191,937,756
G
Micall1
MICAL-like 1
increases expression
ISO
trovafloxacin results in increased expression of MICALL1 mRNA
CTD
PMID:35537566
NCBI chr 7:110,676,706...110,707,171
Ensembl chr 7:110,676,775...110,707,177
G
Micall2
MICAL-like 2
increases expression
ISO
trovafloxacin results in increased expression of MICALL2 mRNA
CTD
PMID:35537566
NCBI chr12:14,899,188...14,927,949
Ensembl chr12:14,899,157...14,927,946
G
Midn
midnolin
increases expression
ISO
trovafloxacin results in increased expression of MIDN mRNA
CTD
PMID:35537566
NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
G
Mief2
mitochondrial elongation factor 2
increases expression
ISO
trovafloxacin results in increased expression of MIEF2 mRNA
CTD
PMID:35537566
NCBI chr10:45,408,055...45,414,144
Ensembl chr10:45,408,082...45,414,144
G
Miip
migration and invasion inhibitory protein
decreases expression
ISO
trovafloxacin results in decreased expression of MIIP mRNA
CTD
PMID:35537566
NCBI chr 5:158,292,510...158,299,533
Ensembl chr 5:158,292,511...158,299,694
G
Mir877
microRNA 877
increases expression
ISO
trovafloxacin results in increased expression of MIR877 mRNA
CTD
PMID:27713024
NCBI chr20:2,811,476...2,811,560
Ensembl chr20:2,811,476...2,811,560
G
Mirlet7bhg
Mirlet7b host gene
increases expression
ISO
trovafloxacin results in increased expression of LNCPPARA mRNA
CTD
PMID:35537566
G
Mis18a
MIS18 kinetochore protein A
decreases expression
ISO
trovafloxacin results in decreased expression of MIS18A mRNA
CTD
PMID:35537566
NCBI chr11:29,968,030...29,981,058
Ensembl chr11:29,967,701...29,981,062
G
Mis18bp1
MIS18 binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of MIS18BP1 mRNA
CTD
PMID:35537566
NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383
G
Mix23
mitochondrial matrix import factor 23
increases expression
ISO
trovafloxacin results in increased expression of MIX23 mRNA
CTD
PMID:35537566
NCBI chr11:64,660,711...64,681,000
Ensembl chr11:64,660,711...64,681,000
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
trovafloxacin results in decreased expression of MKI67 mRNA
CTD
PMID:35537566
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mknk1
MAPK interacting serine/threonine kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of MKNK1 mRNA
CTD
PMID:35537566
NCBI chr 5:129,318,128...129,357,641
Ensembl chr 5:129,318,170...129,357,639
G
Mkrn2
makorin, ring finger protein, 2
decreases expression
ISO
trovafloxacin results in decreased expression of MKRN2 mRNA
CTD
PMID:35537566
NCBI chr 4:148,661,529...148,679,580
Ensembl chr 4:148,661,553...148,679,642
G
Mkrn3
makorin, ring finger protein, 3
increases expression
ISO
trovafloxacin results in increased expression of MKRN3 mRNA
CTD
PMID:35537566
NCBI chr 1:115,926,774...115,929,288
Ensembl chr 1:115,926,776...115,929,283
G
Mlf1
myeloid leukemia factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of MLF1 mRNA
CTD
PMID:35537566
NCBI chr 2:151,648,492...151,681,654
Ensembl chr 2:151,648,511...151,681,652
G
Mlxipl
MLX interacting protein-like
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MLXIPL mRNA
CTD
PMID:18930950
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:21,543,576...21,577,112
G
Mmp13
matrix metallopeptidase 13
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MMP13 mRNA
CTD
PMID:18930950
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
G
Mnd1
meiotic nuclear divisions 1
decreases expression
ISO
trovafloxacin results in decreased expression of MND1 mRNA
CTD
PMID:35537566
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
G
Mnda
myeloid cell nuclear differentiation antigen
increases expression
ISO
trovafloxacin results in increased expression of MNDA mRNA; trovafloxacin results in increased expression of PYHIN1 mRNA
CTD
PMID:35537566
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
G
Mob3b
MOB kinase activator 3B
decreases expression
ISO
trovafloxacin results in decreased expression of MOB3B mRNA
CTD
PMID:35537566
NCBI chr 5:49,546,254...49,737,934
Ensembl chr 5:49,545,815...49,737,934
G
Mogs
mannosyl-oligosaccharide glucosidase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MOGS mRNA
CTD
PMID:18930950
NCBI chr 4:115,621,623...115,625,026
Ensembl chr 4:115,621,623...115,625,032
G
Mok
MOK protein kinase
increases expression
ISO
trovafloxacin results in increased expression of MOK mRNA
CTD
PMID:35537566
NCBI chr 6:129,823,794...129,854,669
Ensembl chr 6:129,823,795...129,854,700
G
Mpeg1
macrophage expressed 1
increases expression
ISO
trovafloxacin results in increased expression of MPEG1 mRNA
CTD
PMID:35537566
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
G
Mpg
N-methylpurine-DNA glycosylase
decreases expression
ISO
trovafloxacin results in decreased expression of MPG mRNA
CTD
PMID:35537566
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
G
Mphosph8
M-phase phosphoprotein 8
increases expression
EXP
trovafloxacin results in increased expression of MPHOSPH8 mRNA
CTD
PMID:24136188
NCBI chr15:30,800,546...30,828,415
Ensembl chr15:30,686,613...30,828,810
G
Mr1
major histocompatibility complex, class I-related
decreases expression
ISO
trovafloxacin results in decreased expression of MR1 mRNA
CTD
PMID:35537566
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Mrc1
mannose receptor, C type 1
decreases expression
ISO
trovafloxacin results in decreased expression of MRC1 mRNA
CTD
PMID:35537566
NCBI chr17:82,157,725...82,239,411
Ensembl chr17:77,249,187...77,330,857
G
Mrnip
MRN complex interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of MRNIP mRNA
CTD
PMID:35537566
NCBI chr10:34,501,359...34,525,474
Ensembl chr10:34,501,384...34,525,469
G
Mroh1
maestro heat-like repeat family member 1
decreases expression
ISO
trovafloxacin results in decreased expression of MROH1 mRNA
CTD
PMID:35537566
NCBI chr 7:108,098,708...108,172,146
Ensembl chr 7:108,102,734...108,172,146
G
Mrpl12
mitochondrial ribosomal protein L12
decreases expression
EXP
trovafloxacin results in decreased expression of MRPL12 mRNA
CTD
PMID:24136188
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
G
Mrpl38
mitochondrial ribosomal protein L38
decreases expression
ISO
trovafloxacin results in decreased expression of MRPL38 mRNA
CTD
PMID:35537566
NCBI chr10:101,365,353...101,372,159
Ensembl chr10:101,365,353...101,372,171
G
Mrps18b
mitochondrial ribosomal protein S18B
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of MRPS18B mRNA trovafloxacin results in increased expression of MRPS18B mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
G
Msh3
mutS homolog 3
decreases expression
ISO
trovafloxacin results in decreased expression of MSH3 mRNA
CTD
PMID:35537566
NCBI chr 2:25,179,400...25,320,857
G
Msh5
mutS homolog 5
decreases expression
ISO
trovafloxacin results in decreased expression of MSH5 mRNA
CTD
PMID:35537566
NCBI chr20:3,779,180...3,797,996
Ensembl chr20:3,776,942...3,793,336
G
Mt1
metallothionein 1
increases expression
EXP
trovafloxacin results in increased expression of MT1A mRNA
CTD
PMID:24136188
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2
metallothionein 2
decreases expression multiple interactions
ISO
trovafloxacin results in decreased expression of MT2 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MT1E mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Mtbp
MDM2 binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of MTBP mRNA
CTD
PMID:35537566
NCBI chr 7:86,973,215...87,055,775
Ensembl chr 7:86,973,069...87,050,827
G
Mtch1
mitochondrial carrier 1
decreases expression
ISO
trovafloxacin results in decreased expression of MTCH1 mRNA
CTD
PMID:35537566
NCBI chr20:7,389,942...7,413,426
Ensembl chr20:7,389,949...7,413,426
G
Mtfr2
mitochondrial fission regulator 2
decreases expression
ISO
trovafloxacin results in decreased expression of MTFR2 mRNA
CTD
PMID:35537566
NCBI chr 1:15,123,232...15,138,632
Ensembl chr 1:15,070,894...15,148,832
G
Mtg1
mitochondrial ribosome-associated GTPase 1
decreases expression
ISO
trovafloxacin results in decreased expression of MTG1 mRNA
CTD
PMID:35537566
NCBI chr 1:194,931,543...194,944,278
Ensembl chr 1:194,931,531...194,944,277
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
decreases expression
ISO
trovafloxacin results in decreased expression of MTHFD1L mRNA
CTD
PMID:35537566
NCBI chr 1:42,849,424...43,038,313
Ensembl chr 1:40,444,008...40,632,905
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
decreases expression
ISO
trovafloxacin results in decreased expression of MTHFD2 mRNA
CTD
PMID:35537566
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:115,811,139...115,822,608
G
Mttp
microsomal triglyceride transfer protein
decreases expression
EXP ISO
trovafloxacin results in decreased expression of MTTP mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Mtus2
microtubule associated scaffold protein 2
increases expression
ISO
trovafloxacin results in increased expression of MTUS2 mRNA
CTD
PMID:35537566
NCBI chr12:6,706,531...7,078,331
Ensembl chr12:6,706,532...7,078,331
G
Mul1
mitochondrial E3 ubiquitin protein ligase 1
increases expression
ISO
trovafloxacin results in increased expression of MUL1 mRNA
CTD
PMID:35537566
NCBI chr 5:155,936,112...155,945,163
Ensembl chr 5:150,652,812...150,661,863
G
Mus81
MUS81 structure-specific endonuclease subunit
decreases expression
ISO
trovafloxacin results in decreased expression of MUS81 mRNA
CTD
PMID:35537566
NCBI chr 1:202,790,295...202,796,008
Ensembl chr 1:202,790,466...202,795,843
G
Mustn1
musculoskeletal, embryonic nuclear protein 1
increases expression
ISO
trovafloxacin results in increased expression of MUSTN1 mRNA
CTD
PMID:35537566
NCBI chr16:6,079,355...6,081,608
Ensembl chr16:6,072,833...6,075,161
G
Mutyh
mutY DNA glycosylase
decreases expression
ISO
trovafloxacin results in decreased expression of MUTYH mRNA
CTD
PMID:35537566
NCBI chr 5:135,510,666...135,522,777
Ensembl chr 5:130,274,122...130,286,146
G
Mx1
MX dynamin like GTPase 1
increases expression
ISO
trovafloxacin results in increased expression of MX2 mRNA
CTD
PMID:35537566
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:36,799,660...36,823,507
G
Mxd3
Max dimerization protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of MXD3 mRNA
CTD
PMID:35537566
NCBI chr17:9,301,430...9,305,156
Ensembl chr17:9,301,399...9,305,157
G
Myadml2
myeloid-associated differentiation marker-like 2
decreases expression
ISO
trovafloxacin results in decreased expression of MYADML2 mRNA
CTD
PMID:35537566
NCBI chr10:105,922,557...105,927,867
Ensembl chr10:105,925,947...105,927,575
G
Mybl2
MYB proto-oncogene like 2
decreases expression
ISO
trovafloxacin results in decreased expression of MYBL2 mRNA
CTD
PMID:35537566
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
G
Mybpc3
myosin binding protein C3
increases expression
ISO
trovafloxacin results in increased expression of MYBPC3 mRNA
CTD
PMID:35537566
NCBI chr 3:97,550,974...97,569,216
Ensembl chr 3:77,095,252...77,113,405
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
trovafloxacin results in increased expression of MYC mRNA
CTD
PMID:35537566
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Mycbp
Myc binding protein
increases expression
ISO
trovafloxacin results in increased expression of MYCBP mRNA
CTD
PMID:35537566
NCBI chr 5:136,135,955...136,143,163
Ensembl chr 5:136,135,931...136,145,616
G
Mycbp2
MYC binding protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of MYCBP2 mRNA
CTD
PMID:35537566
NCBI chr15:79,937,354...80,175,432
Ensembl chr15:79,937,354...80,175,498
G
Mycl
MYCL proto-oncogene, bHLH transcription factor
increases expression
ISO
trovafloxacin results in increased expression of MYCL mRNA
CTD
PMID:35537566
NCBI chr 5:135,274,713...135,281,584
Ensembl chr 5:135,274,748...135,281,582
G
Myd88
MYD88, innate immune signal transduction adaptor
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MYD88 mRNA
CTD
PMID:18930950
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Myh10
myosin heavy chain 10
increases expression
ISO
trovafloxacin results in increased expression of MYH10 mRNA
CTD
PMID:35537566
NCBI chr10:53,891,955...54,024,032
Ensembl chr10:53,394,389...53,525,165
G
Myh14
myosin heavy chain 14
decreases expression
ISO
trovafloxacin results in decreased expression of MYH14 mRNA
CTD
PMID:35537566
NCBI chr 1:104,232,778...104,295,369
Ensembl chr 1:95,096,266...95,158,836
G
Myh7b
myosin heavy chain 7B
decreases expression
ISO
trovafloxacin results in decreased expression of MYH7B mRNA
CTD
PMID:35537566
NCBI chr 3:164,537,211...164,582,441
Ensembl chr 3:144,098,190...144,122,084
G
Myl11
myosin light chain 11
decreases expression
ISO
trovafloxacin results in decreased expression of MYLPF mRNA
CTD
PMID:35537566
NCBI chr 1:181,829,703...181,832,546
Ensembl chr 1:181,829,743...181,832,545
G
Myo9a
myosin IXA
decreases expression
ISO
trovafloxacin results in decreased expression of MYO9A mRNA
CTD
PMID:35537566
NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514
G
Myom1
myomesin 1
decreases expression
ISO
trovafloxacin results in decreased expression of MYOM1 mRNA
CTD
PMID:35537566
NCBI chr 9:110,916,156...111,039,344
Ensembl chr 9:110,915,943...111,039,344
G
Myoz1
myozenin 1
decreases expression
ISO
trovafloxacin results in decreased expression of MYOZ1 mRNA
CTD
PMID:35537566
NCBI chr15:3,644,333...3,651,584
Ensembl chr15:3,644,368...3,652,884
G
Mzf1
myeloid zinc finger 1
decreases expression
ISO
trovafloxacin results in decreased expression of MZF1 mRNA
CTD
PMID:35537566
NCBI chr 1:73,670,522...73,682,885
Ensembl chr 1:73,670,541...73,681,635
G
N4bp2l1
NEDD4 binding protein 2-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of N4BP2L1 mRNA
CTD
PMID:35537566
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
G
N4bp3
Nedd4 binding protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of N4BP3 mRNA
CTD
PMID:35537566
NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
decreases expression
EXP
trovafloxacin results in decreased expression of NAA15 mRNA
CTD
PMID:24136188
NCBI chr 2:135,458,018...135,520,756
Ensembl chr 2:135,457,948...135,520,756
G
Naglu
N-acetyl-alpha-glucosaminidase
decreases expression
ISO
trovafloxacin results in decreased expression of NAGLU mRNA
CTD
PMID:35537566
NCBI chr10:86,001,545...86,009,049
Ensembl chr10:86,001,566...86,008,972
G
Napb
NSF attachment protein beta
increases expression
ISO
trovafloxacin results in increased expression of NAPB mRNA
CTD
PMID:35537566
NCBI chr 3:136,132,248...136,179,280
Ensembl chr 3:136,133,428...136,179,345
G
Naprt
nicotinate phosphoribosyltransferase
increases expression
ISO
trovafloxacin results in increased expression of NAPRT mRNA
CTD
PMID:35537566
NCBI chr 7:107,576,645...107,580,102
Ensembl chr 7:107,576,627...107,580,102
G
Nars1
asparaginyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of NARS1 mRNA
CTD
PMID:35537566
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:57,989,308...58,005,622
G
Nasp
nuclear autoantigenic sperm protein
decreases expression
ISO
trovafloxacin results in decreased expression of NASP mRNA
CTD
PMID:35537566
NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:130,057,363...130,082,928
G
Naxd
NAD(P)HX dehydratase
decreases expression
ISO
trovafloxacin results in decreased expression of NAXD mRNA
CTD
PMID:35537566
NCBI chr16:77,986,148...78,004,200
Ensembl chr16:77,987,726...78,004,192
G
Nbas
NBAS subunit of NRZ tethering complex
decreases expression
ISO
trovafloxacin results in decreased expression of NBAS mRNA
CTD
PMID:35537566
NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPD2 mRNA
CTD
PMID:35537566
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
G
Ncapd3
non-SMC condensin II complex, subunit D3
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPD3 mRNA
CTD
PMID:35537566
NCBI chr 8:25,437,067...25,506,375
Ensembl chr 8:25,437,123...25,506,373
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPG mRNA
CTD
PMID:35537566
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:65,404,163...65,432,902
G
Ncapg2
non-SMC condensin II complex, subunit G2
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPG2 mRNA
CTD
PMID:35537566
NCBI chr 6:137,342,449...137,418,083
Ensembl chr 6:137,342,943...137,415,159
G
Ncaph
non-SMC condensin I complex, subunit H
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPH mRNA
CTD
PMID:35537566
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
G
Ncaph2
non-SMC condensin II complex, subunit H2
decreases expression
ISO
trovafloxacin results in decreased expression of NCAPH2 mRNA
CTD
PMID:35537566
NCBI chr 7:120,422,926...120,439,942
Ensembl chr 7:120,422,956...120,439,938
G
Ncbp3
nuclear cap binding subunit 3
decreases expression
ISO
trovafloxacin results in decreased expression of NCBP3 mRNA
CTD
PMID:35537566
NCBI chr10:57,665,716...57,695,432
Ensembl chr10:57,665,716...57,695,432
G
Ndc80
NDC80 kinetochore complex component
decreases expression
ISO
trovafloxacin results in decreased expression of NDC80 mRNA
CTD
PMID:35537566
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Nde1
nudE neurodevelopment protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of NDE1 mRNA
CTD
PMID:35537566
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
G
Ndrg1
N-myc downstream regulated 1
decreases expression
ISO
trovafloxacin results in decreased expression of NDRG1 mRNA
CTD
PMID:35537566
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndufaf4
NADH:ubiquinone oxidoreductase complex assembly factor 4
decreases expression
EXP
trovafloxacin results in decreased expression of NDUFAF4 mRNA
CTD
PMID:24136188
NCBI chr 5:38,605,169...38,610,341
Ensembl chr 5:38,605,153...38,610,336
G
Ndufv1
NADH:ubiquinone oxidoreductase core subunit V1
decreases expression
ISO
trovafloxacin results in decreased expression of NDUFV1 mRNA
CTD
PMID:35537566
NCBI chr 1:210,729,856...210,735,103
Ensembl chr 1:201,299,985...201,305,466
G
Neat1
nuclear paraspeckle assembly transcript 1
increases expression
ISO
trovafloxacin results in increased expression of NEAT1 mRNA
CTD
PMID:35537566
NCBI chr 1:203,129,229...203,140,014
G
Neb
nebulin
increases expression
ISO
trovafloxacin results in increased expression of NEB mRNA
CTD
PMID:35537566
NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574
G
Necap1
NECAP endocytosis associated 1
increases expression
ISO
trovafloxacin results in increased expression of NECAP1 mRNA
CTD
PMID:35537566
NCBI chr 4:156,103,935...156,119,068
Ensembl chr 4:156,103,988...156,119,068
G
Nedd4l
NEDD4 like E3 ubiquitin protein ligase
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NEDD4L mRNA trovafloxacin results in decreased expression of NEDD4L mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr18:58,393,759...58,726,709
Ensembl chr18:58,393,509...58,723,137
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NEDD9 mRNA trovafloxacin results in decreased expression of NEDD9 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
G
Neil3
nei-like DNA glycosylase 3
decreases expression
ISO
trovafloxacin results in decreased expression of NEIL3 mRNA
CTD
PMID:35537566
NCBI chr16:38,359,305...38,418,528
Ensembl chr16:38,359,371...38,418,527
G
Nek1
NIMA-related kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of NEK1 mRNA
CTD
PMID:35537566
NCBI chr16:28,998,229...29,125,426
Ensembl chr16:28,998,231...29,117,723
G
Nek8
NIMA-related kinase 8
decreases expression
ISO
trovafloxacin results in decreased expression of NEK8 mRNA
CTD
PMID:35537566
NCBI chr10:63,060,868...63,073,546
Ensembl chr10:63,061,253...63,072,416
G
Nemp1
nuclear envelope integral membrane protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of NEMP1 mRNA
CTD
PMID:35537566
NCBI chr 7:63,514,025...63,538,791
Ensembl chr 7:63,479,951...63,534,602
G
Neo1
neogenin 1
decreases expression
ISO
trovafloxacin results in decreased expression of NEO1 mRNA
CTD
PMID:35537566
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
G
Nes
nestin
decreases expression
ISO
trovafloxacin results in decreased expression of NES mRNA
CTD
PMID:35537566
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Neurl1b
neuralized E3 ubiquitin protein ligase 1B
decreases expression
ISO
trovafloxacin results in decreased expression of NEURL1B mRNA
CTD
PMID:35537566
NCBI chr10:16,754,002...16,785,049
Ensembl chr10:16,757,208...16,785,119
G
Nexn
nexilin (F actin binding protein)
decreases expression
ISO
trovafloxacin results in decreased expression of NEXN mRNA
CTD
PMID:35537566
NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
G
Nfatc1
nuclear factor of activated T-cells 1
increases expression
ISO
trovafloxacin results in increased expression of NFATC1 mRNA
CTD
PMID:35537566
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:74,046,904...74,156,028
G
Nfia
nuclear factor I/A
decreases expression
ISO
trovafloxacin results in decreased expression of NFIA mRNA
CTD
PMID:35537566
NCBI chr 5:112,436,655...112,781,878
Ensembl chr 5:112,436,644...112,775,885
G
Nfil3
nuclear factor, interleukin 3 regulated
decreases expression
ISO
trovafloxacin results in decreased expression of NFIL3 mRNA
CTD
PMID:35537566
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nfkbia
NFKB inhibitor alpha
multiple interactions increases expression
ISO
[Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of NFKBIA mRNA; [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFKBIA mRNA; [trovafloxacin co-treated with TNF protein] results in decreased expression of NFKBIA protein; trovafloxacin promotes the reaction [TNF protein results in increased expression of NFKBIA mRNA] trovafloxacin results in increased expression of NFKBIA mRNA; trovafloxacin results in increased expression of NFKBIA protein [trovafloxacin co-treated with TNF protein] results in increased expression of NFKBIA mRNA
CTD
PMID:18930950 PMID:32035082 PMID:35537566
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbid
NFKB inhibitor delta
increases expression
ISO
trovafloxacin results in increased expression of NFKBID mRNA
CTD
PMID:35537566
NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
G
Nfkbiz
NFKB inhibitor zeta
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NFKBIZ mRNA trovafloxacin results in increased expression of NFKBIZ mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Ngfr
nerve growth factor receptor
increases expression
ISO
trovafloxacin results in increased expression of TNFRSF10B mRNA
CTD
PMID:35537566
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Nherf1
NHERF family PDZ scaffold protein 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NHERF1 mRNA
CTD
PMID:18930950
NCBI chr10:100,403,189...100,420,290
Ensembl chr10:100,403,069...100,420,598
G
Nhsl2
NHS-like 2
decreases expression
ISO
trovafloxacin results in decreased expression of NHSL2 mRNA
CTD
PMID:35537566
NCBI chr X:66,969,953...67,209,464
Ensembl chr X:66,970,151...67,200,911
G
Niban2
niban apoptosis regulator 2
increases expression
ISO
trovafloxacin results in increased expression of FAM129B mRNA
CTD
PMID:35537566
NCBI chr 3:16,174,674...16,224,293
Ensembl chr 3:16,174,659...16,224,293
G
Nid2
nidogen 2
decreases expression
ISO
trovafloxacin results in decreased expression of NID2 mRNA
CTD
PMID:35537566
NCBI chr15:4,458,082...4,513,808
Ensembl chr15:4,458,084...4,513,843
G
Nkain1
Sodium/potassium transporting ATPase interacting 1
increases expression
ISO
trovafloxacin results in increased expression of NKAIN1 mRNA
CTD
PMID:35537566
NCBI chr 5:142,747,702...142,792,665
Ensembl chr 5:142,747,505...142,791,863
G
Nlrx1
NLR family member X1
decreases expression
ISO
trovafloxacin results in decreased expression of NLRX1 mRNA
CTD
PMID:35537566
NCBI chr 8:53,486,866...53,503,498
Ensembl chr 8:44,590,048...44,606,484
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
decreases expression
EXP
trovafloxacin results in decreased expression of NME1 mRNA
CTD
PMID:24136188
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:78,906,083...78,916,408
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
decreases expression
EXP
trovafloxacin results in decreased expression of NME2 mRNA
CTD
PMID:24136188
NCBI chr10:79,394,999...79,400,418
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
G
Nmral1
NmrA like redox sensor 1
decreases expression
ISO
trovafloxacin results in decreased expression of NMRAL1 mRNA
CTD
PMID:35537566
NCBI chr10:10,841,693...10,850,199
Ensembl chr10:10,841,799...10,850,192
G
Nnat
neuronatin
increases expression
ISO
trovafloxacin results in increased expression of NNAT mRNA
CTD
PMID:35537566
NCBI chr 3:146,225,941...146,228,868
Ensembl chr 3:146,226,407...146,228,834
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
trovafloxacin results in decreased expression of NNT mRNA
CTD
PMID:35537566
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Noct
nocturnin
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NOCT mRNA
CTD
PMID:18930950
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
G
Nos1
nitric oxide synthase 1
decreases expression
ISO
trovafloxacin results in decreased expression of NOS1 mRNA
CTD
PMID:35537566
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
decreases expression
ISO
trovafloxacin results in decreased expression of NOS2 mRNA
CTD
PMID:35537566
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Notch2
notch receptor 2
decreases expression
EXP
trovafloxacin results in decreased expression of NOTCH2 mRNA
CTD
PMID:24136188
NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:185,610,589...185,744,088
G
Noxred1
NADP-dependent oxidoreductase domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of NOXRED1 mRNA
CTD
PMID:35537566
NCBI chr 6:106,862,350...106,888,113
Ensembl chr 6:106,862,343...106,884,712
G
Nphp4
nephrocystin 4
decreases expression
ISO
trovafloxacin results in decreased expression of NPHP4 mRNA
CTD
PMID:35537566
NCBI chr 5:162,986,157...163,073,708
Ensembl chr 5:162,988,370...163,073,706
G
Npnt
nephronectin
decreases expression
ISO
trovafloxacin results in decreased expression of NPNT mRNA
CTD
PMID:35537566
NCBI chr 2:221,391,151...221,459,527
Ensembl chr 2:221,391,153...221,459,401
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
increases expression
ISO
trovafloxacin results in increased expression of NR1D1 mRNA
CTD
PMID:35537566
NCBI chr10:84,224,599...84,231,812
Ensembl chr10:83,728,318...83,735,705
G
Nr2f6
nuclear receptor subfamily 2, group F, member 6
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of NR2F6 mRNA
CTD
PMID:18930950
NCBI chr16:18,046,012...18,053,914
Ensembl chr16:18,046,013...18,053,459
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases expression
EXP
trovafloxacin results in increased expression of NR3C1 mRNA
CTD
PMID:24136188
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
trovafloxacin results in increased expression of NR4A1 mRNA
CTD
PMID:35537566
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
trovafloxacin results in increased expression of NR4A2 mRNA
CTD
PMID:35537566
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:41,689,851...41,697,877
G
Nradd
neurotrophin receptor associated death domain
increases expression
ISO
trovafloxacin results in increased expression of NRADD mRNA
CTD
PMID:35537566
NCBI chr 8:110,599,667...110,603,068
Ensembl chr 8:110,599,667...110,603,149
G
Nsl1
NSL1 component of MIS12 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of NSL1 mRNA
CTD
PMID:35537566
NCBI chr13:102,649,050...102,674,059
Ensembl chr13:102,649,058...102,674,054
G
Nt5dc2
5'-nucleotidase domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of NT5DC2 mRNA
CTD
PMID:35537566
NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537
G
Nuak2
NUAK family kinase 2
increases expression
ISO
trovafloxacin results in increased expression of NUAK2 mRNA
CTD
PMID:35537566
NCBI chr13:43,753,454...43,770,604
Ensembl chr13:43,753,832...43,770,604
G
Nudt22
nudix hydrolase 22
increases expression
ISO
trovafloxacin results in increased expression of NUDT22 mRNA
CTD
PMID:35537566
NCBI chr 1:204,182,797...204,186,421
Ensembl chr 1:204,182,802...204,186,280
G
Nudt6
nudix hydrolase 6
decreases expression
ISO
trovafloxacin results in decreased expression of NUDT6 mRNA
CTD
PMID:35537566
NCBI chr 2:120,289,908...120,306,197
Ensembl chr 2:120,290,847...120,306,230
G
Nudt7
nudix hydrolase 7
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of NUDT7 mRNA
CTD
PMID:18930950
NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081
G
Nuf2
NUF2 component of NDC80 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of NUF2 mRNA
CTD
PMID:35537566
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
G
Nup205
nucleoporin 205
decreases expression
ISO
trovafloxacin results in decreased expression of NUP205 mRNA
CTD
PMID:35537566
NCBI chr 4:63,854,934...63,920,852
Ensembl chr 4:63,854,783...63,920,844
G
Nup210
nucleoporin 210
decreases expression
ISO
trovafloxacin results in decreased expression of NUP210 mRNA
CTD
PMID:35537566
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:123,511,559...123,609,874
G
Nup98
nucleoporin 98 and 96 precursor
increases expression
EXP
trovafloxacin results in increased expression of NUP98 mRNA
CTD
PMID:24136188
NCBI chr 1:165,906,405...166,003,366
Ensembl chr 1:156,494,423...156,591,415
G
Nupr1
nuclear protein 1, transcriptional regulator
decreases expression
ISO
trovafloxacin results in decreased expression of NUPR1 mRNA
CTD
PMID:35537566
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:181,213,368...181,215,281
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of NUSAP1 mRNA
CTD
PMID:35537566
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
G
Nxn
nucleoredoxin
decreases expression
ISO
trovafloxacin results in decreased expression of NXN mRNA
CTD
PMID:35537566
NCBI chr10:61,109,322...61,247,578
Ensembl chr10:61,110,020...61,248,251
G
Nxnl1
nucleoredoxin-like 1
increases expression
ISO
trovafloxacin results in increased expression of NXNL1 mRNA
CTD
PMID:35537566
NCBI chr16:18,270,604...18,279,797
Ensembl chr16:18,262,688...18,279,987
G
Nxph4
neurexophilin 4
decreases expression
ISO
trovafloxacin results in decreased expression of NXPH4 mRNA
CTD
PMID:35537566
NCBI chr 7:63,367,758...63,376,579
Ensembl chr 7:63,367,761...63,376,579
G
Oas2
2'-5' oligoadenylate synthetase 2
increases expression
ISO
trovafloxacin results in increased expression of OAS2 mRNA
CTD
PMID:35537566
NCBI chr12:41,464,568...41,492,036
Ensembl chr12:35,806,759...35,829,371
G
Oasl
2'-5'-oligoadenylate synthetase-like
increases expression
ISO
trovafloxacin results in increased expression of OASL1 mRNA
CTD
PMID:35537566
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
G
Obp3
alpha-2u globulin PGCL4
increases expression
EXP
trovafloxacin results in increased expression of OBP3 mRNA
CTD
PMID:24136188
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
G
Ogfrl1
opioid growth factor receptor-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of OGFRL1 mRNA
CTD
PMID:35537566
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
G
Oip5
Opa interacting protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of OIP5 mRNA
CTD
PMID:35537566
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
G
Olr1271
olfactory receptor 1271
decreases expression
ISO
trovafloxacin results in decreased expression of OR8D1B mRNA
CTD
PMID:35537566
NCBI chr 8:39,127,409...39,131,889
Ensembl chr 8:39,127,352...39,131,900
G
Oplah
5-oxoprolinase (ATP-hydrolysing)
decreases expression
ISO
trovafloxacin results in decreased expression of OPLAH mRNA
CTD
PMID:35537566
NCBI chr 7:109,892,136...109,932,403
Ensembl chr 7:108,011,475...108,035,297
G
Optn
optineurin
decreases expression
ISO
trovafloxacin results in decreased expression of OPTN mRNA
CTD
PMID:35537566
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:73,209,575...73,260,251
G
Orai2
ORAI calcium release-activated calcium modulator 2
increases expression
ISO
trovafloxacin results in increased expression of ORAI2 mRNA
CTD
PMID:35537566
NCBI chr12:20,500,308...20,520,428
Ensembl chr12:20,497,317...20,520,428
G
Osbpl10
oxysterol binding protein-like 10
decreases expression
ISO
trovafloxacin results in decreased expression of OSBPL10 mRNA
CTD
PMID:35537566
NCBI chr 8:114,661,050...114,918,664
Ensembl chr 8:114,660,743...114,918,625
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression
ISO
trovafloxacin results in decreased expression of OSBPL1A mRNA
CTD
PMID:35537566
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
G
Osgep
O-sialoglycoprotein endopeptidase
decreases expression
ISO
trovafloxacin results in decreased expression of OSGEP mRNA
CTD
PMID:35537566
NCBI chr15:24,137,149...24,144,568
Ensembl chr15:24,137,153...24,144,568
G
Ost4
oligosaccharyltransferase complex subunit 4, non-catalytic
increases expression
ISO
trovafloxacin results in increased expression of OST4 mRNA
CTD
PMID:35537566
NCBI chr 6:25,471,254...25,472,478
G
P2ry2
purinergic receptor P2Y2
decreases expression
EXP
trovafloxacin results in decreased expression of P2RY2 mRNA
CTD
PMID:24136188
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
G
P3h3
prolyl 3-hydroxylase 3
decreases expression
ISO
trovafloxacin results in decreased expression of P3H3 mRNA
CTD
PMID:35537566
NCBI chr 4:159,332,514...159,348,428
Ensembl chr 4:157,646,243...157,662,035
G
Pabir2
PABIR family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of PABIR2 mRNA
CTD
PMID:35537566
NCBI chr X:132,989,124...133,015,625
Ensembl chr X:132,989,124...133,015,580
G
Pabpc1l
poly(A) binding protein, cytoplasmic 1-like
increases expression
ISO
trovafloxacin results in increased expression of PABPC1L mRNA
CTD
PMID:35537566
NCBI chr 3:152,692,825...152,725,997
Ensembl chr 3:152,693,700...152,725,997
G
Pacsin2
protein kinase C and casein kinase substrate in neurons 2
decreases expression
EXP
trovafloxacin results in decreased expression of PACSIN2 mRNA
CTD
PMID:24136188
NCBI chr 7:116,385,571...116,478,609
Ensembl chr 7:114,505,152...114,598,546
G
Pag1
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
decreases expression
ISO
trovafloxacin results in decreased expression of PAG1 mRNA
CTD
PMID:35537566
NCBI chr 2:91,935,378...92,076,937
Ensembl chr 2:92,057,216...92,069,849
G
Pald1
phosphatase domain containing, paladin 1
decreases expression
ISO
trovafloxacin results in decreased expression of PALD1 mRNA
CTD
PMID:35537566
NCBI chr20:29,269,814...29,334,850
Ensembl chr20:29,270,193...29,334,858
G
Pals2
protein associated with LIN7 2, MAGUK p55 family member
decreases expression
ISO
trovafloxacin results in decreased expression of MPP6 mRNA
CTD
PMID:35537566
NCBI chr 4:79,173,488...79,257,542
Ensembl chr 4:79,124,806...79,254,140
G
Paox
polyamine oxidase
decreases expression
ISO
trovafloxacin results in decreased expression of PAOX mRNA
CTD
PMID:35537566
NCBI chr 1:194,919,655...194,928,498
Ensembl chr 1:194,903,273...194,928,504
G
Pard6a
par-6 family cell polarity regulator alpha
decreases expression
ISO
trovafloxacin results in decreased expression of PARD6A mRNA
CTD
PMID:35537566
NCBI chr19:33,589,531...33,591,900
Ensembl chr19:33,589,542...33,591,900
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
trovafloxacin results in increased cleavage of PARP1 protein ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of PARP1 protein]
CTD
PMID:33609687
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Parp10
poly (ADP-ribose) polymerase family, member 10
increases expression
ISO
trovafloxacin results in increased expression of PARP10 mRNA
CTD
PMID:35537566
NCBI chr 7:107,949,031...107,958,377
Ensembl chr 7:107,949,043...107,958,304
G
Parp14
poly (ADP-ribose) polymerase family, member 14
increases expression
ISO
trovafloxacin results in increased expression of PARP14 mRNA
CTD
PMID:35537566
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
G
Parpbp
PARP1 binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of PARPBP mRNA
CTD
PMID:35537566
NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695
G
Pask
PAS domain containing serine/threonine kinase
decreases expression
ISO
trovafloxacin results in decreased expression of PASK mRNA
CTD
PMID:35537566
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
G
Pax6
paired box 6
decreases expression
ISO
trovafloxacin results in decreased expression of PAX6 mRNA
CTD
PMID:35537566
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:92,135,637...92,157,014
G
Pbk
PDZ binding kinase
decreases expression
ISO
trovafloxacin results in decreased expression of PBK mRNA
CTD
PMID:35537566
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
increases expression
EXP
trovafloxacin results in increased expression of PBLD1 mRNA
CTD
PMID:24136188
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
G
Pbx3
PBX homeobox 3
decreases expression
ISO
trovafloxacin results in decreased expression of PBX3 mRNA
CTD
PMID:35537566
NCBI chr 3:17,488,691...17,682,412
Ensembl chr 3:17,488,693...17,682,791
G
Pc
pyruvate carboxylase
decreases expression
ISO
trovafloxacin results in decreased expression of PCX mRNA
CTD
PMID:35537566
NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:201,804,267...201,898,380
G
Pcdhb19
protocadherin beta 19
increases expression
ISO
trovafloxacin results in increased expression of PCDHB12 mRNA
CTD
PMID:35537566
NCBI chr18:29,204,838...29,207,646
G
Pcdhb20
protocadherin beta 20
increases expression
ISO
trovafloxacin results in increased expression of PCDHB14 mRNA
CTD
PMID:35537566
NCBI chr18:29,211,878...29,215,272
Ensembl chr18:29,211,883...29,215,258
G
Pcdhb22
protocadherin beta 22
increases expression
ISO
trovafloxacin results in increased expression of PCDHB22 mRNA
CTD
PMID:35537566
NCBI chr18:29,223,028...29,229,132
Ensembl chr18:29,223,149...29,225,536
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression
ISO
trovafloxacin results in decreased expression of PCK2 mRNA
CTD
PMID:35537566
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
G
Pclaf
PCNA clamp associated factor
decreases expression
ISO
trovafloxacin results in decreased expression of PCLAF mRNA
CTD
PMID:35537566
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcnt
pericentrin
decreases expression
ISO
trovafloxacin results in decreased expression of PCNT mRNA
CTD
PMID:35537566
NCBI chr20:12,190,597...12,278,723
Ensembl chr20:12,191,648...12,278,710
G
Pcsk6
proprotein convertase subtilisin/kexin type 6
decreases expression
EXP
trovafloxacin results in decreased expression of PCSK6 mRNA
CTD
PMID:24136188
NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
G
Pctp
phosphatidylcholine transfer protein
decreases expression
EXP
trovafloxacin results in decreased expression of PCTP mRNA
CTD
PMID:24136188
NCBI chr10:75,305,999...75,351,919
Ensembl chr10:74,808,887...74,849,867
G
Pcyox1l
prenylcysteine oxidase 1 like
decreases expression
ISO
trovafloxacin results in decreased expression of PCYOX1L mRNA
CTD
PMID:35537566
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
G
Pde1b
phosphodiesterase 1B
increases expression
ISO
trovafloxacin results in increased expression of PDE1B mRNA
CTD
PMID:35537566
NCBI chr 7:134,627,378...134,654,581
Ensembl chr 7:134,627,322...134,654,580
G
Pde4b
phosphodiesterase 4B
decreases expression multiple interactions
EXP ISO
trovafloxacin results in decreased expression of PDE4B mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PDE4B mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
G
Pde4d
phosphodiesterase 4D
decreases expression
ISO
trovafloxacin results in decreased expression of PDE4D mRNA
CTD
PMID:35537566
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:40,019,933...41,525,884
G
Pde6b
phosphodiesterase 6B
decreases expression
ISO
trovafloxacin results in decreased expression of PDE6B mRNA
CTD
PMID:35537566
NCBI chr14:1,468,302...1,511,435
Ensembl chr14:1,323,310...1,366,450
G
Pdhx
pyruvate dehydrogenase complex, component X
decreases expression
EXP
trovafloxacin results in decreased expression of PDHX mRNA
CTD
PMID:24136188
NCBI chr 3:89,372,248...89,431,779
Ensembl chr 3:89,371,497...89,431,773
G
Pdlim1
PDZ and LIM domain 1
decreases expression
EXP
trovafloxacin results in decreased expression of PDLIM1 mRNA
CTD
PMID:24136188
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
G
Pdpr
pyruvate dehydrogenase phosphatase regulatory subunit
decreases expression
ISO
trovafloxacin results in decreased expression of PDPR mRNA
CTD
PMID:35537566
NCBI chr19:39,065,226...39,109,695
Ensembl chr19:39,065,157...39,109,688
G
Pds5b
PDS5 cohesin associated factor B
decreases expression
ISO
trovafloxacin results in decreased expression of PDS5B mRNA
CTD
PMID:35537566
NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596
G
Per1
period circadian regulator 1
increases expression
ISO
trovafloxacin results in increased expression of PER1 mRNA
CTD
PMID:35537566
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
increases expression
ISO
trovafloxacin results in increased expression of PER2 mRNA
CTD
PMID:35537566
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Perm1
PPARGC1 and ESRR induced regulator, muscle 1
increases expression
ISO
trovafloxacin results in increased expression of PERM1 mRNA
CTD
PMID:35537566
NCBI chr 5:166,800,030...166,805,323
Ensembl chr 5:166,800,030...166,805,323
G
Perp
p53 apoptosis effector related to PMP22
decreases expression
EXP
trovafloxacin results in decreased expression of PERP mRNA
CTD
PMID:24136188
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
G
Pex2
peroxisomal biogenesis factor 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PEX2 mRNA
CTD
PMID:18930950
NCBI chr 2:97,957,479...97,973,767
Ensembl chr 2:96,045,958...96,073,404
G
Pex7
peroxisomal biogenesis factor 7
decreases expression
ISO
trovafloxacin results in decreased expression of PEX7 mRNA
CTD
PMID:35537566
NCBI chr 1:14,582,698...14,646,686
Ensembl chr 1:14,582,699...14,646,748
G
Pgap1
post-GPI attachment to proteins inositol deacylase 1
decreases expression
ISO
trovafloxacin results in decreased expression of PGAP1 mRNA
CTD
PMID:35537566
NCBI chr 9:55,975,574...56,044,325
Ensembl chr 9:55,975,667...56,044,464
G
Pgghg
protein-glucosylgalactosylhydroxylysine glucosidase
decreases expression
ISO
trovafloxacin results in decreased expression of PGGHG mRNA
CTD
PMID:35537566
NCBI chr 1:196,038,276...196,044,561
Ensembl chr 1:196,039,103...196,044,372
G
Pgk1
phosphoglycerate kinase 1
decreases expression
EXP
trovafloxacin results in decreased expression of PGK1 mRNA
CTD
PMID:24136188
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Pgm1
phosphoglucomutase 1
decreases expression
EXP
trovafloxacin results in decreased expression of PGM1 mRNA
CTD
PMID:24136188
NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:114,595,293...114,654,728
G
Pgm2l1
phosphoglucomutase 2-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of PGM2L1 mRNA
CTD
PMID:35537566
NCBI chr 1:163,983,917...164,033,027
Ensembl chr 1:154,571,766...154,620,902
G
Pheta1
PH domain containing endocytic trafficking adaptor 1
increases expression
ISO
trovafloxacin results in increased expression of FAM109A mRNA
CTD
PMID:35537566
NCBI chr12:34,711,831...34,717,601
Ensembl chr12:34,711,810...34,717,081
G
Phf10
PHD finger protein 10
decreases expression
ISO
trovafloxacin results in decreased expression of PHF10 mRNA
CTD
PMID:35537566
NCBI chr 1:55,952,249...55,968,994
Ensembl chr 1:55,952,253...55,969,038
G
Phf11
PHD finger protein 11
increases expression
ISO
trovafloxacin results in increased expression of PHF11D mRNA
CTD
PMID:35537566
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
G
Phf19
PHD finger protein 19
decreases expression
ISO
trovafloxacin results in decreased expression of PHF19 mRNA
CTD
PMID:35537566
NCBI chr 3:18,175,281...18,197,289
Ensembl chr 3:18,175,282...18,196,405
G
Phf7
PHD finger protein 7
decreases expression
ISO
trovafloxacin results in decreased expression of PHF7 mRNA
CTD
PMID:35537566
NCBI chr16:6,433,535...6,446,314
Ensembl chr16:6,433,537...6,446,911
G
Phgdh
phosphoglycerate dehydrogenase
decreases expression
ISO
trovafloxacin results in decreased expression of PHGDH mRNA
CTD
PMID:35537566
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:185,906,966...185,935,944
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
decreases expression
ISO
trovafloxacin results in decreased expression of PHKA2 mRNA
CTD
PMID:35537566
NCBI chr X:34,170,959...34,293,498
Ensembl chr X:34,171,323...34,293,466
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of PHKB mRNA
CTD
PMID:35537566
NCBI chr19:21,013,719...21,210,671
Ensembl chr19:21,025,733...21,210,633
G
Phlda1
pleckstrin homology-like domain, family A, member 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PHLDA1 mRNA
CTD
PMID:18930950
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Phlda3
pleckstrin homology-like domain, family A, member 3
increases expression
ISO
trovafloxacin results in increased expression of PHLDA3 mRNA
CTD
PMID:35537566
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
G
Pi16
peptidase inhibitor 16
decreases expression
ISO
trovafloxacin results in decreased expression of PI16 mRNA
CTD
PMID:35537566
NCBI chr20:7,376,073...7,385,386
Ensembl chr20:7,376,126...7,385,383
G
Pi4ka
phosphatidylinositol 4-kinase alpha
decreases expression
ISO
trovafloxacin results in decreased expression of PI4KA mRNA
CTD
PMID:35537566
NCBI chr11:83,609,148...83,726,876
Ensembl chr11:83,609,069...83,724,080
G
Pif1
PIF1 5'-to-3' DNA helicase
decreases expression
ISO
trovafloxacin results in decreased expression of PIF1 mRNA
CTD
PMID:35537566
NCBI chr 8:66,110,641...66,120,202
Ensembl chr 8:66,111,072...66,120,200
G
Pign
phosphatidylinositol glycan anchor biosynthesis, class N
decreases expression
ISO
trovafloxacin results in decreased expression of PIGN mRNA
CTD
PMID:35537566
NCBI chr13:21,659,092...21,812,932
Ensembl chr13:21,662,455...21,806,790
G
Pigv
phosphatidylinositol glycan anchor biosynthesis, class V
decreases expression
ISO
trovafloxacin results in decreased expression of PIGV mRNA
CTD
PMID:35537566
NCBI chr 5:145,889,642...145,901,533
Ensembl chr 5:145,889,646...145,901,533
G
Pih1d1
PIH1 domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of PIH1D1 mRNA
CTD
PMID:35537566
NCBI chr 1:95,639,597...95,645,295
Ensembl chr 1:95,639,592...95,645,290
G
Pih1d2
PIH1 domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of PIH1D2 mRNA
CTD
PMID:35537566
NCBI chr 8:50,966,885...50,976,901
Ensembl chr 8:50,966,885...50,975,656
G
Pik3ap1
phosphoinositide-3-kinase adaptor protein 1
increases expression
ISO
trovafloxacin results in increased expression of PIK3AP1 mRNA
CTD
PMID:35537566
NCBI chr 1:240,090,854...240,245,007
Ensembl chr 1:240,093,065...240,204,828
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
decreases expression
ISO
trovafloxacin results in decreased expression of PIK3CG mRNA
CTD
PMID:35537566
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:48,766,864...48,802,043
G
Pimreg
PICALM interacting mitotic regulator
decreases expression
ISO
trovafloxacin results in decreased expression of FAM64A mRNA
CTD
PMID:35537566
NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791
G
Pink1
PTEN induced kinase 1
increases expression
EXP
trovafloxacin results in increased expression of PINK1 mRNA
CTD
PMID:24136188
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:150,530,523...150,542,635
G
Pip5k1a
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PIP5K1A mRNA
CTD
PMID:18930950
NCBI chr 2:182,628,299...182,671,584
Ensembl chr 2:182,628,300...182,671,598
G
Pisd
phosphatidylserine decarboxylase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PISD mRNA
CTD
PMID:18930950
NCBI chr14:77,941,927...77,991,021
Ensembl chr14:77,941,948...77,991,003
G
Piwil2
piwi-like RNA-mediated gene silencing 2
decreases expression
ISO
trovafloxacin results in decreased expression of PIWIL2 mRNA
CTD
PMID:35537566
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
decreases expression
ISO
trovafloxacin results in decreased expression of PKMYT1 mRNA
CTD
PMID:35537566
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
G
Plau
plasminogen activator, urokinase
increases expression
ISO
trovafloxacin results in increased expression of PLAU mRNA
CTD
PMID:35537566
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Plbd1
phospholipase B domain containing 1
decreases expression
EXP
trovafloxacin results in decreased expression of PLBD1 mRNA
CTD
PMID:24136188
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plcg1
phospholipase C, gamma 1
decreases expression
ISO
trovafloxacin results in decreased expression of PLCG1 mRNA
CTD
PMID:35537566
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:149,385,587...149,416,330
G
Plcxd1
phosphatidylinositol-specific phospholipase C, X domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of PLCXD1 mRNA
CTD
PMID:35537566
NCBI chr12:46,578,917...46,582,181
Ensembl chr12:46,579,225...46,582,392
G
Pld6
phospholipase D family, member 6
increases expression
ISO
trovafloxacin results in increased expression of PLD6 mRNA
CTD
PMID:35537566
NCBI chr10:44,578,536...44,581,187
Ensembl chr10:44,577,675...44,581,077
G
Plekhh2
pleckstrin homology, MyTH4 and FERM domain containing H2
decreases expression
ISO
trovafloxacin results in decreased expression of PLEKHH2 mRNA
CTD
PMID:35537566
NCBI chr 6:10,032,837...10,132,081
Ensembl chr 6:10,032,660...10,140,794
G
Plekhn1
pleckstrin homology domain containing N1
increases expression
ISO
trovafloxacin results in increased expression of PLEKHN1 mRNA
CTD
PMID:35537566
NCBI chr 5:166,805,309...166,813,339
Ensembl chr 5:166,804,837...166,813,155
G
Plin2
perilipin 2
decreases expression
EXP
trovafloxacin results in decreased expression of PLIN2 mRNA
CTD
PMID:24136188
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plin3
perilipin 3
decreases expression
EXP
trovafloxacin results in decreased expression of PLIN3 mRNA
CTD
PMID:24136188
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Plk1
polo-like kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of PLK1 mRNA
CTD
PMID:35537566
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:176,716,420...176,726,400
G
Plk2
polo-like kinase 2
increases expression
ISO
trovafloxacin results in increased expression of PLK2 mRNA
CTD
PMID:35537566
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:41,969,176...41,974,947
G
Plk3
polo-like kinase 3
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PLK3 mRNA trovafloxacin results in increased expression of PLK3 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:130,607,142...130,612,317
G
Plpp3
phospholipid phosphatase 3
increases expression
EXP
trovafloxacin results in increased expression of PLPP3 mRNA
CTD
PMID:24136188
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
G
Plppr3
phospholipid phosphatase related 3
increases expression
ISO
trovafloxacin results in increased expression of PLPPR3 mRNA
CTD
PMID:35537566
NCBI chr 7:9,831,162...9,842,434
Ensembl chr 7:9,831,162...9,845,296
G
Plxna3
plexin A3
decreases expression
ISO
trovafloxacin results in decreased expression of PLXNA3 mRNA
CTD
PMID:35537566
NCBI chr X:157,266,986...157,282,896
Ensembl chr X:152,115,819...152,131,603
G
Plxnd1
plexin D1
decreases expression
ISO
trovafloxacin results in decreased expression of PLXND1 mRNA
CTD
PMID:35537566
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
G
Pmepa1
prostate transmembrane protein, androgen induced 1
increases expression
ISO
trovafloxacin results in increased expression of PMEPA1 mRNA
CTD
PMID:35537566
NCBI chr 3:162,011,884...162,060,343
Ensembl chr 3:162,012,751...162,060,454
G
Pms1
PMS1 homolog 1, mismatch repair system component
decreases expression
ISO
trovafloxacin results in decreased expression of PMS1 mRNA
CTD
PMID:35537566
NCBI chr 9:55,721,393...55,832,225
Ensembl chr 9:48,253,410...48,340,237
G
Pnp
purine nucleoside phosphorylase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PNP2 mRNA
CTD
PMID:18930950
NCBI chr15:26,644,147...26,651,808
Ensembl chr15:24,170,602...24,203,986
G
Poc1a
POC1 centriolar protein A
decreases expression
ISO
trovafloxacin results in decreased expression of POC1A mRNA
CTD
PMID:35537566
NCBI chr 8:106,922,058...106,991,678
Ensembl chr 8:106,922,978...106,991,089
G
Poglut2
protein O-glucosyltransferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of KDELC1 mRNA
CTD
PMID:35537566
NCBI chr 9:46,256,388...46,268,714
Ensembl chr 9:46,256,390...46,268,532
G
Pola1
DNA polymerase alpha 1, catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of POLA1 mRNA
CTD
PMID:35537566
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of POLD1 mRNA
CTD
PMID:35537566
NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:95,025,499...95,036,465
G
Pole
DNA polymerase epsilon, catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of POLE mRNA
CTD
PMID:35537566
NCBI chr12:52,005,155...52,053,761
Ensembl chr12:46,345,420...46,393,939
G
Polq
DNA polymerase theta
decreases expression
ISO
trovafloxacin results in decreased expression of POLQ mRNA
CTD
PMID:35537566
NCBI chr11:77,179,190...77,281,270
Ensembl chr11:63,673,816...63,775,878
G
Polr2d
RNA polymerase II subunit D
increases expression
ISO
trovafloxacin results in increased expression of POLR2D mRNA
CTD
PMID:35537566
NCBI chr18:23,692,578...23,699,709
Ensembl chr18:23,418,097...23,425,228
G
Polr2k
RNA polymerase II, I and III subunit K
increases expression
ISO
trovafloxacin results in increased expression of POLR2K mRNA
CTD
PMID:35537566
NCBI chr 7:67,347,118...67,359,466
Ensembl chr 7:67,356,113...67,357,668
G
Polr3b
RNA polymerase III subunit B
decreases expression
ISO
trovafloxacin results in decreased expression of POLR3B mRNA
CTD
PMID:35537566
NCBI chr 7:19,039,179...19,142,450
Ensembl chr 7:19,038,552...19,142,598
G
Polr3g
RNA polymerase III subunit G
increases expression
ISO
trovafloxacin results in increased expression of POLR3G mRNA
CTD
PMID:35537566
NCBI chr 2:11,945,215...11,986,125
Ensembl chr 2:11,945,217...11,986,125
G
Polrmt
RNA polymerase mitochondrial
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of POLRMT mRNA
CTD
PMID:18930950
NCBI chr 7:9,959,532...9,969,791
Ensembl chr 7:9,959,576...9,969,791
G
Pomc
proopiomelanocortin
increases expression
ISO
trovafloxacin results in increased expression of POMC mRNA
CTD
PMID:35537566
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Pomt1
protein-O-mannosyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of POMT1 mRNA
CTD
PMID:35537566
NCBI chr 3:15,520,717...15,538,579
Ensembl chr 3:15,520,481...15,538,581
G
Ppa1
inorganic pyrophosphatase 1
decreases expression
EXP
trovafloxacin results in decreased expression of PPA1 mRNA
CTD
PMID:24136188
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
trovafloxacin results in decreased expression of PPARA mRNA
CTD
PMID:25689681
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppfia4
PTPRF interacting protein alpha 4
decreases expression
ISO
trovafloxacin results in decreased expression of PPFIA4 mRNA
CTD
PMID:35537566
NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261
G
Ppid
peptidylprolyl isomerase D
increases expression
ISO
trovafloxacin results in increased expression of PPID mRNA
CTD
PMID:35537566
NCBI chr 2:167,025,985...167,037,998
Ensembl chr 2:164,727,779...164,740,221
G
Ppie
peptidylprolyl isomerase E
decreases expression
ISO
trovafloxacin results in decreased expression of PPIE mRNA
CTD
PMID:35537566
NCBI chr 5:135,406,172...135,419,332
Ensembl chr 5:135,406,176...135,419,235
G
Ppm1f
protein phosphatase, Mg2+/Mn2+ dependent, 1F
increases expression
ISO
trovafloxacin results in increased expression of PPM1F mRNA
CTD
PMID:35537566
NCBI chr11:84,064,422...84,094,410
Ensembl chr11:84,064,420...84,094,340
G
Ppm1m
protein phosphatase, Mg2+/Mn2+ dependent, 1M
decreases expression
ISO
trovafloxacin results in decreased expression of PPM1M mRNA
CTD
PMID:35537566
NCBI chr 8:106,836,221...106,843,472
Ensembl chr 8:106,837,037...106,842,057
G
Ppox
protoporphyrinogen oxidase
decreases expression
EXP
trovafloxacin results in decreased expression of PPOX mRNA
CTD
PMID:24136188
NCBI chr13:86,230,111...86,235,028
Ensembl chr13:83,664,891...83,701,805
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
increases expression
ISO
trovafloxacin results in increased expression of PPP1R10 mRNA
CTD
PMID:35537566
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
G
Ppp1r11
protein phosphatase 1, regulatory (inhibitor) subunit 11
increases expression
ISO
trovafloxacin results in increased expression of PPP1R11 mRNA
CTD
PMID:35537566
NCBI chr20:1,601,350...1,604,857
Ensembl chr20:1,601,346...1,604,846
G
Ppp1r14a
protein phosphatase 1, regulatory (inhibitor) subunit 14A
decreases expression
EXP
trovafloxacin results in decreased expression of PPP1R14A mRNA
CTD
PMID:24136188
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
decreases expression
EXP
trovafloxacin results in decreased expression of PPP1R14B mRNA
CTD
PMID:24136188
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319 Ensembl chr12:204,163,299...204,167,319
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PPP1R15A mRNA
CTD
PMID:18930950
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r3f
protein phosphatase 1, regulatory subunit 3F
decreases expression
ISO
trovafloxacin results in decreased expression of PPP1R3F mRNA
CTD
PMID:35537566
NCBI chr X:17,581,467...17,617,087
Ensembl chr X:14,929,323...14,945,193
G
Ppp2r3a
protein phosphatase 2, regulatory subunit B'', alpha
decreases expression
ISO
trovafloxacin results in decreased expression of PPP2R3A mRNA
CTD
PMID:35537566
NCBI chr 8:101,703,512...101,841,530
Ensembl chr 8:101,704,778...101,841,502
G
Ppp3cb
protein phosphatase 3 catalytic subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of PPP3CB mRNA
CTD
PMID:35537566
NCBI chr15:3,809,182...3,854,204
Ensembl chr15:3,760,030...3,804,981
G
Ppp3cc
protein phosphatase 3 catalytic subunit gamma
decreases expression
ISO
trovafloxacin results in decreased expression of PPP3CC mRNA
CTD
PMID:35537566
NCBI chr15:51,699,586...51,771,763
Ensembl chr15:45,290,373...45,361,832
G
Pram1
PML-RARA regulated adaptor molecule 1
decreases expression
ISO
trovafloxacin results in decreased expression of PRAM1 mRNA
CTD
PMID:35537566
NCBI chr 7:14,428,548...14,438,081
Ensembl chr 7:14,420,165...14,438,166
G
Prc1
protein regulator of cytokinesis 1
decreases expression
ISO
trovafloxacin results in decreased expression of PRC1 mRNA
CTD
PMID:35537566
NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:134,250,081...134,271,765
G
Prdm1
PR/SET domain 1
increases expression
ISO
trovafloxacin results in increased expression of PRDM1 mRNA
CTD
PMID:35537566
NCBI chr20:49,542,465...49,564,088
Ensembl chr20:47,959,858...47,981,488
G
Prdm13
PR/SET domain 13
decreases expression
ISO
trovafloxacin results in decreased expression of PRDM13 mRNA
CTD
PMID:35537566
NCBI chr 5:35,220,815...35,232,866
Ensembl chr 5:35,225,435...35,232,881
G
Preb
prolactin regulatory element binding
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PREB mRNA
CTD
PMID:18930950
NCBI chr 6:25,418,805...25,422,594
Ensembl chr 6:25,418,776...25,422,590
G
Prickle2
prickle planar cell polarity protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of PRICKLE2 mRNA
CTD
PMID:35537566
NCBI chr 4:124,869,655...125,214,862
Ensembl chr 4:124,869,552...125,214,824
G
Prim1
DNA primase subunit 1
decreases expression
ISO
trovafloxacin results in decreased expression of PRIM1 mRNA
CTD
PMID:35537566
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
G
Prim2
DNA primase subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of PRIM2 mRNA
CTD
PMID:35537566
NCBI chr 9:35,692,376...35,904,521
Ensembl chr 9:35,692,376...35,903,030
G
Prkar1b
protein kinase cAMP-dependent type I regulatory subunit beta
decreases expression
ISO
trovafloxacin results in decreased expression of PRKAR1B mRNA
CTD
PMID:35537566
NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942
G
Prkcg
protein kinase C, gamma
increases expression
ISO
trovafloxacin results in increased expression of PRKCG mRNA
CTD
PMID:35537566
NCBI chr 1:74,748,272...74,777,611
Ensembl chr 1:65,832,855...65,859,384
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
decreases expression
ISO
trovafloxacin results in decreased expression of PRKDC mRNA
CTD
PMID:35537566
NCBI chr11:98,544,952...98,762,499
Ensembl chr11:85,040,792...85,257,952
G
Prkg2
protein kinase cGMP-dependent 2
decreases expression
ISO
trovafloxacin results in decreased expression of PRKG2 mRNA
CTD
PMID:35537566
NCBI chr14:10,559,882...10,668,479
Ensembl chr14:10,559,882...10,666,888
G
Prkrip1
PRKR interacting protein 1
increases expression
ISO
trovafloxacin results in increased expression of PRKRIP1 mRNA
CTD
PMID:35537566
NCBI chr12:20,470,802...20,491,789
Ensembl chr12:20,470,820...20,489,115
G
Prmt6
protein arginine methyltransferase 6
increases expression
ISO
trovafloxacin results in increased expression of PRMT6 mRNA
CTD
PMID:35537566
NCBI chr 2:197,927,750...197,932,760
Ensembl chr 2:197,927,220...197,933,648
G
Procr
protein C receptor
increases expression
ISO
trovafloxacin results in increased expression of PROCR mRNA
CTD
PMID:35537566
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
G
Prokr1
prokineticin receptor 1
increases expression
ISO
trovafloxacin results in increased expression of PROKR1 mRNA
CTD
PMID:35537566
NCBI chr 4:120,022,301...120,033,367
Ensembl chr 4:120,021,747...120,033,379
G
Proser2
proline and serine rich 2
increases expression
EXP
trovafloxacin results in increased expression of PROSER2 mRNA
CTD
PMID:24136188
NCBI chr17:72,151,961...72,187,524
Ensembl chr17:72,151,872...72,185,825
G
Proser3
proline and serine rich 3
decreases expression
ISO
trovafloxacin results in decreased expression of PROSER3 mRNA
CTD
PMID:35537566
NCBI chr 1:85,793,363...85,806,682
Ensembl chr 1:85,793,358...85,805,909
G
Prox2
prospero homeobox 2
decreases expression
ISO
trovafloxacin results in decreased expression of PROX2 mRNA
CTD
PMID:35537566
NCBI chr 6:104,731,385...104,758,619
Ensembl chr 6:104,733,002...104,742,093
G
Prpf3
pre-mRNA processing factor 3
increases expression
ISO
trovafloxacin results in increased expression of PRPF3 mRNA
CTD
PMID:35537566
NCBI chr 2:183,379,041...183,403,526
Ensembl chr 2:183,378,718...183,403,489
G
Prpf39
pre-mRNA processing factor 39
increases expression
ISO
trovafloxacin results in increased expression of PRPF39 mRNA
CTD
PMID:35537566
NCBI chr 6:83,088,981...83,113,826
Ensembl chr 6:83,088,986...83,113,825
G
Prr7
proline rich 7 (synaptic)
increases expression
ISO
trovafloxacin results in increased expression of PRR7 mRNA
CTD
PMID:35537566
NCBI chr17:9,164,375...9,173,669
Ensembl chr17:9,165,269...9,172,536
G
Prss16
serine protease 16
decreases expression
ISO
trovafloxacin results in decreased expression of PRSS16 mRNA
CTD
PMID:35537566
NCBI chr17:42,514,306...42,521,885
Ensembl chr17:42,514,306...42,521,884
G
Prss23
serine protease 23
decreases expression
EXP
trovafloxacin results in decreased expression of PRSS23 mRNA
CTD
PMID:24136188
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
G
Prss36
serine protease 36
decreases expression
ISO
trovafloxacin results in decreased expression of PRSS36 mRNA
CTD
PMID:35537566
NCBI chr 1:182,543,085...182,561,141
Ensembl chr 1:182,543,085...182,559,280
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of PSAT1 mRNA
CTD
PMID:35537566
NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:213,196,709...213,218,682
G
Psd
pleckstrin and Sec7 domain containing
increases expression
ISO
trovafloxacin results in increased expression of PSD mRNA
CTD
PMID:35537566
NCBI chr 1:245,173,279...245,188,681
Ensembl chr 1:245,173,279...245,189,356
G
Psenen
presenilin enhancer gamma secretase subunit
increases expression
ISO
trovafloxacin results in increased expression of PSENEN mRNA
CTD
PMID:35537566
NCBI chr 1:94,942,348...94,943,545
Ensembl chr 1:85,814,905...85,816,192
G
Psip1
PC4 and SRSF1 interacting protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of PSIP1 mRNA
CTD
PMID:35537566
NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257
G
Psma5
proteasome 20S subunit alpha 5
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PSMA5 mRNA
CTD
PMID:18930950
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
G
Psmb10
proteasome 20S subunit beta 10
decreases expression
EXP
trovafloxacin results in decreased expression of PSMB10 mRNA
CTD
PMID:24136188
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Psph
phosphoserine phosphatase
decreases expression
ISO
trovafloxacin results in decreased expression of PSPH mRNA
CTD
PMID:35537566
NCBI chr12:32,527,091...32,541,182
Ensembl chr12:26,883,133...26,905,074
G
Ptbp2
polypyrimidine tract binding protein 2
increases expression
ISO
trovafloxacin results in increased expression of PTBP2 mRNA
CTD
PMID:35537566
NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
G
Pten
phosphatase and tensin homolog
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PTEN mRNA
CTD
PMID:18930950
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptger1
prostaglandin E receptor 1
increases expression
ISO
trovafloxacin results in increased expression of PTGER1 mRNA
CTD
PMID:35537566
NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
G
Ptgr2
prostaglandin reductase 2
decreases expression
EXP
trovafloxacin results in decreased expression of PTGR2 mRNA
CTD
PMID:24136188
NCBI chr 6:103,931,367...103,963,113
Ensembl chr 6:103,931,409...103,963,111
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
trovafloxacin results in increased expression of PTGS2 mRNA
CTD
PMID:35537566
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptma
prothymosin alpha
decreases expression
EXP
trovafloxacin results in decreased expression of PTMA mRNA
CTD
PMID:24136188
NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:87,176,230...87,180,333
G
Ptms
parathymosin
decreases expression
ISO
trovafloxacin results in decreased expression of PTMS mRNA
CTD
PMID:35537566
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
G
Ptp4a1
protein tyrosine phosphatase 4A1
increases expression multiple interactions
EXP ISO
trovafloxacin results in increased expression of PTP4A1 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PTP4A1 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PTPN2 mRNA
CTD
PMID:18930950
NCBI chr18:63,498,890...63,564,571
Ensembl chr18:61,229,014...61,294,627
G
Ptpn21
protein tyrosine phosphatase, non-receptor type 21
decreases expression
EXP
trovafloxacin results in decreased expression of PTPN21 mRNA
CTD
PMID:24136188
NCBI chr 6:117,933,066...117,998,095
Ensembl chr 6:117,933,066...117,998,095
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
decreases expression
ISO
trovafloxacin results in decreased expression of PTPN5 mRNA
CTD
PMID:35537566
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
G
Pts
6-pyruvoyl-tetrahydropterin synthase
decreases expression
ISO
trovafloxacin results in decreased expression of PTS mRNA
CTD
PMID:35537566
NCBI chr 8:59,767,234...59,774,265
Ensembl chr 8:50,870,841...50,877,869
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
EXP ISO
trovafloxacin results in decreased expression of PTTG1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:27,893,689...27,904,837
G
Pvt1
Pvt1 oncogene
increases expression
ISO
trovafloxacin results in increased expression of PVT1 mRNA
CTD
PMID:35537566
NCBI chr 7:93,656,528...93,879,938
G
Pxmp2
peroxisomal membrane protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of PXMP2 mRNA
CTD
PMID:35537566
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
G
Pycr1
pyrroline-5-carboxylate reductase 1
decreases expression
ISO
trovafloxacin results in decreased expression of PYCR1 mRNA
CTD
PMID:35537566
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Qars1
glutaminyl-tRNA synthetase 1
decreases expression
ISO
trovafloxacin results in decreased expression of QARS1 mRNA
CTD
PMID:35537566
NCBI chr 8:118,086,243...118,094,274
Ensembl chr 8:109,207,705...109,215,739
G
Rab11fip4
RAB11 family interacting protein 4
decreases expression
ISO
trovafloxacin results in decreased expression of RAB11FIP4 mRNA
CTD
PMID:35537566
NCBI chr10:64,550,109...64,658,123
Ensembl chr10:64,550,177...64,654,759
G
Rab32
RAB32, member RAS oncogene family
decreases expression
ISO
trovafloxacin results in decreased expression of RAB32 mRNA
CTD
PMID:35537566
NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
G
Rab7b
Rab7b, member RAS oncogene family
increases expression
ISO
trovafloxacin results in increased expression of RAB7B mRNA
CTD
PMID:35537566
NCBI chr13:45,673,396...45,699,798
Ensembl chr13:43,121,226...43,147,581
G
Rabggtb
Rab geranylgeranyltransferase subunit beta
increases expression
ISO
trovafloxacin results in increased expression of RABGGTB mRNA
CTD
PMID:35537566
NCBI chr 2:242,844,758...242,850,951
Ensembl chr 2:242,844,762...242,851,050
G
Rac3
Rac family small GTPase 3
increases expression
ISO
trovafloxacin results in increased expression of RAC3 mRNA
CTD
PMID:35537566
NCBI chr10:106,002,808...106,005,243
Ensembl chr10:105,993,087...106,005,260
G
Racgap1
Rac GTPase-activating protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of RACGAP1 mRNA
CTD
PMID:35537566
NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
trovafloxacin results in decreased expression of RAD23A mRNA
CTD
PMID:35537566
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Rad50
RAD50 double strand break repair protein
decreases expression
ISO
trovafloxacin results in decreased expression of RAD50 mRNA
CTD
PMID:35537566
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:37,808,726...37,861,396
G
Rad51
RAD51 recombinase
decreases expression
ISO
trovafloxacin results in decreased expression of RAD51 mRNA
CTD
PMID:35537566
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:106,100,381...106,125,035
G
Rad51ap1
RAD51 associated protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of RAD51AP1 mRNA
CTD
PMID:35537566
NCBI chr 4:159,759,454...159,772,473
Ensembl chr 4:159,759,459...159,772,524
G
Rad51b
RAD51 paralog B
decreases expression
ISO
trovafloxacin results in decreased expression of RAD51B mRNA
CTD
PMID:35537566
NCBI chr 6:103,829,390...104,373,923
Ensembl chr 6:98,098,868...98,640,979
G
Rad51c
RAD51 paralog C
decreases expression
ISO
trovafloxacin results in decreased expression of RAD51C mRNA
CTD
PMID:35537566
NCBI chr10:72,702,299...72,728,980
Ensembl chr10:72,205,032...72,231,248
G
Rad54b
RAD54 homolog B
decreases expression
ISO
trovafloxacin results in decreased expression of RAD54B mRNA
CTD
PMID:35537566
NCBI chr 5:25,032,112...25,104,630
Ensembl chr 5:25,032,066...25,104,616
G
Rad54l
RAD54 like
decreases expression
ISO
trovafloxacin results in decreased expression of RAD54L mRNA
CTD
PMID:35537566
NCBI chr 5:134,812,158...134,841,821
Ensembl chr 5:129,575,378...129,605,070
G
Radx
RPA1 related single stranded DNA binding protein, X-linked
decreases expression
ISO
trovafloxacin results in decreased expression of RADX mRNA
CTD
PMID:35537566
NCBI chr X:103,089,284...103,176,840
Ensembl chr X:103,089,284...103,176,838
G
Ralgapa2
Ral GTPase activating protein catalytic subunit alpha 2
decreases expression
ISO
trovafloxacin results in decreased expression of RALGAPA2 mRNA
CTD
PMID:35537566
NCBI chr 3:133,658,725...133,938,821
Ensembl chr 3:133,659,761...133,938,916
G
Ran
RAN, member RAS oncogene family
decreases expression
EXP
trovafloxacin results in decreased expression of RAN mRNA
CTD
PMID:24136188
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:27,674,050...27,678,276
G
Ranbp3l
RAN binding protein 3-like
decreases expression
ISO
trovafloxacin results in decreased expression of RANBP3L mRNA
CTD
PMID:35537566
NCBI chr 2:59,785,070...59,840,338
Ensembl chr 2:58,058,263...58,113,172
G
Ranbp6
RAN binding protein 6
increases expression
ISO
trovafloxacin results in increased expression of RANBP6 mRNA
CTD
PMID:35537566
NCBI chr 1:227,572,394...227,576,915
Ensembl chr 1:227,572,105...227,576,942
G
Rangap1
RAN GTPase activating protein 1
decreases expression
EXP
trovafloxacin results in decreased expression of RANGAP1 mRNA
CTD
PMID:24136188
NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:113,224,703...113,250,438
G
Rarb
retinoic acid receptor, beta
decreases expression
EXP
trovafloxacin results in decreased expression of RARB mRNA
CTD
PMID:24136188
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:8,406,492...9,051,288
G
Rasal1
RAS protein activator like 1
decreases expression
ISO
trovafloxacin results in decreased expression of RASAL1 mRNA
CTD
PMID:35537566
NCBI chr12:35,881,269...35,913,727
Ensembl chr12:35,881,270...35,913,727
G
Rasgef1b
RasGEF domain family, member 1B
increases expression
ISO
trovafloxacin results in increased expression of RASGEF1B mRNA
CTD
PMID:35537566
NCBI chr14:10,164,366...10,684,184
Ensembl chr14:9,860,247...10,379,741
G
Rassf1
Ras association domain family member 1
increases expression
ISO
trovafloxacin results in increased expression of RASSF1 mRNA
CTD
PMID:35537566
NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:108,225,023...108,236,164
G
Rassf8
Ras association domain family member 8
increases expression
ISO
trovafloxacin results in increased expression of RASSF8 mRNA
CTD
PMID:35537566
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
G
Rb1
RB transcriptional corepressor 1
decreases expression
EXP ISO
trovafloxacin results in decreased expression of RB1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rb1cc1
RB1-inducible coiled-coil 1
multiple interactions increases expression
ISO
TNF protein inhibits the reaction [trovafloxacin results in increased expression of RB1CC1 mRNA]
CTD
PMID:33609687
NCBI chr 5:17,948,522...18,012,434
Ensembl chr 5:13,161,648...13,225,560
G
Rbak
RB-associated KRAB zinc finger
increases expression
ISO
trovafloxacin results in increased expression of RBAK mRNA
CTD
PMID:35537566
NCBI chr12:11,375,314...11,388,937
Ensembl chr12:11,375,318...11,388,934
G
Rbbp8
RB binding protein 8, endonuclease
decreases expression
ISO
trovafloxacin results in decreased expression of RBBP8 mRNA
CTD
PMID:35537566
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rbl1
RB transcriptional corepressor like 1
decreases expression
ISO
trovafloxacin results in decreased expression of RBL1 mRNA
CTD
PMID:35537566
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbm18
RNA binding motif protein 18
increases expression
ISO
trovafloxacin results in increased expression of RBM18 mRNA
CTD
PMID:35537566
NCBI chr 3:19,467,333...19,487,171
Ensembl chr 3:19,467,335...19,487,178
G
Rbx1
ring-box 1
increases expression
ISO
trovafloxacin results in increased expression of RBX1 mRNA
CTD
PMID:35537566
NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:112,990,835...113,001,051
G
Rc3h1
ring finger and CCCH-type domains 1
increases expression
ISO
trovafloxacin results in increased expression of RC3H1 mRNA
CTD
PMID:35537566
NCBI chr13:73,174,075...73,245,762
Ensembl chr13:73,173,946...73,238,839
G
Rcan1
regulator of calcineurin 1
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of RCAN1 mRNA trovafloxacin results in increased expression of RCAN1 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr11:45,108,123...45,188,065
Ensembl chr11:31,622,210...31,702,045
G
Rcbtb1
RCC1 and BTB domain containing protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of RCBTB1 mRNA
CTD
PMID:35537566
NCBI chr15:33,319,586...33,362,421
Ensembl chr15:33,319,586...33,365,302
G
Rdh12
retinol dehydrogenase 12
decreases expression
ISO
trovafloxacin results in decreased expression of RDH12 mRNA
CTD
PMID:35537566
NCBI chr 6:103,748,457...103,761,379
Ensembl chr 6:98,015,465...98,028,388
G
Rdh14
retinol dehydrogenase 14
decreases expression
ISO
trovafloxacin results in decreased expression of RDH14 mRNA
CTD
PMID:35537566
NCBI chr 6:33,156,569...33,161,712
Ensembl chr 6:33,156,569...33,161,712
G
Rdm1
RAD52 motif containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of RDM1 mRNA
CTD
PMID:35537566
NCBI chr10:86,562,871...86,573,034
Ensembl chr10:86,539,553...86,573,034
G
Rdx
radixin
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of RDX mRNA
CTD
PMID:18930950
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
G
Recql4
RecQ like helicase 4
decreases expression
ISO
trovafloxacin results in decreased expression of RECQL4 mRNA
CTD
PMID:35537566
NCBI chr 7:110,304,092...110,311,426
Ensembl chr 7:108,423,455...108,430,619
G
Reep6
receptor accessory protein 6
decreases expression
EXP ISO
trovafloxacin results in decreased expression of REEP6 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Rel
REL proto-oncogene, NF-kB subunit
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of REL mRNA
CTD
PMID:18930950
NCBI chr14:101,891,238...101,922,324
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions affects localization
ISO
trovafloxacin affects the reaction [TNF protein affects the localization of RELA protein modified form]; trovafloxacin affects the reaction [TNF protein results in increased phosphorylation of RELA protein] trovafloxacin affects the localization of RELA protein trovafloxacin affects the reaction [Lipopolysaccharides affects the localization of RELA protein]
CTD
PMID:32035082
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rell1
RELT-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of RELL1 mRNA
CTD
PMID:35537566
NCBI chr14:44,318,640...44,378,541
Ensembl chr14:44,303,009...44,378,500
G
Rfc2
replication factor C subunit 2
decreases expression
ISO
trovafloxacin results in decreased expression of RFC2 mRNA
CTD
PMID:35537566
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
G
Rfc5
replication factor C subunit 5
decreases expression
ISO
trovafloxacin results in decreased expression of RFC5 mRNA
CTD
PMID:35537566
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
G
Rft1
RFT1 homolog
decreases expression
ISO
trovafloxacin results in decreased expression of RFT1 mRNA
CTD
PMID:35537566
NCBI chr16:5,827,063...5,861,120
Ensembl chr16:5,827,088...5,861,120
G
Rfx2
regulatory factor X2
decreases expression
ISO
trovafloxacin results in decreased expression of RFX2 mRNA
CTD
PMID:35537566
NCBI chr 9:1,604,636...1,671,220
Ensembl chr 9:1,604,646...1,671,027
G
Rgcc
regulator of cell cycle
increases expression
ISO
trovafloxacin results in increased expression of RGCC mRNA
CTD
PMID:35537566
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
G
Rgs1
regulator of G-protein signaling 1
increases expression
ISO
trovafloxacin results in increased expression of RGS1 mRNA
CTD
PMID:35537566
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
trovafloxacin results in increased expression of RGS16 mRNA
CTD
PMID:35537566
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
trovafloxacin results in increased expression of RGS2 mRNA
CTD
PMID:35537566
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:55,798,829...55,802,385
G
Rgs20
regulator of G-protein signaling 20
increases expression
ISO
trovafloxacin results in increased expression of RGS20 mRNA
CTD
PMID:35537566
NCBI chr 5:14,484,436...14,614,317
Ensembl chr 5:14,534,775...14,614,084
G
Rhbdd3
rhomboid domain containing 3
increases expression decreases expression
ISO
trovafloxacin results in increased expression of RHBDD3 mRNA trovafloxacin results in decreased expression of RHBDD3 mRNA
CTD
PMID:35537566
NCBI chr14:79,994,111...80,000,294
Ensembl chr14:79,994,158...80,000,175
G
Rhbdf1
rhomboid 5 homolog 1
increases expression
ISO
trovafloxacin results in increased expression of RHBDF1 mRNA
CTD
PMID:35537566
NCBI chr10:15,406,832...15,419,765
Ensembl chr10:15,406,859...15,419,763
G
Rhbdl1
rhomboid like 1
increases expression
ISO
trovafloxacin results in increased expression of RHBDL1 mRNA
CTD
PMID:35537566
NCBI chr10:14,854,514...14,858,848
Ensembl chr10:14,854,514...14,857,430
G
Rhod
ras homolog family member D
increases expression
ISO
trovafloxacin results in increased expression of RHOD mRNA
CTD
PMID:35537566
NCBI chr 1:201,708,699...201,724,405
Ensembl chr 1:201,708,699...201,722,632
G
Rhoj
ras homolog family member J
decreases expression
ISO
trovafloxacin results in decreased expression of RHOJ mRNA
CTD
PMID:35537566
NCBI chr 6:94,035,307...94,117,642
Ensembl chr 6:94,035,483...94,118,275
G
Rhoq
ras homolog family member Q
decreases expression
ISO
trovafloxacin results in decreased expression of RHOQ mRNA
CTD
PMID:35537566
NCBI chr 6:7,613,632...7,652,047
Ensembl chr 1:106,622,141...106,623,699
G
Rhov
ras homolog family member V
increases expression
ISO
trovafloxacin results in increased expression of RHOV mRNA
CTD
PMID:35537566
NCBI chr 3:106,260,774...106,270,009
Ensembl chr 3:106,260,776...106,269,479
G
Ric8a
RIC8 guanine nucleotide exchange factor A
decreases expression
ISO
trovafloxacin results in decreased expression of RIC8A mRNA
CTD
PMID:35537566
NCBI chr 1:195,935,162...195,941,469
Ensembl chr 1:195,935,349...195,941,467
G
Ripor3
RIPOR family member 3
decreases expression
ISO
trovafloxacin results in decreased expression of FAM65C mRNA
CTD
PMID:35537566
NCBI chr 3:156,687,253...156,760,524
Ensembl chr 3:156,687,517...156,715,061
G
Rmdn1
regulator of microtubule dynamics 1
decreases expression
ISO
trovafloxacin results in decreased expression of RMDN1 mRNA
CTD
PMID:35537566
NCBI chr 5:33,070,267...33,093,922
Ensembl chr 5:33,070,265...33,127,328
G
Rmdn2
regulator of microtubule dynamics 2
decreases expression
EXP
trovafloxacin results in decreased expression of RMDN2 mRNA
CTD
PMID:24136188
NCBI chr 6:15,372,569...15,443,000
Ensembl chr 6:15,375,496...15,441,480
G
Rmi2
RecQ mediated genome instability 2
decreases expression
ISO
trovafloxacin results in decreased expression of RMI2 mRNA
CTD
PMID:35537566
NCBI chr10:4,829,333...4,837,264
Ensembl chr10:4,830,553...4,837,235
G
Rmnd1
required for meiotic nuclear division 1 homolog
decreases expression
ISO
trovafloxacin results in decreased expression of RMND1 mRNA
CTD
PMID:35537566
NCBI chr 1:40,859,829...40,894,376
Ensembl chr 1:40,859,829...40,894,314
G
Rnaseh2c
ribonuclease H2, subunit C
decreases expression
ISO
trovafloxacin results in decreased expression of RNASEH2C mRNA
CTD
PMID:35537566
NCBI chr 1:202,894,626...202,895,675
Ensembl chr 1:202,894,643...202,897,516
G
Rnd1
Rho family GTPase 1
decreases expression
ISO
trovafloxacin results in decreased expression of RND1 mRNA
CTD
PMID:35537566
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnd3
Rho family GTPase 3
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of RND3 mRNA trovafloxacin results in decreased expression of RND3 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
G
Rnf145
ring finger protein 145
increases expression
ISO
trovafloxacin results in increased expression of RNF145 mRNA
CTD
PMID:35537566
NCBI chr10:29,006,391...29,050,788
Ensembl chr10:29,011,548...29,050,781
G
Rnf151
ring finger protein 151
increases expression
ISO
trovafloxacin results in increased expression of RNF151 mRNA
CTD
PMID:35537566
NCBI chr10:13,742,682...13,747,192
Ensembl chr10:13,742,682...13,745,000
G
Rnf157
ring finger protein 157
decreases expression
ISO
trovafloxacin results in decreased expression of RNF157 mRNA
CTD
PMID:35537566
NCBI chr10:101,571,972...101,639,874
Ensembl chr10:101,566,295...101,639,942
G
Rnf180
ring finger protein 180
decreases expression
ISO
trovafloxacin results in decreased expression of RNF180 mRNA
CTD
PMID:35537566
NCBI chr 2:36,330,285...36,511,168
Ensembl chr 2:36,330,292...36,512,614
G
Rnf183
ring finger protein 183
increases expression
ISO
trovafloxacin results in increased expression of RNF183 mRNA
CTD
PMID:35537566
NCBI chr 5:75,877,111...75,886,253
Ensembl chr 5:75,876,003...75,886,191
G
Rnf26
ring finger protein 26
decreases expression
EXP
trovafloxacin results in decreased expression of RNF26 mRNA
CTD
PMID:24136188
NCBI chr 8:44,454,551...44,456,745
Ensembl chr 8:44,454,292...44,457,331
G
Rnf39
ring finger protein 39
increases expression
EXP
trovafloxacin results in increased expression of RNF39 mRNA
CTD
PMID:24136188
NCBI chr20:1,604,794...1,610,283
Ensembl chr20:1,604,794...1,610,283
G
Rnf6
ring finger protein 6
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of RNF6 mRNA
CTD
PMID:18930950
NCBI chr12:13,929,160...13,940,663
Ensembl chr12:8,816,833...8,826,847
G
Rock2
Rho-associated coiled-coil containing protein kinase 2
decreases expression
ISO
trovafloxacin results in decreased expression of ROCK2 mRNA
CTD
PMID:35537566
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
G
Rora
RAR-related orphan receptor A
decreases expression
ISO
trovafloxacin results in decreased expression of RORA mRNA
CTD
PMID:35537566
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpa1
replication protein A1
decreases expression
EXP
trovafloxacin results in decreased expression of RPA1 mRNA
CTD
PMID:24136188
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpain
RPA interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of RPAIN mRNA
CTD
PMID:35537566
NCBI chr10:55,692,410...55,699,910
Ensembl chr10:55,692,417...55,699,933
G
Rpl10a
ribosomal protein L10A
increases expression
ISO
trovafloxacin results in increased expression of RPL10A mRNA
CTD
PMID:35537566
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357 Ensembl chr 9:6,385,823...6,391,357
G
Rpl18
ribosomal protein L18
increases expression
ISO
trovafloxacin results in increased expression of RPL18 mRNA
CTD
PMID:35537566
NCBI chr 1:96,188,811...96,191,452
Ensembl chr 1:96,188,112...96,191,452
G
Rpl3l
ribosomal protein L3-like
increases expression
ISO
trovafloxacin results in increased expression of RPL3L mRNA
CTD
PMID:35537566
NCBI chr10:13,753,914...13,764,458
Ensembl chr10:13,753,886...13,764,457
G
Rpl7l1
ribosomal protein L7-like 1
decreases expression increases expression
EXP ISO
trovafloxacin results in decreased expression of RPL7L1 mRNA trovafloxacin results in increased expression of RPL7L1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 9:14,198,101...14,206,119
Ensembl chr 9:14,198,092...14,206,110
G
Rpph1
ribonuclease P RNA component H1
increases expression
ISO
trovafloxacin results in increased expression of RPPH1 mRNA
CTD
PMID:35537566
NCBI chr15:24,033,679...24,033,935
Ensembl chr15:24,033,662...24,033,959
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
trovafloxacin results in increased expression of RPS27L mRNA
CTD
PMID:35537566
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418 Ensembl chr12:67,562,483...67,567,418 Ensembl chr 2:67,562,483...67,567,418
G
Rps6ka2
ribosomal protein S6 kinase A2
decreases expression
ISO
trovafloxacin results in decreased expression of RPS6KA2 mRNA
CTD
PMID:35537566
NCBI chr 1:52,631,582...52,906,739
Ensembl chr 1:52,631,736...52,906,739
G
Rps6ka4
ribosomal protein S6 kinase A4
decreases expression
ISO
trovafloxacin results in decreased expression of RPS6KA4 mRNA
CTD
PMID:35537566
NCBI chr 1:204,021,805...204,032,781
Ensembl chr 1:204,021,806...204,032,761
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of RPS6KB1 protein
CTD
PMID:33609687
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908
G
Rrm1
ribonucleotide reductase catalytic subunit M1
decreases expression
ISO
trovafloxacin results in decreased expression of RRM1 mRNA
CTD
PMID:35537566
NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:156,823,960...156,848,261
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP ISO
trovafloxacin results in decreased expression of RRM2 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:41,340,557...41,346,773
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression
ISO
trovafloxacin results in increased expression of RSAD2 mRNA
CTD
PMID:35537566
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:43,047,658...43,059,699
G
Rsbn1
round spermatid basic protein 1
increases expression
ISO
trovafloxacin results in increased expression of RSBN1 mRNA
CTD
PMID:35537566
NCBI chr 2:191,416,631...191,470,711
Ensembl chr 2:191,416,631...191,470,711
G
Rsrp1
arginine and serine rich protein 1
increases expression
EXP
trovafloxacin results in increased expression of RSRP1 mRNA
CTD
PMID:24136188
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
RT1-CE16
RT1 class I, locus CE16
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of HLA-A mRNA
CTD
PMID:18930950
NCBI chr20:3,261,656...3,265,548
Ensembl chr20:3,257,123...3,279,563
G
Rtel1
regulator of telomere elongation helicase 1
decreases expression
ISO
trovafloxacin results in decreased expression of RTEL1 mRNA
CTD
PMID:35537566
NCBI chr 3:168,427,247...168,465,349
Ensembl chr 3:168,419,579...168,465,348
G
Rtkn2
rhotekin 2
decreases expression
ISO
trovafloxacin results in decreased expression of RTKN2 mRNA
CTD
PMID:35537566
NCBI chr20:20,536,628...20,609,951
Ensembl chr20:20,525,256...20,609,951
G
Rtp4
receptor (chemosensory) transporter protein 4
increases expression
ISO
trovafloxacin results in increased expression of RTP4 mRNA
CTD
PMID:35537566
NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437
G
Rttn
rotatin
decreases expression
ISO
trovafloxacin results in decreased expression of RTTN mRNA
CTD
PMID:35537566
NCBI chr18:82,220,999...82,398,334
Ensembl chr18:82,221,050...82,398,333
G
Rubcnl
rubicon like autophagy enhancer
decreases expression
ISO
trovafloxacin results in decreased expression of RUBCNL mRNA
CTD
PMID:35537566
NCBI chr15:56,741,897...56,807,086
Ensembl chr15:50,332,418...50,400,849
G
Rundc1
RUN domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of RUNDC1 mRNA
CTD
PMID:35537566
NCBI chr10:86,361,635...86,375,446
Ensembl chr10:86,361,051...86,370,878
G
Runx2
RUNX family transcription factor 2
decreases expression
ISO
trovafloxacin results in decreased expression of RUNX2 mRNA
CTD
PMID:35537566
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167
G
Rwdd2a
RWD domain containing 2A
decreases expression
ISO
trovafloxacin results in decreased expression of RWDD2A mRNA
CTD
PMID:35537566
NCBI chr 8:87,536,153...87,539,301
Ensembl chr 8:87,536,176...87,539,300
G
S100a11
S100 calcium binding protein A11
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of S100A11 mRNA
CTD
PMID:18930950
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a3
S100 calcium binding protein A3
increases expression
ISO
trovafloxacin results in increased expression of S100A3 mRNA
CTD
PMID:35537566
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
G
S1pr1
sphingosine-1-phosphate receptor 1
decreases expression
ISO
trovafloxacin results in decreased expression of S1PR1 mRNA
CTD
PMID:35537566
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
G
Sae1
SUMO1 activating enzyme subunit 1
decreases expression
EXP
trovafloxacin results in decreased expression of SAE1 mRNA
CTD
PMID:24136188
NCBI chr 1:77,030,961...77,086,937
Ensembl chr 1:77,030,965...77,086,986
G
Samd9l
sterile alpha motif domain containing 9 like
increases expression
ISO
trovafloxacin results in increased expression of SAMD9L mRNA
CTD
PMID:35537566
NCBI chr 4:31,362,054...31,376,412
Ensembl chr 4:31,361,669...31,376,415
G
Sapcd2
suppressor APC domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of SAPCD2 mRNA
CTD
PMID:35537566
NCBI chr 3:28,583,615...28,590,694
Ensembl chr 3:8,187,266...8,192,546
G
Sarnp
SAP domain containing ribonucleoprotein
decreases expression
EXP
trovafloxacin results in decreased expression of SARNP mRNA
CTD
PMID:24136188
NCBI chr 7:1,251,096...1,305,335
Ensembl chr 7:1,251,098...1,305,332
G
Sash3
SAM and SH3 domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of SASH3 mRNA
CTD
PMID:35537566
NCBI chr X:127,326,815...127,341,521
Ensembl chr X:127,326,859...127,341,519
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
EXP
trovafloxacin results in increased expression of SAT1 mRNA
CTD
PMID:24136188
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Sbds
Sbds, ribosome maturation factor
increases expression
ISO
trovafloxacin results in increased expression of SBDS mRNA
CTD
PMID:35537566
NCBI chr12:26,420,410...26,429,650
Ensembl chr12:26,420,414...26,429,649
G
Scap
SREBF chaperone
decreases expression
ISO
trovafloxacin results in decreased expression of SCAP mRNA
CTD
PMID:35537566
NCBI chr 8:119,184,366...119,239,086
Ensembl chr 8:110,306,031...110,360,666
G
Scd
stearoyl-CoA desaturase
decreases expression
EXP ISO
trovafloxacin results in decreased expression of SCD1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Scd4
stearoyl-coenzyme A desaturase 4
decreases expression
ISO
trovafloxacin results in decreased expression of SCD4 mRNA
CTD
PMID:35537566
NCBI chr 1:243,203,433...243,216,007
Ensembl chr 1:243,203,881...243,215,148
G
Scel
sciellin
decreases expression
ISO
trovafloxacin results in decreased expression of SCEL mRNA
CTD
PMID:35537566
NCBI chr15:80,339,661...80,456,546
Ensembl chr15:80,339,951...80,456,372
G
Scin
scinderin
increases expression
ISO
trovafloxacin results in increased expression of SCIN mRNA
CTD
PMID:35537566
NCBI chr 6:57,109,500...57,188,123
Ensembl chr 6:57,109,403...57,188,242
G
Sclt1
sodium channel and clathrin linker 1
decreases expression
ISO
trovafloxacin results in decreased expression of SCLT1 mRNA
CTD
PMID:35537566
NCBI chr 2:124,605,445...124,763,964
Ensembl chr 2:124,605,658...124,764,065
G
Scly
selenocysteine lyase
decreases expression
ISO
trovafloxacin results in decreased expression of SCLY mRNA
CTD
PMID:35537566
NCBI chr 9:91,890,269...91,910,947
Ensembl chr 9:91,890,306...91,910,941
G
Scml4
Scm polycomb group protein like 4
decreases expression
ISO
trovafloxacin results in decreased expression of SCML4 mRNA
CTD
PMID:35537566
NCBI chr20:46,347,350...46,441,246
Ensembl chr20:46,347,413...46,440,103
G
Scn11a
sodium voltage-gated channel alpha subunit 11
decreases expression
ISO
trovafloxacin results in decreased expression of SCN11A mRNA
CTD
PMID:35537566
NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044
G
Scrn2
secernin 2
decreases expression
ISO
trovafloxacin results in decreased expression of SCRN2 mRNA
CTD
PMID:35537566
NCBI chr10:82,513,043...82,517,115
Ensembl chr10:82,016,649...82,020,675
G
Sdf2l1
stromal cell-derived factor 2-like 1
decreases expression
ISO
trovafloxacin results in decreased expression of SDF2L1 mRNA
CTD
PMID:35537566
NCBI chr11:97,376,878...97,379,120
Ensembl chr11:83,872,659...83,874,902
G
Sds
serine dehydratase
increases expression
EXP
trovafloxacin results in increased expression of SDS mRNA
CTD
PMID:24136188
NCBI chr12:41,743,796...41,751,108
Ensembl chr12:36,083,229...36,088,203
G
Sec24d
SEC24 homolog D, COPII coat complex component
decreases expression
EXP
trovafloxacin results in decreased expression of SEC24D mRNA
CTD
PMID:24136188
NCBI chr 2:211,418,557...211,526,588
Ensembl chr 2:211,418,623...211,526,587
G
Sele
selectin E
multiple interactions
ISO
[trovafloxacin co-treated with IL1B protein] affects the localization of SELE protein; [trovafloxacin co-treated with IL1B protein] results in increased expression of SELE mRNA; trovafloxacin promotes the reaction [IL1B protein results in increased secretion of SELE protein] [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SELE mRNA
CTD
PMID:10822086 PMID:18930950
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
G
Selenbp1
selenium binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of SELENBP1 mRNA
CTD
PMID:35537566
NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:182,493,978...182,504,594
G
Sell
selectin L
decreases expression
ISO
trovafloxacin results in decreased expression of SELL mRNA
CTD
PMID:35537566
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Sema3e
semaphorin 3E
decreases expression
ISO
trovafloxacin results in decreased expression of SEMA3E mRNA
CTD
PMID:35537566
NCBI chr 4:20,297,534...20,555,287
Ensembl chr 4:20,299,718...20,555,229
G
Sema4b
semaphorin 4B
increases expression
ISO
trovafloxacin results in increased expression of SEMA4B mRNA
CTD
PMID:35537566
NCBI chr 1:134,136,646...134,177,777
Ensembl chr 1:134,149,536...134,177,775
G
Sema6d
semaphorin 6D
increases expression
ISO
trovafloxacin results in increased expression of SEMA6D mRNA
CTD
PMID:35537566
NCBI chr 3:111,883,415...111,941,100
Ensembl chr 3:111,883,872...111,941,094
G
Senp2
SUMO specific peptidase 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SENP2 mRNA
CTD
PMID:18930950
NCBI chr11:78,981,429...79,018,274
Ensembl chr11:78,981,432...79,018,238
G
Senp8
SUMO peptidase family member, NEDD8 specific
decreases expression
ISO
trovafloxacin results in decreased expression of SENP8 mRNA
CTD
PMID:35537566
NCBI chr 8:60,135,446...60,148,836
Ensembl chr 8:60,121,714...60,148,928
G
Septin10
septin 10
decreases expression
ISO
trovafloxacin results in decreased expression of SEPTIN10 mRNA
CTD
PMID:35537566
NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780
G
Serpinb12
serpin family B member 12
decreases expression
ISO
trovafloxacin results in decreased expression of SERPINB12 mRNA
CTD
PMID:35537566
NCBI chr13:23,052,384...23,083,691
Ensembl chr13:23,052,448...23,083,691
G
Serpine1
serpin family E member 1
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SERPINE1 mRNA; SERPINE1 protein results in increased susceptibility to [trovafloxacin co-treated with Lipopolysaccharides]; trovafloxacin promotes the reaction [Lipopolysaccharides results in increased expression of SERPINE1 protein] trovafloxacin results in increased expression of SERPINE1 mRNA
CTD
PMID:18930950 PMID:19367693 PMID:35537566
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
decreases expression
ISO
trovafloxacin results in decreased expression of SERPINF1 mRNA
CTD
PMID:35537566
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Setd6
SET domain containing 6, protein lysine methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of SETD6 mRNA
CTD
PMID:35537566
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
G
Sf3a3
splicing factor 3a, subunit 3
decreases expression
EXP
trovafloxacin results in decreased expression of SF3A3 mRNA
CTD
PMID:24136188
NCBI chr 5:136,967,713...136,987,345
Ensembl chr 5:136,967,691...136,987,361
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
EXP
trovafloxacin results in decreased expression of SFPQ mRNA
CTD
PMID:24136188
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sgcb
sarcoglycan, beta
decreases expression
ISO
trovafloxacin results in decreased expression of SGCB mRNA
CTD
PMID:35537566
NCBI chr14:34,917,663...34,932,661
Ensembl chr14:34,563,608...34,578,583
G
Sgf29
SAGA complex associated factor 29
decreases expression
ISO
trovafloxacin results in decreased expression of SGF29 mRNA
CTD
PMID:35537566
NCBI chr 1:190,668,803...190,702,500
Ensembl chr 1:181,238,468...181,274,781
G
Sgk1
serum/glucocorticoid regulated kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of SGK1 mRNA
CTD
PMID:35537566
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:22,980,261...23,098,283
G
Sgo1
shugoshin 1
decreases expression
ISO
trovafloxacin results in decreased expression of SGO1 mRNA
CTD
PMID:35537566
NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,672,123...6,687,805
G
Sgo2
shugoshin 2
decreases expression
ISO
trovafloxacin results in decreased expression of SGO2A mRNA
CTD
PMID:35537566
NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229
G
Sh2d6
SH2 domain containing 6
decreases expression
ISO
trovafloxacin results in decreased expression of SH2D6 mRNA
CTD
PMID:35537566
NCBI chr 4:104,566,210...104,574,176
Ensembl chr 4:104,566,211...104,574,118
G
Sh3bp2
SH3-domain binding protein 2
increases expression
ISO
trovafloxacin results in increased expression of SH3BP2 mRNA
CTD
PMID:35537566
NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251
G
Sh3bp5
SH3-domain binding protein 5
increases expression
EXP
trovafloxacin results in increased expression of SH3BP5 mRNA
CTD
PMID:24136188
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,583,465...6,698,975
G
Shc4
SHC adaptor protein 4
decreases expression
ISO
trovafloxacin results in decreased expression of SHC4 mRNA
CTD
PMID:35537566
NCBI chr 3:133,334,026...133,428,404
Ensembl chr 3:112,880,600...112,974,366
G
Shcbp1
SHC binding and spindle associated 1
decreases expression
ISO
trovafloxacin results in decreased expression of SHCBP1 mRNA
CTD
PMID:35537566
NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844
G
Shcbp1l
SHC binding and spindle associated 1 like
decreases expression
ISO
trovafloxacin results in decreased expression of SHCBP1L mRNA
CTD
PMID:35537566
NCBI chr13:65,568,863...65,599,155
Ensembl chr13:65,568,863...65,599,154
G
Shisa3
shisa family member 3
decreases expression
ISO
trovafloxacin results in decreased expression of SHISA3 mRNA
CTD
PMID:35537566
NCBI chr14:40,563,672...40,568,244
Ensembl chr14:40,563,673...40,568,244
G
Shmt1
serine hydroxymethyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of SHMT1 mRNA
CTD
PMID:35537566
NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,468,700...45,497,820
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of SHMT2 mRNA
CTD
PMID:35537566
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:63,358,961...63,364,236
G
Siah2
siah E3 ubiquitin protein ligase 2
decreases expression
ISO
trovafloxacin results in decreased expression of SIAH2 mRNA
CTD
PMID:35537566
NCBI chr 2:142,913,924...142,931,752
Ensembl chr 2:142,914,003...142,931,950
G
Sik1
salt-inducible kinase 1
increases expression
ISO
trovafloxacin results in increased expression of SIK1 mRNA
CTD
PMID:35537566
NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,396...9,958,991
G
Six1
SIX homeobox 1
increases expression
ISO
trovafloxacin results in increased expression of SIX1 mRNA
CTD
PMID:35537566
NCBI chr 6:97,482,617...97,487,853
Ensembl chr 6:91,746,739...91,751,975
G
Six5
SIX homeobox 5
increases expression
ISO
trovafloxacin results in increased expression of SIX5 mRNA
CTD
PMID:35537566
NCBI chr 1:78,740,812...78,745,890
Ensembl chr 1:78,741,367...78,745,890
G
Ska1
spindle and kinetochore associated complex subunit 1
decreases expression
ISO
trovafloxacin results in decreased expression of SKA1 mRNA
CTD
PMID:35537566
NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037
G
Ska3
spindle and kinetochore associated complex subunit 3
decreases expression
ISO
trovafloxacin results in decreased expression of SKA3 mRNA
CTD
PMID:35537566
NCBI chr15:31,951,812...31,971,010
Ensembl chr15:31,951,825...31,971,010
G
Skil
SKI-like proto-oncogene
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SKIL mRNA
CTD
PMID:18930950
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
G
Sla
src-like adaptor
decreases expression
ISO
trovafloxacin results in decreased expression of SLA mRNA
CTD
PMID:35537566
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
G
Slamf9
SLAM family member 9
decreases expression
ISO
trovafloxacin results in decreased expression of SLAMF9 mRNA
CTD
PMID:35537566
NCBI chr13:84,941,896...84,944,749
Ensembl chr13:84,941,982...84,944,748
G
Slc11a2
solute carrier family 11 member 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SLC11A2 mRNA
CTD
PMID:18930950
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc13a3
solute carrier family 13 member 3
decreases expression
ISO
trovafloxacin results in decreased expression of SLC13A3 mRNA
CTD
PMID:35537566
NCBI chr 3:174,561,174...174,623,893
Ensembl chr 3:154,141,872...154,204,606
G
Slc17a2
solute carrier family 17, member 2
increases expression
EXP
trovafloxacin results in increased expression of SLC17A2 mRNA
CTD
PMID:24136188
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc17a3
solute carrier family 17 member 3
decreases expression multiple interactions
EXP ISO
trovafloxacin results in decreased expression of SLC17A3 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SLC17A3 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr17:41,270,804...41,300,132
Ensembl chr17:41,270,812...41,295,256
G
Slc17a5
solute carrier family 17 member 5
decreases expression
ISO
trovafloxacin results in decreased expression of SLC17A5 mRNA
CTD
PMID:35537566
NCBI chr 8:88,274,497...88,309,734
G
Slc17a9
solute carrier family 17 member 9
decreases expression
ISO
trovafloxacin results in decreased expression of SLC17A9 mRNA
CTD
PMID:35537566
NCBI chr 3:167,839,246...167,857,462
Ensembl chr 3:167,839,385...167,855,985
G
Slc18a2
solute carrier family 18 member A2
decreases expression
ISO
trovafloxacin results in decreased expression of SLC18A2 mRNA
CTD
PMID:35537566
NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:258,413,959...258,448,325
G
Slc19a2
solute carrier family 19 member 2
increases expression
ISO
trovafloxacin results in increased expression of SLC19A2 mRNA
CTD
PMID:35537566
NCBI chr13:79,135,118...79,149,316
Ensembl chr13:76,601,900...76,616,172
G
Slc1a4
solute carrier family 1 member 4
decreases expression
ISO
trovafloxacin results in decreased expression of SLC1A4 mRNA
CTD
PMID:35537566
NCBI chr14:98,718,646...98,761,672
Ensembl chr14:94,529,084...94,560,418
G
Slc1a5
solute carrier family 1 member 5
decreases expression
ISO
trovafloxacin results in decreased expression of SLC1A5 mRNA
CTD
PMID:35537566
NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:77,456,694...77,470,952
G
Slc22a1
solute carrier family 22 member 1
decreases expression
EXP
trovafloxacin results in decreased expression of SLC22A1 mRNA
CTD
PMID:24136188
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:48,076,666...48,103,678
G
Slc23a1
solute carrier family 23 member 1
increases expression
ISO
trovafloxacin results in increased expression of SLC23A1 mRNA
CTD
PMID:35537566
NCBI chr18:27,490,549...27,504,563
Ensembl chr18:27,216,281...27,230,697
G
Slc25a10
solute carrier family 25 member 10
decreases expression
ISO
trovafloxacin results in decreased expression of SLC25A10 mRNA
CTD
PMID:35537566
NCBI chr10:106,264,396...106,271,895
Ensembl chr10:105,765,372...105,773,556
G
Slc25a38
solute carrier family 25, member 38
increases expression
ISO
trovafloxacin results in increased expression of SLC25A38 mRNA
CTD
PMID:35537566
NCBI chr 8:128,713,180...128,725,968
Ensembl chr 8:119,835,634...119,848,332
G
Slc25a40
solute carrier family 25, member 40
decreases expression
ISO
trovafloxacin results in decreased expression of SLC25A40 mRNA
CTD
PMID:35537566
NCBI chr 4:25,631,447...25,676,454
Ensembl chr 4:25,589,360...25,676,472
G
Slc27a3
solute carrier family 27 member 3
increases expression
ISO
trovafloxacin results in increased expression of SLC27A3 mRNA
CTD
PMID:35537566
NCBI chr 2:175,853,241...175,857,909
Ensembl chr 2:175,853,241...175,857,909
G
Slc28a2
solute carrier family 28 member 2
decreases expression
ISO
trovafloxacin results in decreased expression of SLC28A2 mRNA
CTD
PMID:35537566
NCBI chr 3:129,778,425...129,841,292
Ensembl chr 3:109,366,996...109,387,702
G
Slc29a1
solute carrier family 29 member 1
decreases expression
ISO
trovafloxacin results in decreased expression of SLC29A1 mRNA
CTD
PMID:35537566
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:15,399,612...15,414,203
G
Slc2a8
solute carrier family 2 member 8
decreases expression
ISO
trovafloxacin results in decreased expression of SLC2A8 mRNA
CTD
PMID:35537566
NCBI chr 3:16,274,918...16,284,536
Ensembl chr 3:16,274,925...16,284,464
G
Slc30a9
solute carrier family 30 member 9
decreases expression
ISO
trovafloxacin results in decreased expression of SLC30A9 mRNA
CTD
PMID:35537566
NCBI chr14:40,816,284...40,870,992
Ensembl chr14:40,816,290...40,870,929
G
Slc34a2
solute carrier family 34 member 2
decreases expression
EXP
trovafloxacin results in decreased expression of SLC34A2 mRNA
CTD
PMID:24136188
NCBI chr14:62,123,313...62,153,020
Ensembl chr14:57,910,480...57,930,436
G
Slc35e3
solute carrier family 35, member E3
decreases expression
EXP
trovafloxacin results in decreased expression of SLC35E3 mRNA
CTD
PMID:24136188
NCBI chr 7:53,337,091...53,350,152
Ensembl chr 7:53,337,095...53,350,165
G
Slc35f1
solute carrier family 35, member F1
decreases expression
ISO
trovafloxacin results in decreased expression of SLC35F1 mRNA
CTD
PMID:35537566
NCBI chr20:32,030,350...32,418,762
Ensembl chr20:32,030,368...32,418,611
G
Slc37a2
solute carrier family 37 member 2
increases expression
ISO
trovafloxacin results in increased expression of SLC37A2 mRNA
CTD
PMID:35537566
NCBI chr 8:36,945,787...36,971,748
Ensembl chr 8:36,946,930...36,971,482
G
Slc38a7
solute carrier family 38, member 7
decreases expression
ISO
trovafloxacin results in decreased expression of SLC38A7 mRNA
CTD
PMID:35537566
NCBI chr19:9,209,203...9,225,472
Ensembl chr19:9,209,257...9,225,454
G
Slc39a14
solute carrier family 39 member 14
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SLC39A14 mRNA
CTD
PMID:18930950
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc39a4
solute carrier family 39 member 4
decreases expression
ISO
trovafloxacin results in decreased expression of SLC39A4 mRNA
CTD
PMID:35537566
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc41a2
solute carrier family 41 member 2
decreases expression
EXP
trovafloxacin results in decreased expression of SLC41A2 mRNA
CTD
PMID:24136188
NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166
G
Slc43a3
solute carrier family 43, member 3
decreases expression
ISO
trovafloxacin results in decreased expression of SLC43A3 mRNA
CTD
PMID:35537566
NCBI chr 3:70,008,160...70,030,324
Ensembl chr 3:70,009,313...70,029,749
G
Slc45a3
solute carrier family 45, member 3
increases expression
ISO
trovafloxacin results in increased expression of SLC45A3 mRNA
CTD
PMID:35537566
NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588
G
Slc45a4
solute carrier family 45, member 4
decreases expression
ISO
trovafloxacin results in decreased expression of SLC45A4 mRNA
CTD
PMID:35537566
NCBI chr 7:105,478,886...105,550,160
Ensembl chr 7:105,481,792...105,550,170
G
Slc46a1
solute carrier family 46 member 1
increases expression
EXP
trovafloxacin results in increased expression of SLC46A1 mRNA
CTD
PMID:24136188
NCBI chr10:63,859,551...63,865,987
Ensembl chr10:63,361,486...63,368,848
G
Slc46a3
solute carrier family 46, member 3
decreases expression
ISO
trovafloxacin results in decreased expression of SLC46A3 mRNA
CTD
PMID:35537566
NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
G
Slc49a3
solute carrier family 49 member 3
increases expression
ISO
trovafloxacin results in increased expression of SLC49A3 mRNA
CTD
PMID:35537566
NCBI chr14:1,305,091...1,319,723
Ensembl chr14:1,305,680...1,314,132
G
Slc4a3
solute carrier family 4 member 3
increases expression
ISO
trovafloxacin results in increased expression of SLC4A3 mRNA
CTD
PMID:35537566
NCBI chr 9:77,036,243...77,053,940
Ensembl chr 9:77,037,016...77,049,105
G
Slc4a8
solute carrier family 4 member 8
decreases expression
ISO
trovafloxacin results in decreased expression of SLC4A8 mRNA
CTD
PMID:35537566
NCBI chr 7:133,742,830...133,818,056
Ensembl chr 7:131,864,102...131,931,051
G
Slc52a2
solute carrier family 52 member 2
decreases expression
ISO
trovafloxacin results in decreased expression of SLC52A2 mRNA
CTD
PMID:35537566
NCBI chr 7:108,246,003...108,267,642
Ensembl chr 7:108,262,612...108,268,034
G
Slc6a4
solute carrier family 6 member 4
increases expression
ISO
trovafloxacin results in increased expression of SLC6A4 mRNA
CTD
PMID:35537566
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Slc6a9
solute carrier family 6 member 9
decreases expression
ISO
trovafloxacin results in decreased expression of SLC6A9 mRNA
CTD
PMID:35537566
NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:131,374,542...131,408,728
G
Slc7a1
solute carrier family 7 member 1
decreases expression
ISO
trovafloxacin results in decreased expression of SLC7A1 mRNA
CTD
PMID:35537566
NCBI chr12:11,664,488...11,740,030
Ensembl chr12:6,628,007...6,703,849
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
trovafloxacin results in decreased expression of SLC7A11 mRNA
CTD
PMID:35537566
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Slc7a2
solute carrier family 7 member 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SLC7A2 mRNA
CTD
PMID:18930950
NCBI chr16:58,115,991...58,174,256
Ensembl chr16:51,417,493...51,470,784
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
trovafloxacin results in decreased expression of SLC7A5 mRNA
CTD
PMID:35537566
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
G
Slc9a9
solute carrier family 9 member A9
decreases expression
ISO
trovafloxacin results in decreased expression of SLC9A9 mRNA
CTD
PMID:35537566
NCBI chr 8:95,232,889...95,797,262
Ensembl chr 8:95,232,905...95,796,318
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
EXP
trovafloxacin results in increased expression of SLCO1A2 mRNA
CTD
PMID:24136188
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SLCO1B3 mRNA
CTD
PMID:18930950
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:174,551,480...174,619,981
G
Slco4a1
solute carrier organic anion transporter family, member 4a1
increases expression
ISO
trovafloxacin results in increased expression of SLCO4A1 mRNA
CTD
PMID:35537566
NCBI chr 3:167,559,177...167,578,307
Ensembl chr 3:167,559,316...167,578,305
G
Slfn2
schlafen family member 2
increases expression
ISO
trovafloxacin results in increased expression of SLFN2 mRNA
CTD
PMID:35537566
NCBI chr10:67,953,322...67,959,659
Ensembl chr10:67,953,171...67,959,458
G
Slfn4
schlafen family member 4
increases expression
ISO
trovafloxacin results in increased expression of SLFN4 mRNA
CTD
PMID:35537566
NCBI chr10:67,994,601...68,018,141
Ensembl chr10:68,000,028...68,018,138 Ensembl chr10:68,000,028...68,018,138
G
Slfn5
schlafen family member 5
increases expression
ISO
trovafloxacin results in increased expression of SLFN5 mRNA
CTD
PMID:35537566
NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109
G
Smad6
SMAD family member 6
decreases expression
ISO
trovafloxacin results in decreased expression of SMAD6 mRNA
CTD
PMID:35537566
NCBI chr 8:73,345,457...73,414,985
Ensembl chr 8:64,450,114...64,519,763
G
Smarcd2
SWI/SNF related BAF chromatin remodeling complex subunit D2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SMARCD2 mRNA
CTD
PMID:18930950
NCBI chr10:91,193,752...91,202,817
Ensembl chr10:91,193,752...91,204,341
G
Smarcd3
SWI/SNF related BAF chromatin remodeling complex subunit D3
increases expression
ISO
trovafloxacin results in increased expression of SMARCD3 mRNA
CTD
PMID:35537566
NCBI chr 4:10,548,693...10,580,334
Ensembl chr 4:10,548,751...10,580,326
G
Smc2
structural maintenance of chromosomes 2
decreases expression
ISO
trovafloxacin results in decreased expression of SMC2 mRNA
CTD
PMID:35537566
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
G
Smc4
structural maintenance of chromosomes 4
decreases expression
ISO
trovafloxacin results in decreased expression of SMC4 mRNA
CTD
PMID:35537566
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
G
Smg7
SMG7 nonsense mediated mRNA decay factor
increases expression
ISO
trovafloxacin results in increased expression of SMG7 mRNA
CTD
PMID:35537566
NCBI chr13:64,986,145...65,050,698
Ensembl chr13:64,987,434...65,050,582
G
Smim11
small integral membrane protein 11
increases expression
ISO
trovafloxacin results in increased expression of SMIM11 mRNA
CTD
PMID:35537566
NCBI chr11:31,533,257...31,543,002
Ensembl chr11:31,532,764...31,543,002
G
Smim14
small integral membrane protein 14
decreases expression
ISO
trovafloxacin results in decreased expression of SMIM14 mRNA
CTD
PMID:35537566
NCBI chr14:42,783,361...42,829,762
Ensembl chr14:42,783,332...42,829,760
G
Smim27
small integral membrane protein 27
increases expression
ISO
trovafloxacin results in increased expression of SMIM27 mRNA
CTD
PMID:35537566
NCBI chr 5:55,399,637...55,400,304
Ensembl chr 5:55,398,723...55,400,869
G
Smim5
small integral membrane protein 5
increases expression
ISO
trovafloxacin results in increased expression of SMIM5 mRNA
CTD
PMID:35537566
NCBI chr10:101,134,033...101,139,814
Ensembl chr10:101,134,033...101,139,813
G
Smim7
small integral membrane protein 7
increases expression
ISO
trovafloxacin results in increased expression of SMIM7 mRNA
CTD
PMID:35537566
NCBI chr16:17,274,417...17,278,336
Ensembl chr16:17,273,258...17,278,336
G
Smndc1
survival motor neuron domain containing 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SMNDC1 mRNA
CTD
PMID:18930950
NCBI chr 1:252,389,675...252,400,749
Ensembl chr 1:252,389,673...252,401,616
G
Smpdl3b
sphingomyelin phosphodiesterase, acid-like 3B
decreases expression
ISO
trovafloxacin results in decreased expression of SMPDL3B mRNA
CTD
PMID:35537566
NCBI chr 5:144,944,618...144,966,703
Ensembl chr 5:144,944,636...144,966,720
G
Smtn
smoothelin
decreases expression
ISO
trovafloxacin results in decreased expression of SMTN mRNA
CTD
PMID:35537566
NCBI chr14:78,398,595...78,420,908
Ensembl chr14:78,397,778...78,420,886
G
Snapc4
small nuclear RNA activating complex, polypeptide 4
increases expression
ISO
trovafloxacin results in increased expression of SNAPC4 mRNA
CTD
PMID:35537566
NCBI chr 3:9,182,061...9,200,819
Ensembl chr 3:9,182,067...9,199,518
G
Snd1
staphylococcal nuclease and tudor domain containing 1
decreases expression
EXP ISO
trovafloxacin results in decreased expression of SND1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 4:57,095,205...57,494,501
Ensembl chr 4:57,095,208...57,530,843
G
Snora23
small nucleolar RNA, H/ACA box 23
increases expression
ISO
trovafloxacin results in increased expression of SNORA23 mRNA
CTD
PMID:35537566
NCBI chr 1:164,091,024...164,091,206
Ensembl chr 1:164,091,024...164,091,206
G
Snora31
small nucleolar RNA, H/ACA box 31
increases expression
ISO
trovafloxacin results in increased expression of SNORA31 mRNA
CTD
PMID:35537566
NCBI chr15:51,159,220...51,159,349
Ensembl chr15:51,159,220...51,159,349
G
Snora3a
small nucleolar RNA, H/ACA box 3A
increases expression
ISO
trovafloxacin results in increased expression of SNORA3 mRNA
CTD
PMID:35537566
NCBI chr 1:163,540,664...163,540,793
Ensembl chr 1:163,540,664...163,540,793
G
Snora47
small nucleolar RNA, H/ACA box 47
increases expression
ISO
trovafloxacin results in increased expression of SNORA47 mRNA
CTD
PMID:35537566
NCBI chr 2:26,594,260...26,594,397
Ensembl chr 2:26,594,260...26,594,397
G
Snora52
small nucleolar RNA, H/ACA box 52
increases expression
ISO
trovafloxacin results in increased expression of SNORA52 mRNA
CTD
PMID:35537566
NCBI chr 1:196,547,488...196,547,621
Ensembl chr 1:196,547,488...196,547,621
G
Snora5c
small nucleolar RNA, H/ACA box 5C
increases expression
ISO
trovafloxacin results in increased expression of SNORA5C mRNA
CTD
PMID:35537566
NCBI chr14:81,487,218...81,487,354
Ensembl chr14:81,487,218...81,487,354
G
Snora64
small nucleolar RNA, H/ACA box 64
increases expression
ISO
trovafloxacin results in increased expression of SNORA64 mRNA
CTD
PMID:35537566
NCBI chr10:13,748,139...13,748,272
Ensembl chr10:13,748,139...13,748,272
G
Snora65
small nucleolar RNA, H/ACA box 65
increases expression
ISO
trovafloxacin results in increased expression of SNORA65 mRNA
CTD
PMID:35537566
NCBI chr 3:16,265,801...16,265,930
Ensembl chr 3:16,265,801...16,265,930
G
Snora73b
small nucleolar RNA, H/ACA box 73b
increases expression
ISO
trovafloxacin results in increased expression of SNORA73B mRNA
CTD
PMID:35537566
NCBI chr 5:144,545,179...144,545,382
Ensembl chr 5:144,545,179...144,545,382
G
Snora81
small nucleolar RNA, H/ACA box 81
increases expression
ISO
trovafloxacin results in increased expression of SNORA81 mRNA
CTD
PMID:35537566
NCBI chr11:77,767,579...77,767,756
Ensembl chr10:27,777,322...27,777,469
G
Snord104
small nucleolar RNA, C/D box 104
increases expression
ISO
trovafloxacin results in increased expression of SNORD104 mRNA
CTD
PMID:35537566
NCBI chr10:91,435,313...91,435,382
Ensembl chr10:91,435,313...91,435,382
G
Snord14d
small nucleolar RNA, C/D box 14D
increases expression
ISO
trovafloxacin results in increased expression of SNORD14D mRNA
CTD
PMID:35537566
NCBI chr 8:41,186,057...41,186,142
Ensembl chr 8:41,186,057...41,186,142
G
Snord16
small nucleolar RNA, C/D box 16
increases expression
ISO
trovafloxacin results in increased expression of SNORD16A mRNA
CTD
PMID:35537566
NCBI chr 8:64,673,195...64,673,293
Ensembl chr 8:64,673,195...64,673,293
G
Snord17
small nucleolar RNA, C/D box 17
increases expression
ISO
trovafloxacin results in increased expression of SNORD17 mRNA
CTD
PMID:35537566
NCBI chr 3:131,636,460...131,636,698
Ensembl chr 3:131,636,460...131,636,698
G
Snord19
small nucleolar RNA, C/D box 19
increases expression
ISO
trovafloxacin results in increased expression of SNORD19 mRNA
CTD
PMID:35537566
NCBI chr16:6,210,838...6,210,914
Ensembl chr16:6,210,838...6,210,914
G
Snord1c
small nucleolar RNA, C/D box 1C
increases expression
ISO
trovafloxacin results in increased expression of SNORD1C mRNA
CTD
PMID:35537566
NCBI chr10:101,905,797...101,905,872
Ensembl chr10:101,905,797...101,905,872
G
Snord2
small nucleolar RNA, C/D box 2
increases expression
ISO
trovafloxacin results in increased expression of SNORD2 mRNA
CTD
PMID:35537566
NCBI chr11:77,769,475...77,769,543
Ensembl chr11:77,769,475...77,769,543
G
Snord22
small nucleolar RNA, C/D box 22
increases expression
ISO
trovafloxacin results in increased expression of SNORD22 mRNA
CTD
PMID:35537566
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
G
Snord42b
small nucleolar RNA, C/D box 42B
increases expression
ISO
trovafloxacin results in increased expression of SNORD42B mRNA
CTD
PMID:35537566
NCBI chr10:63,078,825...63,078,893
Ensembl chr10:63,078,825...63,078,893
G
Snord43
small nucleolar RNA, C/D box 43
increases expression
ISO
trovafloxacin results in increased expression of SNORD43 mRNA
CTD
PMID:35537566
NCBI chr 7:111,627,136...111,627,199
Ensembl chr 7:111,627,136...111,627,199
G
Snord49a
small nucleolar RNA, C/D box 49A
increases expression
ISO
trovafloxacin results in increased expression of SNORD49A mRNA
CTD
PMID:35537566
NCBI chr10:47,297,488...47,297,559
Ensembl chr10:47,297,488...47,297,559
G
Snord4a
small nucleolar RNA, C/D box 4A
increases expression
ISO
trovafloxacin results in increased expression of SNORD4A mRNA
CTD
PMID:35537566
NCBI chr10:63,077,419...63,077,489
Ensembl chr10:63,077,419...63,077,489
G
Snord53
small nucleolar RNA, C/D box 53
increases expression
ISO
trovafloxacin results in increased expression of SNORD53 mRNA
CTD
PMID:35537566
NCBI chr 6:23,861,377...23,861,454
Ensembl chr 6:23,861,377...23,861,454
G
Snord55
small nucleolar RNA, C/D box 55
increases expression
ISO
trovafloxacin results in increased expression of SNORD55 mRNA
CTD
PMID:35537566
NCBI chr 5:130,632,614...130,632,692
Ensembl chr 5:130,632,614...130,632,692
G
Snord57
small nucleolar RNA, C/D box 57
increases expression
ISO
trovafloxacin results in increased expression of SNORD57 mRNA
CTD
PMID:35537566
NCBI chr 3:117,480,517...117,480,588
Ensembl chr 3:117,480,517...117,480,588
G
Snord58b
small nucleolar RNA, C/D box 58B
increases expression
ISO
trovafloxacin results in increased expression of SNORD58B mRNA
CTD
PMID:35537566
NCBI chr18:68,581,864...68,581,929
Ensembl chr18:68,581,864...68,581,929
G
Snord69
small nucleolar RNA, C/D box 69
increases expression
ISO
trovafloxacin results in increased expression of SNORD69 mRNA
CTD
PMID:35537566
NCBI chr16:6,208,922...6,209,001
Ensembl chr16:6,208,922...6,209,001
G
Snord72
small nucleolar RNA, C/D box 72
increases expression
ISO
trovafloxacin results in increased expression of SNORD72 mRNA
CTD
PMID:35537566
NCBI chr 2:54,217,160...54,217,239
Ensembl chr 2:54,217,160...54,217,239
G
Snord73b
small nucleolar RNA, C/D box U73B
increases expression
ISO
trovafloxacin results in increased expression of SNORD73B mRNA
CTD
PMID:35537566
NCBI chr 2:171,527,196...171,527,269
Ensembl chr 2:171,527,196...171,527,269
G
Snord8
small nucleolar RNA, C/D box 8
increases expression
ISO
trovafloxacin results in increased expression of SNORD8 mRNA
CTD
PMID:35537566
NCBI chr15:24,917,836...24,917,945
Ensembl chr15:24,917,836...24,917,945
G
Snord83b
small nucleolar RNA, C/D box 83B
increases expression
ISO
trovafloxacin results in increased expression of SNORD83B mRNA
CTD
PMID:35537566
NCBI chr 7:111,622,885...111,622,978
Ensembl chr 7:111,622,885...111,622,978
G
Snord89
small nucleolar RNA, C/D box 89
increases expression
ISO
trovafloxacin results in increased expression of SNORD89 mRNA
CTD
PMID:35537566
NCBI chr 9:41,827,972...41,828,086
Ensembl chr 9:41,827,972...41,828,086
G
Snord99
small nucleolar RNA, C/D box 99
increases expression
ISO
trovafloxacin results in increased expression of SNORD99 mRNA
CTD
PMID:35537566
NCBI chr 5:144,506,901...144,506,974
Ensembl chr 5:144,506,901...144,506,974
G
Snrnp48
small nuclear ribonucleoprotein U11/U12 subunit 48
increases expression
ISO
trovafloxacin results in increased expression of SNRNP48 mRNA
CTD
PMID:35537566
NCBI chr17:26,596,266...26,616,058
Ensembl chr17:26,596,275...26,616,040
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
increases expression
ISO
trovafloxacin results in increased expression of SNRPD3 mRNA
CTD
PMID:35537566
NCBI chr20:13,130,112...13,145,947
Ensembl chr20:13,130,119...13,145,978
G
Snx22
sorting nexin 22
increases expression
ISO
trovafloxacin results in increased expression of SNX22 mRNA
CTD
PMID:35537566
NCBI chr 8:66,609,914...66,612,932
Ensembl chr 8:66,609,970...66,612,850
G
Snx25
sorting nexin 25
decreases expression
ISO
trovafloxacin results in decreased expression of SNX25 mRNA
CTD
PMID:35537566
NCBI chr16:46,134,552...46,238,471
Ensembl chr16:46,125,804...46,238,440
G
Snx32
sorting nexin 32
decreases expression
ISO
trovafloxacin results in decreased expression of SNX32 mRNA
CTD
PMID:35537566
NCBI chr 1:202,801,090...202,818,731
Ensembl chr 1:202,802,394...202,818,743
G
Snx4
sorting nexin 4
multiple interactions
ISO
[trovafloxacin co-treated with TNF protein] results in decreased expression of SNX4 mRNA
CTD
PMID:33609687
NCBI chr11:80,965,965...81,023,234
Ensembl chr11:67,460,870...67,518,174
G
Soat2
sterol O-acyltransferase 2
decreases expression
ISO
trovafloxacin results in decreased expression of SOAT2 mRNA
CTD
PMID:35537566
NCBI chr 7:135,160,424...135,173,521
Ensembl chr 7:133,281,818...133,294,915
G
Socs2
suppressor of cytokine signaling 2
increases expression multiple interactions
EXP ISO
trovafloxacin results in increased expression of SOCS2 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SOCS2 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:30,008,578...30,043,548
G
Socs3
suppressor of cytokine signaling 3
multiple interactions increases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SOCS3 mRNA trovafloxacin results in increased expression of SOCS3 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SOD2 mRNA
CTD
PMID:18930950
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sorbs1
sorbin and SH3 domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of SORBS1 mRNA
CTD
PMID:35537566
NCBI chr 1:249,057,324...249,279,703
Ensembl chr 1:239,108,777...239,330,169
G
Sorbs3
sorbin and SH3 domain containing 3
decreases expression
ISO
trovafloxacin results in decreased expression of SORBS3 mRNA
CTD
PMID:35537566
NCBI chr15:45,252,921...45,284,758
Ensembl chr15:45,253,379...45,284,758
G
Sorl1
sortilin related receptor 1
decreases expression
ISO
trovafloxacin results in decreased expression of SORL1 mRNA
CTD
PMID:35537566
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Sp4
Sp4 transcription factor
decreases expression
ISO
trovafloxacin results in decreased expression of SP4 mRNA
CTD
PMID:35537566
NCBI chr 6:139,187,458...139,252,741
Ensembl chr 6:139,192,147...139,252,126
G
Spag17
sperm associated antigen 17
increases expression
ISO
trovafloxacin results in increased expression of SPAG17 mRNA
CTD
PMID:35537566
NCBI chr 2:189,952,649...190,199,623
Ensembl chr 2:187,264,009...187,510,501
G
Spag5
sperm associated antigen 5
decreases expression
ISO
trovafloxacin results in decreased expression of SPAG5 mRNA
CTD
PMID:35537566
NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,198,768...63,216,745
G
Spart
spartin
decreases expression
EXP
trovafloxacin results in decreased expression of SPART mRNA
CTD
PMID:24136188
NCBI chr 2:141,442,770...141,469,388
Ensembl chr 2:139,292,355...139,319,248
G
Spata24
spermatogenesis associated 24
decreases expression
ISO
trovafloxacin results in decreased expression of SPATA24 mRNA
CTD
PMID:35537566
NCBI chr18:27,249,047...27,257,129
Ensembl chr18:27,248,609...27,257,124
G
Spc24
SPC24 component of NDC80 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of SPC24 mRNA
CTD
PMID:35537566
NCBI chr 8:20,300,315...20,305,354
Ensembl chr 8:20,300,319...20,305,310
G
Spc25
SPC25 component of NDC80 kinetochore complex
decreases expression
ISO
trovafloxacin results in decreased expression of SPC25 mRNA
CTD
PMID:35537566
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
G
Spdl1
spindle apparatus coiled-coil protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of SPDL1 mRNA
CTD
PMID:35537566
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
G
Spef1
sperm flagellar 1
decreases expression
ISO
trovafloxacin results in decreased expression of SPEF1 mRNA
CTD
PMID:35537566
NCBI chr 3:138,843,679...138,849,762
Ensembl chr 3:118,390,575...118,394,531
G
Spn
sialophorin
decreases expression
ISO
trovafloxacin results in decreased expression of SPN mRNA
CTD
PMID:35537566
NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:181,746,429...181,759,628
G
Spred2
sprouty-related, EVH1 domain containing 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SPRED2 mRNA
CTD
PMID:18930950
NCBI chr14:98,350,577...98,452,143
Ensembl chr14:94,148,837...94,249,162
G
Spry2
sprouty RTK signaling antagonist 2
increases expression
ISO
trovafloxacin results in increased expression of SPRY2 mRNA
CTD
PMID:35537566
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
Sptbn4
spectrin, beta, non-erythrocytic 4
increases expression
ISO
trovafloxacin results in increased expression of SPTBN4 mRNA
CTD
PMID:35537566
NCBI chr 1:82,650,750...82,738,345
Ensembl chr 1:82,650,751...82,737,228
G
Sptssa
serine palmitoyltransferase, small subunit A
increases expression
EXP
trovafloxacin results in increased expression of SPTSSA mRNA
CTD
PMID:24136188
NCBI chr 6:72,144,714...72,156,130
Ensembl chr 6:72,144,714...72,156,214
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
increases expression
ISO
trovafloxacin results in increased expression of SRC mRNA
CTD
PMID:35537566
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
trovafloxacin results in decreased expression of SREBF1 mRNA
CTD
PMID:24136188
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Srgap3
SLIT-ROBO Rho GTPase activating protein 3
increases expression
ISO
trovafloxacin results in increased expression of SRGAP3 mRNA
CTD
PMID:35537566
NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:145,840,078...146,070,575
G
Srm
spermidine synthase
decreases expression
EXP
trovafloxacin results in decreased expression of SRM mRNA
CTD
PMID:24136188
NCBI chr 5:164,309,002...164,312,203
Ensembl chr 5:159,025,873...159,029,405
G
Srp72
signal recognition particle 72
decreases expression
EXP
trovafloxacin results in decreased expression of SRP72 mRNA
CTD
PMID:24136188
NCBI chr14:31,168,175...31,195,717
Ensembl chr14:31,168,293...31,195,729
G
Srrm2
serine/arginine repetitive matrix 2
increases expression
EXP
trovafloxacin results in increased expression of SRRM2 mRNA
CTD
PMID:24136188
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
G
Srsf1
serine and arginine rich splicing factor 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SRSF1 mRNA
CTD
PMID:18930950
NCBI chr10:73,335,519...73,342,549
Ensembl chr10:72,839,274...72,845,336
G
Srsf2
serine and arginine rich splicing factor 2
decreases expression multiple interactions
EXP ISO
trovafloxacin results in decreased expression of SRSF2 mRNA [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SRSF2 mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
EXP
trovafloxacin results in decreased expression of SRSF3 mRNA
CTD
PMID:24136188
NCBI chr20:7,093,529...7,103,517
Ensembl chr20:7,091,910...7,101,078
G
Srsf4
serine and arginine rich splicing factor 4
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SRSF4 mRNA
CTD
PMID:18930950
NCBI chr 5:144,060,981...144,090,798
Ensembl chr 5:144,061,463...144,089,229
G
Srsf5
serine and arginine rich splicing factor 5
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SRSF5 mRNA
CTD
PMID:18930950
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
G
Ssbp4
single stranded DNA binding protein 4
decreases expression
ISO
trovafloxacin results in decreased expression of SSBP4 mRNA
CTD
PMID:35537566
NCBI chr16:18,828,014...18,838,941
Ensembl chr16:18,828,054...18,838,947
G
Ssh2
slingshot protein phosphatase 2
decreases expression
ISO
trovafloxacin results in decreased expression of SSH2 mRNA
CTD
PMID:35537566
NCBI chr10:62,057,400...62,309,328
Ensembl chr10:62,057,044...62,306,563
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
EXP
trovafloxacin results in decreased expression of SSX2IP mRNA
CTD
PMID:24136188
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of ST6GAL1 mRNA
CTD
PMID:35537566
NCBI chr11:91,031,481...91,158,111
Ensembl chr11:77,526,837...77,653,310
G
Stag2
STAG2 cohesin complex component
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of STAG2 mRNA
CTD
PMID:18930950
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
G
Stard4
StAR-related lipid transfer domain containing 4
increases expression
EXP
trovafloxacin results in increased expression of STARD4 mRNA
CTD
PMID:24136188
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
G
Stard5
StAR-related lipid transfer domain containing 5
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of STARD5 mRNA trovafloxacin results in decreased expression of STARD5 mRNA
CTD
PMID:18930950 PMID:35537566
NCBI chr 1:137,606,151...137,616,017
Ensembl chr 1:137,606,177...137,616,469
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of STAT3 mRNA
CTD
PMID:18930950
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Stbd1
starch binding domain 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of STBD1 mRNA
CTD
PMID:18930950
NCBI chr14:15,754,769...15,758,174
Ensembl chr14:15,469,582...15,477,443
G
Stc2
stanniocalcin 2
decreases expression
ISO
trovafloxacin results in decreased expression of STC2 mRNA
CTD
PMID:35537566
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stil
STIL, centriolar assembly protein
decreases expression
ISO
trovafloxacin results in decreased expression of STIL mRNA
CTD
PMID:35537566
NCBI chr 5:128,520,837...128,573,732
Ensembl chr 5:128,520,953...128,573,730
G
Stip1
stress-induced phosphoprotein 1
decreases expression
EXP
trovafloxacin results in decreased expression of STIP1 mRNA
CTD
PMID:24136188
NCBI chr 1:213,638,641...213,657,654
Ensembl chr 1:204,178,932...204,228,476
G
Stkld1
serine/threonine kinase-like domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of STKLD1 mRNA
CTD
PMID:35537566
NCBI chr 3:10,261,583...10,280,850
Ensembl chr 3:10,261,828...10,280,566
G
Stmn1
stathmin 1
decreases expression
EXP ISO
trovafloxacin results in decreased expression of STMN1 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Strbp
spermatid perinuclear RNA binding protein
decreases expression
ISO
trovafloxacin results in decreased expression of STRBP mRNA
CTD
PMID:35537566
NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
G
Sts
steroid sulfatase
increases expression
EXP
trovafloxacin results in increased expression of STS mRNA
CTD
PMID:24136188
NCBI chr X:46,102,524...46,110,868
Ensembl chr X:42,225,372...42,233,402
G
Stx1a
syntaxin 1A
increases expression
ISO
trovafloxacin results in increased expression of STX1A mRNA
CTD
PMID:35537566
NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930
G
Stxbp5
syntaxin binding protein 5
decreases expression
ISO
trovafloxacin results in decreased expression of STXBP5 mRNA
CTD
PMID:35537566
NCBI chr 1:4,182,489...4,335,290
Ensembl chr 1:4,185,529...4,335,101
G
Sulf2
sulfatase 2
increases expression
ISO
trovafloxacin results in increased expression of SULF2 mRNA
CTD
PMID:35537566
NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415
G
Sumo2
small ubiquitin-like modifier 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of SUMO2 mRNA
CTD
PMID:18930950
NCBI chr10:100,771,941...100,784,503
Ensembl chr10:100,686,797...100,784,513 Ensembl chr 5:100,686,797...100,784,513
G
Sun2
Sad1 and UNC84 domain containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of SUN2 mRNA
CTD
PMID:35537566
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
G
Supt4h1
SPT4 homolog, DSIF elongation factor subunit
increases expression
ISO
trovafloxacin results in increased expression of SUPT4A mRNA
CTD
PMID:35537566
NCBI chr10:73,036,560...73,042,821
Ensembl chr10:72,539,382...72,545,831
G
Surf1
SURF1, cytochrome c oxidase assembly factor
decreases expression
ISO
trovafloxacin results in decreased expression of SURF1 mRNA
CTD
PMID:35537566
NCBI chr 3:10,241,793...10,244,686
Ensembl chr 3:10,241,837...10,263,315
G
Suv39h1
SUV39H1 histone lysine methyltransferase
decreases expression
ISO
trovafloxacin results in decreased expression of SUV39H1 mRNA
CTD
PMID:35537566
NCBI chr X:17,093,059...17,105,942
Ensembl chr X:14,421,109...14,433,982
G
Suv39h1-ps1
SUV39H1 histone lysine methyltransferase, pseudogene 1
decreases expression
ISO
trovafloxacin results in decreased expression of SUV39H1 mRNA
CTD
PMID:35537566
NCBI chr X:146,828,818...146,831,485
G
Svil
supervillin
decreases expression
ISO
trovafloxacin results in decreased expression of SVIL mRNA
CTD
PMID:35537566
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
G
Sycp1
synaptonemal complex protein 1
increases expression
ISO
trovafloxacin results in increased expression of SYCP1 mRNA
CTD
PMID:35537566
NCBI chr 2:190,296,688...190,456,687
Ensembl chr 2:190,296,954...190,456,737
G
Syn3
synapsin III
decreases expression
ISO
trovafloxacin results in decreased expression of SYN3 mRNA
CTD
PMID:35537566
NCBI chr 7:16,216,055...17,808,790
Ensembl chr 7:17,376,372...17,808,790
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SYNCRIP mRNA
CTD
PMID:18930950
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
G
Syne1
spectrin repeat containing nuclear envelope protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of SYNE1 mRNA
CTD
PMID:35537566
NCBI chr 1:41,512,146...41,983,382
Ensembl chr 1:41,512,030...41,983,322
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
trovafloxacin results in decreased expression of SYNE2 mRNA
CTD
PMID:35537566
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
G
Synrg
synergin, gamma
increases expression
EXP
trovafloxacin results in increased expression of SYNRG mRNA
CTD
PMID:24136188
NCBI chr10:68,848,828...68,931,252
Ensembl chr10:68,849,642...68,931,250
G
Syt7
synaptotagmin 7
decreases expression
ISO
trovafloxacin results in decreased expression of SYT7 mRNA
CTD
PMID:35537566
NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026
G
Taf1a
TATA-box binding protein associated factor, RNA polymerase I subunit A
increases expression
ISO
trovafloxacin results in increased expression of TAF1A mRNA
CTD
PMID:35537566
NCBI chr13:95,012,160...95,048,131
Ensembl chr13:95,029,225...95,048,087
G
Taf1c
TATA-box binding protein associated factor, RNA polymerase 1 subunit C
increases expression
ISO
trovafloxacin results in increased expression of TAF1C mRNA
CTD
PMID:35537566
NCBI chr19:47,652,451...47,658,971
Ensembl chr19:47,652,452...47,658,971
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
increases expression
ISO
trovafloxacin results in increased expression of TAF1D mRNA
CTD
PMID:35537566
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
G
Taf7
TATA-box binding protein associated factor 7
increases expression
ISO
trovafloxacin results in increased expression of TAF7 mRNA
CTD
PMID:35537566
NCBI chr18:29,459,937...29,462,086
Ensembl chr18:29,452,943...29,462,134
G
Tagap
T-cell activation RhoGTPase activating protein
decreases expression
ISO
trovafloxacin results in decreased expression of TAGAP mRNA
CTD
PMID:35537566
NCBI chr 1:49,575,750...49,584,747
Ensembl chr 1:47,170,725...47,179,792
G
Tanc2
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
decreases expression
ISO
trovafloxacin results in decreased expression of TANC2 mRNA
CTD
PMID:35537566
NCBI chr10:90,553,124...90,873,477
Ensembl chr10:90,553,002...90,868,756
G
Tarm1
T cell-interacting, activating receptor on myeloid cells 1
decreases expression
ISO
trovafloxacin results in decreased expression of TARM1 mRNA
CTD
PMID:35537566
NCBI chr 1:65,666,742...65,682,402
Ensembl chr 1:65,671,902...65,679,626
G
Tars3
threonyl-tRNA synthetase 3
decreases expression
ISO
trovafloxacin results in decreased expression of TARS3 mRNA
CTD
PMID:35537566
NCBI chr 1:119,213,189...119,265,492
Ensembl chr 1:119,213,213...119,265,488
G
Tat
tyrosine aminotransferase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TAT mRNA
CTD
PMID:18930950
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:37,947,112...37,958,031
G
Tbc1d14
TBC1 domain family, member 14
increases expression
EXP
trovafloxacin results in increased expression of TBC1D14 mRNA
CTD
PMID:24136188
NCBI chr14:78,397,345...78,496,863
Ensembl chr14:74,172,664...74,272,183
G
Tbc1d31
TBC1 domain family, member 31
decreases expression
ISO
trovafloxacin results in decreased expression of TBC1D31 mRNA
CTD
PMID:35537566
NCBI chr 7:89,427,354...89,506,894
Ensembl chr 7:89,426,780...89,506,894
G
Tbc1d32
TBC1 domain family, member 32
decreases expression
ISO
trovafloxacin results in decreased expression of TBC1D32 mRNA
CTD
PMID:35537566
NCBI chr20:35,359,865...35,590,992
Ensembl chr20:35,359,863...35,590,415
G
Tbc1d8
TBC1 domain family, member 8
increases expression
ISO
trovafloxacin results in increased expression of TBC1D8 mRNA
CTD
PMID:35537566
NCBI chr 9:41,651,394...41,761,432
Ensembl chr 9:41,651,395...41,761,409
G
Tbl3
transducin (beta)-like 3
decreases expression
ISO
trovafloxacin results in decreased expression of TBL3 mRNA
CTD
PMID:35537566
NCBI chr10:13,726,127...13,731,340
Ensembl chr10:13,726,129...13,731,372
G
Tcaim
T cell activation inhibitor, mitochondrial
increases expression
ISO
trovafloxacin results in increased expression of TCAIM mRNA
CTD
PMID:35537566
NCBI chr 8:122,414,827...122,446,105
Ensembl chr 8:122,414,818...122,446,092
G
Tcea2
transcription elongation factor A2
decreases expression
ISO
trovafloxacin results in decreased expression of TCEA2 mRNA
CTD
PMID:35537566
NCBI chr 3:168,796,244...168,804,125
Ensembl chr 3:168,796,331...168,804,116
G
Tcf19
transcription factor 19
decreases expression
ISO
trovafloxacin results in decreased expression of TCF19 mRNA
CTD
PMID:35537566
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
G
Tcirg1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
decreases expression
EXP
trovafloxacin results in decreased expression of TCIRG1 mRNA
CTD
PMID:24136188
NCBI chr 1:210,556,270...210,568,021
Ensembl chr 1:201,127,034...201,138,742
G
Tcof1
treacle ribosome biogenesis factor 1
decreases expression
ISO
trovafloxacin results in decreased expression of TCOF1 mRNA
CTD
PMID:35537566
NCBI chr18:54,267,015...54,300,324
Ensembl chr18:54,267,026...54,300,324
G
Tctn2
tectonic family member 2
decreases expression
ISO
trovafloxacin results in decreased expression of TCTN2 mRNA
CTD
PMID:35537566
NCBI chr12:31,982,440...32,007,242
Ensembl chr12:31,822,733...32,007,069
G
Tdp1
tyrosyl-DNA phosphodiesterase 1
decreases expression
ISO
trovafloxacin results in decreased expression of TDP1 mRNA
CTD
PMID:35537566
NCBI chr 6:119,163,192...119,231,029
Ensembl chr 6:119,163,166...119,231,021
G
Tecpr1
tectonin beta-propeller repeat containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of TECPR1 mRNA
CTD
PMID:35537566
NCBI chr12:15,504,456...15,534,541
Ensembl chr12:10,391,696...10,419,611
G
Tent2
terminal nucleotidyltransferase 2
decreases expression
EXP
trovafloxacin results in decreased expression of TENT2 mRNA
CTD
PMID:24136188
NCBI chr 2:24,380,135...24,432,099
Ensembl chr 2:24,380,225...24,432,099
G
Tent5b
terminal nucleotidyltransferase 5B
decreases expression
ISO
trovafloxacin results in decreased expression of FAM46B mRNA
CTD
PMID:35537566
NCBI chr 5:145,695,358...145,702,668
Ensembl chr 5:145,695,362...145,706,073 Ensembl chr11:145,695,362...145,706,073
G
Tert
telomerase reverse transcriptase
increases expression
ISO
trovafloxacin results in increased expression of TERT mRNA
CTD
PMID:35537566
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tfb1m
transcription factor B1, mitochondrial
decreases expression
ISO
trovafloxacin results in decreased expression of TFB1M mRNA
CTD
PMID:35537566
NCBI chr 1:44,115,240...44,161,737
Ensembl chr 1:44,119,166...44,161,709
G
Tfdp1
transcription factor Dp-1
decreases expression
EXP
trovafloxacin results in decreased expression of TFDP1 mRNA
CTD
PMID:24136188
NCBI chr16:82,864,220...82,903,166
Ensembl chr16:76,162,043...76,200,817
G
Tfdp2
transcription factor Dp-2
decreases expression
ISO
trovafloxacin results in decreased expression of TFDP2 mRNA
CTD
PMID:35537566
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
G
Tfg
trafficking from ER to golgi regulator
multiple interactions decreases expression
ISO EXP
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of TFG mRNA trovafloxacin results in decreased expression of TFG mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr11:57,354,607...57,381,071
Ensembl chr11:43,885,661...43,911,976
G
Tfrc
transferrin receptor
increases expression
ISO
trovafloxacin results in increased expression of TFRC mRNA
CTD
PMID:35537566
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
G
Tgif1
TGFB-induced factor homeobox 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TGIF1 mRNA
CTD
PMID:18930950
NCBI chr 9:118,194,735...118,204,354
Ensembl chr 9:110,720,921...110,757,802
G
Tgm2
transglutaminase 2
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TGM2 mRNA
CTD
PMID:18930950
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:146,772,687...146,801,981
G
Thbs1
thrombospondin 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of THBS1 mRNA
CTD
PMID:18930950
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Thrap3
thyroid hormone receptor associated protein 3
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of THRAP3 mRNA
CTD
PMID:18930950
NCBI chr 5:138,445,284...138,487,544
Ensembl chr 5:138,445,295...138,487,477
G
Thrsp
thyroid hormone responsive
decreases expression
EXP
trovafloxacin results in decreased expression of THRSP mRNA
CTD
PMID:24136188
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Thumpd3-as1
THUMPD3 antisense RNA 1
increases expression
ISO
trovafloxacin results in increased expression of GT(ROSA)26SOR mRNA
CTD
PMID:35537566
NCBI chr 4:146,210,520...146,217,026
G
Ticam2
TIR domain containing adaptor molecule 2
decreases expression
ISO
trovafloxacin results in decreased expression of TICAM2 mRNA
CTD
PMID:35537566
NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
decreases expression
ISO
trovafloxacin results in decreased expression of TICRR mRNA
CTD
PMID:35537566
NCBI chr 1:133,597,618...133,639,513
Ensembl chr 1:133,597,716...133,639,523
G
Timeless
timeless circadian regulator
decreases expression
ISO
trovafloxacin results in decreased expression of TIMELESS mRNA
CTD
PMID:35537566
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
G
Tinf2
TERF1 interacting nuclear factor 2
decreases expression
ISO
trovafloxacin results in decreased expression of TINF2 mRNA
CTD
PMID:35537566
NCBI chr15:29,170,663...29,178,015
Ensembl chr15:29,170,652...29,176,984
G
Tjp3
tight junction protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of TJP3 mRNA
CTD
PMID:35537566
NCBI chr 7:8,427,650...8,446,279
Ensembl chr 7:8,432,811...8,446,279
G
Tk1
thymidine kinase 1
decreases expression
ISO
trovafloxacin results in decreased expression of TK1 mRNA
CTD
PMID:35537566
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920
G
Tkfc
triokinase and FMN cyclase
decreases expression
EXP
trovafloxacin results in decreased expression of TKFC mRNA
CTD
PMID:24136188
NCBI chr 1:207,238,230...207,253,035
Ensembl chr 1:207,236,557...207,252,737
G
Tkt
transketolase
decreases expression
EXP
trovafloxacin results in decreased expression of TKT mRNA
CTD
PMID:24136188
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,723,762...5,748,698
G
Tle1
TLE family member 1, transcriptional corepressor
increases expression
EXP
trovafloxacin results in increased expression of TLE1 mRNA
CTD
PMID:24136188
NCBI chr 5:85,851,827...85,934,806
Ensembl chr 5:85,851,827...85,934,774
G
Tln2
talin 2
decreases expression
ISO
trovafloxacin results in decreased expression of TLN2 mRNA
CTD
PMID:35537566
NCBI chr 8:67,830,920...68,252,240
Ensembl chr 8:67,834,326...68,252,219
G
Tm2d3
TM2 domain containing 3
increases expression
ISO
trovafloxacin results in increased expression of TM2D3 mRNA
CTD
PMID:35537566
NCBI chr 1:119,267,194...119,277,094
Ensembl chr 1:119,264,576...119,277,099
G
Tm7sf2
transmembrane 7 superfamily member 2
decreases expression
ISO
trovafloxacin results in decreased expression of TM7SF2 mRNA
CTD
PMID:35537566
NCBI chr 1:212,785,217...212,789,572
Ensembl chr 1:203,355,931...203,360,270
G
Tm9sf4
transmembrane 9 superfamily member 4
decreases expression
ISO
trovafloxacin results in decreased expression of TM9SF4 mRNA
CTD
PMID:35537566
NCBI chr 3:141,627,128...141,675,386
Ensembl chr 3:141,627,346...141,675,386
G
Tmc8
transmembrane channel-like 8
decreases expression
ISO
trovafloxacin results in decreased expression of TMC8 mRNA
CTD
PMID:35537566
NCBI chr10:103,498,505...103,509,496
Ensembl chr10:102,998,402...103,010,590
G
Tmco4
transmembrane and coiled-coil domains 4
decreases expression
ISO
trovafloxacin results in decreased expression of TMCO4 mRNA
CTD
PMID:35537566
NCBI chr 5:151,216,499...151,294,726
Ensembl chr 5:151,216,812...151,294,723
G
Tmco5a
transmembrane and coiled-coil domains 5A
increases expression
ISO
trovafloxacin results in increased expression of TMCO5 mRNA
CTD
PMID:35537566
NCBI chr 3:103,732,936...103,746,242
Ensembl chr 3:103,732,945...103,746,249
G
Tmco6
transmembrane and coiled-coil domains 6
decreases expression
ISO
trovafloxacin results in decreased expression of TMCO6 mRNA
CTD
PMID:35537566
NCBI chr18:28,349,248...28,355,843
Ensembl chr18:28,349,248...28,355,843
G
Tmem106b
transmembrane protein 106B
increases expression
EXP
trovafloxacin results in increased expression of TMEM106B mRNA
CTD
PMID:24136188
NCBI chr 4:41,328,125...41,347,315
Ensembl chr 4:41,327,994...41,345,619
G
Tmem107
transmembrane protein 107
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM107 mRNA
CTD
PMID:35537566
NCBI chr10:53,772,153...53,774,685
Ensembl chr10:53,771,784...53,774,676
G
Tmem123
transmembrane protein 123
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM123 mRNA
CTD
PMID:35537566
NCBI chr 8:4,922,077...4,952,228
Ensembl chr 8:4,922,098...4,952,224
G
Tmem128
transmembrane protein 128
increases expression
ISO
trovafloxacin results in increased expression of TMEM128 mRNA
CTD
PMID:35537566
NCBI chr14:72,539,530...72,548,623
Ensembl chr14:72,539,532...72,548,550
G
Tmem144
transmembrane protein 144
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM144 mRNA
CTD
PMID:35537566
NCBI chr 2:164,960,649...164,993,562
Ensembl chr 2:164,961,247...164,992,368
G
Tmem158
transmembrane protein 158
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM158 mRNA
CTD
PMID:35537566
NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:122,913,675...122,914,673
G
Tmem171
transmembrane protein 171
increases expression
ISO
trovafloxacin results in increased expression of TMEM171 mRNA
CTD
PMID:35537566
NCBI chr 2:30,035,278...30,045,996
Ensembl chr 2:30,035,278...30,045,049
G
Tmem191c
transmembrane protein 191C
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM191C mRNA
CTD
PMID:35537566
NCBI chr11:83,726,155...83,728,926
Ensembl chr11:83,725,185...83,730,172
G
Tmem209
transmembrane protein 209
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM209 mRNA
CTD
PMID:35537566
NCBI chr 4:59,102,943...59,128,636
Ensembl chr 4:59,101,550...59,128,630
G
Tmem216
transmembrane protein 216
increases expression
ISO
trovafloxacin results in increased expression of TMEM216 mRNA
CTD
PMID:35537566
NCBI chr 1:207,196,454...207,201,704
Ensembl chr 1:207,196,454...207,201,754
G
Tmem221
transmembrane protein 221
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM221 mRNA
CTD
PMID:35537566
NCBI chr16:18,253,622...18,271,094
Ensembl chr16:18,262,052...18,266,967
G
Tmem260
transmembrane protein 260
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM260 mRNA
CTD
PMID:35537566
NCBI chr15:21,734,119...21,804,049
Ensembl chr15:21,734,151...21,806,801
G
Tmem267
transmembrane protein 267
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM267 mRNA
CTD
PMID:35537566
NCBI chr 2:51,580,210...51,588,937
Ensembl chr 2:51,581,252...51,587,636
G
Tmem41a
transmembrane protein 41a
decreases expression
EXP
trovafloxacin results in decreased expression of TMEM41A mRNA
CTD
PMID:24136188
NCBI chr11:79,084,005...79,090,613
Ensembl chr11:79,084,001...79,090,613
G
Tmem71
transmembrane protein 71
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM71 mRNA
CTD
PMID:35537566
NCBI chr 7:98,276,975...98,323,161
Ensembl chr 7:98,276,975...98,315,858
G
Tmem74
transmembrane protein 74
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM74 mRNA
CTD
PMID:35537566
NCBI chr 7:76,814,000...76,822,633
Ensembl chr 7:74,931,694...74,937,934
G
Tmem79
transmembrane protein 79
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM79 mRNA
CTD
PMID:35537566
NCBI chr 2:173,798,267...173,803,151
Ensembl chr 2:173,798,267...173,803,046
G
Tmem94
transmembrane protein 94
decreases expression
ISO
trovafloxacin results in decreased expression of TMEM94 mRNA
CTD
PMID:35537566
NCBI chr10:100,991,523...101,027,046
Ensembl chr10:100,991,573...101,027,394
G
Tmod4
tropomodulin 4
increases expression
ISO
trovafloxacin results in increased expression of TMOD4 mRNA
CTD
PMID:35537566
NCBI chr 2:182,695,709...182,700,540
Ensembl chr 2:182,695,709...182,700,540
G
Tmpo
thymopoietin
decreases expression
EXP ISO
trovafloxacin results in decreased expression of TMPO mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:25,586,725...25,667,727
G
Tmx2
thioredoxin-related transmembrane protein 2
decreases expression
EXP
trovafloxacin results in decreased expression of TMX2 mRNA
CTD
PMID:24136188
NCBI chr 3:69,754,937...69,762,587
Ensembl chr 3:69,754,939...69,762,587
G
Tmx4
thioredoxin-related transmembrane protein 4
increases expression
EXP
trovafloxacin results in increased expression of TMX4 mRNA
CTD
PMID:24136188
NCBI chr 3:121,856,237...121,899,680
Ensembl chr 3:121,856,261...121,899,641
G
Tnf
tumor necrosis factor
multiple interactions increases response to substance decreases uptake increases secretion increases expression decreases expression
ISO EXP
4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; [IFNG protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin; [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to trovafloxacin; [TNF protein co-treated with IL6 protein co-treated with IL1B protein] promotes the reaction [trovafloxacin results in increased activity of CASP3 protein]; [TNF protein co-treated with trovafloxacin] results in increased activity of CASP3 protein; [TNF protein co-treated with trovafloxacin] results in increased expression of H2AX protein modified form; [trovafloxacin co-treated with [TNF protein co-treated with IL6 protein co-treated with IL1B protein]] results in increased activity of CASP3 protein; [trovafloxacin co-treated with TNF protein] results in decreased expression of ATG4C mRNA; [trovafloxacin co-treated with TNF protein] results in decreased expression of BIRC2 mRNA; [trovafloxacin co-treated with TNF protein] results in decreased expression of SNX4 mRNA; [trovafloxacin co-treated with TNF protein] results in decreased expression of XIAP mRNA; [trovafloxacin co-treated with TNF protein] results in increased activity of CASP3 protein; [trovafloxacin co-treated with TNF protein] results in increased activity of CASP8 protein; [trovafloxacin co-treated with TNF protein] results in increased activity of CASP9 protein; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG10 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG16L1 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG2A mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG3 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ATG4A mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of BIRC3 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of GABARAPL1 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of ICAM1 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of MAP1LC3B mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of NFKBIA mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 protein; [trovafloxacin co-treated with TNF protein] results in increased expression of ULK2 mRNA; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of and results in increased activity of ATR protein; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of MAPK1 protein; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of MAPK3 protein; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of RPS6KB1 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased expression of H2AX protein modified form]; Sirolimus inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of EIF4EBP1 protein]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG14 mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG5 mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of GABARAPL2 mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3A mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3B2 mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3C mRNA]; TNF protein inhibits the reaction [trovafloxacin results in increased expression of RB1CC1 mRNA]; TNF protein promotes the reaction [trovafloxacin results in increased expression of ATG9B mRNA]; TNF protein promotes the reaction [trovafloxacin results in increased expression of H2AX protein modified form]; TNF protein promotes the reaction [trovafloxacin results in increased phosphorylation of AKT1 protein]; trovafloxacin affects the reaction [TNF protein affects the localization of RELA protein modified form]; trovafloxacin affects the reaction [TNF protein results in increased phosphorylation of RELA protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of ATG9B mRNA]; U 0126 inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased activity of CASP3 protein] TNF protein results in increased susceptibility to trovafloxacin trovafloxacin results in decreased uptake of TNF protein 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased expression of and results in increased stability of TNF mRNA]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased expression of TNF protein]; [Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of TNF mRNA; [Pentoxifylline results in decreased expression of TNF mRNA] results in decreased susceptibility to [lipopolysaccharide, E coli O55-B5 co-treated with trovafloxacin]; [TNF protein co-treated with trovafloxacin] results in increased cleavage of CASP3 protein; [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TNF protein; [trovafloxacin co-treated with TNF protein] results in decreased expression of NFKBIA protein; IFNG protein promotes the reaction [[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TNF protein]; pyrazolanthrone inhibits the reaction [trovafloxacin promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; pyrazolanthrone inhibits the reaction [trovafloxacin results in increased expression of TNF mRNA]; TNF protein affects the susceptibility to [lipopolysaccharide, E coli O55-B5 co-treated with trovafloxacin]; TNF protein results in increased susceptibility to [Lipopolysaccharides co-treated with trovafloxacin]; trovafloxacin inhibits the reaction [TNF protein results in increased expression of BIRC2 mRNA]; trovafloxacin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; trovafloxacin promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]; trovafloxacin promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of CCL2 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of CXCL1 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of CXCL2 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IFNG protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IL18 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IL1B protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of IL6 protein]; trovafloxacin promotes the reaction [TNF protein results in increased expression of NFKBIA mRNA]; trovafloxacin promotes the reaction [TNF protein results in increased expression of TNFAIP3 mRNA]; trovafloxacin results in increased expression of and results in increased stability of TNF mRNA; U 0126 inhibits the reaction [trovafloxacin promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; U 0126 inhibits the reaction [trovafloxacin results in increased expression of TNF mRNA] trovafloxacin results in increased secretion of TNF protein trovafloxacin results in increased susceptibility to TNF protein trovafloxacin results in increased expression of TNF mRNA; trovafloxacin results in increased expression of TNF protein trovafloxacin results in decreased expression of TNF
CTD
PMID:17709330 PMID:18930950 PMID:19362101 PMID:19638433 PMID:24097668 PMID:24136188 PMID:24525298 PMID:24817034 PMID:25748550 PMID:30876886 PMID:32035082 PMID:33609687 PMID:35537566 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions increases expression
ISO
[Lipopolysaccharides co-treated with trovafloxacin] results in increased expression of TNFAIP3 mRNA; [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of TNFAIP3 mRNA; trovafloxacin promotes the reaction [TNF protein results in increased expression of TNFAIP3 mRNA] trovafloxacin results in increased expression of TNFAIP3 mRNA; trovafloxacin results in increased expression of TNFAIP3 protein [trovafloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 mRNA; [trovafloxacin co-treated with TNF protein] results in increased expression of TNFAIP3 protein
CTD
PMID:18930950 PMID:32035082 PMID:35537566
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip8l1
TNF alpha induced protein 8 like 1
decreases expression
ISO
trovafloxacin results in decreased expression of TNFAIP8L1 mRNA
CTD
PMID:35537566
NCBI chr 9:988,587...999,342
Ensembl chr 9:988,594...1,002,254
G
Tnfrsf11a
TNF receptor superfamily member 11A
increases expression
ISO
trovafloxacin results in increased expression of TNFRSF11A mRNA
CTD
PMID:35537566
NCBI chr13:22,442,930...22,501,257
Ensembl chr13:21,928,408...21,986,695
G
Tnfrsf4
TNF receptor superfamily member 4
increases expression
ISO
trovafloxacin results in increased expression of TNFRSF4 mRNA
CTD
PMID:35537566
NCBI chr 5:171,889,134...171,891,824
Ensembl chr 5:166,606,909...166,609,599
G
Tnfrsf9
TNF receptor superfamily member 9
decreases expression
ISO
trovafloxacin results in decreased expression of TNFRSF9 mRNA
CTD
PMID:35537566
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf13
TNF superfamily member 13
increases expression
ISO
trovafloxacin results in increased expression of TNFSF13 mRNA
CTD
PMID:35537566
NCBI chr10:54,898,805...54,901,815
Ensembl chr10:54,400,065...54,403,042
G
Tnfsf14
TNF superfamily member 14
decreases expression
ISO
trovafloxacin results in decreased expression of TNFSF14 mRNA
CTD
PMID:35537566
NCBI chr 9:2,155,270...2,160,100
Ensembl chr 9:2,069,104...2,073,216
G
Tnfsf18
TNF superfamily member 18
decreases expression
ISO
trovafloxacin results in decreased expression of TNFSF18 mRNA
CTD
PMID:35537566
NCBI chr13:73,833,478...73,907,249
Ensembl chr13:73,831,252...73,843,169
G
Tnip3
TNFAIP3 interacting protein 3
increases expression
ISO
trovafloxacin results in increased expression of TNIP3 mRNA
CTD
PMID:35537566
NCBI chr 4:94,867,258...94,908,780
Ensembl chr 4:94,811,097...94,907,605
G
Tnks1bp1
tankyrase 1 binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of TNKS1BP1 mRNA
CTD
PMID:35537566
NCBI chr 3:70,135,335...70,160,071
Ensembl chr 3:70,137,837...70,160,038
G
Tnnc1
troponin C1, slow skeletal and cardiac type
increases expression
ISO
trovafloxacin results in increased expression of TNNC1 mRNA
CTD
PMID:35537566
NCBI chr16:6,408,607...6,412,070
Ensembl chr16:6,402,171...6,405,634
G
Tns2
tensin 2
decreases expression
ISO
trovafloxacin results in decreased expression of TNS2 mRNA
CTD
PMID:35537566
NCBI chr 7:133,229,746...133,247,889
Ensembl chr 7:133,206,364...133,247,888
G
Tob2
transducer of ERBB2, 2
increases expression
EXP
trovafloxacin results in increased expression of TOB2 mRNA
CTD
PMID:24136188
NCBI chr 7:113,362,703...113,371,423
Ensembl chr 7:113,361,148...113,372,688
G
Tomm70
translocase of outer mitochondrial membrane 70
decreases expression
EXP
trovafloxacin results in decreased expression of TOMM70A mRNA
CTD
PMID:24136188
NCBI chr11:56,847,837...56,886,302
Ensembl chr11:43,377,216...43,417,202
G
Top2a
DNA topoisomerase II alpha
decreases activity decreases expression
ISO
trovafloxacin results in decreased activity of TOP2A protein trovafloxacin results in decreased expression of TOP2A mRNA
CTD
PMID:24817034 PMID:35537566
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874
G
Topbp1
DNA topoisomerase II binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of TOPBP1 mRNA
CTD
PMID:35537566
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
G
Tor1aip2
torsin 1A interacting protein 2
increases expression
ISO
trovafloxacin results in increased expression of TOR1AIP2 mRNA
CTD
PMID:35537566
NCBI chr13:68,225,226...68,256,536
Ensembl chr13:68,230,009...68,256,536 Ensembl chr13:68,230,009...68,256,536
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
trovafloxacin results in increased expression of TRP53INP1 mRNA
CTD
PMID:35537566
NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:24,260,568...24,267,968
G
Tpi1
triosephosphate isomerase 1
decreases expression
EXP
trovafloxacin results in decreased expression of TPI1 mRNA
CTD
PMID:24136188
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:157,615,386...157,619,541
G
Tpm3
tropomyosin 3
decreases expression
EXP
trovafloxacin results in decreased expression of TPM3 mRNA
CTD
PMID:24136188
NCBI chr 2:177,812,534...177,842,661
Ensembl chr 2:175,517,226...175,545,013
G
Tpst1
tyrosylprotein sulfotransferase 1
increases expression
EXP
trovafloxacin results in increased expression of TPST1 mRNA
CTD
PMID:24136188
NCBI chr12:26,544,536...26,605,706
Ensembl chr12:26,544,536...26,605,704
G
Tpx2
TPX2, microtubule nucleation factor
decreases expression
ISO
trovafloxacin results in decreased expression of TPX2 mRNA
CTD
PMID:35537566
NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
trovafloxacin results in increased expression of TRAF1 mRNA
CTD
PMID:35537566
NCBI chr 3:38,607,707...38,639,641
Ensembl chr 3:18,222,054...18,241,807
G
Traf2
Tnf receptor-associated factor 2
increases expression
ISO
trovafloxacin results in increased expression of TRAF2 mRNA
CTD
PMID:35537566
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:8,341,951...8,366,538
G
Traf3ip3
TRAF3 interacting protein 3
decreases expression
ISO
trovafloxacin results in decreased expression of TRAF3IP3 mRNA
CTD
PMID:35537566
NCBI chr13:104,694,802...104,719,655
Ensembl chr13:104,694,805...104,719,673
G
Trafd1
TRAF type zinc finger domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of TRAFD1 mRNA
CTD
PMID:35537566
NCBI chr12:35,165,606...35,179,525
Ensembl chr12:35,165,606...35,179,525
G
Traip
TRAF-interacting protein
decreases expression
ISO
trovafloxacin results in decreased expression of TRAIP mRNA
CTD
PMID:35537566
NCBI chr 8:108,641,860...108,661,640
Ensembl chr 8:108,641,852...108,661,638
G
Trak1
trafficking kinesin protein 1
increases expression
EXP
trovafloxacin results in increased expression of TRAK1 mRNA
CTD
PMID:24136188
NCBI chr 8:129,861,967...130,016,870
Ensembl chr 8:120,984,431...121,139,367
G
Triap1
TP53 regulated inhibitor of apoptosis 1
increases expression
ISO
trovafloxacin results in increased expression of TRIAP1 mRNA
CTD
PMID:35537566
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
G
Trib3
tribbles pseudokinase 3
decreases expression
ISO
trovafloxacin results in decreased expression of TRIB3 mRNA
CTD
PMID:35537566
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim11
tripartite motif-containing 11
increases expression
ISO
trovafloxacin results in increased expression of TRIM11 mRNA
CTD
PMID:35537566
NCBI chr10:43,758,299...43,771,138
Ensembl chr10:43,758,354...43,771,138
G
Trim21
tripartite motif-containing 21
increases expression
ISO
trovafloxacin results in increased expression of TRIM21 mRNA
CTD
PMID:35537566
NCBI chr 1:166,376,829...166,399,441
Ensembl chr 1:156,964,913...156,987,440
G
Trim25
tripartite motif-containing 25
increases expression
ISO
trovafloxacin results in increased expression of TRIM25 mRNA
CTD
PMID:35537566
NCBI chr10:74,310,024...74,328,473
Ensembl chr10:73,812,818...73,831,257
G
Trim26
tripartite motif-containing 26
increases expression
ISO
trovafloxacin results in increased expression of TRIM26 mRNA
CTD
PMID:35537566
NCBI chr20:1,708,297...1,731,176
Ensembl chr20:1,709,788...1,731,120
G
Trim34
tripartite motif-containing 34
increases expression
ISO
trovafloxacin results in increased expression of TRIM34A mRNA
CTD
PMID:35537566
NCBI chr 1:158,707,172...158,720,214
Ensembl chr 1:158,707,172...158,718,674
G
Trim37
tripartite motif-containing 37
decreases expression
ISO
trovafloxacin results in decreased expression of TRIM37 mRNA
CTD
PMID:35537566
NCBI chr10:71,943,384...72,075,563
Ensembl chr10:71,943,375...72,075,558
G
Trim39
tripartite motif-containing 39
increases expression
ISO
trovafloxacin results in increased expression of TRIM39 mRNA
CTD
PMID:35537566
NCBI chr20:2,003,320...2,017,175
Ensembl chr20:1,983,533...2,020,117
G
Trim45
tripartite motif-containing 45
decreases expression
ISO
trovafloxacin results in decreased expression of TRIM45 mRNA
CTD
PMID:35537566
NCBI chr 2:188,349,979...188,359,205
Ensembl chr 2:188,349,744...188,359,204
G
Trim46
tripartite motif-containing 46
decreases expression
ISO
trovafloxacin results in decreased expression of TRIM46 mRNA
CTD
PMID:35537566
NCBI chr 2:176,939,253...176,952,285
Ensembl chr 2:174,641,496...174,654,141
G
Trim47
tripartite motif-containing 47
decreases expression
ISO
trovafloxacin results in decreased expression of TRIM47 mRNA
CTD
PMID:35537566
NCBI chr10:101,337,573...101,342,044
Ensembl chr10:101,337,573...101,342,044
G
Trim7
tripartite motif-containing 7
increases expression
ISO
trovafloxacin results in increased expression of TRIM7 mRNA
CTD
PMID:35537566
NCBI chr10:33,205,491...33,221,482
Ensembl chr10:33,205,491...33,221,468
G
Trip13
thyroid hormone receptor interactor 13
decreases expression
ISO
trovafloxacin results in decreased expression of TRIP13 mRNA
CTD
PMID:35537566
NCBI chr 1:29,357,093...29,402,078
Ensembl chr 1:29,357,130...29,402,074
G
Trmt2a
tRNA methyltransferase 2 homolog A
increases expression
ISO
trovafloxacin results in increased expression of TRMT2A mRNA
CTD
PMID:35537566
NCBI chr11:82,737,689...82,742,423
Ensembl chr11:82,737,689...82,742,336
G
Trmt44
tRNA methyltransferase 44
increases expression
ISO
trovafloxacin results in increased expression of TRMT44 mRNA
CTD
PMID:35537566
NCBI chr14:75,175,331...75,204,291
Ensembl chr14:75,182,029...75,200,147
G
Trmu
tRNA mitochondrial 2-thiouridylase
decreases expression
ISO
trovafloxacin results in decreased expression of TRMU mRNA
CTD
PMID:35537566
NCBI chr 7:116,969,750...116,987,704
Ensembl chr 7:116,969,756...116,986,355
G
Troap
trophinin associated protein
decreases expression
ISO
trovafloxacin results in decreased expression of TROAP mRNA
CTD
PMID:35537566
NCBI chr 7:130,233,534...130,242,369
Ensembl chr 7:130,234,544...130,242,365
G
Trpt1
tRNA phosphotransferase 1
decreases expression
ISO
trovafloxacin results in decreased expression of TRPT1 mRNA
CTD
PMID:35537566
NCBI chr 1:204,186,295...204,191,294
Ensembl chr 1:204,186,295...204,191,294
G
Tsc22d3
TSC22 domain family, member 3
decreases expression
ISO
trovafloxacin results in decreased expression of TSC22D3 mRNA
CTD
PMID:35537566
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tshz1
teashirt zinc finger homeobox 1
decreases expression
ISO
trovafloxacin results in decreased expression of TSHZ1 mRNA
CTD
PMID:35537566
NCBI chr18:77,376,399...77,452,815
Ensembl chr18:77,377,394...77,453,509
G
Tsku
tsukushi, small leucine rich proteoglycan
increases expression
ISO
trovafloxacin results in increased expression of TSKU mRNA
CTD
PMID:35537566
NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
G
Tspan10
tetraspanin 10
decreases expression
ISO
trovafloxacin results in decreased expression of TSPAN10 mRNA
CTD
PMID:35537566
NCBI chr10:105,715,803...105,721,503
Ensembl chr10:105,715,961...105,719,813
G
Tspan13
tetraspanin 13
decreases expression
ISO
trovafloxacin results in decreased expression of TSPAN13 mRNA
CTD
PMID:35537566
NCBI chr 6:52,738,748...52,765,503
Ensembl chr 6:52,738,758...52,765,547
G
Tspoap1
TSPO associated protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of TSPOAP1 mRNA
CTD
PMID:35537566
NCBI chr10:73,053,414...73,083,640
Ensembl chr10:72,560,980...72,586,412
G
Tspyl2
TSPY-like 2
increases expression
ISO
trovafloxacin results in increased expression of TSPYL2 mRNA
CTD
PMID:35537566
NCBI chr X:24,918,851...24,924,462
Ensembl chr X:21,439,478...21,445,089
G
Tsr1
TSR1, ribosome maturation factor
increases expression
ISO
trovafloxacin results in increased expression of TSR1 mRNA
CTD
PMID:35537566
NCBI chr10:59,760,420...59,771,868
Ensembl chr10:59,760,409...59,771,864
G
Tssk4
testis-specific serine kinase 4
decreases expression
ISO
trovafloxacin results in decreased expression of TSSK4 mRNA
CTD
PMID:35537566
NCBI chr15:29,140,803...29,144,128
Ensembl chr15:29,141,792...29,144,128
G
Tst
thiosulfate sulfurtransferase
decreases expression
ISO
trovafloxacin results in decreased expression of TST mRNA
CTD
PMID:35537566
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
G
Tstd2
thiosulfate sulfurtransferase like domain containing 2
increases expression
ISO
trovafloxacin results in increased expression of TSTD2 mRNA
CTD
PMID:35537566
NCBI chr 5:60,371,751...60,415,916
Ensembl chr 5:60,393,454...60,415,916
G
Ttc28
tetratricopeptide repeat domain 28
decreases expression
ISO
trovafloxacin results in decreased expression of TTC28 mRNA
CTD
PMID:35537566
NCBI chr12:45,342,986...45,783,968
Ensembl chr12:45,345,399...45,783,547
G
Ttc3
tetratricopeptide repeat domain 3
decreases expression
ISO
trovafloxacin results in decreased expression of TTC3 mRNA
CTD
PMID:35537566
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Ttc39a
tetratricopeptide repeat domain 39A
decreases expression
ISO
trovafloxacin results in decreased expression of TTC39A mRNA
CTD
PMID:35537566
NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973
G
Ttc39b
tetratricopeptide repeat domain 39B
decreases expression
ISO
trovafloxacin results in decreased expression of TTC39B mRNA
CTD
PMID:35537566
NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:97,609,392...97,736,270
G
Ttc7a
tetratricopeptide repeat domain 7A
decreases expression
EXP ISO
trovafloxacin results in decreased expression of TTC7A mRNA trovafloxacin results in decreased expression of TTC7 mRNA
CTD
PMID:24136188 PMID:35537566
NCBI chr 6:7,159,285...7,261,826
Ensembl chr 6:7,159,061...7,261,892
G
Ttf2
transcription termination factor 2
decreases expression
ISO
trovafloxacin results in decreased expression of TTF2 mRNA
CTD
PMID:35537566
NCBI chr 2:188,366,321...188,397,750
Ensembl chr 2:188,366,331...188,397,689
G
Ttk
Ttk protein kinase
decreases expression
ISO
trovafloxacin results in decreased expression of TTK mRNA
CTD
PMID:35537566
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
G
Ttll3
tubulin tyrosine ligase like 3
increases expression
ISO
trovafloxacin results in increased expression of TTLL3 mRNA
CTD
PMID:35537566
NCBI chr 4:148,088,575...148,113,526
Ensembl chr 4:146,533,953...146,557,889
G
Ttll5
tubulin tyrosine ligase like 5
decreases expression
ISO
trovafloxacin results in decreased expression of TTLL5 mRNA
CTD
PMID:35537566
NCBI chr 6:111,214,048...111,431,892
Ensembl chr 6:105,483,191...105,700,934
G
Tuba1c
tubulin, alpha 1C
decreases expression
EXP
trovafloxacin results in decreased expression of TUBA1C mRNA
CTD
PMID:24136188
NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tuba4a
tubulin, alpha 4A
decreases expression
EXP
trovafloxacin results in decreased expression of TUBA4A mRNA
CTD
PMID:24136188
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
EXP
trovafloxacin results in decreased expression of TUBB2A mRNA
CTD
PMID:24136188
NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,747,503...30,800,714
G
Tubb4b
tubulin, beta 4B class IVb
multiple interactions decreases expression
ISO EXP
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of TUBB4B mRNA trovafloxacin results in decreased expression of TUBB4B mRNA
CTD
PMID:18930950 PMID:24136188
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
decreases expression
EXP
trovafloxacin results in decreased expression of TUBB5 mRNA
CTD
PMID:24136188
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tube1
tubulin, epsilon 1
decreases expression
ISO
trovafloxacin results in decreased expression of TUBE1 mRNA
CTD
PMID:35537566
NCBI chr20:42,552,390...42,570,324
Ensembl chr20:42,552,437...42,570,314
G
Tubg1
tubulin, gamma 1
decreases expression
ISO
trovafloxacin results in decreased expression of TUBG1 mRNA
CTD
PMID:35537566
NCBI chr10:86,052,845...86,059,436
Ensembl chr10:86,052,743...86,059,433
G
Tubgcp2
tubulin gamma complex component 2
decreases expression
ISO
trovafloxacin results in decreased expression of TUBGCP2 mRNA
CTD
PMID:35537566
NCBI chr 1:194,791,113...194,817,807
Ensembl chr 1:194,792,142...194,817,619
G
Tug1
taurine up-regulated 1
increases expression
ISO
trovafloxacin results in increased expression of TUG1 mRNA
CTD
PMID:35537566
NCBI chr14:82,743,501...82,750,534
Ensembl chr14:78,522,506...78,526,927
G
Tulp2
TUB like protein 2
increases expression
ISO
trovafloxacin results in increased expression of TULP2 mRNA
CTD
PMID:35537566
NCBI chr 1:95,962,496...95,999,775
Ensembl chr 1:95,962,496...96,000,628
G
Txlng
taxilin gamma
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of TXLNG mRNA
CTD
PMID:18930950
NCBI chr X:31,864,111...31,912,931
Ensembl chr X:31,864,111...31,912,926
G
Txndc15
thioredoxin domain containing 15
decreases expression
ISO
trovafloxacin results in decreased expression of TXNDC15 mRNA
CTD
PMID:35537566
NCBI chr17:8,898,074...8,910,538
Ensembl chr17:8,845,084...8,910,539 Ensembl chr 7:8,845,084...8,910,539
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
EXP
trovafloxacin results in decreased expression of UBE2C mRNA
CTD
PMID:24136188
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2g2
ubiquitin-conjugating enzyme E2G 2
increases expression
ISO
trovafloxacin results in increased expression of UBE2G2 mRNA
CTD
PMID:35537566
NCBI chr20:10,983,322...11,005,060
Ensembl chr20:10,983,742...11,005,447
G
Ube2i
ubiquitin-conjugating enzyme E2I
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of UBE2I mRNA
CTD
PMID:18930950
NCBI chr10:14,782,245...14,802,911
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Ube2t
ubiquitin-conjugating enzyme E2T
decreases expression
ISO
trovafloxacin results in decreased expression of UBE2T mRNA
CTD
PMID:35537566
NCBI chr13:46,403,352...46,413,854
Ensembl chr13:46,403,375...46,414,835
G
Ube3b
ubiquitin protein ligase E3B
decreases expression
ISO
trovafloxacin results in decreased expression of UBE3B mRNA
CTD
PMID:35537566
NCBI chr12:42,183,756...42,230,094
Ensembl chr12:42,183,760...42,230,094
G
Ube3d
ubiquitin protein ligase E3D
decreases expression
ISO
trovafloxacin results in decreased expression of UBE3D mRNA
CTD
PMID:35537566
NCBI chr 8:87,245,503...87,413,104
Ensembl chr 8:87,245,589...87,413,057
G
Ubqln1
ubiquilin 1
decreases expression
EXP
trovafloxacin results in decreased expression of UBQLN1 mRNA
CTD
PMID:24136188
NCBI chr17:6,438,456...6,482,498
Ensembl chr17:6,439,002...6,477,090
G
Ubxn6
UBX domain protein 6
decreases expression
ISO
trovafloxacin results in decreased expression of UBXN6 mRNA
CTD
PMID:35537566
NCBI chr 9:988,051...993,221
Ensembl chr 9:900,884...906,124
G
Uck1
uridine-cytidine kinase 1
increases expression
ISO
trovafloxacin results in increased expression of UCK1 mRNA
CTD
PMID:35537566
NCBI chr 3:15,538,580...15,544,465
Ensembl chr 3:15,538,591...15,544,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases expression
EXP
trovafloxacin results in decreased expression of UGT2B17 mRNA
CTD
PMID:24136188
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,024,006...21,035,986
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
decreases expression
ISO
trovafloxacin results in decreased expression of UHRF1 mRNA
CTD
PMID:35537566
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
G
Ulk1
unc-51 like autophagy activating kinase 1
increases expression
EXP
trovafloxacin results in increased expression of ULK1 mRNA
CTD
PMID:24136188
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:45,851,710...45,877,966
G
Ulk2
unc-51 like autophagy activating kinase 2
increases expression multiple interactions decreases expression
ISO
trovafloxacin results in increased expression of ULK2 mRNA [trovafloxacin co-treated with TNF protein] results in increased expression of ULK2 mRNA trovafloxacin results in decreased expression of ULK2 mRNA
CTD
PMID:33609687 PMID:35537566
NCBI chr10:46,951,038...47,029,844
Ensembl chr10:46,454,030...46,530,407
G
Ulk4
unc-51 like kinase 4
decreases expression
ISO
trovafloxacin results in decreased expression of ULK4 mRNA
CTD
PMID:35537566
NCBI chr 8:120,670,879...120,966,026
Ensembl chr 8:120,670,866...120,966,924
G
Umps
uridine monophosphate synthetase
decreases expression
EXP
trovafloxacin results in decreased expression of UMPS mRNA
CTD
PMID:24136188
NCBI chr11:80,311,269...80,321,678
Ensembl chr11:66,806,045...66,821,903
G
Unc119b
unc-119 lipid binding chaperone B
increases expression
ISO
trovafloxacin results in increased expression of UNC119B mRNA
CTD
PMID:35537566
NCBI chr12:41,478,808...41,491,432
Ensembl chr12:41,478,808...41,491,432
G
Unc5b
unc-5 netrin receptor B
decreases expression
ISO
trovafloxacin results in decreased expression of UNC5B mRNA
CTD
PMID:35537566
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Unkl
unk like zinc finger
increases expression
ISO
trovafloxacin results in increased expression of UNKL mRNA
CTD
PMID:35537566
NCBI chr10:14,206,125...14,252,226
Ensembl chr10:14,206,189...14,252,225
G
Upf1
UPF1, RNA helicase and ATPase
increases expression
ISO
trovafloxacin results in increased expression of UPF1 mRNA
CTD
PMID:35537566
NCBI chr16:19,076,594...19,097,365
Ensembl chr16:19,076,322...19,096,568
G
Upk1a
uroplakin 1A
increases expression
ISO
trovafloxacin results in increased expression of UPK1A mRNA
CTD
PMID:35537566
NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354
G
Upp1
uridine phosphorylase 1
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of UPP1 mRNA
CTD
PMID:18930950
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Uqcc1
ubiquinol-cytochrome c reductase complex assembly factor 1
increases expression
ISO
trovafloxacin results in increased expression of UQCC1 mRNA
CTD
PMID:35537566
NCBI chr 3:144,353,276...144,445,810
Ensembl chr 3:144,353,287...144,445,711
G
Urm1
ubiquitin related modifier 1
increases expression
ISO
trovafloxacin results in increased expression of URM1 mRNA
CTD
PMID:35537566
NCBI chr 3:13,100,340...13,117,064
Ensembl chr 3:13,092,200...13,117,642 Ensembl chr 3:13,092,200...13,117,642
G
Usp1
ubiquitin specific peptidase 1
decreases expression
ISO
trovafloxacin results in decreased expression of USP1 mRNA
CTD
PMID:35537566
NCBI chr 5:113,587,564...113,598,934
Ensembl chr 5:113,587,564...113,598,932
G
Usp18
ubiquitin specific peptidase 18
increases expression
ISO
trovafloxacin results in increased expression of USP18 mRNA
CTD
PMID:35537566
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Usp2
ubiquitin specific peptidase 2
decreases expression
ISO
trovafloxacin results in decreased expression of USP2 mRNA
CTD
PMID:35537566
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
G
Usp27x
ubiquitin specific peptidase 27, X-linked
increases expression
ISO
trovafloxacin results in increased expression of USP27X mRNA
CTD
PMID:35537566
NCBI chr X:17,795,506...17,798,741
Ensembl chr X:15,124,596...15,125,912
G
Usp39
ubiquitin specific peptidase 39
decreases expression
ISO
trovafloxacin results in decreased expression of USP39 mRNA
CTD
PMID:35537566
NCBI chr 4:104,373,948...104,406,359
Ensembl chr 4:104,373,955...104,406,359
G
Uspl1
ubiquitin specific peptidase like 1
increases expression
ISO
trovafloxacin results in increased expression of USPL1 mRNA
CTD
PMID:35537566
NCBI chr12:5,823,460...5,850,470
Ensembl chr12:5,823,359...5,850,366
G
Utrn
utrophin
decreases expression
ISO
trovafloxacin results in decreased expression of UTRN mRNA
CTD
PMID:35537566
NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:6,722,594...7,224,313
G
Vash1
vasohibin 1
decreases expression
ISO
trovafloxacin results in decreased expression of VASH1 mRNA
CTD
PMID:35537566
NCBI chr 6:106,330,374...106,345,740
Ensembl chr 6:106,329,123...106,345,726
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of VEGFA mRNA
CTD
PMID:18930950
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
increases expression
ISO
trovafloxacin results in increased expression of VEGFC mRNA
CTD
PMID:35537566
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:37,712,262...37,827,848
G
Vps13a
vacuolar protein sorting 13 homolog A
decreases expression
ISO
trovafloxacin results in decreased expression of VPS13A mRNA
CTD
PMID:35537566
NCBI chr 1:213,901,999...214,128,638
Ensembl chr 1:213,901,999...214,128,555
G
Vps13b
vacuolar protein sorting 13 homolog B
decreases expression
ISO
trovafloxacin results in decreased expression of VPS13B mRNA
CTD
PMID:35537566
NCBI chr 7:66,557,862...67,128,429
Ensembl chr 7:66,558,471...67,128,429
G
Vps13c
vacuolar protein sorting 13 homolog C
decreases expression
ISO
trovafloxacin results in decreased expression of VPS13C mRNA
CTD
PMID:35537566
NCBI chr 8:77,359,499...77,533,009
Ensembl chr 8:68,478,395...68,651,895
G
Vps16
VPS16 core subunit of CORVET and HOPS complexes
decreases expression
ISO
trovafloxacin results in decreased expression of VPS16 mRNA
CTD
PMID:35537566
NCBI chr 3:138,075,649...138,097,154
Ensembl chr 3:117,622,542...117,646,441
G
Vsig8
V-set and immunoglobulin domain containing 8
increases expression
ISO
trovafloxacin results in increased expression of VSIG8 mRNA
CTD
PMID:35537566
NCBI chr13:85,023,177...85,031,364
Ensembl chr13:85,023,177...85,031,364
G
Vwa8
von Willebrand factor A domain containing 8
decreases expression
ISO
trovafloxacin results in decreased expression of VWA8 mRNA
CTD
PMID:35537566
NCBI chr15:54,252,703...54,576,871
Ensembl chr15:54,252,584...54,576,870
G
Wbp1l
WW domain binding protein 1-like
increases expression
EXP
trovafloxacin results in increased expression of WBP1L mRNA
CTD
PMID:24136188
NCBI chr 1:245,472,292...245,528,627
Ensembl chr 1:245,472,296...245,528,627
G
Wdfy4
WDFY family member 4
decreases expression
ISO
trovafloxacin results in decreased expression of WDFY4 mRNA
CTD
PMID:35537566
NCBI chr16:8,221,853...8,450,494
Ensembl chr16:8,221,719...8,450,491
G
Wdhd1
WD repeat and HMG-box DNA binding protein 1
decreases expression
ISO
trovafloxacin results in decreased expression of WDHD1 mRNA
CTD
PMID:35537566
NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096
G
Wdpcp
WD repeat containing planar cell polarity effector
decreases expression
ISO
trovafloxacin results in decreased expression of WDPCP mRNA
CTD
PMID:35537566
NCBI chr14:99,847,463...100,178,392
Ensembl chr14:95,646,038...95,977,113
G
Wdr11
WD repeat domain 11
decreases expression
ISO
trovafloxacin results in decreased expression of WDR11 mRNA
CTD
PMID:35537566
NCBI chr 1:193,595,606...193,641,149
Ensembl chr 1:184,165,571...184,210,846
G
Wdr45b
WD repeat domain 45B
increases expression
ISO
trovafloxacin results in increased expression of WDR45B mRNA
CTD
PMID:35537566
NCBI chr10:107,097,655...107,127,839
Ensembl chr10:106,599,364...106,629,441
G
Wdr62
WD repeat domain 62
decreases expression
ISO
trovafloxacin results in decreased expression of WDR62 mRNA
CTD
PMID:35537566
NCBI chr 1:85,491,531...85,530,643
Ensembl chr 1:85,491,533...85,530,637
G
Wdr76
WD repeat domain 76
decreases expression
ISO
trovafloxacin results in decreased expression of WDR76 mRNA
CTD
PMID:35537566
NCBI chr 3:108,456,784...108,491,528
Ensembl chr 3:108,456,815...108,490,840
G
Wdr86
WD repeat domain 86
increases expression
ISO
trovafloxacin results in increased expression of WDR86 mRNA
CTD
PMID:35537566
NCBI chr 4:10,423,496...10,443,473
Ensembl chr 4:10,424,008...10,441,465
G
Wdr90
WD repeat domain 90
decreases expression
ISO
trovafloxacin results in decreased expression of WDR90 mRNA
CTD
PMID:35537566
NCBI chr10:14,864,672...14,881,285
Ensembl chr10:14,864,670...14,881,292
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
trovafloxacin results in decreased expression of WEE1 mRNA
CTD
PMID:35537566
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wfikkn1
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
increases expression
ISO
trovafloxacin results in increased expression of WFIKKN1 mRNA
CTD
PMID:35537566
NCBI chr10:14,896,442...14,898,770
Ensembl chr10:14,896,378...14,899,863
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
decreases expression
ISO
trovafloxacin results in decreased expression of WIPI1 mRNA
CTD
PMID:33609687
NCBI chr10:95,042,451...95,079,679
Ensembl chr10:94,542,946...94,579,846
G
Wnt2b
Wnt family member 2B
decreases expression
ISO
trovafloxacin results in decreased expression of WNT2B mRNA
CTD
PMID:35537566
NCBI chr 2:195,142,573...195,156,945
Ensembl chr 2:192,453,824...192,470,308
G
Wrn
WRN RecQ like helicase
decreases expression
ISO
trovafloxacin results in decreased expression of WRN mRNA
CTD
PMID:35537566
NCBI chr16:65,466,552...65,602,951
Ensembl chr16:58,763,504...58,895,450
G
Xaf1
XIAP associated factor 1
increases expression
ISO
trovafloxacin results in increased expression of XAF1 mRNA
CTD
PMID:35537566
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Xbp1
X-box binding protein 1
increases expression
EXP
trovafloxacin results in increased expression of XBP1 mRNA
CTD
PMID:24136188
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xdh
xanthine dehydrogenase
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of XDH mRNA
CTD
PMID:18930950
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions decreases expression
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of XIAP mRNA trovafloxacin results in decreased expression of XIAP mRNA [trovafloxacin co-treated with TNF protein] results in decreased expression of XIAP mRNA
CTD
PMID:18930950 PMID:32035082
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Xkr5
XK related 5
decreases expression
ISO
trovafloxacin results in decreased expression of XKR5 mRNA
CTD
PMID:35537566
NCBI chr16:70,874,983...70,892,972
Ensembl chr16:70,875,093...70,892,967
G
Xpnpep2
X-prolyl aminopeptidase 2
decreases expression
EXP
trovafloxacin results in decreased expression of XPNPEP2 mRNA
CTD
PMID:24136188
NCBI chr X:127,287,765...127,317,036
Ensembl chr X:127,287,979...127,317,223
G
Xpo1
exportin 1
decreases expression
EXP
trovafloxacin results in decreased expression of XPO1 mRNA
CTD
PMID:24136188
NCBI chr14:101,434,450...101,476,705
Ensembl chr14:97,233,270...97,275,498
G
Xpot
exportin for tRNA
decreases expression
ISO
trovafloxacin results in decreased expression of XPOT mRNA
CTD
PMID:35537566
NCBI chr 7:57,111,536...57,152,013
Ensembl chr 7:57,111,536...57,152,099
G
Xylt2
xylosyltransferase 2
increases expression
ISO
trovafloxacin results in increased expression of XYLT2 mRNA
CTD
PMID:35537566
NCBI chr10:80,102,776...80,116,346
Ensembl chr10:79,606,007...79,619,391
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
EXP
trovafloxacin results in decreased expression of YARS1 mRNA
CTD
PMID:24136188
NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:141,535,759...141,563,833
G
Ydjc
YdjC chitooligosaccharide deacetylase homolog
decreases expression
ISO
trovafloxacin results in decreased expression of YDJC mRNA
CTD
PMID:35537566
NCBI chr11:83,832,177...83,844,691
Ensembl chr11:83,841,306...83,846,336
G
Ykt6
YKT6 v-SNARE homolog
increases expression
ISO
trovafloxacin results in increased expression of YKT6 mRNA
CTD
PMID:35537566
NCBI chr14:80,832,187...80,843,394
Ensembl chr14:80,832,187...80,843,385
G
Ypel3
yippee-like 3
increases expression
EXP
trovafloxacin results in increased expression of YPEL3 mRNA
CTD
PMID:24136188
NCBI chr 1:181,384,385...181,387,706
Ensembl chr 1:181,384,357...181,387,705
G
Ypel5
yippee-like 5
increases expression
EXP
trovafloxacin results in increased expression of YPEL5 mRNA
CTD
PMID:24136188
NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691
G
Yy2
YY2 transcription factor
increases expression
ISO
trovafloxacin results in increased expression of YY2 mRNA
CTD
PMID:35537566
NCBI chr X:37,438,425...37,442,047
Ensembl chr X:37,410,811...37,464,430
G
Zan
zonadhesin
decreases expression
ISO
trovafloxacin results in decreased expression of ZAN mRNA
CTD
PMID:35537566
NCBI chr12:19,215,018...19,322,789
Ensembl chr12:19,215,102...19,271,240
G
Zbed5
zinc finger BED-type containing 5
increases expression
ISO
trovafloxacin results in increased expression of ZBED5 mRNA
CTD
PMID:35537566
NCBI chr12:26,807,652...26,813,706
Ensembl chr12:26,807,600...26,813,664
G
Zbp1
Z-DNA binding protein 1
increases expression
ISO
trovafloxacin results in increased expression of ZBP1 mRNA
CTD
PMID:35537566
NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870
G
Zbtb48
zinc finger and BTB domain containing 48
increases expression
ISO
trovafloxacin results in increased expression of ZBTB48 mRNA
CTD
PMID:35537566
NCBI chr 5:162,525,234...162,533,604
Ensembl chr 5:162,525,235...162,533,585
G
Zbtb49
zinc finger and BTB domain containing 49
increases expression
ISO
trovafloxacin results in increased expression of ZBTB49 mRNA
CTD
PMID:35537566
NCBI chr14:72,590,692...72,612,404
Ensembl chr14:72,590,708...72,612,404
G
Zc2hc1c
zinc finger, C2HC-type containing 1C
increases expression
ISO
trovafloxacin results in increased expression of ZC2HC1C mRNA
CTD
PMID:35537566
NCBI chr 6:104,932,631...104,941,555
Ensembl chr 6:104,932,631...104,941,554
G
Zc3h12c
zinc finger CCCH type containing 12C
increases expression
ISO
trovafloxacin results in increased expression of ZC3H12C mRNA
CTD
PMID:35537566
NCBI chr 8:52,443,791...52,508,643
Ensembl chr 8:52,448,320...52,504,315
G
Zc3h6
zinc finger CCCH type containing 6
decreases expression
ISO
trovafloxacin results in decreased expression of ZC3H6 mRNA
CTD
PMID:35537566
NCBI chr 3:116,203,466...116,254,186
Ensembl chr 3:116,204,197...116,253,282
G
Zcchc24
zinc finger CCHC-type containing 24
decreases expression
ISO
trovafloxacin results in decreased expression of ZCCHC24 mRNA
CTD
PMID:35537566
NCBI chr16:1,274,544...1,326,664
Ensembl chr16:1,274,548...1,326,696
G
Zcwpw1
zinc finger CW-type and PWWP domain containing 1
decreases expression
ISO
trovafloxacin results in decreased expression of ZCWPW1 mRNA
CTD
PMID:35537566
NCBI chr12:18,880,625...18,910,713
Ensembl chr12:18,880,633...18,910,711
G
Zfand2a
zinc finger AN1-type containing 2A
increases expression
ISO
trovafloxacin results in increased expression of ZFAND2A mRNA
CTD
PMID:35537566
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfand4
zinc finger AN1-type containing 4
decreases expression
ISO
trovafloxacin results in decreased expression of ZFAND4 mRNA
CTD
PMID:35537566
NCBI chr 4:149,327,339...149,399,495
Ensembl chr 4:149,327,412...149,399,487
G
Zfand5
zinc finger AN1-type containing 5
multiple interactions
ISO
[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ZFAND5 mRNA
CTD
PMID:18930950
NCBI chr 1:218,765,735...218,780,391
Ensembl chr 1:218,766,614...218,775,843
G
Zfp142
zinc finger protein 142
increases expression
ISO
trovafloxacin results in increased expression of ZFP142 mRNA
CTD
PMID:35537566
NCBI chr 9:76,141,053...76,164,784
Ensembl chr 9:76,142,227...76,164,856
G
Zfp157
zinc finger protein 157
increases expression
ISO
trovafloxacin results in increased expression of ZFP157 mRNA
CTD
PMID:35537566
NCBI chr12:21,356,253...21,393,006
Ensembl chr12:16,248,230...16,270,698
G
Zfp2
zinc finger protein 2
increases expression
ISO
trovafloxacin results in increased expression of ZFP2 mRNA
CTD
PMID:35537566
NCBI chr10:35,209,187...35,228,849
Ensembl chr10:35,207,260...35,228,853
G
Zfp263
zinc finger protein 263
increases expression
ISO
trovafloxacin results in increased expression of ZFP263 mRNA
CTD
PMID:35537566
NCBI chr10:11,764,424...11,774,324
Ensembl chr10:11,764,427...11,771,235
G
Zfp275
zinc finger protein 275
increases expression
ISO
trovafloxacin results in increased expression of ZFP275 mRNA
CTD
PMID:35537566
NCBI chr X:151,057,530...151,074,392
Ensembl chr X:151,057,573...151,074,276
G
Zfp334
zinc finger protein 334
increases expression
ISO
trovafloxacin results in increased expression of ZFP334 mRNA
CTD
PMID:35537566
NCBI chr 3:154,112,537...154,125,087
Ensembl chr 3:154,113,561...154,125,057
G
Zfp346
zinc finger protein 346
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP346 mRNA
CTD
PMID:35537566
NCBI chr17:9,493,787...9,523,681
Ensembl chr17:9,493,803...9,523,635
G
Zfp36
zinc finger protein 36
increases expression
ISO
trovafloxacin results in increased expression of ZFP36 mRNA
CTD
PMID:35537566
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564
G
Zfp420
zinc finger protein 420
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP420 mRNA
CTD
PMID:35537566
NCBI chr 1:85,092,810...85,143,682
Ensembl chr 1:85,132,520...85,143,679
G
Zfp422
zinc finger protein 422
increases expression
ISO
trovafloxacin results in increased expression of ZFP422 mRNA
CTD
PMID:35537566
NCBI chr 4:149,885,805...149,893,287
Ensembl chr 4:149,885,600...149,893,257
G
Zfp449
zinc finger protein 449
increases expression
ISO
trovafloxacin results in increased expression of ZFP449 mRNA
CTD
PMID:35537566
NCBI chr X:134,120,820...134,140,921
Ensembl chr X:134,122,636...134,140,924
G
Zfp457
zinc finger protein 457
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP457 mRNA
CTD
PMID:35537566
NCBI chr 2:84,625,360...84,642,535
Ensembl chr 2:84,608,705...84,684,942
G
Zfp462
zinc finger protein 462
increases expression
ISO
trovafloxacin results in increased expression of ZFP462 mRNA
CTD
PMID:35537566
NCBI chr 5:69,670,085...69,810,729
Ensembl chr 5:69,670,328...69,810,327
G
Zfp469
zinc finger protein 469
increases expression
ISO
trovafloxacin results in increased expression of ZFP469 mRNA
CTD
PMID:35537566
NCBI chr19:50,282,337...50,324,010
G
Zfp473
zinc finger protein 473
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP473 mRNA
CTD
PMID:35537566
NCBI chr 1:95,222,683...95,243,328
Ensembl chr 1:95,223,433...95,243,325
G
Zfp513
zinc finger protein 513
increases expression
ISO
trovafloxacin results in increased expression of ZFP513 mRNA
CTD
PMID:35537566
NCBI chr 6:25,174,181...25,177,442
Ensembl chr 6:25,174,178...25,177,439
G
Zfp551
zinc finger protein 551
increases expression
ISO
trovafloxacin results in increased expression of ZFP551 mRNA
CTD
PMID:35537566
NCBI chr 1:72,543,815...72,554,060
Ensembl chr 1:72,540,108...72,554,071
G
Zfp574
zinc finger protein 574
increases expression
ISO
trovafloxacin results in increased expression of ZFP574 mRNA
CTD
PMID:35537566
NCBI chr 1:80,667,984...80,678,257
Ensembl chr 1:80,664,259...80,679,427
G
Zfp579
zinc finger protein 579
increases expression
ISO
trovafloxacin results in increased expression of ZFP579 mRNA
CTD
PMID:35537566
NCBI chr 1:68,847,547...68,850,751
Ensembl chr 1:68,847,500...68,850,751
G
Zfp58
zinc finger protein 58
increases expression
ISO
trovafloxacin results in increased expression of ZFP58 mRNA
CTD
PMID:35537566
NCBI chr 1:35,020,477...35,053,203
Ensembl chr 1:35,002,321...35,033,216
G
Zfp580
zinc finger protein 580
decreases expression
ISO
trovafloxacin results in decreased expression of ZFP580 mRNA
CTD
PMID:35537566
NCBI chr 1:68,787,118...68,789,286
Ensembl chr 1:68,787,118...68,789,286
G
Zfp599
zinc finger protein 599
increases expression
ISO
trovafloxacin results in increased expression of ZFP599 mRNA
CTD
PMID:35537566
NCBI chr 8:20,756,257...20,772,683
Ensembl chr 8:20,757,584...20,772,663
G
Zfp619
zinc finger protein 619
increases expression
ISO
trovafloxacin results in increased expression of ZFP619 mRNA
CTD
PMID:35537566
NCBI chr 1:91,148,016...91,167,764
Ensembl chr 1:91,148,121...91,166,403
G
Zfp629
zinc finger protein 629
increases expression
ISO
trovafloxacin results in increased expression of ZFP629 mRNA
CTD
PMID:35537566
NCBI chr 1:182,217,499...182,258,585
Ensembl chr 1:182,210,935...182,230,016
G
Zfp748
zinc finger protein 748
increases expression
ISO
trovafloxacin results in increased expression of ZFP748 mRNA
CTD
PMID:35537566
NCBI chr 1:35,075,408...35,091,416
Ensembl chr 1:35,074,172...35,091,389
G
Zfp768
zinc finger protein 768
increases expression
ISO
trovafloxacin results in increased expression of ZFP768 mRNA
CTD
PMID:35537566
NCBI chr 1:181,966,314...181,968,950
Ensembl chr 1:181,966,316...181,969,147
G
Zfp770
zinc finger protein 770
increases expression
ISO
trovafloxacin results in increased expression of ZFP770 mRNA
CTD
PMID:35537566
NCBI chr 3:100,963,430...100,971,663
Ensembl chr 3:100,963,427...100,971,684
G
Zfp791
zinc finger protein 791
increases expression
ISO
trovafloxacin results in increased expression of ZFP791 mRNA
CTD
PMID:35537566
NCBI chr19:23,018,418...23,033,580
Ensembl chr19:23,018,918...23,033,504
G
Zfp799
zinc finger protein 799
increases expression
ISO
trovafloxacin results in increased expression of ZFP799 mRNA
CTD
PMID:35537566
NCBI chr 7:11,894,224...11,910,809
Ensembl chr 7:11,898,149...11,910,798
G
Zfp84
zinc finger protein 84
increases expression
ISO
trovafloxacin results in increased expression of ZFP84 mRNA
CTD
PMID:35537566
NCBI chr 1:84,987,352...85,015,478
Ensembl chr 1:85,004,920...85,015,478 Ensembl chr 1:85,004,920...85,015,478
G
Zfp870
zinc finger protein 870
increases expression
ISO
trovafloxacin results in increased expression of ZFP870 mRNA
CTD
PMID:35537566
NCBI chr 7:11,990,146...12,003,813
Ensembl chr 7:11,990,148...12,003,813
G
Zfp955b
zinc finger protein 955B
increases expression
ISO
trovafloxacin results in increased expression of ZFP955B mRNA
CTD
PMID:35537566
NCBI chr 7:12,610,224...12,625,537
Ensembl chr 7:12,610,196...12,622,587
G
Zfta
zinc finger translocation associated
increases expression
ISO
trovafloxacin results in increased expression of ZFTA mRNA
CTD
PMID:35537566
NCBI chr 1:204,604,557...204,612,688
Ensembl chr 1:204,604,103...204,612,688
G
Zglp1
zinc finger, GATA-like protein 1
increases expression
ISO
trovafloxacin results in increased expression of ZGLP1 mRNA
CTD
PMID:35537566
NCBI chr 8:19,599,871...19,604,762
Ensembl chr 8:19,599,998...19,604,547
G
Zmat3
zinc finger, matrin type 3
increases expression
ISO
trovafloxacin results in increased expression of ZMAT3 mRNA
CTD
PMID:35537566
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
G
Znf408
zinc finger protein 408
increases expression
ISO
trovafloxacin results in increased expression of ZFP408 mRNA
CTD
PMID:35537566
NCBI chr 3:77,615,595...77,621,325
Ensembl chr 3:77,616,808...77,621,055
G
Znf780b
zinc finger protein 780B
increases expression
ISO
trovafloxacin results in increased expression of ZFP780B mRNA
CTD
PMID:35537566
NCBI chr 1:92,136,761...92,159,076
Ensembl chr 1:83,009,189...83,082,107
G
Znfx1
zinc finger, NFX1-type containing 1
increases expression
ISO
trovafloxacin results in increased expression of ZNFX1 mRNA
CTD
PMID:35537566
NCBI chr 3:155,764,073...155,791,777
Ensembl chr 3:155,764,980...155,821,242
G
Znrd2
zinc ribbon domain containing 2
increases expression
ISO
trovafloxacin results in increased expression of ZNRD2 mRNA
CTD
PMID:35537566
NCBI chr 1:203,017,682...203,019,465
Ensembl chr 1:203,017,682...203,019,465
G
Zscan25
zinc finger and SCAN domain containing 25
increases expression
ISO
trovafloxacin results in increased expression of ZSCAN25 mRNA
CTD
PMID:35537566
NCBI chr12:9,327,347...9,338,206
Ensembl chr12:9,326,404...9,338,221
G
Zscan30
zinc finger and SCAN domain containing 30
increases expression
ISO
trovafloxacin results in increased expression of ZSCAN30 mRNA
CTD
PMID:35537566
NCBI chr18:15,245,140...15,266,204
Ensembl chr18:15,244,379...15,264,632
G
Zwilch
zwilch kinetochore protein
decreases expression
ISO
trovafloxacin results in decreased expression of ZWILCH mRNA
CTD
PMID:35537566
NCBI chr 8:64,638,401...64,670,911
Ensembl chr 8:64,637,672...64,675,916
G
Zxdb
zinc finger, X-linked, duplicated B
increases expression
ISO
trovafloxacin results in increased expression of ZXDB mRNA
CTD
PMID:35537566
NCBI chr X:59,700,765...59,706,737
Ensembl chr X:59,701,178...59,703,871 Ensembl chr X:59,701,178...59,703,871
G
Zxdc
ZXD family zinc finger C
increases expression
ISO
trovafloxacin results in increased expression of ZXDA mRNA
CTD
PMID:35537566
NCBI chr 4:122,882,389...122,914,486
Ensembl chr 4:122,882,336...122,916,496
G
Zyg11a
zyg-11 family member A, cell cycle regulator
decreases expression
ISO
trovafloxacin results in decreased expression of ZYG11A mRNA
CTD
PMID:35537566
NCBI chr 5:122,935,439...122,973,766
Ensembl chr 5:122,937,136...122,973,649
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions
ISO
vosaroxin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein]]
CTD
PMID:29800573
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:182,997,736...183,056,580
G
Casp3
caspase 3
increases activity
ISO
vosaroxin results in increased activity of CASP3 protein
CTD
PMID:29800573
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions decreases expression
ISO
dorsomorphin inhibits the reaction [vosaroxin results in decreased expression of HIF1A protein]; SIRT3 protein inhibits the reaction [vosaroxin results in decreased expression of HIF1A protein]; vosaroxin inhibits the reaction [Oxygen deficiency affects the localization of HIF1A protein]; vosaroxin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein]]
CTD
PMID:29800573
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
increases activity multiple interactions
ISO
vosaroxin results in increased activity of IDH2 protein SIRT2 protein affects the reaction [vosaroxin results in increased activity of IDH2 protein]
CTD
PMID:29800573
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Sirt2
sirtuin 2
multiple interactions
ISO
SIRT2 protein affects the reaction [vosaroxin results in increased activity of IDH2 protein]; SIRT2 protein affects the reaction [vosaroxin results in increased activity of SOD2 protein]
CTD
PMID:29800573
NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:84,052,903...84,076,975
G
Sirt3
sirtuin 3
multiple interactions
ISO
SIRT3 protein inhibits the reaction [vosaroxin results in decreased expression of HIF1A protein]
CTD
PMID:29800573
NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:195,942,073...195,964,808
G
Sod2
superoxide dismutase 2
increases activity multiple interactions
ISO
vosaroxin results in increased activity of SOD2 protein SIRT2 protein affects the reaction [vosaroxin results in increased activity of SOD2 protein]
CTD
PMID:29800573
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19904
chemical entity
19902
molecular entity
19901
mancude ring
11345
organic mancude parent
11345
mancude organic heterocyclic parent
11345
mancude organic heterobicyclic parent
8378
naphthyridine
2258
1,8-naphthyridine
1914
1,8-naphthyridine derivative
1914
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid +
0
enoxacin
4
gemifloxacin +
0
nalidixic acid
2
trovafloxacin
1907
vosaroxin
7
Path 2
CHEBI ontology
19904
subatomic particle
19902
composite particle
19902
hadron
19902
baryon
19902
nucleon
19902
atomic nucleus
19902
atom
19902
main group element atom
19841
p-block element atom
19841
carbon group element atom
19779
carbon atom
19776
organic molecular entity
19776
organic molecule
19730
organic cyclic compound
19522
organic heterocyclic compound
18896
organic heteropolycyclic compound
18320
organic heterobicyclic compound
17261
mancude organic heterobicyclic parent
8378
naphthyridine
2258
1,8-naphthyridine
1914
1,8-naphthyridine derivative
1914
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid +
0
enoxacin
4
gemifloxacin +
0
nalidixic acid
2
trovafloxacin
1907
vosaroxin
7